_id,cohorts.0.id,cohorts.0.label,dataUseConditions.id,dataUseConditions.label,description,histologicalDiagnosis.id,histologicalDiagnosis.label,icdoMorphology.id,icdoMorphology.label,icdoTopography.id,icdoTopography.label,id,individualAgeAtCollection,individualId,info.callsetIds.0,info.cnvstatistics.cnvcoverage,info.cnvstatistics.cnvfraction,info.cnvstatistics.delcoverage,info.cnvstatistics.delfraction,info.cnvstatistics.dupcoverage,info.cnvstatistics.dupfraction,info.legacyId.0,pathologicalStage,provenance.geoLocation.geometry.coordinates.0,provenance.geoLocation.geometry.coordinates.1,provenance.geoLocation.geometry.type,provenance.geoLocation.properties.ISO3166alpha3,provenance.geoLocation.properties.city,provenance.geoLocation.properties.country,provenance.geoLocation.properties.label,provenance.geoLocation.properties.latitude,provenance.geoLocation.properties.longitude,provenance.geoLocation.properties.precision,provenance.geoLocation.type,provenance.material.id,provenance.material.label,sampledTissue.id,sampledTissue.label,tumorGrade,updated,externalReferences.0.id,externalReferences.0.label,info.death,info.followupMonths,tumorGrade.id,tumorGrade.label,info.tnm,pathologicalStage.id,pathologicalStage.label,pathologicalTnmFindings.0.id,pathologicalTnmFindings.0.label,pathologicalTnmFindings.1.id,pathologicalTnmFindings.1.label,cohorts.1.id,cohorts.1.label,info.legacyId.1,info.cnvstatistics,info.callsetIds.1,externalReferences.1.id,externalReferences.1.label,externalReferences.0.description,histologicalDiagnosis.description,icdoMorphology.description,icdoTopography.description,info.grade,info.histone,info.location,info.methylation,info.mgmt,info.months,info.provenance,info.sampling,info.status,externalReferences.1.description,externalReferences.2.description,externalReferences.2.id,externalReferences.2.label,cohorts.2.id,cohorts.2.label,info.tumorStage,cohorts.3.id,cohorts.3.label,cohorts.4.id,cohorts.4.label,externalReferences.3.description,externalReferences.3.id,externalReferences.3.label,externalReferences.4.description,externalReferences.4.id,externalReferences.4.label,provenance.populations.0.confidence,provenance.populations.0.description,provenance.populations.0.type.id,provenance.populations.0.type.label,provenance.populations.1.confidence,provenance.populations.1.description,provenance.populations.1.type.id,provenance.populations.1.type.label,info.cellLine,info.samplesource,info.seer,projectId,sex
5bab56c2727983b2e00abf78,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ependymoma [4th ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgngl,P1Y,pgxind-kftx2ejj,pgxcs-kftvnkr5,218617371,0.076,201817354,0.07,16800017,0.006,PGX_AM_BS_20192643_PB-far-21,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.473000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac462,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Left cerebral],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp1t,P5Y,pgxind-kftx2gil,pgxcs-kftvo1xi,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB1044,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.211000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac463,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp1u,P33Y,pgxind-kftx2gin,pgxcs-kftvo1xy,783226021,0.272,0,0,783226021,0.272,PGX_AM_BS_19865800_EP-rou-NB1144,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.213000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac464,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp1w,P17Y,pgxind-kftx2gip,pgxcs-kftvo1yf,2200654895,0.765,1431087354,0.498,769567541,0.268,PGX_AM_BS_19865800_EP-rou-NB1239,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.214000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac465,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp1y,P32Y,pgxind-kftx2gir,pgxcs-kftvo1yw,1916797912,0.667,989467593,0.344,927330319,0.323,PGX_AM_BS_19865800_EP-rou-NB1270,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.215000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac466,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [dorsal],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp1z,P42Y,pgxind-kftx2git,pgxcs-kftvo1zd,1627420936,0.566,872322058,0.303,755098878,0.263,PGX_AM_BS_19865800_EP-rou-NB1320,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.217000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac467,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [spinal cord],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp21,P38Y,pgxind-kftx2giv,pgxcs-kftvo1zv,1554725418,0.541,546802545,0.19,1007922873,0.351,PGX_AM_BS_19865800_EP-rou-NB1374,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.218000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac469,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp25,P47Y,pgxind-kftx2giz,pgxcs-kftvo20t,1623986349,0.565,867552251,0.302,756434098,0.263,PGX_AM_BS_19865800_EP-rou-NB1654,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.221000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac46a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp26,P6Y,pgxind-kftx2gj1,pgxcs-kftvo21a,2463935209,0.857,1271763610,0.442,1192171599,0.415,PGX_AM_BS_19865800_EP-rou-NB166,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.223000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac46b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp28,P36Y,pgxind-kftx2gj3,pgxcs-kftvo21s,1112928963,0.387,37891471,0.013,1075037492,0.374,PGX_AM_BS_19865800_EP-rou-NB1820,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.224000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac46c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cervical],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2a,P24Y,pgxind-kftx2gj5,pgxcs-kftvo229,294856134,0.103,136034551,0.047,158821583,0.055,PGX_AM_BS_19865800_EP-rou-NB1838,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.225000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac46d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Suprasellar],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2b,P21Y,pgxind-kftx2gj7,pgxcs-kftvo22q,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB1865,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.227000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac46f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2f,P40Y,pgxind-kftx2gjb,pgxcs-kftvo23n,2059049869,0.716,1323355021,0.46,735694848,0.256,PGX_AM_BS_19865800_EP-rou-NB1867,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.229000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac471,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2i,P42Y,pgxind-kftx2gjf,pgxcs-kftvo24m,1149605863,0.4,45200045,0.016,1104405818,0.384,PGX_AM_BS_19865800_EP-rou-NB1870,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.232000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac472,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Conus],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2k,P47Y,pgxind-kftx2gjh,pgxcs-kftvo253,1117002651,0.389,37891471,0.013,1079111180,0.375,PGX_AM_BS_19865800_EP-rou-NB1871,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.234000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac473,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2l,P20Y,pgxind-kftx2gjj,pgxcs-kftvo25k,1087159081,0.378,133797556,0.047,953361525,0.332,PGX_AM_BS_19865800_EP-rou-NB189,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.235000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac474,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [Conus],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2n,P33Y,pgxind-kftx2gjl,pgxcs-kftvo261,1096135546,0.381,307341460,0.107,788794086,0.274,PGX_AM_BS_19865800_EP-rou-NB1899,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.236000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac477,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp2s,P8Y,pgxind-kftx2gjs,pgxcs-kftvo27g,170649890,0.059,0,0,170649890,0.059,PGX_AM_BS_19865800_EP-rou-NB192,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.241000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac478,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cervical],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2t,P45Y,pgxind-kftx2gju,pgxcs-kftvo27x,1115699662,0.388,226803228,0.079,888896434,0.309,PGX_AM_BS_19865800_EP-rou-NB1950,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.242000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac47a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Temporal],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2x,P49Y,pgxind-kftx2gjy,pgxcs-kftvo28v,906910029,0.315,401484134,0.14,505425895,0.176,PGX_AM_BS_19865800_EP-rou-NB1974,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.245000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac47b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp2y,P20Y,pgxind-kftx2gk0,pgxcs-kftvo29b,1864283118,0.648,1114661447,0.388,749621671,0.261,PGX_AM_BS_19865800_EP-rou-NB2000,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.246000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac47c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,subependymoma [both lateral ventricles],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp30,P55Y,pgxind-kftx2gk2,pgxcs-kftvo29s,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB2004,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.248000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac47d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cerebellum],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp31,P2Y6M,pgxind-kftx2gk4,pgxcs-kftvo2a9,546697277,0.19,50627305,0.018,496069972,0.173,PGX_AM_BS_19865800_EP-rou-NB207,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.249000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac47e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cervical],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp33,P67Y,pgxind-kftx2gk6,pgxcs-kftvo2aq,437749191,0.152,437749191,0.152,0,0,PGX_AM_BS_19865800_EP-rou-NB217,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.250000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac480,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [left occipital],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp36,P2Y,pgxind-kftx2gka,pgxcs-kftvo2bo,270394861,0.094,147445018,0.051,122949843,0.043,PGX_AM_BS_19865800_EP-rou-NB231,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.253000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac481,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp38,P44Y,pgxind-kftx2gkc,pgxcs-kftvo2c4,730556459,0.254,328271054,0.114,402285405,0.14,PGX_AM_BS_19865800_EP-rou-NB333,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.254000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac482,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,subependymoma [left lateral ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp39,P38Y,pgxind-kftx2gke,pgxcs-kftvo2cl,278308917,0.097,96817713,0.034,181491204,0.063,PGX_AM_BS_19865800_EP-rou-NB341,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.256000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac483,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [cervical],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3b,P38Y,pgxind-kftx2gkg,pgxcs-kftvo2d2,1708056309,0.594,772650845,0.269,935405464,0.325,PGX_AM_BS_19865800_EP-rou-NB464,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.257000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac485,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp3e,P2Y6M,pgxind-kftx2gkk,pgxcs-kftvo2e0,268088625,0.093,0,0,268088625,0.093,PGX_AM_BS_19865800_EP-rou-NB527,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.260000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac486,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [right cerebral],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3g,P22Y,pgxind-kftx2gkm,pgxcs-kftvo2eh,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB550,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.261000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac487,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [dorsal],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3h,P27Y,pgxind-kftx2gko,pgxcs-kftvo2ey,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB590,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.263000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac488,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Conus],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp3j,P40Y,pgxind-kftx2gkq,pgxcs-kftvo2ff,1501449085,0.522,625970963,0.218,875478122,0.305,PGX_AM_BS_19865800_EP-rou-NB633,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.264000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac489,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Left cerebral],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3l,P5Y,pgxind-kftx2gks,pgxcs-kftvo2fw,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB649,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.266000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac48a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [right temporo-parieto-occipital junction],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3m,P66Y,pgxind-kftx2gku,pgxcs-kftvo2gd,247249967,0.086,124300124,0.043,122949843,0.043,PGX_AM_BS_19865800_EP-rou-NB651,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.267000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac48c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp3p,P15Y,pgxind-kftx2gky,pgxcs-kftvo2hb,1720109523,0.598,576536877,0.201,1143572646,0.398,PGX_AM_BS_19865800_EP-rou-NB677,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.270000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac48e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [cauda equina],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvgp3t,P43Y,pgxind-kftx2gl3,pgxcs-kftvo2i9,643019059,0.224,0,0,643019059,0.224,PGX_AM_BS_19865800_EP-rou-NB983,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:15.273000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxq9,P13Y4M,pgxind-kftx2rcj,pgxcs-kftvqqk0,611701500,0.213,373015942,0.13,238685558,0.083,PGX_AM_BS_EPD-mod-01,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.785000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqa,P26Y,pgxind-kftx2rcl,pgxcs-kftvqqkh,10740015,0.004,10740015,0.004,0,0,PGX_AM_BS_EPD-mod-02,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.786000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqc,P2Y5M,pgxind-kftx2rcn,pgxcs-kftvqqky,732137034,0.255,325846614,0.113,406290420,0.141,PGX_AM_BS_EPD-mod-03,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.787000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqd,P3Y8M,pgxind-kftx2rcp,pgxcs-kftvqqlf,545207034,0.19,357736839,0.124,187470195,0.065,PGX_AM_BS_EPD-mod-04,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.789000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqh,P3Y10M,pgxind-kftx2rct,pgxcs-kftvqqmd,369474269,0.129,290734186,0.101,78740083,0.027,PGX_AM_BS_EPD-mod-06,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.792000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf72,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxql,P4Y4M,pgxind-kftx2rcz,pgxcs-kftvqqnu,527577972,0.184,318307756,0.111,209270216,0.073,PGX_AM_BS_EPD-mod-09,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.796000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf73,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqn,P11Y,pgxind-kftx2rd1,pgxcs-kftvqqob,450745788,0.157,384615718,0.134,66130070,0.023,PGX_AM_BS_EPD-mod-10,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.797000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf75,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqq,P3Y2M,pgxind-kftx2rd6,pgxcs-kftvqqp9,1066180458,0.371,555699930,0.193,510480528,0.178,PGX_AM_BS_EPD-mod-12,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.800000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf76,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqs,P14Y6M,pgxind-kftx2rd8,pgxcs-kftvqqpq,362982308,0.126,231235550,0.08,131746758,0.046,PGX_AM_BS_EPD-mod-13,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.801000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf77,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqt,P1Y2M,pgxind-kftx2rda,pgxcs-kftvqqq7,499266982,0.174,316566791,0.11,182700191,0.064,PGX_AM_BS_EPD-mod-14,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.803000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf78,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqv,P12Y,pgxind-kftx2rdc,pgxcs-kftvqqqo,291060306,0.101,98810106,0.034,192250200,0.067,PGX_AM_BS_EPD-mod-15,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.804000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf7a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqz,P2Y11M,pgxind-kftx2rdg,pgxcs-kftvqqrn,51190058,0.018,51190058,0.018,0,0,PGX_AM_BS_EPD-mod-17,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.807000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf7d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxr3,P1Y10M,pgxind-kftx2rdm,pgxcs-kftvqqt2,299420323,0.104,183170195,0.064,116250128,0.04,PGX_AM_BS_EPD-mod-20,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.811000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7ac,P4Y,pgxind-kftx32vo,pgxcs-kftvtlwa,516207829,0.18,0,0,516207829,0.18,PGX_AM_BS_ClinEpend-01,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.398000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7af,P4Y10M,pgxind-kftx32vs,pgxcs-kftvtlx9,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-03,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.401000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ah,P8Y7M,pgxind-kftx32vu,pgxcs-kftvtlxq,174749894,0.061,0,0,174749894,0.061,PGX_AM_BS_ClinEpend-04,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.402000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ai,P5Y7M,pgxind-kftx32vw,pgxcs-kftvtly7,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-05,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.404000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7am,P4Y10M,pgxind-kftx32w0,pgxcs-kftvtlz6,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-07,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.406000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7an,P3Y11M,pgxind-kftx32w2,pgxcs-kftvtlzn,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-08,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.408000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ap,P11Y6M,pgxind-kftx32w4,pgxcs-kftvtm04,261344699,0.091,0,0,261344699,0.091,PGX_AM_BS_ClinEpend-09,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.409000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ar,P4Y2M,pgxind-kftx32w6,pgxcs-kftvtm0l,132506112,0.046,132506112,0.046,0,0,PGX_AM_BS_ClinEpend-10,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.410000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc4e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7av,P9Y11M,pgxind-kftx32wc,pgxcs-kftvtm2b,291303130,0.101,92236057,0.032,199067073,0.069,PGX_AM_BS_ClinEpend-13,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.415000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc4f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ax,P5Y4M,pgxind-kftx32we,pgxcs-kftvtm2s,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-14,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.416000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc52,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b2,P4Y6M,pgxind-kftx32wl,pgxcs-kftvtm48,240044857,0.083,94906075,0.033,145138782,0.05,PGX_AM_BS_ClinEpend-17,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.420000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b7,P11Y10M,pgxind-kftx32wr,pgxcs-kftvtm5o,1337286975,0.465,379700801,0.132,957586174,0.333,PGX_AM_BS_ClinEpend-20,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.424000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bf,P1Y4M,pgxind-kftx32x1,pgxcs-kftvtm83,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-25,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.432000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bg,P2Y6M,pgxind-kftx32x3,pgxcs-kftvtm8k,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-26,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.433000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bi,P2Y7M,pgxind-kftx32x5,pgxcs-kftvtm92,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-27,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.434000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bl,P2Y5M,pgxind-kftx32x9,pgxcs-kftvtma0,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-29,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.437000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7bp,P2Y10M,pgxind-kftx32xd,pgxcs-kftvtmay,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-31,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.440000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bs,P2Y2M,pgxind-kftx32xh,pgxcs-kftvtmbw,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-33,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.442000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc64,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bv,P9Y10M,pgxind-kftx32xl,pgxcs-kftvtmcu,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-35,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.445000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc69,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7c3,P1Y2M,pgxind-kftx32xw,pgxcs-kftvtmhi,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-40,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.452000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7c5,P1Y6M,pgxind-kftx32xy,pgxcs-kftvtmhz,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-41,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.453000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7c7,P1Y6M,pgxind-kftx32y0,pgxcs-kftvtmig,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-42,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.455000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wf,P6Y,pgxind-kftx33n9,pgxcs-kftvtss4,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-006,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.075000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe33,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7ws,P10Y,pgxind-kftx33nq,pgxcs-kftvtsvy,751176501,0.261,591726807,0.206,159449694,0.055,PGX_AM_BS_Ependymoma-195,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.086000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",0,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wt,P3Y,pgxind-kftx33ns,pgxcs-kftvtswf,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-217,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.087000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7ww,P3Y1M,pgxind-kftx33nw,pgxcs-kftvtsxe,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-232,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.090000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",0,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afe3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7x3,P10Y,pgxind-kftx33o4,pgxcs-kftvtsza,774118643,0.269,167602164,0.058,606516479,0.211,PGX_AM_BS_Ependymoma-282,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.096000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0235,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, supratentorial]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh975,P28Y,pgxind-kftx359n,pgxcs-kftvu770,761006547,0.265,435009718,0.151,325996829,0.113,PGX_AM_BS_Epend-car-03,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.498000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0238,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97a,P6Y6M,pgxind-kftx359u,pgxcs-kftvu78i,0,0,0,0,0,0,PGX_AM_BS_Epend-car-06,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.502000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b023a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97d,P26Y,pgxind-kftx359y,pgxcs-kftvu79g,1987103362,0.691,0,0,1987103362,0.691,PGX_AM_BS_Epend-car-08,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.505000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b023c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97g,P18Y,pgxind-kftx35a2,pgxcs-kftvu7ah,0,0,0,0,0,0,PGX_AM_BS_Epend-car-10,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.508000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b023f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97l,P5Y11M,pgxind-kftx35a8,pgxcs-kftvu7dz,0,0,0,0,0,0,PGX_AM_BS_Epend-car-13,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.512000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0242,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97q,P44Y,pgxind-kftx35ae,pgxcs-kftvu7ff,1443235253,0.502,0,0,1443235253,0.502,PGX_AM_BS_Epend-car-16,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.516000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0246,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97w,P67Y,pgxind-kftx35am,pgxcs-kftvu7hf,334542374,0.116,334542374,0.116,0,0,PGX_AM_BS_Epend-car-20,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.522000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0248,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, supratentorial]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh97z,P35Y,pgxind-kftx35aq,pgxcs-kftvu7ie,0,0,0,0,0,0,PGX_AM_BS_Epend-car-22,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.524000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b024d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh988,P34Y,pgxind-kftx35b1,pgxcs-kftvu7kt,1765193872,0.614,0,0,1765193872,0.614,PGX_AM_BS_Epend-car-27,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.531000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b024f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh98b,P36Y,pgxind-kftx35b5,pgxcs-kftvu7ls,0,0,0,0,0,0,PGX_AM_BS_Epend-car-29,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.534000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0250,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh98d,P38Y,pgxind-kftx35b7,pgxcs-kftvu7ma,0,0,0,0,0,0,PGX_AM_BS_Epend-car-30,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.536000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0251,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh98e,P3Y5M,pgxind-kftx35b9,pgxcs-kftvu7ms,0,0,0,0,0,0,PGX_AM_BS_Epend-car-31,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.537000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0257,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh98o,P46Y,pgxind-kftx35bl,pgxcs-kftvu7pp,1725743341,0.6,20893551,0.007,1704849790,0.593,PGX_AM_BS_Epend-car-37,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.546000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,224,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0258,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh98q,P54Y,pgxind-kftx35bn,pgxcs-kftvu7q6,1527182839,0.531,25391458,0.009,1501791381,0.522,PGX_AM_BS_Epend-car-38,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.547000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b025c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh98w,P29Y,pgxind-kftx35bv,pgxcs-kftvu7s9,1104844433,0.384,145138782,0.05,959705651,0.334,PGX_AM_BS_Epend-car-42,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.553000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b025d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh98y,P45Y,pgxind-kftx35bx,pgxcs-kftvu7sq,931865755,0.324,49691482,0.017,882174273,0.307,PGX_AM_BS_Epend-car-43,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.554000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b025e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh990,P44Y,pgxind-kftx35bz,pgxcs-kftvu7t7,163834577,0.057,163834577,0.057,0,0,PGX_AM_BS_Epend-car-44,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.556000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0260,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh993,P35Y,pgxind-kftx35c4,pgxcs-kftvu7u6,1468472922,0.511,0,0,1468472922,0.511,PGX_AM_BS_Epend-car-46,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.558000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,145,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0263,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh998,P24Y,pgxind-kftx35ca,pgxcs-kftvu7vm,1976845386,0.688,0,0,1976845386,0.688,PGX_AM_BS_Epend-car-49,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.563000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0267,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh99f,P29Y,pgxind-kftx35ci,pgxcs-kftvu7xl,0,0,0,0,0,0,PGX_AM_BS_Epend-car-53,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.568000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0268,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh99h,P61Y,pgxind-kftx35ck,pgxcs-kftvu7y2,1082100495,0.376,74568661,0.026,1007531834,0.35,PGX_AM_BS_Epend-car-54,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.570000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b026a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, supratentorial]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh99k,P28Y,pgxind-kftx35co,pgxcs-kftvu7z0,0,0,0,0,0,0,PGX_AM_BS_Epend-car-56,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.572000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b026b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh99l,P29Y,pgxind-kftx35cq,pgxcs-kftvu7zi,208513065,0.073,49691482,0.017,158821583,0.055,PGX_AM_BS_Epend-car-57,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.574000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b026d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh99p,P32Y,pgxind-kftx35cu,pgxcs-kftvu80h,1124017054,0.391,0,0,1124017054,0.391,PGX_AM_BS_Epend-car-59,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.577000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b026e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh99q,P32Y,pgxind-kftx35cw,pgxcs-kftvu80z,1155301607,0.402,49691482,0.017,1105610125,0.385,PGX_AM_BS_Epend-car-60,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.578000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0271,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh99v,P61Y,pgxind-kftx35d2,pgxcs-kftvu82f,228033623,0.079,228033623,0.079,0,0,PGX_AM_BS_Epend-car-63,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.582000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0272,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh99x,P17Y,pgxind-kftx35d4,pgxcs-kftvu82w,1012622796,0.352,0,0,1012622796,0.352,PGX_AM_BS_Epend-car-64,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.584000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0274,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, supratentorial]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh9a0,P6Y5M,pgxind-kftx35d8,pgxcs-kftvu83v,0,0,0,0,0,0,PGX_AM_BS_Epend-car-66,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.586000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0278,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, supratentorial]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh9a6,P1Y10M,pgxind-kftx35dg,pgxcs-kftvu85r,0,0,0,0,0,0,PGX_AM_BS_Epend-car-70,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.592000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b027b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh9ab,P3Y10M,pgxind-kftx35dm,pgxcs-kftvu877,216447359,0.075,93497516,0.033,122949843,0.043,PGX_AM_BS_Epend-car-73,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.596000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0281,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh9al,P2Y11M,pgxind-kftx35dz,pgxcs-kftvu8a2,216447359,0.075,93497516,0.033,122949843,0.043,PGX_AM_BS_Epend-car-79,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.604000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0282,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh9an,P4Y6M,pgxind-kftx35e1,pgxcs-kftvu8ak,216447359,0.075,93497516,0.033,122949843,0.043,PGX_AM_BS_Epend-car-80,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.606000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0287,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh9av,P47Y,pgxind-kftx35eb,pgxcs-kftvu8cy,1496224629,0.52,331613314,0.115,1164611315,0.405,PGX_AM_BS_Epend-car-85,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.613000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0288,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh9ax,P50Y,pgxind-kftx35ed,pgxcs-kftvu8df,1221710073,0.425,49691482,0.017,1172018591,0.408,PGX_AM_BS_Epend-car-86,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.614000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf79,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ependymoma [temporal],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgngn,P15Y,pgxind-kftx2ejl,pgxcs-kftvnkrm,661088958,0.23,338200337,0.118,322888621,0.112,PGX_AM_BS_20192643_PB-far-22,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.474000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf7a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ependymoma [4th ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgngp,P10Y,pgxind-kftx2ejn,pgxcs-kftvnks3,1733613705,0.603,973802794,0.339,759810911,0.264,PGX_AM_BS_20192643_PB-far-23,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.475000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac468,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Medulla],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgp23,P83Y,pgxind-kftx2gix,pgxcs-kftvo20c,346963085,0.121,346963085,0.121,0,0,PGX_AM_BS_19865800_EP-rou-NB1653,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:15.220000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac470,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp2g,P14Y,pgxind-kftx2gjd,pgxcs-kftvo245,303498179,0.106,246923380,0.086,56574799,0.02,PGX_AM_BS_19865800_EP-rou-NB187,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.231000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac475,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [left temporo-parieto-occipital junction],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2p,P53Y,pgxind-kftx2gjn,pgxcs-kftvo26i,998600818,0.347,0,0,998600818,0.347,PGX_AM_BS_19865800_EP-rou-NB1917,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.238000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac476,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Right temp and parietal],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp2q,P25Y,pgxind-kftx2gjp,pgxcs-kftvo26z,1821194823,0.633,563321118,0.196,1257873705,0.438,PGX_AM_BS_19865800_EP-rou-NB1919,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.239000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac479,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [Posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp2v,P14Y,pgxind-kftx2gjw,pgxcs-kftvo28e,0,0,0,0,0,0,PGX_AM_BS_19865800_EP-rou-NB196,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.243000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac484,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [right lateral ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgp3d,P37Y,pgxind-kftx2gki,pgxcs-kftvo2dj,1644530731,0.572,829980164,0.289,814550567,0.283,PGX_AM_BS_19865800_EP-rou-NB513,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:15.259000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac48d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [fourth ventricle],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgp3r,P31Y,pgxind-kftx2gl0,pgxcs-kftvo2hs,2093545089,0.728,882028848,0.307,1211516241,0.421,PGX_AM_BS_19865800_EP-rou-NB705,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.271000,PMID:19865800,"Rousseau A, Idbaih A et al. (2010): Specific chromosomal imbalances as detected by...",1,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00adf6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqf,P1Y10M,pgxind-kftx2rcr,pgxcs-kftvqqlx,312289169,0.109,197589048,0.069,114700121,0.04,PGX_AM_BS_EPD-mod-05,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.790000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf70,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqi,P2Y10M,pgxind-kftx2rcv,pgxcs-kftvqqmv,608247098,0.212,469276952,0.163,138970146,0.048,PGX_AM_BS_EPD-mod-07,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.793000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf71,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqk,P5Y4M,pgxind-kftx2rcx,pgxcs-kftvqqnc,1101759970,0.383,362365688,0.126,739394282,0.257,PGX_AM_BS_EPD-mod-08,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.795000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf74,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqp,P1Y8M,pgxind-kftx2rd3,pgxcs-kftvqqos,148980155,0.052,115250120,0.04,33730035,0.012,PGX_AM_BS_EPD-mod-11,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.799000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf79,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxqx,P0Y10M,pgxind-kftx2rde,pgxcs-kftvqqr6,344605411,0.12,218555280,0.076,126050131,0.044,PGX_AM_BS_EPD-mod-16,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.805000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf7b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxr0,P1Y10M,pgxind-kftx2rdi,pgxcs-kftvqqs4,419434324,0.146,289964189,0.101,129470135,0.045,PGX_AM_BS_EPD-mod-18,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.808000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00adf7c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [infratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgxr2,P2Y,pgxind-kftx2rdk,pgxcs-kftvqqsl,396419258,0.138,203989060,0.071,192430198,0.067,PGX_AM_BS_EPD-mod-19,{},9.19,45.46,Point,ITA,Milano,Italy,"Milano, Italy",45.46,9.19,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.810000,PMID:17114655,"Modena P, Lualdi E et al. (2006): Identification of tumor-specific molecular signatures in...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7ad,P6Y1M,pgxind-kftx32vq,pgxcs-kftvtlwr,434117878,0.151,200697622,0.07,233420256,0.081,PGX_AM_BS_ClinEpend-02,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.399000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,182,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ak,P11Y4M,pgxind-kftx32vy,pgxcs-kftvtlyo,596342809,0.207,29938946,0.01,566403863,0.197,PGX_AM_BS_ClinEpend-06,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.405000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7as,P3Y10M,pgxind-kftx32w8,pgxcs-kftvtm1c,406483481,0.141,0,0,406483481,0.141,PGX_AM_BS_ClinEpend-11,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.412000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7au,P12Y8M,pgxind-kftx32wa,pgxcs-kftvtm1t,769170945,0.268,274995834,0.096,494175111,0.172,PGX_AM_BS_ClinEpend-12,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.413000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7az,P5Y11M,pgxind-kftx32wh,pgxcs-kftvtm3a,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-15,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.417000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b0,P8Y7M,pgxind-kftx32wj,pgxcs-kftvtm3r,216447359,0.075,93497516,0.033,122949843,0.043,PGX_AM_BS_ClinEpend-16,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.419000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b4,P12Y6M,pgxind-kftx32wn,pgxcs-kftvtm4q,233688730,0.081,177113931,0.062,56574799,0.02,PGX_AM_BS_ClinEpend-18,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.422000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc54,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b5,P4Y5M,pgxind-kftx32wp,pgxcs-kftvtm57,210543461,0.073,87593618,0.03,122949843,0.043,PGX_AM_BS_ClinEpend-19,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.423000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7b8,P10Y8M,pgxind-kftx32wt,pgxcs-kftvtm65,1994379329,0.694,1192173115,0.415,802206214,0.279,PGX_AM_BS_ClinEpend-21,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.426000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7ba,P3Y6M,pgxind-kftx32wv,pgxcs-kftvtm6n,2407792993,0.837,1095679311,0.381,1312113682,0.456,PGX_AM_BS_ClinEpend-22,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.427000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,220,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bc,P6Y11M,pgxind-kftx32wx,pgxcs-kftvtm74,2916709698,1,1527665209,0.531,1389044489,0.483,PGX_AM_BS_ClinEpend-23,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.429000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bd,P4Y6M,pgxind-kftx32wz,pgxcs-kftvtm7m,2211029654,0.769,1059317460,0.368,1151712194,0.401,PGX_AM_BS_ClinEpend-24,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.430000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bk,P3Y10M,pgxind-kftx32x7,pgxcs-kftvtm9j,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-28,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.436000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bn,P1Y10M,pgxind-kftx32xb,pgxcs-kftvtmah,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-30,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.438000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7bq,P8Y6M,pgxind-kftx32xf,pgxcs-kftvtmbf,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-32,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.441000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bu,P2Y10M,pgxind-kftx32xj,pgxcs-kftvtmcd,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-34,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.444000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,180,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc65,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bx,P3Y5M,pgxind-kftx32xn,pgxcs-kftvtmfj,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-36,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.446000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc66,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7bz,P1Y10M,pgxind-kftx32xp,pgxcs-kftvtmg1,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-37,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.448000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc67,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [supratentorial],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvh7c0,P1Y5M,pgxind-kftx32xr,pgxcs-kftvtmgj,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-38,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:35.449000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afc68,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma [posterior fossa],NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh7c2,P2Y6M,pgxind-kftx32xu,pgxcs-kftvtmh0,0,0,0,0,0,0,PGX_AM_BS_ClinEpend-39,{},-1.9,52.48,Point,GBR,Birmingham,United Kingdom,"Birmingham, United Kingdom",52.48,-1.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:35.451000,PMID:12466129,"Dyer S, Prebble E et al. (2002): Genomic imbalances in pediatric intracranial ependymomas...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wg,P3Y,pgxind-kftx33nc,pgxcs-kftvtssl,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-022,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.076000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afe2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wi,P6Y,pgxind-kftx33ne,pgxcs-kftvtst2,162943491,0.057,0,0,162943491,0.057,PGX_AM_BS_Ependymoma-023,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.078000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afe2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wk,P2Y,pgxind-kftx33ng,pgxcs-kftvtstk,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-062,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.079000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wn,P5Y,pgxind-kftx33nk,pgxcs-kftvtsui,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-088,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.082000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wo,P1Y10M,pgxind-kftx33nm,pgxcs-kftvtsv0,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-140,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.083000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afe32,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wq,P6Y,pgxind-kftx33no,pgxcs-kftvtsvh,201724664,0.07,0,0,201724664,0.07,PGX_AM_BS_Ependymoma-166,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.084000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afe37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wy,P0Y8M,pgxind-kftx33ny,pgxcs-kftvtsxv,392107978,0.136,0,0,392107978,0.136,PGX_AM_BS_Ependymoma-258,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.092000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afe38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoma,NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh7wz,P0Y8M,pgxind-kftx33o0,pgxcs-kftvtsyc,0,0,0,0,0,0,PGX_AM_BS_Ependymoma-266,{},2.36,48.79,Point,FRA,Villejuif,France,"Villejuif, France",48.79,2.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:36.093000,PMID:12237235,"Grill J, Avet-Loiseau H et al. (2002): Comparative genomic hybridization detects specific cytogenetic...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b023d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97i,P66Y,pgxind-kftx35a4,pgxcs-kftvu7cz,1204544898,0.419,83306063,0.029,1121238835,0.39,PGX_AM_BS_Epend-car-11,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.509000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0243,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh97r,P48Y,pgxind-kftx35ag,pgxcs-kftvu7fy,440378396,0.153,0,0,440378396,0.153,PGX_AM_BS_Epend-car-17,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.518000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b024e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh989,P36Y,pgxind-kftx35b3,pgxcs-kftvu7lb,1962364804,0.683,0,0,1962364804,0.683,PGX_AM_BS_Epend-car-28,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.533000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b025f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, medullary]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh991,P57Y,pgxind-kftx35c2,pgxcs-kftvu7to,967891524,0.337,49691482,0.017,918200042,0.319,PGX_AM_BS_Epend-car-45,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.557000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0261,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh995,P44Y,pgxind-kftx35c6,pgxcs-kftvu7un,2007789255,0.698,66006046,0.023,1941783209,0.675,PGX_AM_BS_Epend-car-47,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.560000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0264,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh99a,P23Y,pgxind-kftx35cc,pgxcs-kftvu7w4,734510513,0.255,49691482,0.017,684819031,0.238,PGX_AM_BS_Epend-car-50,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.564000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0266,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, filum terminale]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C72.0,Spinal cord,pgxbs-kftvh99d,P70Y,pgxind-kftx35cg,pgxcs-kftvu7x4,928919021,0.323,0,0,928919021,0.323,PGX_AM_BS_Epend-car-52,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.567000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0273,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh99y,P8Y2M,pgxind-kftx35d6,pgxcs-kftvu83d,0,0,0,0,0,0,PGX_AM_BS_Epend-car-65,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.585000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0279,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh9a8,P8Y,pgxind-kftx35di,pgxcs-kftvu869,0,0,0,0,0,0,PGX_AM_BS_Epend-car-71,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.593000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0284,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [classic, posterior fossa]",NCIT:C3017,Ependymoma,icdom-93913,"Ependymoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh9aq,P47Y,pgxind-kftx35e5,pgxcs-kftvu8bi,1818397512,0.632,218080598,0.076,1600316914,0.557,PGX_AM_BS_Epend-car-82,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.608000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab57f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8f,P13Y,pgxind-kftx2am6,pgxcs-kftvmlzg,143229895,0.05,40406194,0.014,102823701,0.036,DIPG_BS_0524,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.837000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.166666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab580,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8h,P12Y,pgxind-kftx2am8,pgxcs-kftvmlzx,746553349,0.26,237085634,0.082,509467715,0.177,PGX_AM_BS_23079654-pfi-dkfz_11_004,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.838000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.083333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab585,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8p,P14Y,pgxind-kftx2ami,pgxcs-kftvmm2a,259718356,0.09,84173463,0.029,175544893,0.061,PGX_AM_BS_23079654-pfi-dkfz_11_009,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.845000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.25,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab586,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgk8q,P2Y,pgxind-kftx2amk,pgxcs-kftvmm2q,40685102,0.014,40075917,0.014,609185,0,DIPG_BS_0531,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.847000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,9.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab58d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk92,P9Y,pgxind-kftx2amy,pgxcs-kftvmm60,424652236,0.148,237597647,0.083,187054589,0.065,DIPG_BS_0538,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.857000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab594,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9e,P14Y,pgxind-kftx2anb,pgxcs-kftvmmbj,591912187,0.206,261971256,0.091,329940931,0.115,PGX_AM_BS_23079654-pfi-dkfz_11_018,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.867000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.25,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0539,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab597,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9j,P14Y,pgxind-kftx2anh,pgxcs-kftvmmcy,391221403,0.136,358079340,0.125,33142063,0.012,PGX_AM_BS_23079654-pfi-dkfz_11_027,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.871000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0547,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5a0,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgk9x,P5Y,pgxind-kftx2anz,pgxcs-kftvmmh6,337860225,0.118,228822966,0.08,109037259,0.038,DIPG_BS_0556,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.884000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.475,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5be,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkba,P23Y,pgxind-kftx2app,pgxcs-kftvmmv7,682319331,0.237,344755150,0.12,337564181,0.117,DIPG_BS_0570,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.927000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.833333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_066,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c4,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkbk,P15Y,pgxind-kftx2aq1,pgxcs-kftvmmy0,124697272,0.043,70935878,0.025,53761394,0.019,DIPG_BS_0576,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.935000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.416666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5ca,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkbu,P49Y,pgxind-kftx2aqd,pgxcs-kftvmn0s,254668480,0.089,81227006,0.028,173441474,0.06,PGX_AM_BS_23079654-pfi-dkfz_11_093,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.944000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5cb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkbw,P53Y,pgxind-kftx2aqf,pgxcs-kftvmn19,109160661,0.038,106979693,0.037,2180968,0.001,PGX_AM_BS_23079654-pfi-dkfz_11_094,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.945000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5ce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkc1,P52Y,pgxind-kftx2aql,pgxcs-kftvmn2n,384527560,0.134,213754214,0.074,170773346,0.059,PGX_AM_BS_23079654-pfi-dkfz_11_097,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.950000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkc4,P49Y,pgxind-kftx2aqp,pgxcs-kftvmn3m,594064574,0.207,407710224,0.142,186354350,0.065,PGX_AM_BS_23079654-pfi-dkfz_11_099,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.952000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcg,P41Y,pgxind-kftx2ar3,pgxcs-kftvmn6v,254748826,0.089,143561028,0.05,111187798,0.039,PGX_AM_BS_23079654-pfi-dkfz_11_106,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.962000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5db,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcm,P43Y,pgxind-kftx2arb,pgxcs-kftvmn8r,486931644,0.169,385752877,0.134,101178767,0.035,PGX_AM_BS_23079654-pfi-dkfz_11_110,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.968000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcu,P33Y,pgxind-kftx2arl,pgxcs-kftvmnb3,11460371,0.004,5392704,0.002,6067667,0.002,PGX_AM_BS_23079654-pfi-dkfz_11_115,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.975000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcw,P47Y,pgxind-kftx2arn,pgxcs-kftvmnbj,207251706,0.072,166471198,0.058,40780508,0.014,PGX_AM_BS_23079654-pfi-dkfz_11_116,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.976000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5e2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcx,P47Y,pgxind-kftx2arp,pgxcs-kftvmnc0,700373174,0.244,489952193,0.17,210420981,0.073,PGX_AM_BS_23079654-pfi-dkfz_11_117,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.978000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcz,P49Y,pgxind-kftx2ars,pgxcs-kftvmnci,69025632,0.024,44177889,0.015,24847743,0.009,PGX_AM_BS_23079654-pfi-dkfz_11_118,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.979000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkd4,P34Y,pgxind-kftx2arx,pgxcs-kftvmnfx,567196719,0.197,117029369,0.041,450167350,0.157,PGX_AM_BS_23079654-pfi-dkfz_11_121,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.984000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkd9,P47Y,pgxind-kftx2as3,pgxcs-kftvmnhd,438462588,0.153,280429750,0.098,158032838,0.055,PGX_AM_BS_23079654-pfi-dkfz_11_124,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.989000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5eb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkdc,P51Y,pgxind-kftx2as7,pgxcs-kftvmnia,435101158,0.151,169943920,0.059,265157238,0.092,PGX_AM_BS_23079654-pfi-dkfz_11_126,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.991000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5fc,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgke4,P22Y,pgxind-kftx2at6,pgxcs-kftvmnqb,431523710,0.15,321484275,0.112,110039435,0.038,PGX_AM_BS_23079654-pfi-dkfz_11_143,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.016000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.583333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab60a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgker,P67Y,pgxind-kftx2aty,pgxcs-kftvmo1h,526608092,0.183,382168566,0.133,144439526,0.05,PGX_AM_BS_23079654-pfi-TCGA_06_5413,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.036000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab60c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkeu,P61Y,pgxind-kftx2au2,pgxcs-kftvmo2g,521352416,0.181,254060217,0.088,267292199,0.093,PGX_AM_BS_23079654-pfi-TCGA_06_5414,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.039000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab60d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkew,P60Y,pgxind-kftx2au3,pgxcs-kftvmo2w,685380182,0.238,332410776,0.116,352969406,0.123,PGX_AM_BS_23079654-pfi-TCGA_06_5415,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.040000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab60e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkey,P23Y,pgxind-kftx2au5,pgxcs-kftvmo3d,234221438,0.081,159857112,0.056,74364326,0.026,PGX_AM_BS_23079654-pfi-TCGA_06_5416,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.042000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab60f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkez,P45Y,pgxind-kftx2au7,pgxcs-kftvmo3u,468374736,0.163,367312931,0.128,101061805,0.035,PGX_AM_BS_23079654-pfi-TCGA_06_5417,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.043000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab612,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf4,P45Y,pgxind-kftx2aud,pgxcs-kftvmo58,302117971,0.105,83973222,0.029,218144749,0.076,PGX_AM_BS_23079654-pfi-TCGA_06_5858,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.048000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab613,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf6,P63Y,pgxind-kftx2auf,pgxcs-kftvmo5p,1031975051,0.359,757001134,0.263,274973917,0.096,PGX_AM_BS_23079654-pfi-TCGA_06_5859,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.049000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab614,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf7,P50Y,pgxind-kftx2auh,pgxcs-kftvmo66,433142274,0.151,311007564,0.108,122134710,0.042,PGX_AM_BS_23079654-pfi-TCGA_06_6389,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.051000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab61d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfm,P52Y,pgxind-kftx2auz,pgxcs-kftvmoae,536200223,0.187,274846238,0.096,261353985,0.091,PGX_AM_BS_23079654-pfi-TCGA_19_5950,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.064000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab620,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfr,P72Y,pgxind-kftx2av5,pgxcs-kftvmobt,480970529,0.167,274260787,0.095,206709742,0.072,PGX_AM_BS_23079654-pfi-TCGA_19_5954,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.068000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab621,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfs,P47Y,pgxind-kftx2av7,pgxcs-kftvmoca,822918479,0.286,359922076,0.125,462996403,0.161,PGX_AM_BS_23079654-pfi-TCGA_28_5219,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.069000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab623,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfw,P56Y,pgxind-kftx2avb,pgxcs-kftvmod8,517337548,0.18,296393615,0.103,220943933,0.077,PGX_AM_BS_23079654-pfi-TCGA_19_5958,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.072000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab624,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfx,P77Y,pgxind-kftx2avd,pgxcs-kftvmodp,595822941,0.207,368835084,0.128,226987857,0.079,PGX_AM_BS_23079654-pfi-TCGA_19_5959,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.073000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab625,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfz,P56Y,pgxind-kftx2avf,pgxcs-kftvmoe6,861091814,0.3,631601466,0.22,229490348,0.08,PGX_AM_BS_23079654-pfi-TCGA_19_5960,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.075000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab626,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg0,P74Y,pgxind-kftx2avh,pgxcs-kftvmoen,521036036,0.181,352217962,0.123,168818074,0.059,PGX_AM_BS_23079654-pfi-TCGA_26_5132,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.076000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab627,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg2,P59Y,pgxind-kftx2avj,pgxcs-kftvmof4,632829880,0.22,602454559,0.21,30375321,0.011,PGX_AM_BS_23079654-pfi-TCGA_26_5133,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.078000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab628,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg4,P43Y,pgxind-kftx2avl,pgxcs-kftvmofl,251723515,0.088,210643881,0.073,41079634,0.014,PGX_AM_BS_23079654-pfi-TCGA_26_1442,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.079000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,2.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab629,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg5,P74Y,pgxind-kftx2avn,pgxcs-kftvmog2,236949715,0.082,231375027,0.08,5574688,0.002,PGX_AM_BS_23079654-pfi-TCGA_26_5134,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.081000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab62b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg9,P78Y,pgxind-kftx2avr,pgxcs-kftvmogz,704468445,0.245,365070870,0.127,339397575,0.118,PGX_AM_BS_23079654-pfi-TCGA_26_5136,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.084000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab62c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkga,P65Y,pgxind-kftx2avt,pgxcs-kftvmohh,379093958,0.132,182974049,0.064,196119909,0.068,PGX_AM_BS_23079654-pfi-TCGA_26_5139,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.085000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab631,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgi,P52Y,pgxind-kftx2aw3,pgxcs-kftvmojw,364489875,0.127,234260450,0.081,130229425,0.045,PGX_AM_BS_23079654-pfi-TCGA_28_5208,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.092000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab632,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgk,P66Y,pgxind-kftx2aw5,pgxcs-kftvmokd,509513782,0.177,296308878,0.103,213204904,0.074,PGX_AM_BS_23079654-pfi-TCGA_28_5209,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.094000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab633,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgm,P72Y,pgxind-kftx2aw7,pgxcs-kftvmoku,413857485,0.144,282953683,0.098,130903802,0.046,PGX_AM_BS_23079654-pfi-TCGA_28_5213,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.095000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab634,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgn,P53Y,pgxind-kftx2aw9,pgxcs-kftvmolb,458213340,0.159,188949036,0.066,269264304,0.094,PGX_AM_BS_23079654-pfi-TCGA_28_5214,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.097000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab636,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgr,P52Y,pgxind-kftx2awd,pgxcs-kftvmom9,530789658,0.185,328881821,0.114,201907837,0.07,PGX_AM_BS_23079654-pfi-TCGA_28_5216,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.099000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,1.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab638,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgu,P53Y,pgxind-kftx2awh,pgxcs-kftvmon6,341117966,0.119,276996543,0.096,64121423,0.022,PGX_AM_BS_23079654-pfi-TCGA_19_5956,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.102000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab639,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgw,P67Y,pgxind-kftx2awj,pgxcs-kftvmono,812407161,0.283,631882698,0.22,180524463,0.063,PGX_AM_BS_23079654-pfi-TCGA_28_5220,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.103000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab63c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh1,P66Y,pgxind-kftx2awp,pgxcs-kftvmor0,902409080,0.314,256032690,0.089,646376390,0.225,PGX_AM_BS_23079654-pfi-TCGA_32_5222,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.107000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab63f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh5,P59Y,pgxind-kftx2awv,pgxcs-kftvmosh,737168834,0.256,447538680,0.156,289630154,0.101,PGX_AM_BS_23079654-pfi-TCGA_41_5651,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.112000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab647,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhj,P52Y,pgxind-kftx2axb,pgxcs-kftvmowa,528483471,0.184,367571714,0.128,160911757,0.056,PGX_AM_BS_23079654-pfi-TCGA_76_4935,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.124000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,0.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab64d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkht,P50Y,pgxind-kftx2axn,pgxcs-kftvmoz6,489354070,0.17,296674878,0.103,192679192,0.067,PGX_AM_BS_23079654-pfi-TCGA_87_5896,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.132000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab727,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkrr,P0Y,pgxind-kftx2b9n,pgxcs-kftvmrvy,779722,0,357740,0,421982,0,PGX_AM_BS_22389665-gri-P09,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.439000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,3.38,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0208,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab744,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkt2,P7Y1M,pgxind-kftx2bba,pgxcs-kftvmsb9,650893322,0.226,326865707,0.114,324027615,0.113,PGX_AM_BS_22389665-gri-P42,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.479000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,4.56,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab751,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkto,P0Y6M,pgxind-kftx2bc0,pgxcs-kftvmshb,576747,0,576747,0,0,0,PGX_AM_BS_22389665-gri-P60,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.497000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,7.01,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0254,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab765,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkuk,P0Y1M,pgxind-kftx2bd3,pgxcs-kftvmsqk,26279501,0.009,26249279,0.009,30222,0,PGX_AM_BS_22389665-gri-P88,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.525000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,6.44,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0281,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abac7,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C72.3,Optic chiasm,pgxbs-kftvgly0,P5Y10M,pgxind-kl8hk39r,pgxcs-kftvn4hb,221744591,0.077,54098420,0.019,167646171,0.058,DIPG_BS_0880,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000959,optic chiasma,{},2020-09-10 17:44:11.738000,geo:GSE21420,,0,5.83,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21138945-bar-HGG15,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd9c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv0,P57Y,pgxind-kftx2dsl,pgxcs-kftvne99,307611013,0.107,27100027,0.009,280510986,0.098,PGX_AM_BS_20591577_AT-jin-50,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.795000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abda1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv8,P63Y,pgxind-kftx2dsv,pgxcs-kftvnebl,764891978,0.266,450319809,0.157,314572169,0.109,PGX_AM_BS_20591577_AT-jin-55,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.802000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abda2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmva,P54Y,pgxind-kftx2dsx,pgxcs-kftvnec2,323850043,0.113,0,0,323850043,0.113,PGX_AM_BS_20591577_AT-jin-56,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.804000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abda3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliosarcoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvb,P15Y5M,pgxind-kftx2dsz,pgxcs-kftvnecj,284803305,0.099,187603988,0.065,97199317,0.034,PGX_AM_BS_20570930-jon-ICR_G021_RMH2474,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.805000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",0,3.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abda7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvi,P50Y,pgxind-kftx2dt7,pgxcs-kftvneee,0,0,0,0,0,0,PGX_AM_BS_20591577_AT-jin-61,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.811000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abda8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvk,P57Y,pgxind-kftx2dta,pgxcs-kftvneev,418770348,0.146,418770348,0.146,0,0,PGX_AM_BS_20591577_AT-jin-62,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.813000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abda9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvl,P69Y,pgxind-kftx2dtc,pgxcs-kftvnefb,369081496,0.128,158821583,0.055,210259913,0.073,PGX_AM_BS_20591577_AT-jin-63,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.814000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvt,P0Y6M,pgxind-kftx2dtl,pgxcs-kftvnehn,484755161,0.169,288263722,0.1,196491439,0.068,PGX_AM_BS_20570930-jon-ICR_G006_RMH2450,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.822000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",0,8.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw0,P0Y10M,pgxind-kftx2dtu,pgxcs-kftvneji,154139056,0.054,41052729,0.014,113086327,0.039,PGX_AM_BS_20570930-jon-ICR_G011_RMH2458,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.828000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",0,3.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmw9,P59Y,pgxind-kftx2du6,pgxcs-kftvnemd,608153546,0.212,271864363,0.095,336289183,0.117,PGX_AM_BS_20591577_AT-jin-57,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.837000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abe03,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzp,P16Y6M,pgxind-kftx2dye,,,,,,,,PGX_AM_BS_20479398-pau-HGG008,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.947000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",0,4.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0396,{},,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe06,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzu,P13Y10M,pgxind-kftx2dyk,pgxcs-kftvnfoq,223053634,0.078,252892,0,222800742,0.077,PGX_AM_BS_20479398-pau-HGG020,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.952000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",0,3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0400,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe09,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzz,P19Y10M,pgxind-kftx2dyq,pgxcs-kftvnfq5,538542095,0.187,408263428,0.142,130278667,0.045,DIPG_BS_0405,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.956000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",0,7.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG026,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac3aa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [supratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgoth,P14Y,pgxind-kftx2g86,pgxcs-kftvnzf7,217044627,0.075,88827343,0.031,128217284,0.045,PGX_AM_BS_20052518_PA-war-IN1262,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.960000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3ad,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [supratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgotm,P6Y,pgxind-kftx2g8d,pgxcs-kftvnzgl,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN1495,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.964000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3b2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [infratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgotu,P12Y,pgxind-kftx2g8n,pgxcs-kftvnziy,238449773,0.083,37549573,0.013,200900200,0.07,PGX_AM_BS_20052518_PA-war-IN1566,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:14.971000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [infratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgovj,P10Y,pgxind-kftx2gar,pgxcs-kftvo005,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN3182,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.021000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad64d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgusl,P65Y,pgxind-kftx2np7,pgxcs-kftvptx2,421005058,0.146,390434505,0.136,30570553,0.011,PGX_AM_BS_18077431_ber_PGBM003,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.537000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,35.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad650,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgusq,P40Y,pgxind-kftx2npd,pgxcs-kftvptyi,706422966,0.246,523305249,0.182,183117717,0.064,PGX_AM_BS_18077431_ber_PGBM012,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.541000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,62.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad65b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgut7,P78Y,pgxind-kftx2nq0,pgxcs-kftvpu3u,733533929,0.255,166200039,0.058,567333890,0.197,PGX_AM_BS_18077431_ber_PGBM001,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.557000,geo:GSE9635,,0,22.8,,,,,,,,,,,,,,,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad65c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgut9,P64Y,pgxind-kftx2nq2,pgxcs-kftvpu4b,640384067,0.223,362593495,0.126,277790572,0.097,PGX_AM_BS_18077431_ber_PGBM002,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.558000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,21.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad65d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutb,P42Y,pgxind-kftx2nq4,pgxcs-kftvpu4t,334928507,0.116,303814343,0.106,31114164,0.011,PGX_AM_BS_18077431_ber_PGBM027,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.560000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,23.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad65e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutc,P53Y,pgxind-kftx2nq6,pgxcs-kftvpu5a,352853448,0.123,345466081,0.12,7387367,0.003,PGX_AM_BS_18077431_ber_PGBM005,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.561000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad65f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgute,P50Y,pgxind-kftx2nq8,pgxcs-kftvpu5r,897819559,0.312,667621055,0.232,230198504,0.08,PGX_AM_BS_18077431_ber_PGBM006,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.562000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad660,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutg,P82Y,pgxind-kftx2nqa,pgxcs-kftvpu68,526436019,0.183,365597535,0.127,160838484,0.056,PGX_AM_BS_18077431_ber_PGBM007,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.564000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad661,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguth,P20Y,pgxind-kftx2nqc,pgxcs-kftvpu6p,919048023,0.32,534383407,0.186,384664616,0.134,PGX_AM_BS_18077431_ber_PGBM008,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.565000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,29.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad662,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutj,P35Y,pgxind-kftx2nqe,pgxcs-kftvpu77,867396303,0.302,594258694,0.207,273137609,0.095,PGX_AM_BS_18077431_ber_PGBM009,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.567000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad663,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutk,P54Y,pgxind-kftx2nqg,pgxcs-kftvpu7o,472310382,0.164,358771106,0.125,113539276,0.039,PGX_AM_BS_18077431_ber_PGBM010,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.568000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad664,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutm,P69Y,pgxind-kftx2nqi,pgxcs-kftvpu86,905498328,0.315,625566643,0.218,279931685,0.097,PGX_AM_BS_18077431_ber_PGBM011,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.570000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad666,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutp,P56Y,pgxind-kftx2nqm,pgxcs-kftvpu95,582637765,0.203,544885901,0.19,37751864,0.013,PGX_AM_BS_18077431_ber_PGBM013,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.572000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad667,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutr,P41Y,pgxind-kftx2nqo,pgxcs-kftvpu9n,585162389,0.204,290637046,0.101,294525343,0.102,PGX_AM_BS_18077431_ber_PGBM014,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.574000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,60.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad668,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutt,P44Y,pgxind-kftx2nqq,pgxcs-kftvpua4,890923620,0.31,293894409,0.102,597029211,0.208,PGX_AM_BS_18077431_ber_PGBM015,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.575000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,20.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad669,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutu,P40Y,pgxind-kftx2nqs,pgxcs-kftvpual,98435596,0.034,69886148,0.024,28549448,0.01,PGX_AM_BS_18077431_ber_PGBM016,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.577000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad66a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutw,P62Y,pgxind-kftx2nqu,pgxcs-kftvpub2,785537776,0.273,435751839,0.152,349785937,0.122,PGX_AM_BS_18077431_ber_PGBM017,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.578000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,36.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad66b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguty,P63Y,pgxind-kftx2nqw,pgxcs-kftvpubj,115279833,0.04,104060150,0.036,11219683,0.004,PGX_AM_BS_18077431_ber_PGBM018,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.580000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad66c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgutz,P42Y,pgxind-kftx2nqy,pgxcs-kftvpuc0,200252567,0.07,41573477,0.014,158679090,0.055,PGX_AM_BS_18077431_ber_PGBM019,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.581000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,28.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad66d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu1,P54Y,pgxind-kftx2nr0,pgxcs-kftvpuci,393389659,0.137,310533156,0.108,82856503,0.029,PGX_AM_BS_18077431_ber_PGBM020,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.582000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,17.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad66e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu3,P43Y,pgxind-kftx2nr2,pgxcs-kftvpucz,59824782,0.021,30833885,0.011,28990897,0.01,PGX_AM_BS_18077431_ber_PGBM021,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.584000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad66f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu5,P42Y,pgxind-kftx2nr4,pgxcs-kftvpudg,831146731,0.289,386894132,0.135,444252599,0.155,PGX_AM_BS_18077431_ber_PGBM022,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.585000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad670,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu6,P82Y,pgxind-kftx2nr6,pgxcs-kftvpudx,481864458,0.168,259091529,0.09,222772929,0.077,PGX_AM_BS_18077431_ber_PGBM023,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.586000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad671,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu8,P45Y,pgxind-kftx2nr8,pgxcs-kftvpuef,1257602948,0.437,634746914,0.221,622856034,0.217,PGX_AM_BS_18077431_ber_PGBM024,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.588000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad672,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguu9,P56Y,pgxind-kftx2nra,pgxcs-kftvpuew,986081480,0.343,578214030,0.201,407867450,0.142,PGX_AM_BS_18077431_ber_PGBM025,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.589000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad673,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguub,P75Y,pgxind-kftx2nrb,pgxcs-kftvpufe,662868972,0.231,426597920,0.148,236271052,0.082,PGX_AM_BS_18077431_ber_PGBM026,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.591000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad674,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguud,P54Y,pgxind-kftx2nrd,pgxcs-kftvpufu,343493074,0.119,180954430,0.063,162538644,0.057,PGX_AM_BS_18077431_ber_PGBM004,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.592000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,3.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad675,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguue,P52Y,pgxind-kftx2nrf,pgxcs-kftvpugc,546653684,0.19,374829962,0.13,171823722,0.06,PGX_AM_BS_18077431_ber_PGBM028,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.593000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad676,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguug,P56Y,pgxind-kftx2nrh,pgxcs-kftvpugt,520634624,0.181,331210319,0.115,189424305,0.066,PGX_AM_BS_18077431_ber_PGBM029,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.595000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad677,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuh,P60Y,pgxind-kftx2nrj,pgxcs-kftvpuha,883572035,0.307,759342061,0.264,124229974,0.043,PGX_AM_BS_18077431_ber_PGBM030,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.596000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad678,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuj,P76Y,pgxind-kftx2nrl,pgxcs-kftvpuhr,93361253,0.032,72794932,0.025,20566321,0.007,PGX_AM_BS_18077431_ber_PGBM031,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.598000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad679,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguul,P33Y,pgxind-kftx2nrn,pgxcs-kftvpui8,734141043,0.255,231848824,0.081,502292219,0.175,PGX_AM_BS_18077431_ber_PGBM032,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.599000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,66.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad67a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguum,P50Y,pgxind-kftx2nrp,pgxcs-kftvpuip,976410534,0.34,398826083,0.139,577584451,0.201,PGX_AM_BS_18077431_ber_PGBM033,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.600000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,12,,,,,,,,,,,,,,,geo:GSE9635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad67b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuo,P48Y,pgxind-kftx2nrr,pgxcs-kftvpuj7,289735297,0.101,52342141,0.018,237393156,0.083,PGX_AM_BS_18077431_ber_PGBM034,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.602000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,57.4,,,,,,,,,,,,,,,geo:GSE9635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad67c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuq,P55Y,pgxind-kftx2nrt,pgxcs-kftvpujo,812202736,0.283,297384563,0.103,514818173,0.179,PGX_AM_BS_18077431_ber_PGBM035,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.603000,geo:GSE9635,,0,15,,,,,,,,,,,,,,,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad67d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguur,P68Y,pgxind-kftx2nrv,pgxcs-kftvpuk6,786951858,0.274,500907625,0.174,286044233,0.099,PGX_AM_BS_18077431_ber_PGBM036,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.604000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad67e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguut,P40Y,pgxind-kftx2nrx,pgxcs-kftvpukn,201429898,0.07,31017102,0.011,170412796,0.059,PGX_AM_BS_18077431_ber_PGBM037,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.606000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,32.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad67f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuu,P49Y,pgxind-kftx2nrz,pgxcs-kftvpul4,1099083825,0.382,519907030,0.181,579176795,0.201,PGX_AM_BS_18077431_ber_PGBM038,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.607000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad680,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuw,P47Y,pgxind-kftx2ns2,pgxcs-kftvpulm,1791787302,0.623,684005258,0.238,1107782044,0.385,PGX_AM_BS_18077431_ber_PGBM039,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.609000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,20.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad681,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguuy,P61Y,pgxind-kftx2ns4,pgxcs-kftvpum3,564645168,0.196,198632723,0.069,366012445,0.127,PGX_AM_BS_18077431_ber_PGBM040,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.610000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad682,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv0,P75Y,pgxind-kftx2ns6,pgxcs-kftvpumk,292934018,0.102,194269540,0.068,98664478,0.034,PGX_AM_BS_18077431_ber_PGBM041,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.612000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad683,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv1,P44Y,pgxind-kftx2ns8,pgxcs-kftvpun2,598577789,0.208,206324295,0.072,392253494,0.136,PGX_AM_BS_18077431_ber_PGBM042,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.613000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,28.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad684,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv3,P77Y,pgxind-kftx2nsa,pgxcs-kftvpunj,575683640,0.2,260968159,0.091,314715481,0.109,PGX_AM_BS_18077431_ber_PGBM043,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.615000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad685,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv5,P57Y,pgxind-kftx2nsc,pgxcs-kftvpuo1,1056004444,0.367,730322391,0.254,325682053,0.113,PGX_AM_BS_18077431_ber_PGBM044,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.616000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,48.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad686,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv6,P59Y,pgxind-kftx2nse,pgxcs-kftvpuoi,394784983,0.137,134603106,0.047,260181877,0.09,PGX_AM_BS_18077431_ber_PGBM045,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.617000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad687,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguv8,P73Y,pgxind-kftx2nsg,pgxcs-kftvpuoz,159896930,0.056,93078274,0.032,66818656,0.023,PGX_AM_BS_18077431_ber_PGBM046,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.619000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,23.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad688,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguva,P67Y,pgxind-kftx2nsi,pgxcs-kftvpupg,743690165,0.259,397515680,0.138,346174485,0.12,PGX_AM_BS_18077431_ber_PGBM047,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.620000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad689,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvb,P72Y,pgxind-kftx2nsk,pgxcs-kftvpupy,1322981583,0.46,439946021,0.153,883035562,0.307,PGX_AM_BS_18077431_ber_PGBM048,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.621000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad68a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvd,P59Y,pgxind-kftx2nsm,pgxcs-kftvpuqf,539095902,0.188,182850030,0.064,356245872,0.124,PGX_AM_BS_18077431_ber_PGBM049,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.623000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad68b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguve,P34Y,pgxind-kftx2nso,pgxcs-kftvpuqx,1616528297,0.562,687234747,0.239,929293550,0.323,PGX_AM_BS_18077431_ber_PGBM050,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.624000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad68c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvg,P59Y,pgxind-kftx2nsq,pgxcs-kftvpure,1288474675,0.448,580316550,0.202,708158125,0.246,PGX_AM_BS_18077431_ber_PGBM051,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.626000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad68d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvi,P47Y,pgxind-kftx2nss,pgxcs-kftvpurw,301730958,0.105,147429418,0.051,154301540,0.054,PGX_AM_BS_18077431_ber_PGBM052,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.627000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad68e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvj,P52Y,pgxind-kftx2nsu,pgxcs-kftvpusd,642700702,0.224,302592543,0.105,340108159,0.118,PGX_AM_BS_18077431_ber_PGBM053,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.629000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,13.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad68f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvl,P82Y,pgxind-kftx2nsw,pgxcs-kftvpusu,1095325793,0.381,464947427,0.162,630378366,0.219,PGX_AM_BS_18077431_ber_PGBM054,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.630000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad690,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvn,P71Y,pgxind-kftx2nsy,pgxcs-kftvputc,850233619,0.296,496293202,0.173,353940417,0.123,PGX_AM_BS_18077431_ber_PGBM055,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.631000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad691,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvo,P68Y,pgxind-kftx2nt0,pgxcs-kftvputu,337535617,0.117,324815857,0.113,12719760,0.004,PGX_AM_BS_18077431_ber_PGBM056,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.633000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad692,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvq,P63Y,pgxind-kftx2nt2,pgxcs-kftvpuub,1325490034,0.461,965606618,0.336,359883416,0.125,PGX_AM_BS_18077431_ber_PGBM057,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.634000,geo:GSE9635,,0,6.6,,,,,,,,,,,,,,,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad693,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvr,P63Y,pgxind-kftx2nt4,pgxcs-kftvpuus,536055080,0.186,467076164,0.162,68978916,0.024,PGX_AM_BS_18077431_ber_PGBM058,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.636000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad694,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvt,P68Y,pgxind-kftx2nt6,pgxcs-kftvpuva,1244265093,0.433,846887017,0.295,397378076,0.138,PGX_AM_BS_18077431_ber_PGBM059,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.637000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad695,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvu,P41Y,pgxind-kftx2nt8,pgxcs-kftvpuvr,897812296,0.312,504205869,0.175,393606427,0.137,PGX_AM_BS_18077431_ber_PGBM060,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.638000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad696,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvw,P50Y,pgxind-kftx2nta,pgxcs-kftvpuw8,1087324740,0.378,819125725,0.285,268199015,0.093,PGX_AM_BS_18077431_ber_PGBM061,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.640000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad697,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvy,P37Y,pgxind-kftx2ntc,pgxcs-kftvpuwp,1140290340,0.397,747590167,0.26,392700173,0.137,PGX_AM_BS_18077431_ber_PGBM062,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.641000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,6.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad698,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguvz,P64Y,pgxind-kftx2nte,pgxcs-kftvpux7,1279048644,0.445,920345319,0.32,358703325,0.125,PGX_AM_BS_18077431_ber_PGBM063,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.643000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad699,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw1,P32Y,pgxind-kftx2ntg,pgxcs-kftvpuxp,284110811,0.099,161841197,0.056,122269614,0.043,PGX_AM_BS_18077431_ber_PGBM064,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.644000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,47.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad69a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw2,P68Y,pgxind-kftx2nti,pgxcs-kftvpv05,1287447977,0.448,959703442,0.334,327744535,0.114,PGX_AM_BS_18077431_ber_PGBM065,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.646000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad69b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw4,P63Y,pgxind-kftx2ntk,pgxcs-kftvpv0o,1000412949,0.348,724558843,0.252,275854106,0.096,PGX_AM_BS_18077431_ber_PGBM066,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.647000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad69c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw6,P52Y,pgxind-kftx2ntm,pgxcs-kftvpv15,1080756605,0.376,625379558,0.218,455377047,0.158,PGX_AM_BS_18077431_ber_PGBM067,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.648000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad69d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw7,P63Y,pgxind-kftx2ntp,pgxcs-kftvpv1n,1277700508,0.444,855340181,0.298,422360327,0.147,PGX_AM_BS_18077431_ber_PGBM068,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.650000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,13.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad69e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguw9,P62Y,pgxind-kftx2ntr,pgxcs-kftvpv24,1313001543,0.457,960939850,0.334,352061693,0.122,PGX_AM_BS_18077431_ber_PGBM069,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.651000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad69f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwb,P65Y,pgxind-kftx2ntt,pgxcs-kftvpv2n,1408586583,0.49,751099372,0.261,657487211,0.229,PGX_AM_BS_18077431_ber_PGBM070,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.653000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwc,P60Y,pgxind-kftx2ntv,pgxcs-kftvpv35,519305041,0.181,324267345,0.113,195037696,0.068,PGX_AM_BS_18077431_ber_PGBM071,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.654000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,19.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwe,P70Y,pgxind-kftx2ntx,pgxcs-kftvpv3m,439186317,0.153,265431653,0.092,173754664,0.06,PGX_AM_BS_18077431_ber_PGBM072,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.656000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwf,P52Y,pgxind-kftx2ntz,pgxcs-kftvpv44,325956228,0.113,307534313,0.107,18421915,0.006,PGX_AM_BS_18077431_ber_PGBM096,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.657000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwh,P47Y,pgxind-kftx2nu1,pgxcs-kftvpv4l,933530794,0.325,791810326,0.275,141720468,0.049,PGX_AM_BS_18077431_ber_PGBM074,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.658000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwj,P60Y,pgxind-kftx2nu3,pgxcs-kftvpv52,438810613,0.153,256577104,0.089,182233509,0.063,PGX_AM_BS_18077431_ber_PGBM075,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.660000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,29.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwk,P21Y,pgxind-kftx2nu5,pgxcs-kftvpv5j,5690367,0.002,5653859,0.002,36508,0,PGX_AM_BS_18077431_ber_PGBM076,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.661000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,22.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6a6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwm,P56Y,pgxind-kftx2nu7,pgxcs-kftvpv61,617638287,0.215,414649970,0.144,202988317,0.071,PGX_AM_BS_18077431_ber_PGBM077,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.663000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwn,P74Y,pgxind-kftx2nu9,pgxcs-kftvpv6i,302511293,0.105,277433823,0.096,25077470,0.009,PGX_AM_BS_18077431_ber_PGBM078,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.664000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6a8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwp,P56Y,pgxind-kftx2nub,pgxcs-kftvpv6z,293420787,0.102,74462668,0.026,218958119,0.076,PGX_AM_BS_18077431_ber_PGBM079,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.665000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,25.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6a9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwr,P75Y,pgxind-kftx2nud,pgxcs-kftvpv7h,620029696,0.216,167129950,0.058,452899746,0.158,PGX_AM_BS_18077431_ber_PGBM080,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.667000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6aa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguws,P55Y,pgxind-kftx2nuf,pgxcs-kftvpv7y,639914312,0.223,468649826,0.163,171264486,0.06,PGX_AM_BS_18077431_ber_PGBM081,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.668000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,40.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6ab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwu,P46Y,pgxind-kftx2nuh,pgxcs-kftvpv8f,346935520,0.121,98530361,0.034,248405159,0.086,PGX_AM_BS_18077431_ber_PGBM082,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.669000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6ac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwv,P36Y,pgxind-kftx2nuj,pgxcs-kftvpv8x,682873422,0.238,476497423,0.166,206375999,0.072,PGX_AM_BS_18077431_ber_PGBM083,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.671000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,10.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6ad,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwx,P63Y,pgxind-kftx2nul,pgxcs-kftvpv9f,897157280,0.312,407674550,0.142,489482730,0.17,PGX_AM_BS_18077431_ber_PGBM084,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.672000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,23.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6ae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguwz,P70Y,pgxind-kftx2nun,pgxcs-kftvpv9w,713986415,0.248,480216450,0.167,233769965,0.081,PGX_AM_BS_18077431_ber_PGBM085,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.674000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6af,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux0,P60Y,pgxind-kftx2nup,pgxcs-kftvpvad,400531562,0.139,167537369,0.058,232994193,0.081,PGX_AM_BS_18077431_ber_PGBM086,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.675000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,21.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux2,P60Y,pgxind-kftx2nur,pgxcs-kftvpvav,667959222,0.232,410888758,0.143,257070464,0.089,PGX_AM_BS_18077431_ber_PGBM087,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.676000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux3,P71Y,pgxind-kftx2nut,pgxcs-kftvpvbc,727262888,0.253,557721650,0.194,169541238,0.059,PGX_AM_BS_18077431_ber_PGBM088,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.678000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux5,P56Y,pgxind-kftx2nuv,pgxcs-kftvpvbu,613863145,0.214,589272493,0.205,24590652,0.009,PGX_AM_BS_18077431_ber_PGBM089,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.679000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux7,P78Y,pgxind-kftx2nux,pgxcs-kftvpvcb,735292369,0.256,349841023,0.122,385451346,0.134,PGX_AM_BS_18077431_ber_PGBM090,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.681000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgux8,P49Y,pgxind-kftx2nuz,pgxcs-kftvpvct,710003769,0.247,245238776,0.085,464764993,0.162,PGX_AM_BS_18077431_ber_PGBM091,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.682000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6b5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxa,P75Y,pgxind-kftx2nv1,pgxcs-kftvpvda,171052703,0.059,162798133,0.057,8254570,0.003,PGX_AM_BS_18077431_ber_PGBM092,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.683000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxc,P60Y,pgxind-kftx2nv3,pgxcs-kftvpvdr,445291782,0.155,249549164,0.087,195742618,0.068,PGX_AM_BS_18077431_ber_PGBM093,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.685000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,27.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxd,P57Y,pgxind-kftx2nv5,pgxcs-kftvpve8,530110308,0.184,510799427,0.178,19310881,0.007,PGX_AM_BS_18077431_ber_PGBM094,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.686000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6b8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxf,P41Y,pgxind-kftx2nv7,pgxcs-kftvpveq,1816276084,0.632,788081729,0.274,1028194355,0.358,PGX_AM_BS_18077431_ber_PGBM095,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.688000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,22.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6b9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxh,P72Y,pgxind-kftx2nv9,pgxcs-kftvpvf8,1131516760,0.394,854646189,0.297,276870571,0.096,PGX_AM_BS_18077431_ber_PGBM073,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.689000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,22.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6ba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxi,P63Y,pgxind-kftx2nvb,pgxcs-kftvpvfp,279362981,0.097,234621183,0.082,44741798,0.016,PGX_AM_BS_18077431_ber_PGBM097,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.690000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,22.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6bb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxk,P73Y,pgxind-kftx2nvd,pgxcs-kftvpvg7,699275059,0.243,539636815,0.188,159638244,0.056,PGX_AM_BS_18077431_ber_PGBM098,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.692000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6bc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxl,P53Y,pgxind-kftx2nvg,pgxcs-kftvpvgo,655028662,0.228,400253127,0.139,254775535,0.089,PGX_AM_BS_18077431_ber_PGBM099,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.693000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,18.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6bd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxn,P52Y,pgxind-kftx2nvi,pgxcs-kftvpvh5,611339513,0.213,514117037,0.179,97222476,0.034,PGX_AM_BS_18077431_ber_PGBM100,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.695000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,29.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6be,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxp,P50Y,pgxind-kftx2nvk,pgxcs-kftvpvhn,742609046,0.258,465315706,0.162,277293340,0.096,PGX_AM_BS_18077431_ber_PGBM101,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.696000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,28.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6bf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxq,P48Y,pgxind-kftx2nvm,pgxcs-kftvpvi4,143770393,0.05,108911450,0.038,34858943,0.012,PGX_AM_BS_18077431_ber_PGBM102,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.698000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxs,P48Y,pgxind-kftx2nvo,pgxcs-kftvpvim,922240016,0.321,530204833,0.184,392035183,0.136,PGX_AM_BS_18077431_ber_PGBM103,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.699000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,22.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxt,P66Y,pgxind-kftx2nvq,pgxcs-kftvpvj3,284318888,0.099,174670317,0.061,109648571,0.038,PGX_AM_BS_18077431_ber_PGBM104,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.700000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxv,P61Y,pgxind-kftx2nvs,pgxcs-kftvpvjk,512228776,0.178,495413220,0.172,16815556,0.006,PGX_AM_BS_18077431_ber_PGBM105,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.702000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,25.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxx,P47Y,pgxind-kftx2nvu,pgxcs-kftvpvk2,1673120080,0.582,803353936,0.279,869766144,0.303,PGX_AM_BS_18077431_ber_PGBM106,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.703000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6c4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [primary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguxy,P43Y,pgxind-kftx2nvw,pgxcs-kftvpvkk,570134452,0.198,302351312,0.105,267783140,0.093,PGX_AM_BS_18077431_ber_PGBM107,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.705000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,31.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6c5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy0,P48Y,pgxind-kftx2nvy,pgxcs-kftvpvl1,309898263,0.108,297191062,0.103,12707201,0.004,PGX_AM_BS_18077431_ber_SGBM01,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.706000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,167.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy1,P38Y,pgxind-kftx2nw0,pgxcs-kftvpvli,859942079,0.299,417441560,0.145,442500519,0.154,PGX_AM_BS_18077431_ber_SGBM02,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.707000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,96.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy3,P23Y,pgxind-kftx2nw2,pgxcs-kftvpvm0,859161663,0.299,712612696,0.248,146548967,0.051,PGX_AM_BS_18077431_ber_SGBM03,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.709000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,99.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy5,P28Y,pgxind-kftx2nw4,pgxcs-kftvpvmh,926683118,0.322,597874504,0.208,328808614,0.114,PGX_AM_BS_18077431_ber_SGBM04,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.710000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6c9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy6,P42Y,pgxind-kftx2nw6,pgxcs-kftvpvmz,1012308794,0.352,686328132,0.239,325980662,0.113,PGX_AM_BS_18077431_ber_SGBM05,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.712000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,165.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6ca,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguy8,P50Y,pgxind-kftx2nw8,pgxcs-kftvpvnh,1680710540,0.585,638477587,0.222,1042232953,0.363,PGX_AM_BS_18077431_ber_SGBM06,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.713000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,120.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6cc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyb,P39Y,pgxind-kftx2nwc,pgxcs-kftvpvog,1144283970,0.398,780198063,0.271,364085907,0.127,PGX_AM_BS_18077431_ber_SGBM08,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.716000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,90.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6cd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyd,P32Y,pgxind-kftx2nwe,pgxcs-kftvpvox,723514055,0.252,409665272,0.142,313848783,0.109,PGX_AM_BS_18077431_ber_SGBM09,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.717000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,28.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6ce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguye,P38Y,pgxind-kftx2nwg,pgxcs-kftvpvpe,1155304944,0.402,478862649,0.167,676442295,0.235,PGX_AM_BS_18077431_ber_SGBM10,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.719000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,150.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6cf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyg,P31Y,pgxind-kftx2nwi,pgxcs-kftvpvpw,674816113,0.235,513153371,0.178,161662742,0.056,PGX_AM_BS_18077431_ber_SGBM11,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.720000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,44.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6d0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyi,P35Y,pgxind-kftx2nwk,pgxcs-kftvpvqd,445804825,0.155,278606250,0.097,167198575,0.058,PGX_AM_BS_18077431_ber_SGBM12,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.722000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6d1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyj,P46Y,pgxind-kftx2nwm,pgxcs-kftvpvqu,583781004,0.203,457745224,0.159,126035780,0.044,PGX_AM_BS_18077431_ber_SGBM13,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.723000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,44.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad6d2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguyl,P50Y,pgxind-kftx2nwo,pgxcs-kftvpvrc,964189921,0.335,558373456,0.194,405816465,0.141,PGX_AM_BS_18077431_ber_SGBM14,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.724000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad6d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [secondary],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvguym,P36Y,pgxind-kftx2nwq,pgxcs-kftvpvru,975795487,0.339,565170223,0.197,410625264,0.143,PGX_AM_BS_18077431_ber_SGBM15,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:21.726000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,53.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb90,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhg,P63Y,pgxind-kftx2pt8,pgxcs-kftvqctg,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G19,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.425000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb9b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhz,P26Y,pgxind-kftx2ptu,pgxcs-kftvqcyq,465427331,0.162,182479946,0.063,282947385,0.098,PGX_AM_BS_17390041_GBM-tah-G30,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.440000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adba1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi9,P48Y,pgxind-kftx2pu6,pgxcs-kftvqd1m,609407337,0.212,196972619,0.069,412434718,0.143,PGX_AM_BS_17390041_GBM-tah-G36rec,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.448000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adc14,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwng,P14Y,pgxind-kftx2q0p,pgxcs-kftvqemk,476467813,0.166,135717752,0.047,340750061,0.119,PGX_AM_BS_17367075_GBM-tak-03,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.605000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af923,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ad,P30Y,pgxind-kftx31mp,pgxcs-kftvtanq,69117685,0.024,69117685,0.024,0,0,PGX_AM_BS_GBM-11,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.298000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",0,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af929,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6am,P39Y,pgxind-kftx31n1,pgxcs-kftvtaqk,126017742,0.044,126017742,0.044,0,0,PGX_AM_BS_GBM-17,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.306000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",0,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c15,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcd4,P26Y,pgxind-kftx3981,pgxcs-kftvv6rv,544532723,0.189,205183832,0.071,339348891,0.118,PGX_AM_BS_OA-N182,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.988000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b177a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbd,P42Y,pgxind-kftx3drs,pgxcs-kftvwbvl,741136698,0.258,553530533,0.193,187606165,0.065,PGX_AM_BS_10389929_GB-huh-RR06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.024000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b177b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbf,P24Y,pgxind-kftx3dru,pgxcs-kftvwbw2,741227425,0.258,57227473,0.02,683999952,0.238,PGX_AM_BS_10389929_GB-huh-RR07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.025000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1784,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbt,P50Y,pgxind-kftx3dsd,pgxcs-kftvwc0e,460994049,0.16,188097610,0.065,272896439,0.095,PGX_AM_BS_10389929_GB-huh-RR16,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.038000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1787,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgby,P40Y,pgxind-kftx3dsj,pgxcs-kftvwc1v,457179321,0.159,298357738,0.104,158821583,0.055,PGX_AM_BS_10389929_GB-huh-RR19,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.042000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1788,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc0,P65Y,pgxind-kftx3dsl,pgxcs-kftvwc2c,753177455,0.262,617781760,0.215,135395695,0.047,PGX_AM_BS_10389929_GB-huh-RR20,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.043000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b178d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [occipital],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc8,P33Y,pgxind-kftx3dsv,pgxcs-kftvwc6x,994118515,0.346,483027373,0.168,511091142,0.178,PGX_AM_BS_10389929_GB-huh-RS05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.050000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab57d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8c,P14Y,pgxind-kftx2am2,pgxcs-kftvmlyj,485820540,0.169,283159184,0.098,202661356,0.07,DIPG_BS_0522,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.834000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.833333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab57e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgk8d,P12Y,pgxind-kftx2am4,pgxcs-kftvmlyz,1056716131,0.368,325405981,0.113,731310150,0.254,PGX_AM_BS_23079654-pfi-dkfz_11_002,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:09.836000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0523,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab581,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk8i,P11Y,pgxind-kftx2ama,pgxcs-kftvmm0f,207523001,0.072,80230512,0.028,127292489,0.044,DIPG_BS_0526,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.840000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab582,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk8k,P10Y,pgxind-kftx2amc,pgxcs-kftvmm0v,839645889,0.292,503050701,0.175,336595188,0.117,PGX_AM_BS_23079654-pfi-dkfz_11_006,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.841000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab584,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk8n,P11Y,pgxind-kftx2amg,pgxcs-kftvmm1t,206275608,0.072,146178482,0.051,60097126,0.021,PGX_AM_BS_23079654-pfi-dkfz_11_008,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.844000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,2.666666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab587,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8s,P12Y,pgxind-kftx2amm,pgxcs-kftvmm37,394215464,0.137,283607075,0.099,110608389,0.038,DIPG_BS_0532,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.848000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.166666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab588,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.5,Ventricle,pgxbs-kftvgk8u,P10Y,pgxind-kftx2amo,pgxcs-kftvmm3o,1026871239,0.357,819110886,0.285,207760353,0.072,DIPG_BS_0534,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,{},2020-09-10 17:44:09.850000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab589,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8v,P12Y,pgxind-kftx2amq,pgxcs-kftvmm45,681920128,0.237,227199865,0.079,454720263,0.158,PGX_AM_BS_23079654-pfi-dkfz_11_012,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.852000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.416666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab58a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8x,P10Y,pgxind-kftx2ams,pgxcs-kftvmm4m,375429473,0.131,209110625,0.073,166318848,0.058,DIPG_BS_0535,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.853000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.833333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab58b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk8z,P13Y,pgxind-kftx2amu,pgxcs-kftvmm53,612768956,0.213,37486713,0.013,575282243,0.2,DIPG_BS_0536,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.854000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.333333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab58c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk90,P8Y,pgxind-kftx2amw,pgxcs-kftvmm5j,875157375,0.304,486983597,0.169,388173778,0.135,DIPG_BS_0537,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.856000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_016,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab58e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk94,P13Y,pgxind-kftx2an0,pgxcs-kftvmm8n,283295067,0.099,207972728,0.072,75322339,0.026,PGX_AM_BS_23079654-pfi-dkfz_11_019,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.858000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.083333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0540,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab590,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk97,P13Y,pgxind-kftx2an4,pgxcs-kftvmm9n,388500947,0.135,303798295,0.106,84702652,0.029,PGX_AM_BS_23079654-pfi-dkfz_11_020,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.861000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab592,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9b,P14Y,pgxind-kftx2an7,pgxcs-kftvmmal,753462007,0.262,122593295,0.043,630868712,0.219,DIPG_BS_0543,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.864000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab593,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk9c,P6Y,pgxind-kftx2an9,pgxcs-kftvmmb2,123032359,0.043,115324105,0.04,7708254,0.003,PGX_AM_BS_23079654-pfi-dkfz_11_024,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.865000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab596,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgk9h,P11Y,pgxind-kftx2anf,pgxcs-kftvmmch,5085736,0.002,2692223,0.001,2393513,0.001,DIPG_BS_0546,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.870000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.583333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_026,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab599,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9m,P13Y,pgxind-kftx2anm,pgxcs-kftvmmdw,485383250,0.169,346246036,0.12,139137214,0.048,DIPG_BS_0549,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.874000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.083333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab59a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9o,P13Y,pgxind-kftx2ann,pgxcs-kftvmmed,72418496,0.025,70837040,0.025,1581456,0.001,PGX_AM_BS_23079654-pfi-dkfz_11_031,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.875000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,3.166666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0551,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab59f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgk9v,P14Y,pgxind-kftx2anx,pgxcs-kftvmmgq,338917259,0.118,76675056,0.027,262242203,0.091,DIPG_BS_0555,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.883000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5b1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkap,P42Y,pgxind-kftx2aoy,pgxcs-kftvmmp4,445840113,0.155,266211029,0.093,179629084,0.062,PGX_AM_BS_23079654-pfi-dkfz_11_053,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.908000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5b9,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkb2,P14Y,pgxind-kftx2ape,,,,,,,,DIPG_BS_0565,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.920000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_061,{},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5ba,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkb4,P9Y,pgxind-kftx2aph,,,,,,,,DIPG_BS_0566,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.921000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.833333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_062,{},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5bb,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkb5,P5Y,pgxind-kftx2apj,pgxcs-kftvmmtt,517313077,0.18,137612174,0.048,379700903,0.132,DIPG_BS_0568,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.923000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5bc,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkb7,P9Y,pgxind-kftx2apl,pgxcs-kftvmmua,203565265,0.071,101763128,0.035,101802137,0.035,PGX_AM_BS_23079654-pfi-dkfz_11_063,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.924000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5bd,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkb8,P19Y,pgxind-kftx2apn,pgxcs-kftvmmur,46065979,0.016,38963211,0.014,7102768,0.002,PGX_AM_BS_23079654-pfi-dkfz_11_065,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.926000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5bf,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkbc,P31Y,pgxind-kftx2apr,pgxcs-kftvmmvo,494657107,0.172,245063701,0.085,249593406,0.087,PGX_AM_BS_23079654-pfi-dkfz_11_067,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.928000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,2.083333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c0,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgkbd,P8Y,pgxind-kftx2apt,pgxcs-kftvmmw5,274867411,0.096,273816915,0.095,1050496,0,PGX_AM_BS_23079654-pfi-dkfz_11_068,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:09.930000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.583333333,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c1,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkbf,P7Y,pgxind-kftx2apv,pgxcs-kftvmmwl,185318540,0.064,167631953,0.058,17686587,0.006,PGX_AM_BS_23079654-pfi-dkfz_11_069,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.931000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c2,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.5,Ventricle,pgxbs-kftvgkbh,P16Y,pgxind-kftx2apx,,,,,,,,PGX_AM_BS_23079654-pfi-dkfz_11_070,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,{},2020-09-10 17:44:09.932000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,2.25,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0574,{},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c3,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkbi,P4Y,pgxind-kftx2apz,pgxcs-kftvmmxj,337714404,0.117,211257015,0.073,126457389,0.044,DIPG_BS_0575,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.934000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.916666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5c8,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgkbr,P12Y,pgxind-kftx2aq9,pgxcs-kftvmmzv,456398960,0.159,405493830,0.141,50905130,0.018,PGX_AM_BS_23079654-pfi-dkfz_11_091,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.941000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,2.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0580,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5c9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkbs,P44Y,pgxind-kftx2aqb,pgxcs-kftvmn0c,6017884,0.002,3272892,0.001,2744992,0.001,PGX_AM_BS_23079654-pfi-dkfz_11_092,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.942000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5cc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkbx,P52Y,pgxind-kftx2aqh,pgxcs-kftvmn1q,752362887,0.262,571773552,0.199,180589335,0.063,PGX_AM_BS_23079654-pfi-dkfz_11_095,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.947000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkc6,P45Y,pgxind-kftx2aqr,pgxcs-kftvmn42,309090862,0.108,255756507,0.089,53334355,0.019,PGX_AM_BS_23079654-pfi-dkfz_11_100,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.954000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkc7,P45Y,pgxind-kftx2aqt,pgxcs-kftvmn4j,291503640,0.101,249437293,0.087,42066347,0.015,PGX_AM_BS_23079654-pfi-dkfz_11_101,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.955000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkc9,P48Y,pgxind-kftx2aqv,pgxcs-kftvmn50,341971049,0.119,186860303,0.065,155110746,0.054,PGX_AM_BS_23079654-pfi-dkfz_11_102,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.957000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcc,P40Y,pgxind-kftx2aqz,pgxcs-kftvmn5y,559638519,0.195,401328552,0.14,158309967,0.055,PGX_AM_BS_23079654-pfi-dkfz_11_104,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.959000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkce,P48Y,pgxind-kftx2ar1,pgxcs-kftvmn6f,292868994,0.102,196721994,0.068,96147000,0.033,PGX_AM_BS_23079654-pfi-dkfz_11_105,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.961000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkch,P42Y,pgxind-kftx2ar5,pgxcs-kftvmn7c,607479554,0.211,342647332,0.119,264832222,0.092,PGX_AM_BS_23079654-pfi-dkfz_11_107,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.964000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcj,P48Y,pgxind-kftx2ar7,pgxcs-kftvmn7t,570005447,0.198,415977275,0.145,154028172,0.054,PGX_AM_BS_23079654-pfi-dkfz_11_108,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.965000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcn,P44Y,pgxind-kftx2ard,pgxcs-kftvmn97,403654121,0.14,257095462,0.089,146558659,0.051,PGX_AM_BS_23079654-pfi-dkfz_11_111,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.969000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5de,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkcr,P39Y,pgxind-kftx2arh,pgxcs-kftvmna5,521556560,0.181,250025790,0.087,271530770,0.094,PGX_AM_BS_23079654-pfi-dkfz_11_113,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.972000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5e5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkd2,P50Y,pgxind-kftx2arw,pgxcs-kftvmnfg,246640084,0.086,96607820,0.034,150032264,0.052,PGX_AM_BS_23079654-pfi-dkfz_11_120,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.983000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5e7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkd5,P49Y,pgxind-kftx2arz,pgxcs-kftvmnge,228355168,0.079,133969018,0.047,94386150,0.033,PGX_AM_BS_23079654-pfi-dkfz_11_122,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.986000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5e8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkd7,P51Y,pgxind-kftx2as1,pgxcs-kftvmngw,635064248,0.221,500721105,0.174,134343143,0.047,PGX_AM_BS_23079654-pfi-dkfz_11_123,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.987000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5ea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkda,P52Y,pgxind-kftx2as5,pgxcs-kftvmnhu,232680790,0.081,161784439,0.056,70896351,0.025,PGX_AM_BS_23079654-pfi-dkfz_11_125,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.990000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5ec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkde,P51Y,pgxind-kftx2as9,pgxcs-kftvmnir,498107692,0.173,217325576,0.076,280782116,0.098,PGX_AM_BS_23079654-pfi-dkfz_11_127,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.993000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5ed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkdf,P47Y,pgxind-kftx2asb,pgxcs-kftvmnj8,386876713,0.135,190833581,0.066,196043132,0.068,PGX_AM_BS_23079654-pfi-dkfz_11_128,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:09.994000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkdh,P53Y,pgxind-kftx2asd,pgxcs-kftvmnjp,396007151,0.138,183118674,0.064,212888477,0.074,PGX_AM_BS_23079654-pfi-dkfz_11_129,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.996000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5ef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkdj,P54Y,pgxind-kftx2asg,pgxcs-kftvmnk6,427818401,0.149,350152113,0.122,77666288,0.027,PGX_AM_BS_23079654-pfi-dkfz_11_130,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.997000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.658333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5f0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkdk,P51Y,pgxind-kftx2asi,pgxcs-kftvmnkn,779764672,0.271,625365967,0.218,154398705,0.054,PGX_AM_BS_23079654-pfi-dkfz_11_131,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:09.998000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.966666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5f1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkdm,P52Y,pgxind-kftx2ask,pgxcs-kftvmnl4,755921831,0.263,488519186,0.17,267402645,0.093,PGX_AM_BS_23079654-pfi-dkfz_11_132,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},10.09.20 17:44,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkdo,P52Y,pgxind-kftx2asm,pgxcs-kftvmnll,620514464,0.216,379327998,0.132,241186466,0.084,PGX_AM_BS_23079654-pfi-dkfz_11_133,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.001000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.341666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab5fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgke2,P57Y,pgxind-kftx2at4,pgxcs-kftvmnpu,553857046,0.193,404933381,0.141,148923665,0.052,PGX_AM_BS_23079654-pfi-dkfz_11_142,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.014000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab5fd,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgke6,P19Y,pgxind-kftx2at8,pgxcs-kftvmnqs,960242725,0.334,640182673,0.223,320060052,0.111,DIPG_BS_0582,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.017000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab5fe,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgke8,P7Y,pgxind-kftx2ata,pgxcs-kftvmnr9,641626642,0.223,485845630,0.169,155781012,0.054,PGX_AM_BS_23079654-pfi-dkfz_11_145,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.019000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab600,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkeb,P12Y,pgxind-kftx2ate,pgxcs-kftvmnwm,348074760,0.121,236688386,0.082,111386374,0.039,PGX_AM_BS_23079654-pfi-dkfz_11_147,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.022000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0585,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab601,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvgkec,P6Y,pgxind-kftx2atg,pgxcs-kftvmnx6,252967765,0.088,139039735,0.048,113928030,0.04,DIPG_BS_0586,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.023000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.416666667,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_23079654-pfi-dkfz_11_148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab605,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkej,P39Y,pgxind-kftx2ato,pgxcs-kftvmnz2,346719212,0.121,320376042,0.111,26343170,0.009,PGX_AM_BS_23079654-pfi-TCGA_06_0650,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.029000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab606,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkek,P54Y,pgxind-kftx2atp,pgxcs-kftvmnzk,576027206,0.2,440199254,0.153,135827952,0.047,PGX_AM_BS_23079654-pfi-TCGA_06_5408,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.030000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab607,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkem,P81Y,pgxind-kftx2atr,pgxcs-kftvmo01,561697543,0.195,399650125,0.139,162047418,0.056,PGX_AM_BS_23079654-pfi-TCGA_06_1804,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.032000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab608,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkeo,P51Y,pgxind-kftx2att,pgxcs-kftvmo0j,426532422,0.148,268638553,0.093,157893869,0.055,PGX_AM_BS_23079654-pfi-TCGA_06_5411,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.033000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab609,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkep,P72Y,pgxind-kftx2atv,pgxcs-kftvmo10,385799418,0.134,367404264,0.128,18395154,0.006,PGX_AM_BS_23079654-pfi-TCGA_06_5410,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.035000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab60b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgket,P78Y,pgxind-kftx2au0,pgxcs-kftvmo1y,351645055,0.122,336777515,0.117,14867540,0.005,PGX_AM_BS_23079654-pfi-TCGA_06_5412,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.038000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab610,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf1,P75Y,pgxind-kftx2au9,pgxcs-kftvmo4b,457626040,0.159,298060970,0.104,159565070,0.056,PGX_AM_BS_23079654-pfi-TCGA_06_5418,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.045000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab611,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf3,P58Y,pgxind-kftx2aub,pgxcs-kftvmo4r,1014034774,0.353,638262763,0.222,375772011,0.131,PGX_AM_BS_23079654-pfi-TCGA_06_5856,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.046000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab615,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkf9,P58Y,pgxind-kftx2auj,pgxcs-kftvmo6n,681711728,0.237,464395782,0.162,217315946,0.076,PGX_AM_BS_23079654-pfi-TCGA_06_6390,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.052000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab616,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfb,P44Y,pgxind-kftx2aul,pgxcs-kftvmo74,207847069,0.072,136342344,0.047,71504725,0.025,PGX_AM_BS_23079654-pfi-TCGA_06_6391,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.054000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab617,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfc,P60Y,pgxind-kftx2aun,pgxcs-kftvmo7k,732978880,0.255,511846261,0.178,221132619,0.077,PGX_AM_BS_23079654-pfi-TCGA_12_5295,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.055000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab618,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfe,P56Y,pgxind-kftx2aup,pgxcs-kftvmo81,536560115,0.187,262857234,0.091,273702881,0.095,PGX_AM_BS_23079654-pfi-TCGA_12_5299,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.057000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab619,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkff,P59Y,pgxind-kftx2aur,pgxcs-kftvmo8j,459499490,0.16,321096153,0.112,138403337,0.048,PGX_AM_BS_23079654-pfi-TCGA_12_5301,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.058000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab61a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfh,P49Y,pgxind-kftx2aut,pgxcs-kftvmo90,70110859,0.024,68771607,0.024,1339252,0,PGX_AM_BS_23079654-pfi-TCGA_14_0781,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.059000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab61c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfk,P47Y,pgxind-kftx2aux,pgxcs-kftvmo9x,658229808,0.229,507266159,0.176,150963649,0.053,PGX_AM_BS_23079654-pfi-TCGA_19_5947,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.062000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab61e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfo,P76Y,pgxind-kftx2av1,pgxcs-kftvmoav,247698472,0.086,134788473,0.047,112909999,0.039,PGX_AM_BS_23079654-pfi-TCGA_19_5951,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.065000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab61f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfp,P62Y,pgxind-kftx2av3,pgxcs-kftvmobc,485180517,0.169,359645611,0.125,125534906,0.044,PGX_AM_BS_23079654-pfi-TCGA_19_5952,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.066000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab622,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkfu,P83Y,pgxind-kftx2av9,pgxcs-kftvmocr,213487885,0.074,190672177,0.066,22815708,0.008,PGX_AM_BS_23079654-pfi-TCGA_19_5955,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.070000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab62a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkg7,P72Y,pgxind-kftx2avp,pgxcs-kftvmogi,308526884,0.107,149641157,0.052,158885727,0.055,PGX_AM_BS_23079654-pfi-TCGA_26_5135,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.082000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.666666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab62e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgd,P72Y,pgxind-kftx2avx,pgxcs-kftvmoig,689735904,0.24,521908538,0.182,167827366,0.058,PGX_AM_BS_23079654-pfi-TCGA_28_5204,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.088000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab630,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgh,P71Y,pgxind-kftx2aw1,pgxcs-kftvmojf,452387887,0.157,290666711,0.101,161721176,0.056,PGX_AM_BS_23079654-pfi-TCGA_28_5207,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.091000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab635,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgp,P62Y,pgxind-kftx2awb,pgxcs-kftvmols,460634542,0.16,361438424,0.126,99196118,0.035,PGX_AM_BS_23079654-pfi-TCGA_28_5215,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.098000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.833333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab637,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgs,P63Y,pgxind-kftx2awf,pgxcs-kftvmomp,468714315,0.163,38814351,0.014,429899964,0.15,PGX_AM_BS_23079654-pfi-TCGA_28_5218,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.101000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab63a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgx,P69Y,pgxind-kftx2awl,pgxcs-kftvmoo4,284321783,0.099,165206577,0.057,119115206,0.041,PGX_AM_BS_23079654-pfi-TCGA_32_1979,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.105000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.583333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab63b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkgz,P60Y,pgxind-kftx2awn,pgxcs-kftvmoom,510963692,0.178,277460962,0.097,233502730,0.081,PGX_AM_BS_23079654-pfi-TCGA_28_6450,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.106000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab63d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh2,P72Y,pgxind-kftx2awr,pgxcs-kftvmorh,327005686,0.114,280164155,0.097,46841531,0.016,PGX_AM_BS_23079654-pfi-TCGA_32_1980,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.109000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab63e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh4,P76Y,pgxind-kftx2awt,pgxcs-kftvmos0,717654098,0.25,445061119,0.155,272592979,0.095,PGX_AM_BS_23079654-pfi-TCGA_76_4925,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.110000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab640,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh7,P68Y,pgxind-kftx2awx,pgxcs-kftvmosy,312879745,0.109,156168734,0.054,156711011,0.055,PGX_AM_BS_23079654-pfi-TCGA_76_4926,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.114000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab641,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkh9,P58Y,pgxind-kftx2awz,pgxcs-kftvmotf,356964571,0.124,167652648,0.058,189311923,0.066,PGX_AM_BS_23079654-pfi-TCGA_76_4927,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.115000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab642,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkha,P85Y,pgxind-kftx2ax1,pgxcs-kftvmotw,298097893,0.104,225256914,0.078,72840979,0.025,PGX_AM_BS_23079654-pfi-TCGA_76_4928,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.117000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab643,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhc,P76Y,pgxind-kftx2ax3,pgxcs-kftvmoud,864092926,0.301,627999764,0.218,236093162,0.082,PGX_AM_BS_23079654-pfi-TCGA_76_4929,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.118000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab645,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhg,P50Y,pgxind-kftx2ax7,pgxcs-kftvmovb,555875600,0.193,174493750,0.061,381381850,0.133,PGX_AM_BS_23079654-pfi-TCGA_76_4932,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.121000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,3.916666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab646,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhh,P66Y,pgxind-kftx2ax9,pgxcs-kftvmovs,468139926,0.163,416872400,0.145,51267526,0.018,PGX_AM_BS_23079654-pfi-TCGA_76_4934,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.122000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab648,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhl,P57Y,pgxind-kftx2axd,pgxcs-kftvmows,483525328,0.168,341650918,0.119,141874410,0.049,PGX_AM_BS_23079654-pfi-TCGA_76_6191,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.125000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.333333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab649,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhm,P74Y,pgxind-kftx2axf,pgxcs-kftvmox9,354134079,0.123,286939109,0.1,67194970,0.023,PGX_AM_BS_23079654-pfi-TCGA_76_6192,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.127000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab64a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkho,P78Y,pgxind-kftx2axh,pgxcs-kftvmoxr,311747478,0.108,293783920,0.102,17963558,0.006,PGX_AM_BS_23079654-pfi-TCGA_76_6193,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.128000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.166666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab64b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhq,P63Y,pgxind-kftx2axj,pgxcs-kftvmoy8,530280089,0.184,392528130,0.137,137751959,0.048,PGX_AM_BS_23079654-pfi-TCGA_76_6282,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.129000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,1.416666667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab64c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgkhr,P64Y,pgxind-kftx2axl,pgxcs-kftvmoyp,502148951,0.175,334995976,0.117,167152975,0.058,PGX_AM_BS_23079654-pfi-TCGA_81_5910,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:10.131000,PMID:23079654,"Sturm D, Witt H et al. (2012): Hotspot mutations in H3F3A and IDH1...",1,0.083333333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab6a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgklm,P6Y7M,pgxind-kftx2b27,pgxcs-kftvmq3b,521149411,0.181,430099297,0.15,91050114,0.032,PGX_AM_BS_22661320-haw-DIPG13,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.248000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,0.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab6a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgkln,P6Y7M,pgxind-kftx2b29,pgxcs-kftvmq3s,690970947,0.24,519573492,0.181,171397455,0.06,PGX_AM_BS_22661320-haw-DIPG23,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.250000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,0.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab6a2,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk2ya,P8Y1M,pgxind-kl8hk2zl,pgxcs-kftvmq49,467483894,0.163,345578364,0.12,121905530,0.043,PGX_AM_BS_22661320-haw-DIPG29,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.251000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,1.73,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0509,,pgxcs-kftwqhaz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab6a3,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk4so,P7Y7M,pgxind-kl8hk4tf,pgxcs-kftvmq4q,366116994,0.128,359258713,0.125,6858281,0.003,DIPG_BS_0510,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.253000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,1.06,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22661320-haw-DIPG30,,pgxcs-kftwqhbg,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab6a4,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk3u7,P3Y11M,pgxind-kl8hk3wd,pgxcs-kftvmq56,569500240,0.198,315104659,0.11,254395580,0.088,DIPG_BS_0506,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.254000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,0.09,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22661320-haw-DIPG26,,pgxcs-kftwqh9j,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab6a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgklu,P14Y2M,pgxind-kftx2b2h,pgxcs-kftvmq5n,842487870,0.293,672600268,0.234,169887602,0.059,PGX_AM_BS_22661320-haw-DIPG31,{},-73.59,45.51,Point,CAN,Montreal,Canada,"Montreal, Canada",45.51,-73.59,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.256000,PMID:22661320,Khuong-Quang DA et al. (2012): K27M mutation in histone H3.3 defines...,1,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab723,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkrk,P3Y9M,pgxind-kftx2b9f,pgxcs-kftvmru3,95264125,0.033,86379869,0.03,8884256,0.003,PGX_AM_BS_22389665-gri-P03,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.434000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0347,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab725,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgkro,P6Y3M,pgxind-kftx2b9j,pgxcs-kftvmrv1,999757,0,0,0,999757,0,DIPG_BS_0206,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.436000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.62,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab728,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkrt,P16Y5M,pgxind-kftx2b9p,pgxcs-kftvmrwe,0,0,0,0,0,0,PGX_AM_BS_22389665-gri-P10,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.440000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0209,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab729,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgkru,P4Y9M,pgxind-kftx2b9r,pgxcs-kftvmrwv,40267420,0.014,39674385,0.014,593035,0,PGX_AM_BS_22389665-gri-P11,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.442000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.69,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0210,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab72a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgkrw,P4Y6M,pgxind-kftx2b9t,pgxcs-kftvmrxc,79223065,0.028,78393555,0.027,829510,0,DIPG_BS_0211,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.443000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab73d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgksr,P15Y2M,pgxind-kftx2baw,pgxcs-kftvms63,164572079,0.057,116947650,0.041,47624429,0.017,DIPG_BS_0229,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.469000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.66,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab740,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgksw,P11Y3M,pgxind-kftx2bb2,pgxcs-kftvms7h,8978549,0.003,0,0,8978549,0.003,PGX_AM_BS_22389665-gri-P37,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.473000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.38,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab74c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgktg,P3Y3M,pgxind-kftx2bbq,pgxcs-kftvmsf0,324713483,0.113,229146569,0.08,95566914,0.033,PGX_AM_BS_22389665-gri-P54,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.490000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab74d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkth,P1Y2M,pgxind-kftx2bbs,pgxcs-kftvmsfh,58885437,0.02,1518550,0.001,57366887,0.02,PGX_AM_BS_22389665-gri-P55,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.491000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.58,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab74f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgktk,P8Y3M,pgxind-kftx2bbw,pgxcs-kftvmsge,731847081,0.255,423087317,0.147,308759764,0.107,DIPG_BS_0252,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.494000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,3.97,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab754,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgktt,P5Y3M,pgxind-kftx2bc6,pgxcs-kftvmsip,832685,0,0,0,832685,0,DIPG_BS_0257,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.501000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.99,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab755,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgktu,P17Y10M,pgxind-kftx2bc7,pgxcs-kftvmsj6,526492588,0.183,444594332,0.155,81898256,0.028,DIPG_BS_0258,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.502000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab758,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgktz,P6Y9M,pgxind-kftx2bcd,pgxcs-kftvmskj,18372080,0.006,0,0,18372080,0.006,DIPG_BS_0263,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.506000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.39,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab75a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgku3,P13Y6M,pgxind-kftx2bch,pgxcs-kftvmslg,1147737,0,199897,0,947840,0,PGX_AM_BS_22389665-gri-P72,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.509000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.41,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0265,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab75c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgku6,P4Y6M,pgxind-kftx2bcl,pgxcs-kftvmsme,1092307,0,0,0,1092307,0,DIPG_BS_0268,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.512000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab75d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgku7,P11Y3M,pgxind-kftx2bcn,pgxcs-kftvmsmu,579044221,0.201,369850782,0.129,209193439,0.073,PGX_AM_BS_22389665-gri-P76,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.514000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.97,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0269,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab75f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgkub,P16Y10M,pgxind-kftx2bcr,pgxcs-kftvmsnr,745377505,0.259,575020149,0.2,170357356,0.059,PGX_AM_BS_22389665-gri-P78,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.517000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.54,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab760,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgkuc,P6Y9M,pgxind-kftx2bct,pgxcs-kftvmso9,73384854,0.026,72403173,0.025,981681,0,DIPG_BS_0274,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.518000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.17,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab853,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5d,P11Y10M,pgxind-kftx2bq8,pgxcs-kftvmvyy,448835374,0.156,343514282,0.119,105321092,0.037,PGX_AM_BS_21931021-pau-BSG001T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.858000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.37,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0356,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab854,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5f,P3Y11M,pgxind-kftx2bqa,pgxcs-kftvmvzf,1410095731,0.49,964668567,0.336,445427164,0.155,PGX_AM_BS_21931021-pau-BSG025T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.859000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.66,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0921,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab855,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5h,P7Y11M,pgxind-kftx2bqc,,,,,,,,DIPG_BS_0916,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.861000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,15.12,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG003TBS,{},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab856,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5i,P7Y11M,pgxind-kftx2bqe,pgxcs-kftvmw0d,718252313,0.25,685207952,0.238,33044361,0.011,DIPG_BS_0357,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.862000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,15.12,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG003TCB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab857,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5k,P5Y6M,pgxind-kftx2bqg,pgxcs-kftvmw0u,619449494,0.215,600647151,0.209,18802343,0.007,DIPG_BS_0358,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.863000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.03,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG004TD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab858,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5m,P4Y4M,pgxind-kftx2bqi,pgxcs-kftvmw1b,418164029,0.145,261271283,0.091,156892746,0.055,PGX_AM_BS_21931021-pau-BSG005T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.865000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5q,P3Y8M,pgxind-kftx2bqo,pgxcs-kftvmw2p,134357396,0.047,130843309,0.046,3514087,0.001,DIPG_BS_0377,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.869000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.22,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG033T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5s,P13Y8M,pgxind-kftx2bqq,pgxcs-kftvmw36,177045910,0.062,139420448,0.048,37625462,0.013,DIPG_BS_0361,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.870000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.09,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG010T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5v,P5Y6M,pgxind-kftx2bqu,pgxcs-kftvmw44,179366060,0.062,118828233,0.041,60537827,0.021,DIPG_BS_0362,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.873000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,2.78,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG012T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab860,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl5z,P5Y2M,pgxind-kftx2bqy,pgxcs-kftvmw51,242780559,0.084,240597348,0.084,2183211,0.001,PGX_AM_BS_21931021-pau-BSG015T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.876000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.28,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0363,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab861,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl60,P5Y8M,pgxind-kftx2br0,pgxcs-kftvmw5i,187746309,0.065,38509491,0.013,149236818,0.052,PGX_AM_BS_21931021-pau-BSG017T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.877000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.39,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0364,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab863,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl63,P15Y8M,pgxind-kftx2br4,pgxcs-kftvmw6f,715561697,0.249,408785322,0.142,306776375,0.107,DIPG_BS_0918,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.880000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.45,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG019T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab864,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl65,P5Y11M,pgxind-kftx2br7,pgxcs-kftvmw6w,283575074,0.099,184235309,0.064,99339765,0.035,DIPG_BS_0366,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.882000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG020T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab865,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl67,P7Y4M,pgxind-kftx2br9,pgxcs-kftvmw7d,376236118,0.131,216198131,0.075,160037987,0.056,DIPG_BS_0919,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.883000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.06,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG021T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab866,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl68,P5Y4M,pgxind-kftx2brb,pgxcs-kftvmw7u,817452944,0.284,620284365,0.216,197168579,0.069,PGX_AM_BS_21931021-pau-BSG022T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.885000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab867,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6a,P5Y4M,pgxind-kftx2brd,pgxcs-kftvmw8b,1295280782,0.451,562659812,0.196,732620970,0.255,DIPG_BS_0920,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.886000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.76,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG022TD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab868,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6b,P3Y7M,pgxind-kftx2brf,pgxcs-kftvmw8s,559273311,0.195,390893587,0.136,168379724,0.059,DIPG_BS_0369,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.887000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.62,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG023T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab869,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6d,P14Y11M,pgxind-kftx2brg,pgxcs-kftvmw99,811385262,0.282,592158868,0.206,219226394,0.076,PGX_AM_BS_21931021-pau-BSG024T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.889000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6f,P14Y11M,pgxind-kftx2bri,pgxcs-kftvmw9q,972039738,0.338,795891041,0.277,176148697,0.061,PGX_AM_BS_21931021-pau-BSG024TD,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.890000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.14,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6i,P6Y5M,pgxind-kftx2brm,pgxcs-kftvmwao,532867703,0.185,532867703,0.185,0,0,PGX_AM_BS_21931021-pau-BSG026T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.893000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.16,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0922,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6k,P5Y2M,pgxind-kftx2bro,pgxcs-kftvmwb4,493963449,0.172,144480180,0.05,349483269,0.122,PGX_AM_BS_21931021-pau-BSG029T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.895000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.92,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0924,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6l,P12Y4M,pgxind-kftx2brq,pgxcs-kftvmwbl,48430889,0.017,1016190,0,47414699,0.016,PGX_AM_BS_21931021-pau-BSG030T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.896000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.63,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0374,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6n,P5Y2M,pgxind-kftx2brs,pgxcs-kftvmwc2,468946244,0.163,136444604,0.047,332501640,0.116,PGX_AM_BS_21931021-pau-BSG031T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.897000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.31,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0375,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab870,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6p,P10Y11M,pgxind-kftx2bru,pgxcs-kftvmwcj,285462715,0.099,154752905,0.054,130709810,0.045,DIPG_BS_0376,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.899000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.53,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG032T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab871,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6q,P6Y1M,pgxind-kftx2brw,pgxcs-kftvmwd0,534421336,0.186,421508398,0.147,112912938,0.039,PGX_AM_BS_21931021-pau-BSG009T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.900000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.21,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0360,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab872,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6s,P8Y11M,pgxind-kftx2bry,pgxcs-kftvmwdh,610610294,0.212,234599255,0.082,376011039,0.131,DIPG_BS_0378,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.902000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.81,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG034T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab873,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6u,P13Y2M,pgxind-kftx2bs0,pgxcs-kftvmwdy,1419399289,0.494,1067370581,0.371,352028708,0.122,PGX_AM_BS_21931021-pau-BSG035T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.903000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.62,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab874,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6v,P15Y8M,pgxind-kftx2bs2,pgxcs-kftvmwef,749337592,0.261,733688982,0.255,15648610,0.005,DIPG_BS_0380,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.905000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG037T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab875,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6x,P6Y11M,pgxind-kftx2bs4,pgxcs-kftvmwew,222923227,0.078,96869800,0.034,126053427,0.044,DIPG_BS_0925,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.906000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.68,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG038T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab876,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl6z,P6Y,pgxind-kftx2bs6,pgxcs-kftvmwfc,577333795,0.201,442862324,0.154,134471471,0.047,PGX_AM_BS_21931021-pau-BSG039T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.907000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.66,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab877,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl70,P12Y6M,pgxind-kftx2bs9,pgxcs-kftvmwft,878006949,0.305,468911941,0.163,409095008,0.142,DIPG_BS_0383,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.909000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG040T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab878,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl72,P10Y2M,pgxind-kftx2bsb,pgxcs-kftvmwga,685964961,0.239,163616291,0.057,522348670,0.182,PGX_AM_BS_21931021-pau-BSG042T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.910000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab879,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl73,P6Y7M,pgxind-kftx2bsc,pgxcs-kftvmwgr,388751493,0.135,54793409,0.019,333958084,0.116,PGX_AM_BS_21931021-pau-BSG043T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.912000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.86,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0926,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl75,P9Y,pgxind-kftx2bsf,pgxcs-kftvmwh7,698771820,0.243,503204022,0.175,195567798,0.068,DIPG_BS_0386,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.913000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.69,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG044T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl76,P5Y7M,pgxind-kftx2bsh,pgxcs-kftvmwhp,3754771,0.001,2186678,0.001,1568093,0.001,DIPG_BS_0927,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.915000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.57,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21931021-pau-BSG045T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl78,P3Y,pgxind-kftx2bsj,pgxcs-kftvmwi6,160422852,0.056,115959203,0.04,44463649,0.015,PGX_AM_BS_21931021-pau-BSG046T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.916000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.85,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl7b,P5Y7M,pgxind-kftx2bsn,pgxcs-kftvmwj5,455721749,0.159,345431012,0.12,110290737,0.038,PGX_AM_BS_21931021-pau-BSG509T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.919000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.93,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl7d,P6Y1M,pgxind-kftx2bsp,pgxcs-kftvmwjn,850293476,0.296,100933814,0.035,749359662,0.261,PGX_AM_BS_21931021-pau-BSG529T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.920000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0930,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab880,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl7f,P6Y5M,pgxind-kftx2bsr,pgxcs-kftvmwk5,2844470,0.001,540344,0,2304126,0.001,PGX_AM_BS_21931021-pau-BSG900TD,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.922000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,1.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab882,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgl7i,P9Y10M,pgxind-kftx2bsv,pgxcs-kftvmwl5,433403066,0.151,339652138,0.118,93750928,0.033,PGX_AM_BS_21931021-pau-BSG902TD,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.924000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,0.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0932,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abac2,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvglxr,P12Y7M,pgxind-kl8hk4g9,pgxcs-kftvn4ez,341481335,0.119,272834426,0.095,68646909,0.024,PGX_AM_BS_21138945-bar-BSG10,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:11.731000,geo:GSE21420,,1,1.33,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0862,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abac4,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvglxv,P5Y7M,pgxind-kl8hk3jl,pgxcs-kftvn4fw,515047470,0.179,215086090,0.075,299961380,0.104,PGX_AM_BS_21138945-bar-BSG6,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:11.734000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,0.92,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0858,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abac5,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvglxw,P12Y6M,pgxind-kl8hk4v2,,,,,,,,PGX_AM_BS_21138945-bar-BSG9,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:11.735000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,0.08,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0861,{},,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abac6,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvglxy,P0Y,pgxind-kl8hk41w,pgxcs-kftvn4gu,717805903,0.25,422381204,0.147,295424699,0.103,PGX_AM_BS_21138945-bar-HGG14,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.737000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,0.08,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0879,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abac8,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly1,P7Y4M,pgxind-kl8hk4up,pgxcs-kftvn4hr,854093846,0.297,617920244,0.215,236173602,0.082,PGX_AM_BS_21138945-bar-HGG2,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.740000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,0.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0867,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abac9,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly3,P12Y10M,pgxind-kl8hk3tn,pgxcs-kftvn4i8,506061216,0.176,300281481,0.104,205779735,0.072,DIPG_BS_0886,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.741000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21138945-bar-HGG21,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abaca,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly4,P4Y6M,pgxind-kl8hk4r3,pgxcs-kftvn4iq,206011334,0.072,169229744,0.059,36781590,0.013,PGX_AM_BS_21138945-bar-HGG22,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.743000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,1.67,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0887,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abacb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly6,P4Y6M,pgxind-kftx2cpa,pgxcs-kftvn4j8,222976738,0.078,168603954,0.059,54372784,0.019,PGX_AM_BS_21138945-bar-HGG23,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.744000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,1.67,,,,,,,,,,,,,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abacc,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly8,P4Y,pgxind-kl8hk4dg,pgxcs-kftvn4jp,193621802,0.067,153651176,0.053,39970626,0.014,DIPG_BS_0868,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.746000,geo:GSE21420,,1,0.25,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21138945-bar-HGG3,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abacd,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgly9,P6Y,pgxind-kl8hk4c0,pgxcs-kftvn4k7,570228012,0.198,413796255,0.144,156431757,0.054,DIPG_BS_0869,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.747000,geo:GSE21420,,1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21138945-bar-HGG4,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abace,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvglyb,P6Y8M,pgxind-kl8hk4b8,pgxcs-kftvn4ko,344453572,0.12,80991045,0.028,263462527,0.092,DIPG_BS_0872,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:11.748000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_21138945-bar-HGG7,,,geo:GSE21420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd8c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmua,P53Y,pgxind-kftx2dro,pgxcs-kftvne1s,1265280801,0.44,423905332,0.147,841375469,0.293,PGX_AM_BS_20591577_AT-jin-33,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.771000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd8d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmuc,P59Y,pgxind-kftx2drq,pgxcs-kftvne29,816016706,0.284,168877305,0.059,647139401,0.225,PGX_AM_BS_20591577_AT-jin-34,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.772000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd8e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmud,P56Y,pgxind-kftx2drs,pgxcs-kftvne2q,1484441464,0.516,276775253,0.096,1207666211,0.42,PGX_AM_BS_20591577_AT-jin-35,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.774000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd90,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmug,P36Y,pgxind-kftx2drw,pgxcs-kftvne3o,884192157,0.308,133797556,0.047,750394601,0.261,PGX_AM_BS_20591577_AT-jin-37,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.777000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd91,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmui,P68Y,pgxind-kftx2drz,pgxcs-kftvne45,915943543,0.319,45927462,0.016,870016081,0.303,PGX_AM_BS_20591577_AT-jin-38,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.778000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd95,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmup,P83Y,pgxind-kftx2ds7,pgxcs-kftvne60,290808110,0.101,35336000,0.012,255472110,0.089,PGX_AM_BS_20591577_AT-jin-43,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.785000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd96,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmuq,P49Y,pgxind-kftx2ds9,pgxcs-kftvne6h,798885509,0.278,373058309,0.13,425827200,0.148,PGX_AM_BS_20591577_AT-jin-44,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.786000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd97,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmus,P50Y,pgxind-kftx2dsb,pgxcs-kftvne6x,429133574,0.149,232232679,0.081,196900895,0.068,PGX_AM_BS_20591577_AT-jin-45,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.788000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd99,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmuv,P55Y,pgxind-kftx2dsf,pgxcs-kftvne7v,613875467,0.214,191640596,0.067,422234871,0.147,PGX_AM_BS_20591577_AT-jin-47,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.791000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd9a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmux,P54Y,pgxind-kftx2dsh,pgxcs-kftvne8b,497434973,0.173,242168828,0.084,255266145,0.089,PGX_AM_BS_20591577_AT-jin-48,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.792000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd9d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv2,P28Y,pgxind-kftx2dsn,pgxcs-kftvne9r,433138604,0.151,175039091,0.061,258099513,0.09,PGX_AM_BS_20591577_AT-jin-51,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.797000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd9e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv3,P61Y,pgxind-kftx2dsp,pgxcs-kftvnea7,535821226,0.186,0,0,535821226,0.186,PGX_AM_BS_20591577_AT-jin-52,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.798000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd9f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv5,P65Y,pgxind-kftx2dsr,pgxcs-kftvneao,701297944,0.244,425451721,0.148,275846223,0.096,PGX_AM_BS_20591577_AT-jin-53,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.799000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abda0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmv6,P52Y,pgxind-kftx2dst,pgxcs-kftvneb5,479164967,0.167,185548711,0.065,293616256,0.102,PGX_AM_BS_20591577_AT-jin-54,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.801000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abda4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvd,P71Y,pgxind-kftx2dt1,pgxcs-kftvned0,355288806,0.124,355288806,0.124,0,0,PGX_AM_BS_20591577_AT-jin-58,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.807000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abda5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmve,P41Y,pgxind-kftx2dt3,pgxcs-kftvnedg,363592329,0.126,363592329,0.126,0,0,PGX_AM_BS_20591577_AT-jin-59,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.808000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abda6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvg,P41Y,pgxind-kftx2dt5,pgxcs-kftvnedx,143649678,0.05,143649678,0.05,0,0,PGX_AM_BS_20591577_AT-jin-60,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.810000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdaa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgmvn,P59Y,pgxind-kftx2dtd,pgxcs-kftvnefs,591310011,0.206,546109966,0.19,45200045,0.016,PGX_AM_BS_20591577_AT-jin-41,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.816000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvp,P17Y,pgxind-kftx2dtf,pgxcs-kftvneg9,1364470499,0.475,666382637,0.232,698087862,0.243,PGX_AM_BS_20570930-jon-ICR_G002_RMH2446,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.818000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgmvq,P5Y8M,pgxind-kftx2dth,pgxcs-kftvnegq,520074062,0.181,232652935,0.081,287421127,0.1,PGX_AM_BS_20570930-jon-ICR_G004_RMH2448,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.819000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdad,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C72.0,Spinal cord,pgxbs-kftvgmvs,P11Y,pgxind-kftx2dtj,pgxcs-kftvneh7,218401594,0.076,74496368,0.026,143905226,0.05,PGX_AM_BS_20570930-jon-ICR_G005_RMH2449,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:12.821000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdaf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvv,P3Y10M,pgxind-kftx2dtn,pgxcs-kftvnei4,179952593,0.063,57144206,0.02,122808387,0.043,PGX_AM_BS_20570930-jon-ICR_G007_RMH2452,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.824000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvw,P17Y,pgxind-kftx2dtp,pgxcs-kftvneil,476612075,0.166,173010434,0.06,303601641,0.106,PGX_AM_BS_20570930-jon-ICR_G009_RMH2455,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.825000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmvy,P13Y4M,pgxind-kftx2dts,pgxcs-kftvnej2,464807289,0.162,294128954,0.102,170678335,0.059,PGX_AM_BS_20570930-jon-ICR_G010_RMH2456,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.826000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw1,P13Y11M,pgxind-kftx2dtv,pgxcs-kftvnejz,667597711,0.232,542197970,0.189,125399741,0.044,PGX_AM_BS_20570930-jon-ICR_G015_RMH2465,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.829000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw3,P9Y8M,pgxind-kftx2dtx,pgxcs-kftvnekf,895800319,0.312,523926151,0.182,371874168,0.129,PGX_AM_BS_20570930-jon-ICR_G016_RMH2466,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.831000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw5,P10Y4M,pgxind-kftx2du0,pgxcs-kftvnekx,156469089,0.054,99177067,0.034,57292022,0.02,PGX_AM_BS_20570930-jon-ICR_G017_RMH2467,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.832000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,3.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw6,P14Y4M,pgxind-kftx2du2,pgxcs-kftvnele,735853440,0.256,453330760,0.158,282522680,0.098,PGX_AM_BS_20570930-jon-ICR_G019_RMH2470,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.834000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmw8,P12Y5M,pgxind-kftx2du4,pgxcs-kftvnelv,1344111426,0.468,591772788,0.206,752338638,0.262,PGX_AM_BS_20570930-jon-ICR_G020_RMH2471,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.835000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,2.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdb9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmwb,P15Y3M,pgxind-kftx2du8,pgxcs-kftvnemu,497896263,0.173,234959504,0.082,262936759,0.091,PGX_AM_BS_20570930-jon-ICR_G022_RMH2475,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.838000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgmwd,P11Y6M,pgxind-kftx2dua,pgxcs-kftvnena,1816681660,0.632,859195941,0.299,957485719,0.333,PGX_AM_BS_20570930-jon-ICR_G025_RMH2478,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.840000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdbd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmwh,P9Y10M,pgxind-kftx2dug,pgxcs-kftvneop,847650334,0.295,452336824,0.157,395313510,0.138,PGX_AM_BS_20570930-jon-ICR_G039_RMH3491,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.845000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdc1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmwo,P14Y,pgxind-kftx2duo,pgxcs-kftvneqk,347103366,0.121,179076413,0.062,168026953,0.058,PGX_AM_BS_20570930-jon-ICR_G055_RMH3951,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.851000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,3.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdc3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgmwr,P12Y2M,pgxind-kftx2dus,pgxcs-kftvneri,339120467,0.118,199129317,0.069,139991150,0.049,PGX_AM_BS_20570930-jon-ICR_G061_RMH3547,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.854000,PMID:20570930,"Bax DA, Mackay A et al. (2010): A distinct spectrum of copy number...",1,0.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abdff,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzi,P6Y6M,pgxind-kftx2dy6,pgxcs-kftvnflg,2392570,0.001,654260,0,1738310,0.001,PGX_AM_BS_20479398-pau-HGG003,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.941000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0896,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe00,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Gliosarcoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzk,P10Y2M,pgxind-kftx2dy8,pgxcs-kftvnflx,149380050,0.052,145280373,0.051,4099677,0.001,PGX_AM_BS_20479398-pau-HGG004,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.942000,geo:GSE19578,,1,1.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0897,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe01,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzl,P16Y6M,pgxind-kftx2dya,pgxcs-kftvnfme,564718008,0.196,454083098,0.158,110634910,0.038,DIPG_BS_0393,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.944000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG005,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe02,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzn,P6Y4M,pgxind-kftx2dyc,pgxcs-kftvnfmv,685237975,0.238,543841836,0.189,141396139,0.049,DIPG_BS_0394,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.945000,geo:GSE19578,,1,0.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG006,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe04,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzq,P11Y,pgxind-kftx2dyg,pgxcs-kftvnfnt,1690958,0.001,28675,0,1662283,0.001,PGX_AM_BS_20479398-pau-HGG012,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.949000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0898,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe05,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzs,P7Y,pgxind-kftx2dyi,,,,,,,,DIPG_BS_0398,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.950000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG014,{},,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe07,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzv,P14Y1M,pgxind-kftx2dym,pgxcs-kftvnfp7,430602487,0.15,186648830,0.065,243953657,0.085,PGX_AM_BS_20479398-pau-HGG022,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.953000,geo:GSE19578,,1,2.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0900,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe08,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgmzx,P9Y11M,pgxind-kftx2dyo,pgxcs-kftvnfpo,493733063,0.172,314124529,0.109,179608534,0.062,PGX_AM_BS_20479398-pau-HGG023,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.955000,geo:GSE19578,,1,1.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0403,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn01,P9Y8M,pgxind-kftx2dys,pgxcs-kftvnfqm,33922356,0.012,21222777,0.007,12699579,0.004,PGX_AM_BS_20479398-pau-HGG027,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.957000,geo:GSE19578,,1,2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0406,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn02,P19Y10M,pgxind-kftx2dyu,pgxcs-kftvnfr2,638332715,0.222,273272942,0.095,365059773,0.127,PGX_AM_BS_20479398-pau-HGG028,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.959000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0407,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn04,P1Y2M,pgxind-kftx2dyw,pgxcs-kftvnfrl,2031354,0.001,1548,0,2029806,0.001,PGX_AM_BS_20479398-pau-HGG031,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.960000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,2.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0409,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn06,P7Y8M,pgxind-kftx2dyy,pgxcs-kftvnfs2,574091256,0.2,349681502,0.122,224409754,0.078,PGX_AM_BS_20479398-pau-HGG043,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.962000,geo:GSE19578,,1,0.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0902,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn07,P2Y11M,pgxind-kftx2dz0,pgxcs-kftvnfsj,54984018,0.019,52336434,0.018,2647584,0.001,PGX_AM_BS_20479398-pau-HGG044,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.963000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0903,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe0f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn09,P0Y1M,pgxind-kftx2dz2,pgxcs-kftvnft0,3200940,0.001,11825,0,3189115,0.001,PGX_AM_BS_20479398-pau-HGG046,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.965000,geo:GSE19578,,1,0.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0411,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe10,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn0b,P7Y4M,pgxind-kftx2dz4,pgxcs-kftvnfth,377787026,0.131,369306709,0.128,8480317,0.003,PGX_AM_BS_20479398-pau-HGG047,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.966000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0412,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe11,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0c,P3Y7M,pgxind-kftx2dz6,pgxcs-kftvnfty,193482,0,2541,0,190941,0,DIPG_BS_0413,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.968000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,2.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG048,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe12,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0e,P9Y2M,pgxind-kftx2dz8,pgxcs-kftvnfuf,520317606,0.181,515072505,0.179,5245101,0.002,PGX_AM_BS_20479398-pau-HGG050,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.969000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,2.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0414,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe13,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn0f,P5Y7M,pgxind-kftx2dza,pgxcs-kftvnfuw,252689063,0.088,121302210,0.042,131386853,0.046,DIPG_BS_0904,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.970000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG051,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe14,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0h,P4Y4M,pgxind-kftx2dzc,pgxcs-kftvnfvc,143563926,0.05,142820360,0.05,743566,0,PGX_AM_BS_20479398-pau-HGG053,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.972000,geo:GSE19578,,1,2.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0906,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe16,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0k,P4Y8M,pgxind-kftx2dzg,pgxcs-kftvnfwa,1600142,0.001,314028,0,1286114,0,DIPG_BS_0416,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.975000,geo:GSE19578,,1,0.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG056,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe17,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn0m,P12Y4M,pgxind-kftx2dzi,pgxcs-kftvnfwr,380985242,0.133,204157186,0.071,176828056,0.062,DIPG_BS_0908,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.976000,geo:GSE19578,,1,0.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG057,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe18,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0n,P14Y4M,pgxind-kftx2dzk,pgxcs-kftvnfx7,424288047,0.148,391163985,0.136,33124062,0.012,PGX_AM_BS_20479398-pau-HGG059,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.977000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0417,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe19,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0p,P14Y1M,pgxind-kftx2dzm,pgxcs-kftvnfxo,281874875,0.098,31772690,0.011,250102185,0.087,PGX_AM_BS_20479398-pau-HGG061,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.979000,geo:GSE19578,,1,0.8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0419,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe1a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0r,P3Y4M,pgxind-kftx2dzp,pgxcs-kftvnfy5,3618288,0.001,837038,0,2781250,0.001,DIPG_BS_0910,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.980000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG066,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe1b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0s,P2Y4M,pgxind-kftx2dzr,pgxcs-kftvnfym,10055503,0.003,9510085,0.003,545418,0,DIPG_BS_0911,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.982000,geo:GSE19578,,1,0.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG067,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe1c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn0u,P4Y10M,pgxind-kftx2dzt,pgxcs-kftvnfz2,603807515,0.21,399269772,0.139,204537743,0.071,PGX_AM_BS_20479398-pau-HGG068,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.983000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0912,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe1e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn0x,P3Y11M,pgxind-kftx2dzx,pgxcs-kftvng00,174268232,0.061,124263742,0.043,50004490,0.017,PGX_AM_BS_20479398-pau-HGG077,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.986000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0030,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe23,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn15,P11Y3M,pgxind-kftx2e08,pgxcs-kftvng2c,135558535,0.047,134292244,0.047,1266291,0,DIPG_BS_0033,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.993000,geo:GSE19578,,1,1.67,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG093,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe24,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn17,P5Y,pgxind-kftx2e0a,pgxcs-kftvng2s,306594584,0.107,54904371,0.019,251690213,0.088,PGX_AM_BS_20479398-pau-HGG095,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:12.995000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0038,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe25,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn18,P10Y,pgxind-kftx2e0c,pgxcs-kftvng39,611336210,0.213,208999244,0.073,402336966,0.14,PGX_AM_BS_20479398-pau-HGG098,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.996000,geo:GSE19578,,1,2.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0041,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe26,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1a,P11Y6M,pgxind-kftx2e0e,pgxcs-kftvng5o,2015871,0.001,1004493,0,1011378,0,PGX_AM_BS_20479398-pau-HGG099,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.998000,geo:GSE19578,,1,0.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0042,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe27,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1b,P3Y,pgxind-kftx2e0g,pgxcs-kftvng67,1016478503,0.354,706950245,0.246,309528258,0.108,DIPG_BS_0425,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.999000,geo:GSE19578,,1,0.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG140,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe28,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgn1d,P8Y,pgxind-kftx2e0i,pgxcs-kftvng6q,650389019,0.226,228017471,0.079,422371548,0.147,PGX_AM_BS_20479398-pau-HGG143,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:13.001000,geo:GSE19578,,1,0.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0914,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe29,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1f,P19Y,pgxind-kftx2e0k,pgxcs-kftvng77,621475526,0.216,304760113,0.106,316715413,0.11,PGX_AM_BS_20479398-pau-HGG144,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.002000,geo:GSE19578,,1,1.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0426,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1g,P14Y,pgxind-kftx2e0m,pgxcs-kftvng7p,630723782,0.219,419780570,0.146,210943212,0.073,PGX_AM_BS_20479398-pau-HGG145,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.004000,geo:GSE19578,,1,1.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0427,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1i,P8Y11M,pgxind-kftx2e0o,pgxcs-kftvng86,654304725,0.228,496939052,0.173,157365673,0.055,PGX_AM_BS_20479398-pau-HGG151,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.005000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,2.25,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0429,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1k,P13Y1M,pgxind-kftx2e0q,pgxcs-kftvng8n,3312944,0.001,1255986,0,2056958,0.001,PGX_AM_BS_20479398-pau-HGG153,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.006000,geo:GSE19578,,1,2.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0430,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1l,P14Y10M,pgxind-kftx2e0s,pgxcs-kftvng94,741287606,0.258,481862356,0.168,259425250,0.09,DIPG_BS_0434,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.008000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG157,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1n,P10Y8M,pgxind-kftx2e0u,pgxcs-kftvng9m,283188154,0.099,30143689,0.01,253044465,0.088,DIPG_BS_0435,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.009000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG158,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe2f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1p,P13Y1M,pgxind-kftx2e0w,pgxcs-kftvnga3,740070318,0.257,575522856,0.2,164547462,0.057,PGX_AM_BS_20479398-pau-HGG159,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.011000,geo:GSE19578,,1,0.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0436,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abe30,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn1q,P13Y6M,pgxind-kftx2e0y,pgxcs-kftvngak,682550343,0.237,455306996,0.158,227243347,0.079,DIPG_BS_0438,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.012000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,0.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG162,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgndu,P66Y,pgxind-kftx2eg3,pgxcs-kftvnjyc,143997567,0.05,133797556,0.047,10200011,0.004,PGX_AM_BS_20406234_GB-nob-PB161a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.388000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgndw,P66Y,pgxind-kftx2eg5,pgxcs-kftvnjyt,156897580,0.055,133797556,0.047,23100024,0.008,PGX_AM_BS_20406234_GB-nob-PB161b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.389000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf3d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgndy,P66Y,pgxind-kftx2eg7,pgxcs-kftvnjza,143997567,0.05,133797556,0.047,10200011,0.004,PGX_AM_BS_20406234_GB-nob-PB161c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.391000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgndz,P82Y,pgxind-kftx2eg9,pgxcs-kftvnjzr,1085763232,0.378,1071363217,0.373,14400015,0.005,PGX_AM_BS_20406234_GB-nob-PB36a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.392000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf3f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne1,P82Y,pgxind-kftx2egb,pgxcs-kftvnk07,1111773241,0.387,1111773241,0.387,0,0,PGX_AM_BS_20406234_GB-nob-PB36b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.393000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne2,P82Y,pgxind-kftx2egd,pgxcs-kftvnk0o,236840640,0.082,236840640,0.082,0,0,PGX_AM_BS_20406234_GB-nob-PB36d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.395000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [multinucleated giant cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne4,P55Y,pgxind-kftx2egf,pgxcs-kftvnk15,86317240,0.03,83417237,0.029,2900003,0.001,PGX_AM_BS_20406234_GB-nob-PB551a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.396000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne6,P55Y,pgxind-kftx2egh,pgxcs-kftvnk1m,12900013,0.004,7300007,0.003,5600006,0.002,PGX_AM_BS_20406234_GB-nob-PB551b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.398000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne7,P33Y,pgxind-kftx2egj,pgxcs-kftvnk22,225483368,0.078,195914751,0.068,29568617,0.01,PGX_AM_BS_20406234_GB-nob-PB574a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.399000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgne9,P33Y,pgxind-kftx2egl,pgxcs-kftvnk2j,122400122,0.043,93900093,0.033,28500029,0.01,PGX_AM_BS_20406234_GB-nob-PB574b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.400000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnea,P33Y,pgxind-kftx2egn,pgxcs-kftvnk30,308079011,0.107,279610395,0.097,28468616,0.01,PGX_AM_BS_20406234_GB-nob-PB574c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.402000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnec,P33Y,pgxind-kftx2egp,pgxcs-kftvnk3h,114600114,0.04,93900093,0.033,20700021,0.007,PGX_AM_BS_20406234_GB-nob-PB574d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.403000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [gemistocytic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnee,P59Y,pgxind-kftx2egr,pgxcs-kftvnk3y,159197582,0.055,133797556,0.047,25400026,0.009,PGX_AM_BS_20406234_GB-nob-PB578a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.404000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnef,P59Y,pgxind-kftx2egt,pgxcs-kftvnk4f,254940659,0.089,229540633,0.08,25400026,0.009,PGX_AM_BS_20406234_GB-nob-PB578b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.406000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [gemistocytic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgneh,P52Y,pgxind-kftx2egv,pgxcs-kftvnk4v,52500053,0.018,0,0,52500053,0.018,PGX_AM_BS_20406234_GB-nob-PB603a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.407000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnej,P52Y,pgxind-kftx2egx,pgxcs-kftvnk5c,52500053,0.018,0,0,52500053,0.018,PGX_AM_BS_20406234_GB-nob-PB603b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.408000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [multinucleated giant cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnek,P47Y,pgxind-kftx2egz,pgxcs-kftvnk5t,242040646,0.084,236840640,0.082,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB605a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.410000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [oligodendroglial component],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnem,P47Y,pgxind-kftx2eh2,pgxcs-kftvnk69,242040646,0.084,236840640,0.082,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB605b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.411000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnen,P72Y,pgxind-kftx2eh4,pgxcs-kftvnk6q,245166253,0.085,221066229,0.077,24100024,0.008,PGX_AM_BS_20406234_GB-nob-PB606a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.413000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnep,P72Y,pgxind-kftx2eh6,pgxcs-kftvnk77,138997561,0.048,133797556,0.047,5200005,0.002,PGX_AM_BS_20406234_GB-nob-PB606b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.414000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf4f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgner,P72Y,pgxind-kftx2eh8,pgxcs-kftvnk7n,0,0,0,0,0,0,PGX_AM_BS_20406234_GB-nob-PB606c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.416000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnes,P72Y,pgxind-kftx2eha,pgxcs-kftvnk84,163415201,0.057,133797556,0.047,29617645,0.01,PGX_AM_BS_20406234_GB-nob-PB606d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.417000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgneu,P73Y,pgxind-kftx2ehc,pgxcs-kftvnk8l,14700015,0.005,0,0,14700015,0.005,PGX_AM_BS_20406234_GB-nob-PB614a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.418000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf52,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnev,P73Y,pgxind-kftx2ehe,pgxcs-kftvnk91,9500010,0.003,0,0,9500010,0.003,PGX_AM_BS_20406234_GB-nob-PB614b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.420000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnex,P73Y,pgxind-kftx2ehg,pgxcs-kftvnk9i,14700015,0.005,0,0,14700015,0.005,PGX_AM_BS_20406234_GB-nob-PB614c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.421000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf54,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnez,P73Y,pgxind-kftx2ehi,pgxcs-kftvnk9z,9500010,0.003,0,0,9500010,0.003,PGX_AM_BS_20406234_GB-nob-PB614d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.422000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf0,P57Y,pgxind-kftx2ehk,pgxcs-kftvnkaf,71197495,0.025,59197482,0.021,12000013,0.004,PGX_AM_BS_20406234_GB-nob-PB636a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.424000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf2,P57Y,pgxind-kftx2ehm,pgxcs-kftvnkaw,69597493,0.024,59197482,0.021,10400011,0.004,PGX_AM_BS_20406234_GB-nob-PB636b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.425000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [gemistocytic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf4,P80Y,pgxind-kftx2eho,pgxcs-kftvnkbd,62200063,0.022,8000008,0.003,54200055,0.019,PGX_AM_BS_20406234_GB-nob-PB638a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.426000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [oligodendroglial component],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf5,P80Y,pgxind-kftx2ehq,pgxcs-kftvnkbt,62400063,0.022,8200008,0.003,54200055,0.019,PGX_AM_BS_20406234_GB-nob-PB638b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.427000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf7,P69Y,pgxind-kftx2ehs,pgxcs-kftvnkca,138997562,0.048,133797556,0.047,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB74a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.429000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnf8,P69Y,pgxind-kftx2ehu,pgxcs-kftvnkcs,138997562,0.048,133797556,0.047,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB74b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.430000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfa,P69Y,pgxind-kftx2ehw,pgxcs-kftvnkd8,138997562,0.048,133797556,0.047,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB74c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.432000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfc,P69Y,pgxind-kftx2ehy,pgxcs-kftvnkdp,138997562,0.048,133797556,0.047,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB74d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.433000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [small neoplastic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfd,P69Y,pgxind-kftx2ei0,pgxcs-kftvnke6,138997562,0.048,133797556,0.047,5200006,0.002,PGX_AM_BS_20406234_GB-nob-PB74e,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.434000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [gemistocytic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnff,P57Y,pgxind-kftx2ei2,pgxcs-kftvnken,18400019,0.006,0,0,18400019,0.006,PGX_AM_BS_20406234_GB-nob-PB948a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.436000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfg,P57Y,pgxind-kftx2ei4,pgxcs-kftvnkf3,25600026,0.009,0,0,25600026,0.009,PGX_AM_BS_20406234_GB-nob-PB948b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.437000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfi,P58Y,pgxind-kftx2ei6,pgxcs-kftvnkfl,109643091,0.038,95743077,0.033,13900014,0.005,PGX_AM_BS_20406234_GB-nob-PB963a,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.439000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfk,P58Y,pgxind-kftx2ei8,pgxcs-kftvnkg2,0,0,0,0,0,0,PGX_AM_BS_20406234_GB-nob-PB963b,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.440000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfl,P58Y,pgxind-kftx2eia,pgxcs-kftvnkgj,0,0,0,0,0,0,PGX_AM_BS_20406234_GB-nob-PB963c,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.441000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [pleomorphic cells],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgnfn,P58Y,pgxind-kftx2eic,pgxcs-kftvnkh3,0,0,0,0,0,0,PGX_AM_BS_20406234_GB-nob-PB963d,{},4.85,45.75,Point,FRA,Lyon,France,"Lyon, France",45.75,4.85,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:13.443000,PMID:20406234,"Nobusawa S, Lachuer J et al. (2010): Intratumoral patterns of genomic imbalance in...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac29b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk4k8,P10Y8M,pgxind-kl8hk4mb,pgxcs-kftvnvp1,472084319,0.164,389503401,0.136,82580917,0.029,DIPG_BS_0496,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.589000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.85,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20142589-zar-DIPG04,,pgxcs-kftwqh7l,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac29c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk31p,P9Y,pgxind-kl8hk339,pgxcs-kftvnvpi,322800132,0.112,226517960,0.079,96282172,0.034,PGX_AM_BS_20142589-zar-DIPG05,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.590000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.97,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0497,,pgxcs-kftwqh82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac29d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk3cf,P7Y2M,pgxind-kl8hk3dw,pgxcs-kftvnvpz,481176357,0.167,441238627,0.153,39937730,0.014,PGX_AM_BS_20142589-zar-DIPG06,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.591000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0498,,pgxcs-kftwqh8k,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac29e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk48q,P5Y,pgxind-kl8hk49y,pgxcs-kftvnvs1,471175863,0.164,463352188,0.162,7823675,0.003,PGX_AM_BS_20142589-zar-DIPG07,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.593000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.54,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0499,,pgxcs-kftwqhh9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac29f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgohb,P5Y10M,pgxind-kl8hk4af,pgxcs-kftvnvsj,242044443,0.084,240172815,0.084,1871628,0.001,DIPG_BS_0500,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.594000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.41,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20142589-zar-DIPG08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac2a0,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kl8hk3lu,P9Y9M,pgxind-kl8hk3oa,,,,,,,,DIPG_BS_0892,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.596000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.86,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20142589-zar-DIPG09,{},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac2a1,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvgohf,P7Y7M,pgxind-kftx2ft7,pgxcs-kftvnvth,578189762,0.201,294833081,0.103,283356681,0.099,DIPG_BS_0893,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.597000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.24,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20142589-zar-DIPG10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [supratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgotf,P8Y,pgxind-kftx2g84,pgxcs-kftvnzep,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN1180,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.958000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3ac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [supratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgotk,P8Y6M,pgxind-kftx2g8b,pgxcs-kftvnzg4,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN1419,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.962000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3af,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [infratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgotp,P17Y,pgxind-kftx2g8h,pgxcs-kftvnzhj,1404761150,0.489,672255715,0.234,732505435,0.255,PGX_AM_BS_20052518_PA-war-IN1523,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:14.966000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3b4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgotx,P13Y,pgxind-kftx2g8r,pgxcs-kftvnzjv,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN178,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.973000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3be,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [infratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgoue,P14Y,pgxind-kftx2g9c,pgxcs-kftvnzoi,1123912235,0.391,88827343,0.031,1035084892,0.36,PGX_AM_BS_20052518_PA-war-IN2240,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:14.987000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme [infratentorial],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgovk,P6Y6M,pgxind-kftx2gat,pgxcs-kftvo00m,472135301,0.164,408885517,0.142,63249784,0.022,PGX_AM_BS_20052518_PA-war-IN3183,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.022000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb8f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhf,P57Y,pgxind-kftx2pt6,pgxcs-kftvqcsy,452292698,0.157,266371088,0.093,185921610,0.065,PGX_AM_BS_17390041_GBM-tah-G18,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.424000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb91,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhi,P60Y,pgxind-kftx2pta,pgxcs-kftvqctx,353119200,0.123,194297617,0.068,158821583,0.055,PGX_AM_BS_17390041_GBM-tah-G20,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.426000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb92,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhj,P56Y,pgxind-kftx2ptc,pgxcs-kftvqcue,458079323,0.159,262457704,0.091,195621619,0.068,PGX_AM_BS_17390041_GBM-tah-G21,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.428000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb93,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhl,P65Y,pgxind-kftx2pte,pgxcs-kftvqcuw,416255229,0.145,180197603,0.063,236057626,0.082,PGX_AM_BS_17390041_GBM-tah-G22,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.429000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb94,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhn,P76Y,pgxind-kftx2ptg,pgxcs-kftvqcvd,485098278,0.169,263840668,0.092,221257610,0.077,PGX_AM_BS_17390041_GBM-tah-G23,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.430000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb95,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhp,P51Y,pgxind-kftx2pti,pgxcs-kftvqcvv,387658151,0.135,217136556,0.076,170521595,0.059,PGX_AM_BS_17390041_GBM-tah-G24,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.432000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb96,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhq,P52Y,pgxind-kftx2ptk,pgxcs-kftvqcwc,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G25,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.433000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb97,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhs,P43Y,pgxind-kftx2ptm,pgxcs-kftvqcwt,556250085,0.193,306492447,0.107,249757638,0.087,PGX_AM_BS_17390041_GBM-tah-G26,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.434000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb98,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhu,P57Y,pgxind-kftx2pto,pgxcs-kftvqcxa,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G27,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.436000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb99,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhv,P31Y,pgxind-kftx2ptq,pgxcs-kftvqcxs,148770385,0.052,98143080,0.034,50627305,0.018,PGX_AM_BS_17390041_GBM-tah-G28,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.437000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb9a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwhx,P47Y,pgxind-kftx2pts,pgxcs-kftvqcy9,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G29,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.438000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb9c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi0,P70Y,pgxind-kftx2ptw,pgxcs-kftvqcz7,827178764,0.288,341252617,0.119,485926147,0.169,PGX_AM_BS_17390041_GBM-tah-G31,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.441000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb9d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi2,P60Y,pgxind-kftx2pty,pgxcs-kftvqczp,57000057,0.02,51800051,0.018,5200006,0.002,PGX_AM_BS_17390041_GBM-tah-G32,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.442000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb9e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi4,P48Y,pgxind-kftx2pu0,pgxcs-kftvqd06,414755226,0.144,164997588,0.057,249757638,0.087,PGX_AM_BS_17390041_GBM-tah-G33,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.444000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb9f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi5,P60Y,pgxind-kftx2pu2,pgxcs-kftvqd0n,313735492,0.109,0,0,313735492,0.109,PGX_AM_BS_17390041_GBM-tah-G34,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.445000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adba0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwi7,P40Y,pgxind-kftx2pu4,pgxcs-kftvqd14,367957851,0.128,229197651,0.08,138760200,0.048,PGX_AM_BS_17390041_GBM-tah-G35,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.447000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adba2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwia,P37Y,pgxind-kftx2pu8,pgxcs-kftvqd23,292619139,0.102,133797556,0.047,158821583,0.055,PGX_AM_BS_17390041_GBM-tah-G37rec,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.450000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adc12,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwnd,P53Y,pgxind-kftx2q0l,pgxcs-kftvqell,855642538,0.298,481335055,0.167,374307483,0.13,PGX_AM_BS_17367075_GBM-tak-01,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.603000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adc16,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwnj,P66Y,pgxind-kftx2q0t,pgxcs-kftvqepg,590152948,0.205,251806723,0.088,338346225,0.118,PGX_AM_BS_17367075_GBM-tak-05,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.608000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adc17,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma multiforme,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvgwnl,P79Y,pgxind-kftx2q0v,pgxcs-kftvqepy,1117121053,0.389,448958972,0.156,668162081,0.232,PGX_AM_BS_17367075_GBM-tak-06,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:23.610000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af919,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh69w,P45Y,pgxind-kftx31m5,pgxcs-kftvtaiy,292619139,0.102,133797556,0.047,158821583,0.055,PGX_AM_BS_GBM-01,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.284000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af91a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh69y,P45Y,pgxind-kftx31m7,pgxcs-kftvtajf,347850067,0.121,75400075,0.026,272449992,0.095,PGX_AM_BS_GBM-02,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.286000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af91b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh69z,P50Y,pgxind-kftx31m9,pgxcs-kftvtajw,292619139,0.102,133797556,0.047,158821583,0.055,PGX_AM_BS_GBM-03,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.287000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af91c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a1,P56Y,pgxind-kftx31mb,pgxcs-kftvtake,202997624,0.071,177797599,0.062,25200025,0.009,PGX_AM_BS_GBM-04,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.288000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af91d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a3,P61Y,pgxind-kftx31md,pgxcs-kftvtakv,0,0,0,0,0,0,PGX_AM_BS_GBM-05,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.290000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af91e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a5,P50Y,pgxind-kftx31mf,pgxcs-kftvtalc,140017756,0.049,114817731,0.04,25200025,0.009,PGX_AM_BS_GBM-06,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.291000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af91f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a6,P68Y,pgxind-kftx31mh,pgxcs-kftvtalt,149597572,0.052,133797556,0.047,15800016,0.005,PGX_AM_BS_GBM-07,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.293000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af920,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a8,P72Y,pgxind-kftx31mj,pgxcs-kftvtama,319531377,0.111,133797556,0.047,185733821,0.065,PGX_AM_BS_GBM-08,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.294000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af921,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6a9,P68Y,pgxind-kftx31ml,pgxcs-kftvtamr,389020651,0.135,230199068,0.08,158821583,0.055,PGX_AM_BS_GBM-09,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.295000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af922,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ab,P40Y,pgxind-kftx31mn,pgxcs-kftvtan8,616925441,0.215,262097683,0.091,354827758,0.123,PGX_AM_BS_GBM-10,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.297000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af924,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ae,P49Y,pgxind-kftx31mr,pgxcs-kftvtao7,126017742,0.044,126017742,0.044,0,0,PGX_AM_BS_GBM-12,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.299000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af926,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ai,P48Y,pgxind-kftx31mv,pgxcs-kftvtap5,160897583,0.056,133797556,0.047,27100027,0.009,PGX_AM_BS_GBM-14,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.302000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af928,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6al,P56Y,pgxind-kftx31mz,pgxcs-kftvtaq3,122066297,0.042,49691482,0.017,72374815,0.025,PGX_AM_BS_GBM-16,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.305000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af92a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ao,P56Y,pgxind-kftx31n3,pgxcs-kftvtar2,141391573,0.049,141391573,0.049,0,0,PGX_AM_BS_GBM-18,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.308000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af92c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvh6ar,P53Y,pgxind-kftx31n7,pgxcs-kftvtas0,272449992,0.095,0,0,272449992,0.095,PGX_AM_BS_GBM-20,{},30.52,39.78,Point,TUR,Eskisehir,Turkey,"Eskisehir, Turkey",39.78,30.52,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.310000,PMID:12845540,"Arslantas A, Artan S et al. (2004): The importance of genomic copy number...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c0b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [high grade],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcco,P48Y,pgxind-kftx397g,pgxcs-kftvv6n0,619919998,0.216,584519963,0.203,35400035,0.012,PGX_AM_BS_OA-N113,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,,2020-09-10 17:44:40.974000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,6,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c0c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [high grade],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhccq,P64Y,pgxind-kftx397i,pgxcs-kftvv6ni,812147743,0.282,439794576,0.153,372353167,0.13,PGX_AM_BS_OA-N116,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,,2020-09-10 17:44:40.975000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,4,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c0d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [high grade],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhccr,P72Y,pgxind-kftx397l,pgxcs-kftvv6nz,332414888,0.116,292114848,0.102,40300040,0.014,PGX_AM_BS_OA-N124,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,,2020-09-10 17:44:40.977000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,8,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c0f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [high grade],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhccu,P55Y,pgxind-kftx397p,pgxcs-kftvv6oy,1147091033,0.399,749537841,0.261,397553192,0.138,PGX_AM_BS_OA-N158,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,,2020-09-10 17:44:40.980000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,12,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c10,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma [high grade],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhccw,P58Y,pgxind-kftx397r,pgxcs-kftvv6pg,454725280,0.158,295903697,0.103,158821583,0.055,PGX_AM_BS_OA-N161,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,,2020-09-10 17:44:40.981000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,18,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c17,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcd7,P59Y,pgxind-kftx3984,pgxcs-kftvv6su,731548971,0.254,413527229,0.144,318021742,0.111,PGX_AM_BS_OA-N3,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.991000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c18,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcd9,P62Y,pgxind-kftx3987,pgxcs-kftvv6tb,822871806,0.286,270338845,0.094,552532961,0.192,PGX_AM_BS_OA-N4,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.992000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c19,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcdb,P69Y,pgxind-kftx3989,pgxcs-kftvv6tt,381446482,0.133,222624899,0.077,158821583,0.055,PGX_AM_BS_OA-N44,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.993000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c1a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcdc,P68Y,pgxind-kftx398b,pgxcs-kftvv6ua,494957884,0.172,254140658,0.088,240817226,0.084,PGX_AM_BS_OA-N51,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.995000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c1c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcdf,P67Y,pgxind-kftx398f,pgxcs-kftvv6va,620386801,0.216,185597607,0.065,434789194,0.151,PGX_AM_BS_OA-N88,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.997000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c1d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhcdh,P78Y,pgxind-kftx398h,pgxcs-kftvv6vs,1105328685,0.384,641586261,0.223,463742424,0.161,PGX_AM_BS_OA-N96,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:40.999000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1775,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgb5,P42Y,pgxind-kftx3dri,pgxcs-kftvwbt7,0,0,0,0,0,0,PGX_AM_BS_10389929_GB-huh-RR01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.017000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1776,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgb7,P41Y,pgxind-kftx3drk,pgxcs-kftvwbto,827205634,0.288,577447996,0.201,249757638,0.087,PGX_AM_BS_10389929_GB-huh-RR02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.018000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1777,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgb8,P61Y,pgxind-kftx3drm,pgxcs-kftvwbu5,607593117,0.211,386335507,0.134,221257610,0.077,PGX_AM_BS_10389929_GB-huh-RR03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.020000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1778,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgba,P42Y,pgxind-kftx3dro,pgxcs-kftvwbum,42495602,0.015,0,0,42495602,0.015,PGX_AM_BS_10389929_GB-huh-RR04,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.021000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1779,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbc,P73Y,pgxind-kftx3drq,pgxcs-kftvwbv3,660737052,0.23,443715412,0.154,217021640,0.075,PGX_AM_BS_10389929_GB-huh-RR05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.022000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b177c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbg,P61Y,pgxind-kftx3drw,pgxcs-kftvwbwj,705754750,0.245,425879465,0.148,279875285,0.097,PGX_AM_BS_10389929_GB-huh-RR08,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.027000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b177d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbi,P63Y,pgxind-kftx3dry,pgxcs-kftvwbx1,391439431,0.136,79200079,0.028,312239352,0.109,PGX_AM_BS_10389929_GB-huh-RR09,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.028000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b177e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbk,P56Y,pgxind-kftx3ds0,pgxcs-kftvwbxi,595324410,0.207,291364045,0.101,303960365,0.106,PGX_AM_BS_10389929_GB-huh-RR10,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.029000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b177f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbl,P62Y,pgxind-kftx3ds2,pgxcs-kftvwbxz,595196157,0.207,399120955,0.139,196075202,0.068,PGX_AM_BS_10389929_GB-huh-RR11,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.031000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1780,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbn,P42Y,pgxind-kftx3ds4,pgxcs-kftvwbyh,1079731965,0.376,676342898,0.235,403389067,0.14,PGX_AM_BS_10389929_GB-huh-RR12,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.032000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1781,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbo,P58Y,pgxind-kftx3ds6,pgxcs-kftvwbyy,345839386,0.12,107000106,0.037,238839280,0.083,PGX_AM_BS_10389929_GB-huh-RR13,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.033000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1782,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbq,P78Y,pgxind-kftx3ds9,pgxcs-kftvwbzf,284919132,0.099,126097549,0.044,158821583,0.055,PGX_AM_BS_10389929_GB-huh-RR14,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.035000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1783,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbs,P38Y,pgxind-kftx3dsb,pgxcs-kftvwbzx,1522431468,0.53,568917644,0.198,953513824,0.332,PGX_AM_BS_10389929_GB-huh-RR15,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.036000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1785,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbv,P43Y,pgxind-kftx3dsf,pgxcs-kftvwc0w,451575830,0.157,234136572,0.081,217439258,0.076,PGX_AM_BS_10389929_GB-huh-RR17,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.039000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1786,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgbx,P44Y,pgxind-kftx3dsh,pgxcs-kftvwc1d,318933952,0.111,232339147,0.081,86594805,0.03,PGX_AM_BS_10389929_GB-huh-RR18,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.040000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1789,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc1,P54Y,pgxind-kftx3dsn,pgxcs-kftvwc2u,341019186,0.119,167397589,0.058,173621597,0.06,PGX_AM_BS_10389929_GB-huh-RS01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.044000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b178a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc3,P35Y,pgxind-kftx3dsp,pgxcs-kftvwc5c,563026832,0.196,378250557,0.132,184776275,0.064,PGX_AM_BS_10389929_GB-huh-RS02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.046000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b178b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc5,P46Y,pgxind-kftx3dsr,pgxcs-kftvwc5v,439061229,0.153,262803664,0.091,176257565,0.061,PGX_AM_BS_10389929_GB-huh-RS03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.047000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b178c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc6,P43Y,pgxind-kftx3dst,pgxcs-kftvwc6e,471368288,0.164,369946762,0.129,101421526,0.035,PGX_AM_BS_10389929_GB-huh-RS04,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.049000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b178e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [parietal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgc9,P54Y,pgxind-kftx3dsx,pgxcs-kftvwc7e,430355279,0.15,214306223,0.075,216049056,0.075,PGX_AM_BS_10389929_GB-huh-RS06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.051000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b178f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [frontal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgcb,P38Y,pgxind-kftx3dsz,pgxcs-kftvwc7w,625137598,0.217,325557229,0.113,299580369,0.104,PGX_AM_BS_10389929_GB-huh-RS07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.053000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1790,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgcd,P69Y,pgxind-kftx3dt1,pgxcs-kftvwc8d,312560909,0.109,216043196,0.075,96517713,0.034,PGX_AM_BS_10389929_GB-huh-RS08,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.054000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1791,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgce,P70Y,pgxind-kftx3dt3,pgxcs-kftvwc8v,373664779,0.13,183243164,0.064,190421615,0.066,PGX_AM_BS_10389929_GB-huh-RS09,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.055000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1792,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,glioblastoma [temporal],NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,cerebrum,pgxbs-kftvhgcg,P44Y,pgxind-kftx3dt5,pgxcs-kftvwc9c,1154376087,0.402,909912278,0.316,244463809,0.085,PGX_AM_BS_10389929_GB-huh-RS10,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:45.057000,PMID:10389929,"Huhn SL, Mohapatra G et al. (1999): Chromosomal abnormalities in glioblastoma multiforme by...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262e7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36qpx,P8Y10M,pgxind-khv36qqc,pgxcs-khv36qqf,767321348,0.253,688361193,0.227,78960155,0.026,PGX_AM_BS_AM20130503HAW-29T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:06.593000,geogpl-GPL6801,,1,1.73,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262ea,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36qx7,P6Y8M,pgxind-khv36qxm,pgxcs-khv36qxq,0,0,0,0,0,0,PGX_AM_BS_AM20130503HAW-03T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:06.789000,geogpl-GPL6801,,1,0.96,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262eb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36qyg,P16Y8M,pgxind-khv36qyx,pgxcs-khv36qz0,790064642,0.261,625205951,0.206,164858691,0.054,PGX_AM_BS_AM20130503HAW-04T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:06.954000,geogpl-GPL6801,,1,0.85,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262ec,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36r32,P9Y,pgxind-khv36r3i,pgxcs-khv36r3l,304257463,0.1,262139266,0.086,42118197,0.014,PGX_AM_BS_AM20130503HAW-05T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.053000,geogpl-GPL6801,,1,0.97,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262ed,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36r5t,P8Y8M,pgxind-khv36r69,pgxcs-khv36r6c,797429425,0.263,722683152,0.238,74746273,0.025,PGX_AM_BS_AM20130503HAW-06T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.164000,geogpl-GPL6801,,1,0.5,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262ee,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36r8v,P5Y,pgxind-khv36r9a,pgxcs-khv36r9d,788582463,0.26,772157986,0.255,16424477,0.005,PGX_AM_BS_AM20130503HAW-07T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.268000,geogpl-GPL6801,,1,0.54,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262ef,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rbr,P13Y4M,pgxind-khv36rc8,pgxcs-khv36rcb,236241364,0.078,234447445,0.077,1793919,0.001,PGX_AM_BS_AM20130503HAW-08T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.353000,geogpl-GPL6801,,1,0.41,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262f0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36re4,P16Y6M,pgxind-khv36rel,pgxcs-khv36reo,754623748,0.249,441441836,0.146,313181912,0.103,PGX_AM_BS_AM20130503HAW-09T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.453000,geogpl-GPL6801,,1,0.86,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262f1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rgx,P12Y10M,pgxind-khv36rhe,pgxcs-khv36rhh,577019750,0.19,294464833,0.097,282554917,0.093,PGX_AM_BS_AM20130503HAW-10T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.528000,geogpl-GPL3718,,1,0.24,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262f3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rl0,P11Y10M,pgxind-khv36rlg,pgxcs-khv36rlk,513926199,0.17,423185773,0.14,90740426,0.03,PGX_AM_BS_AM20130503HAW-13T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.724000,geogpl-GPL6801,,1,0.83,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262f4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rog,P13Y4M,pgxind-khv36rov,pgxcs-khv36roy,0,0,0,0,0,0,PGX_AM_BS_AM20130503HAW-16T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.769000,geogpl-GPL6801,,1,0.31,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262f5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rpo,P10Y2M,pgxind-khv36rq5,pgxcs-khv36rq8,0,0,0,0,0,0,PGX_AM_BS_AM20130503HAW-17T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.814000,geogpl-GPL6801,,1,0.46,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262f8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36rvo,P11Y10M,pgxind-khv36rw4,pgxcs-khv36rw6,701225411,0.231,529839265,0.175,171386146,0.057,PGX_AM_BS_AM20130503HAW-23T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:08.165000,geogpl-GPL6801,,1,0.78,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262fb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36s3h,P12Y2M,pgxind-khv36s3x,pgxcs-khv36s40,0,0,0,0,0,0,PGX_AM_BS_AM20130503HAW-26T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:08.311000,geogpl-GPL6801,,1,0.09,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262fc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36s4q,P12Y10M,pgxind-khv36s55,pgxcs-khv36s59,528538850,0.174,514764157,0.17,13774693,0.005,PGX_AM_BS_AM20130503HAW-30T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:08.417000,geogpl-GPL6801,,1,1.06,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262fd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-khv36s7o,P15Y8M,pgxind-khv36s83,pgxcs-khv36s86,835957905,0.276,667601933,0.22,168355972,0.056,PGX_AM_BS_AM20130503HAW-31T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:08.536000,geogpl-GPL6801,,1,1.6,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c865f2009d374f2dc33e5d0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinqy,P70Y,pgxind-kftx4d80,pgxcs-kftw9rf0,438581712,0.153,253919837,0.088,184661875,0.064,PGX_AM_BS_GSM434357,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.683000,geo:GSM434357,,1,11,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE17381,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL4091,,,,,,,,,,,,,,,,,F
5c865f2009d374f2dc33e5d2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinr1,P67Y,pgxind-kftx4d84,pgxcs-kftw9rfz,371505789,0.129,150767643,0.052,220738146,0.077,PGX_AM_BS_GSM434359,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.686000,geo:GPL4091,,1,37,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE17381,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM434359,,,,,,,,,,,,,,,,,F
5c865f2009d374f2dc33e5d3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinr3,P42Y,pgxind-kftx4d86,pgxcs-kftw9rgh,12330275,0.004,3821203,0.001,8509072,0.003,PGX_AM_BS_GSM434360,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.687000,geo:GSM434360,,1,34,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL4091,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE17381,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,pubmed,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",,,,,,,,,,,,,,,,M
5c865f2009d374f2dc33e5d4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinr4,P56Y,pgxind-kftx4d88,pgxcs-kftw9rgy,668999266,0.233,220494968,0.077,448504298,0.156,PGX_AM_BS_GSM434361,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.689000,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",1,15,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL4091,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE17381,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM434361,,,,,,,,,,,,,,,,,M
5c865f2009d374f2dc33e5d6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinr7,P52Y,pgxind-kftx4d8c,pgxcs-kftw9rhx,418526490,0.146,164271216,0.057,254255274,0.088,PGX_AM_BS_GSM434363,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.692000,geo:GSM434363,,1,8,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL4091,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE17381,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",,,,,,,,,,,,,,,,M
5c865f2009d374f2dc33e5d9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinrc,P59Y,pgxind-kftx4d8i,pgxcs-kftw9rjd,41394653,0.014,5914506,0.002,35480147,0.012,PGX_AM_BS_GSM434366,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.696000,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",1,11,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL4091,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE17381,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM434366,,,,,,,,,,,,,,,,,M
5c865f2009d374f2dc33e5dc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinrh,P60Y,pgxind-kftx4d8o,pgxcs-kftw9rkt,400353739,0.139,235534318,0.082,164819421,0.057,PGX_AM_BS_GSM434369,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.700000,geo:GSM434369,,1,12,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL4091,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE17381,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",,,,,,,,,,,,,,,,F
5c865f2109d374f2dc33e5de,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"Brain, NOS",pgxbs-kftvinrk,P49Y,pgxind-kftx4d8s,pgxcs-kftw9rlt,614496476,0.214,299520285,0.104,314976191,0.11,PGX_AM_BS_GSM434371,{},-74.01,40.71,Point,USA,New York City,United States of America,"New York City, United States",40.71,-74.01,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:45:33.703000,geo:GSM434371,,1,21,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19915670,"Brennan C, Momota H et al. (2009): Glioblastoma subclasses can be defined by...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL4091,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE17381,,,,,,,,,,,,,,,,,M
5dc180df09d374f6dd7f879a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2pw,P13Y4M,pgxind-kftx62ty,pgxcs-kftwogr8,2394010711,0.833,1438368152,0.5,955642559,0.332,PGX_AM_BS_GSM487776,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.611000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487776,,,,,,,,,,,,,,,,,
5dc180df09d374f6dd7f87fa,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2py,P11Y,pgxind-kftx62u0,pgxcs-kftwogrj,1191936,0,479542,0,712394,0,PGX_AM_BS_GSM487777,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.613000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,21.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487777,,,,,,,,,,,,,,,,,
5dc180df09d374f6dd7f880d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2pz,P21Y,pgxind-kftx62u2,pgxcs-kftwogrv,518059331,0.18,411819365,0.143,106239966,0.037,PGX_AM_BS_GSM487778,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.614000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487778,,,,,,,,,,,,,,,,,
5dc180df09d374f6dd7f8859,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2q1,P9Y4M,pgxind-kftx62u4,pgxcs-kftwogs6,587565761,0.204,468661927,0.163,118903834,0.041,PGX_AM_BS_GSM487779,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.615000,geo:GSM487779,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180e009d374f6dd7f888e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2q4,P25Y4M,pgxind-kftx62u8,pgxcs-kftwogst,1753261384,0.61,1028043372,0.358,725218012,0.252,PGX_AM_BS_GSM487781,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.617000,geo:GSM487781,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e009d374f6dd7f89b8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2q6,P11Y,pgxind-kftx62ua,pgxcs-kftwogt6,2364481,0.001,26245,0,2338236,0.001,PGX_AM_BS_GSM487782,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.618000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487782,,,,,,,,,,,,,,,,,
5dc180e009d374f6dd7f89c0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2q7,P7Y,pgxind-kftx62uc,pgxcs-kftwogth,1200925900,0.418,382632510,0.133,818293390,0.285,PGX_AM_BS_GSM487783,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.619000,geo:GSM487783,,1,19.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e109d374f6dd7f8a16,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qc,P14Y10M,pgxind-kftx62ui,pgxcs-kftwoguf,423970283,0.147,181572540,0.063,242397743,0.084,PGX_AM_BS_GSM487786,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.622000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,31.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487786,,,,,,,,,,,,,,,,,
5dc180e109d374f6dd7f8a2e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qe,P18Y2M,pgxind-kftx62uk,pgxcs-kftwogur,463824208,0.161,303219110,0.105,160605098,0.056,PGX_AM_BS_GSM487787,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.623000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487787,,,,,,,,,,,,,,,,,
5dc180e109d374f6dd7f8a6e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qh,P15Y8M,pgxind-kftx62uo,pgxcs-kftwogve,24733812,0.009,13028989,0.005,11704823,0.004,PGX_AM_BS_GSM487789,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.625000,geo:GSE19578,,1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487789,,,,,,,,,,,,,,,,,
5dc180e109d374f6dd7f8a81,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qi,P27Y4M,pgxind-kftx62uq,pgxcs-kftwogvp,602275190,0.209,271411388,0.094,330863802,0.115,PGX_AM_BS_GSM487790,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.626000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487790,,,,,,,,,,,,,,,,,
5dc180e209d374f6dd7f8aad,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qm,P2Y8M,pgxind-kftx62uu,pgxcs-kftwogwc,3262577,0.001,1548,0,3261029,0.001,PGX_AM_BS_GSM487792,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.628000,geo:GSM487792,,1,30,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180e209d374f6dd7f8ab7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qn,P13Y8M,pgxind-kftx62uw,pgxcs-kftwogwn,510677751,0.178,308029578,0.107,202648173,0.07,PGX_AM_BS_GSM487793,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.630000,geo:GPL3718,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487793,,,,,,,,,,,,,,,,,
5dc180e209d374f6dd7f8aeb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qp,P11Y2M,pgxind-kftx62uy,pgxcs-kftwogwy,55106235,0.019,52551997,0.018,2554238,0.001,PGX_AM_BS_GSM487794,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.631000,geo:GSM487794,,1,15.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e309d374f6dd7f8b03,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qr,P0Y10M,pgxind-kftx62v0,pgxcs-kftwogxa,3193127,0.001,172,0,3192955,0.001,PGX_AM_BS_GSM487795,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.632000,geo:GSM487795,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e309d374f6dd7f8b0c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qs,P10Y4M,pgxind-kftx62v2,pgxcs-kftwogxl,382325872,0.133,374610134,0.13,7715738,0.003,PGX_AM_BS_GSM487796,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.633000,geo:GPL3718,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487796,,,,,,,,,,,,,,,,,
5dc180e309d374f6dd7f8b27,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qu,P10Y10M,pgxind-kftx62v5,pgxcs-kftwogxw,228907789,0.08,119895726,0.042,109012063,0.038,PGX_AM_BS_GSM487797,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.634000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487797,,,,,,,,,,,,,,,,,
5dc180e309d374f6dd7f8b38,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qw,P7Y4M,pgxind-kftx62v7,pgxcs-kftwogy7,143474713,0.05,143034861,0.05,439852,0,PGX_AM_BS_GSM487798,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.635000,geo:GSM487798,,1,30,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e309d374f6dd7f8b58,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2qz,P10Y8M,pgxind-kftx62vb,pgxcs-kftwogyt,1373104,0,86390,0,1286714,0,PGX_AM_BS_GSM487800,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.637000,geo:GPL3718,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487800,,,,,,,,,,,,,,,,,
5dc180e409d374f6dd7f8b69,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r0,P15Y4M,pgxind-kftx62vd,pgxcs-kftwogz5,380065293,0.132,204255652,0.071,175809641,0.061,PGX_AM_BS_GSM487801,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.638000,geo:GSE19578,,1,8.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487801,,,,,,,,,,,,,,,,,
5dc180e409d374f6dd7f8b82,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r2,P17Y4M,pgxind-kftx62vf,pgxcs-kftwogzg,423548666,0.147,390310326,0.136,33238340,0.012,PGX_AM_BS_GSM487802,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.639000,geo:GPL3718,,1,20.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487802,,,,,,,,,,,,,,,,,
5dc180e409d374f6dd7f8bb6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r4,P14Y10M,pgxind-kftx62vh,pgxcs-kftwogzr,283158459,0.098,31753982,0.011,251404477,0.087,PGX_AM_BS_GSM487803,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.640000,geo:GSM487803,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180e409d374f6dd7f8bc7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r5,P20Y4M,pgxind-kftx62vj,pgxcs-kftwoh03,1991142210,0.693,951891595,0.331,1039250615,0.361,PGX_AM_BS_GSM487804,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.641000,geo:GPL3718,,1,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487804,,,,,,,,,,,,,,,,,
5dc180e509d374f6dd7f8c56,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r7,P6Y4M,pgxind-kftx62vl,pgxcs-kftwoh0e,3079905,0.001,767876,0,2312029,0.001,PGX_AM_BS_GSM487805,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.642000,geo:GSM487805,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e509d374f6dd7f8c68,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2r9,P5Y4M,pgxind-kftx62vn,pgxcs-kftwoh0p,8681190,0.003,8163124,0.003,518066,0,PGX_AM_BS_GSM487806,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.644000,geo:GSM487806,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e509d374f6dd7f8c7e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2ra,P12Y4M,pgxind-kftx62vp,pgxcs-kftwoh11,599282481,0.208,399044489,0.139,200237992,0.07,PGX_AM_BS_GSM487807,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.645000,geo:GSM487807,,1,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e509d374f6dd7f8cca,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rc,P12Y2M,pgxind-kftx62vr,pgxcs-kftwoh1c,178402485,0.062,130235584,0.045,48166901,0.017,PGX_AM_BS_GSM487808,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.646000,geo:GSM487808,,1,1.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e609d374f6dd7f8d19,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rh,P14Y4M,pgxind-kftx62vx,pgxcs-kftwoh2a,134320491,0.047,133561137,0.046,759354,0,PGX_AM_BS_GSM487811,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.649000,geo:GSM487811,,1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e609d374f6dd7f8d2f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2ri,P5Y,pgxind-kftx62vz,pgxcs-kftwoh2l,308929327,0.107,54345807,0.019,254583520,0.089,PGX_AM_BS_GSM487812,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.650000,geo:GSM487812,,1,2.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e609d374f6dd7f8d53,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rk,P10Y,pgxind-kftx62w1,pgxcs-kftwoh2w,560519005,0.195,209579619,0.073,350939386,0.122,PGX_AM_BS_GSM487813,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.651000,geo:GSE19578,,1,33,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487813,,,,,,,,,,,,,,,,,
5dc180e609d374f6dd7f8d6d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rm,P16Y,pgxind-kftx62w3,pgxcs-kftwoh38,1748524,0.001,743103,0,1005421,0,PGX_AM_BS_GSM487814,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.652000,geo:GSM487814,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e709d374f6dd7f8d7b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rn,P3Y,pgxind-kftx62w5,pgxcs-kftwoh3j,984232354,0.342,700840241,0.244,283392113,0.099,PGX_AM_BS_GSM487815,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.653000,geo:GSM487815,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc180e709d374f6dd7f8dea,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rr,P8Y,pgxind-kftx62wa,pgxcs-kftwoh45,520177527,0.181,222438701,0.077,297738826,0.104,PGX_AM_BS_GSM487817,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.655000,geo:GPL3718,,1,7.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487817,,,,,,,,,,,,,,,,,
5dc180e709d374f6dd7f8e77,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rs,P19Y,pgxind-kftx62wc,pgxcs-kftwoh4h,621155927,0.216,305144799,0.106,316011128,0.11,PGX_AM_BS_GSM487818,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.656000,geo:GPL3718,,1,13.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487818,,,,,,,,,,,,,,,,,
5dc180e709d374f6dd7f8e95,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2ru,P14Y,pgxind-kftx62we,pgxcs-kftwoh4r,625075738,0.217,415421728,0.144,209654010,0.073,PGX_AM_BS_GSM487819,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.657000,geo:GSE19578,,1,16.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487819,,,,,,,,,,,,,,,,,
5dc180e809d374f6dd7f8ec1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rx,P17Y2M,pgxind-kftx62wi,pgxcs-kftwoh5d,620469378,0.216,493163580,0.172,127305798,0.044,PGX_AM_BS_GSM487821,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.659000,geo:GSE19578,,1,27,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487821,,,,,,,,,,,,,,,,,
5dc180e809d374f6dd7f8f05,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2rz,P13Y10M,pgxind-kftx62wk,pgxcs-kftwoh5o,4259778,0.001,480688,0,3779090,0.001,PGX_AM_BS_GSM487822,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.660000,geo:GSM487822,,1,31.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc180e809d374f6dd7f8f1a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s1,P11Y4M,pgxind-kftx62wm,pgxcs-kftwoh5z,2721240887,0.947,1646241071,0.573,1074999816,0.374,PGX_AM_BS_GSM487823,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.661000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487823,,,,,,,,,,,,,,,,,
5dc180e909d374f6dd7f8f82,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s2,P22Y4M,pgxind-kftx62wo,pgxcs-kftwoh6b,735833258,0.256,477051739,0.166,258781519,0.09,PGX_AM_BS_GSM487824,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.663000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,13.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487824,,,,,,,,,,,,,,,,,
5dc180e909d374f6dd7f8fbe,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s4,P16Y8M,pgxind-kftx62wq,pgxcs-kftwoh6m,262992047,0.091,26080657,0.009,236911390,0.082,PGX_AM_BS_GSM487825,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.664000,geo:GSM487825,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180e909d374f6dd7f9019,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s6,P13Y10M,pgxind-kftx62ws,pgxcs-kftwoh6x,695171423,0.242,567291573,0.197,127879850,0.044,PGX_AM_BS_GSM487826,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.665000,geo:GSM487826,,1,8.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180e909d374f6dd7f9062,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s7,P18Y,pgxind-kftx62wu,pgxcs-kftwoh78,686132120,0.239,455711822,0.159,230420298,0.08,PGX_AM_BS_GSM487827,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.666000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487827,,,,,,,,,,,,,,,,,
5dc180ea09d374f6dd7f909d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Gliosarcoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2s9,P11Y8M,pgxind-kftx62ww,pgxcs-kftwoh7j,144132981,0.05,140326895,0.049,3806086,0.001,PGX_AM_BS_GSM487828,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.667000,geo:GSM487828,,1,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,,,,,,,,,,,,,
5dc180ea09d374f6dd7f90ba,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2sa,P8Y10M,pgxind-kftx62wy,pgxcs-kftwoh7v,151904,0,2541,0,149363,0,PGX_AM_BS_GSM487829,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.668000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,33.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM487829,,,,,,,,,,,,,,,,,
5dc180ea09d374f6dd7f90c6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2sc,P10Y8M,pgxind-kftx62x0,pgxcs-kftwoh86,504056403,0.175,498228696,0.173,5827707,0.002,PGX_AM_BS_GSM487830,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.669000,geo:GSM487830,,1,28.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837009d374f6dd82f3d3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yi,P13Y4M,pgxind-kftx680h,pgxcs-kftwpgi8,2345917497,0.816,1390605912,0.484,955311585,0.332,PGX_AM_BS_GSM487854,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.973000,geo:GPL3720,,1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487854,,,,,,,,,,,,,,,,,
5dc1837009d374f6dd82f404,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yk,P11Y,pgxind-kftx680j,pgxcs-kftwpgik,1787060,0.001,96713,0,1690347,0.001,PGX_AM_BS_GSM487855,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.974000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,21.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487855,,,,,,,,,,,,,,,,,
5dc1837009d374f6dd82f40b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yl,P21Y,pgxind-kftx680l,pgxcs-kftwpgiv,531701993,0.185,431037950,0.15,100664043,0.035,PGX_AM_BS_GSM487856,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.975000,geo:GSE19578,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487856,,,,,,,,,,,,,,,,,
5dc1837009d374f6dd82f429,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yn,P9Y4M,pgxind-kftx680o,pgxcs-kftwpgj6,683106283,0.238,542996612,0.189,140109671,0.049,PGX_AM_BS_GSM487857,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.977000,geo:GSM487857,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837109d374f6dd82f552,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6ys,P11Y,pgxind-kftx680u,pgxcs-kftwpgk4,2430,0,2430,0,0,0,PGX_AM_BS_GSM487860,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.980000,geo:GSM487860,,1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc1837109d374f6dd82f557,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yu,P7Y,pgxind-kftx680w,pgxcs-kftwpgkf,1296958616,0.451,386327982,0.134,910630634,0.317,PGX_AM_BS_GSM487861,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.981000,geo:GSE19578,,1,19.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487861,,,,,,,,,,,,,,,,,
5dc1837209d374f6dd82f58b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6yz,P14Y10M,pgxind-kftx6812,pgxcs-kftwpglc,428000152,0.149,184579957,0.064,243420195,0.085,PGX_AM_BS_GSM487864,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.984000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,31.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487864,,,,,,,,,,,,,,,,,
5dc1837209d374f6dd82f5a0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6z0,P18Y2M,pgxind-kftx6814,pgxcs-kftwpgln,427846949,0.149,249802892,0.087,178044057,0.062,PGX_AM_BS_GSM487865,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.985000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487865,,,,,,,,,,,,,,,,,
5dc1837209d374f6dd82f5d7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6z4,P15Y8M,pgxind-kftx6818,pgxcs-kftwpgma,34162829,0.012,22571692,0.008,11591137,0.004,PGX_AM_BS_GSM487867,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.987000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487867,,,,,,,,,,,,,,,,,
5dc1837309d374f6dd82f5e8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6z5,P27Y4M,pgxind-kftx681a,pgxcs-kftwpgml,636046921,0.221,272072259,0.095,363974662,0.127,PGX_AM_BS_GSM487868,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.988000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487868,,,,,,,,,,,,,,,,,
5dc1837309d374f6dd82f612,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6za,P13Y8M,pgxind-kftx681g,pgxcs-kftwpgni,550863511,0.192,341246402,0.119,209617109,0.073,PGX_AM_BS_GSM487871,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.992000,geo:GSE19578,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487871,,,,,,,,,,,,,,,,,
5dc1837309d374f6dd82f646,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zc,P11Y2M,pgxind-kftx681i,pgxcs-kftwpgnt,70273,0,70273,0,0,0,PGX_AM_BS_GSM487872,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.993000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,15.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487872,,,,,,,,,,,,,,,,,
5dc1837409d374f6dd82f64d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6ze,P0Y10M,pgxind-kftx681k,pgxcs-kftwpgo4,3174499,0.001,11653,0,3162846,0.001,PGX_AM_BS_GSM487873,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.994000,geo:GSM487873,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc1837409d374f6dd82f657,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zf,P10Y4M,pgxind-kftx681m,pgxcs-kftwpgof,370860421,0.129,370164679,0.129,695742,0,PGX_AM_BS_GSM487874,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.995000,geo:GSE19578,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487874,,,,,,,,,,,,,,,,,
5dc1837409d374f6dd82f66e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zh,P10Y10M,pgxind-kftx681o,pgxcs-kftwpgoq,251374448,0.087,121475420,0.042,129899028,0.045,PGX_AM_BS_GSM487875,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.996000,geo:GSM487875,,1,10.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837409d374f6dd82f67a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zj,P7Y4M,pgxind-kftx681q,pgxcs-kftwpgp1,141892964,0.049,141190491,0.049,702473,0,PGX_AM_BS_GSM487876,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.997000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,30,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487876,,,,,,,,,,,,,,,,,
5dc1837409d374f6dd82f686,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zm,P10Y8M,pgxind-kftx681u,pgxcs-kftwpgpn,227638,0,227638,0,0,0,PGX_AM_BS_GSM487878,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:33.999000,geo:GSM487878,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837509d374f6dd82f68c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zo,P15Y4M,pgxind-kftx681w,pgxcs-kftwpgpy,382707734,0.133,204398563,0.071,178309171,0.062,PGX_AM_BS_GSM487879,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},10.09.20 17:46,geo:GSM487879,,1,8.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837509d374f6dd82f69f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zp,P17Y4M,pgxind-kftx681y,pgxcs-kftwpgq9,423409709,0.147,390790119,0.136,32619590,0.011,PGX_AM_BS_GSM487880,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.001000,geo:GSM487880,,1,20.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837509d374f6dd82f6cd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zr,P14Y10M,pgxind-kftx6820,pgxcs-kftwpgqk,282738499,0.098,31526726,0.011,251211773,0.087,PGX_AM_BS_GSM487881,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.002000,geo:GSE19578,,1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487881,,,,,,,,,,,,,,,,,
5dc1837509d374f6dd82f6d7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zs,P20Y4M,pgxind-kftx6822,pgxcs-kftwpgqv,2086733077,0.726,972715480,0.338,1114017597,0.387,PGX_AM_BS_GSM487882,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.003000,geo:GSM487882,,1,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc1837609d374f6dd82f736,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zu,P6Y4M,pgxind-kftx6824,pgxcs-kftwpgr6,2171297,0.001,337436,0,1833861,0.001,PGX_AM_BS_GSM487883,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.004000,geo:GSM487883,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc1837609d374f6dd82f73d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zw,P5Y4M,pgxind-kftx6826,pgxcs-kftwpgrh,7045382,0.002,7018031,0.002,27351,0,PGX_AM_BS_GSM487884,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.005000,geo:GSM487884,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837609d374f6dd82f745,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zx,P12Y4M,pgxind-kftx6828,pgxcs-kftwpgrs,599484656,0.209,399219563,0.139,200265093,0.07,PGX_AM_BS_GSM487885,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.006000,geo:GSM487885,,1,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837609d374f6dd82f799,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk6zz,P12Y2M,pgxind-kftx682b,pgxcs-kftwpgs3,169320889,0.059,122077526,0.042,47243363,0.016,PGX_AM_BS_GSM487886,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.007000,geo:GSM487886,,1,1.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837709d374f6dd82f7c8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk704,P14Y4M,pgxind-kftx682g,pgxcs-kftwpgvu,134593737,0.047,134086801,0.047,506936,0,PGX_AM_BS_GSM487889,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.010000,geo:GSM487889,,1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837709d374f6dd82f7d2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk706,P5Y,pgxind-kftx682i,pgxcs-kftwpgw9,303645442,0.106,54613059,0.019,249032383,0.087,PGX_AM_BS_GSM487890,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.011000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,2.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487890,,,,,,,,,,,,,,,,,
5dc1837709d374f6dd82f7eb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk708,P10Y,pgxind-kftx682k,pgxcs-kftwpgwl,505392135,0.176,101858151,0.035,403533984,0.14,PGX_AM_BS_GSM487891,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.012000,geo:GSM487891,,1,33,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837709d374f6dd82f7fe,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk709,P16Y,pgxind-kftx682m,pgxcs-kftwpgww,1811044,0.001,841276,0,969768,0,PGX_AM_BS_GSM487892,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.013000,geo:GSM487892,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837809d374f6dd82f808,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70b,P3Y,pgxind-kftx682p,pgxcs-kftwpgx8,881633356,0.307,701269721,0.244,180363635,0.063,PGX_AM_BS_GSM487893,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.015000,geo:GSM487893,,1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837809d374f6dd82f858,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70e,P8Y,pgxind-kftx682t,pgxcs-kftwpgxu,565504022,0.197,172061400,0.06,393442622,0.137,PGX_AM_BS_GSM487895,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.017000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,7.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487895,,,,,,,,,,,,,,,,,
5dc1837809d374f6dd82f8cd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70g,P19Y,pgxind-kftx682v,pgxcs-kftwpgy6,618527707,0.215,305374339,0.106,313153368,0.109,PGX_AM_BS_GSM487896,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.018000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,13.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487896,,,,,,,,,,,,,,,,,
5dc1837809d374f6dd82f8ed,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70i,P14Y,pgxind-kftx682x,pgxcs-kftwpgyh,497594889,0.173,287312613,0.1,210282276,0.073,PGX_AM_BS_GSM487897,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.019000,geo:GSM487897,,1,16.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837909d374f6dd82f909,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70l,P17Y2M,pgxind-kftx6831,pgxcs-kftwpgz4,651695248,0.227,494912875,0.172,156782373,0.055,PGX_AM_BS_GSM487899,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.021000,geo:GSE19578,,1,27,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487899,,,,,,,,,,,,,,,,,
5dc1837909d374f6dd82f93a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70n,P13Y10M,pgxind-kftx6833,pgxcs-kftwpgzg,4704053,0.002,903856,0,3800197,0.001,PGX_AM_BS_GSM487900,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.022000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,31.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487900,,,,,,,,,,,,,,,,,
5dc1837909d374f6dd82f942,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70o,P11Y4M,pgxind-kftx6835,pgxcs-kftwpgzr,2783543329,0.968,1702670848,0.592,1080872481,0.376,PGX_AM_BS_GSM487901,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.023000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487901,,,,,,,,,,,,,,,,,
5dc1837909d374f6dd82f96d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70q,P22Y4M,pgxind-kftx6837,pgxcs-kftwph03,646374644,0.225,478114880,0.166,168259764,0.059,PGX_AM_BS_GSM487902,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.025000,geo:GSM487902,,1,13.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837a09d374f6dd82f995,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70s,P16Y8M,pgxind-kftx6839,pgxcs-kftwph0e,214262803,0.075,4685950,0.002,209576853,0.073,PGX_AM_BS_GSM487903,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.026000,geo:GSE19578,,1,4.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487903,,,,,,,,,,,,,,,,,
5dc1837a09d374f6dd82f9a7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70t,P13Y10M,pgxind-kftx683b,pgxcs-kftwph0p,648993979,0.226,503981582,0.175,145012397,0.05,PGX_AM_BS_GSM487904,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.027000,geo:GSM487904,,1,8.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3720,,,,,,,,,,,,,,,,,
5dc1837a09d374f6dd82f9d1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70v,P18Y,pgxind-kftx683d,pgxcs-kftwph11,567763128,0.197,435420854,0.151,132342274,0.046,PGX_AM_BS_GSM487905,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.028000,geo:GSM487905,,1,1.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837a09d374f6dd82f9f2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Gliosarcoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70x,P11Y8M,pgxind-kftx683f,pgxcs-kftwph1c,146346839,0.051,144878602,0.05,1468237,0.001,PGX_AM_BS_GSM487906,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.029000,geo:GSE19578,,1,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487906,,,,,,,,,,,,,,,,,
5dc1837b09d374f6dd82fa02,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk70y,P8Y10M,pgxind-kftx683h,pgxcs-kftwph1n,129589,0,88010,0,41579,0,PGX_AM_BS_GSM487907,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.030000,geo:GSM487907,,1,33.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837b09d374f6dd82fa09,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.9,"brain, nos",pgxbs-kftvk710,P10Y8M,pgxind-kftx683j,pgxcs-kftwph1y,515104781,0.179,513048807,0.178,2055974,0.001,PGX_AM_BS_GSM487908,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.031000,geo:GSE19578,,1,28.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM487908,,,,,,,,,,,,,,,,,
5dc1842609d374f6dd8384fa,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk89y,P10Y4M,pgxind-kl8hk4up,pgxcs-kftwppsq,554429312,0.193,368971195,0.128,185458117,0.065,PGX_AM_BS_GSM535545,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.343000,geo:GSM535545,,1,6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0867,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL4091,,,,,,,,,geo:gse,geo:GSE21420,,,,,,,,,,,,,,,,,M
5dc1842709d374f6dd83855b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8a0,P4Y,pgxind-kl8hk4dg,pgxcs-kftwppt1,15311952,0.005,2068326,0.001,13243626,0.005,DIPG_BS_0868,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.344000,geo:GSM535546,,1,3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_GSM535546,,,geo:GSE21420,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,,,,,,,,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,M
5dc1842709d374f6dd838580,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8a1,P6Y,pgxind-kl8hk4c0,pgxcs-kftwpptd,346739789,0.121,259362531,0.09,87377258,0.03,DIPG_BS_0869,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.345000,geo:GSM535547,,1,12,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_GSM535547,,,geo:GSE21420,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,,,,,,,,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,M
5dc1842709d374f6dd838610,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8a6,P12Y8M,pgxind-kl8hk4b8,pgxcs-kftwppub,114996122,0.04,28829562,0.01,86166560,0.03,PGX_AM_BS_GSM535550,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.348000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,24,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0872,,,geo:GSE21420,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,,,,,,,,geo:gsm,geo:GSM535550,,,,,,,,,,,,,,,,,M
5dc1842909d374f6dd838860,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8ag,,pgxind-kl8hk41w,pgxcs-kftwppw9,446046905,0.155,256277703,0.089,189769202,0.066,DIPG_BS_0879,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.355000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_GSM535557,,,geo:GPL4091,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE21420,,,,,,,,,geo:gsm,geo:GSM535557,,,,,,,,,,,,,,,,,M
5dc1842a09d374f6dd8389e9,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8aq,P20Y4M,pgxind-kl8hk3tn,pgxcs-kftwppy7,300060434,0.104,218365387,0.076,81695047,0.028,DIPG_BS_0886,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.362000,geo:GSE21420,,1,48,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_GSM535564,,,geo:GPL4091,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,geo:gsm,geo:GSM535564,,,,,,,,,,,,,,,,,M
5dc1842a09d374f6dd838a3e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8ar,P9Y,pgxind-kl8hk4r3,pgxcs-kftwppyi,14544661,0.005,4447148,0.002,10097513,0.004,PGX_AM_BS_GSM535565,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.363000,geo:GSM535565,,1,20,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0887,,,geo:GSE21420,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,,,,,,,,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,M
5dc1842b09d374f6dd838a63,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.0,Cerebrum,pgxbs-kftvk8at,P9Y,pgxind-kftx69o0,pgxcs-kftwppyu,17888629,0.006,4717483,0.002,13171146,0.005,PGX_AM_BS_GSM535566,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:35.364000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,20,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE21420,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM535566,,,,,,,,,,,,,,,,,
5dc1842c09d374f6dd838c20,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvk8b6,P10Y10M,pgxind-kl8hk3jl,pgxcs-kftwpq1f,328949182,0.114,200672723,0.07,128276459,0.045,PGX_AM_BS_GSM535574,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:35.373000,geo:GSE21420,,1,11,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0858,,,geo:GPL4091,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,geo:gsm,geo:GSM535574,,,,,,,,,,,,,,,,,F
5dc1842c09d374f6dd838c46,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvk8b7,P10Y4M,pgxind-kftx69oi,pgxcs-kftwpq1q,1456691621,0.507,425677211,0.148,1031014410,0.359,PGX_AM_BS_GSM535575,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:35.374000,geo:GSM535575,,1,10,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE21420,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL4091,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,,,,,,,,,
5dc1842d09d374f6dd838de3,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvk8bb,P17Y,pgxind-kl8hk4v2,pgxcs-kftwpq2e,1402065231,0.488,883131073,0.307,518934158,0.18,DIPG_BS_0861,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:35.376000,geo:GSM535577,,1,1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_GSM535577,,,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL4091,,,,,,,,,geo:gse,geo:GSE21420,,,,,,,,,,,,,,,,,M
5dc1842d09d374f6dd838e25,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvk8bc,P17Y10M,pgxind-kl8hk4g9,pgxcs-kftwpq2p,140168892,0.049,123439344,0.043,16729548,0.006,PGX_AM_BS_GSM535578,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:35.377000,geo:GSE21420,,1,16,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0862,,,geo:GPL4091,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",,,,,,,,geo:gsm,geo:GSM535578,,,,,,,,,,,,,,,,,M
5dc1842e09d374f6dd838eb6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Glioblastoma,NCIT:C3058,Glioblastoma,icdom-94403,Glioblastoma,icdot-C71.7,brain stem,pgxbs-kftvk8bh,P9Y,pgxind-kftx69ou,pgxcs-kftwpq3o,1446043571,0.503,527730485,0.184,918313086,0.319,PGX_AM_BS_GSM535581,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:35.381000,PMID:21138945,"Barrow J, Adamowicz-Brice M et al. (2011): Homozygous loss of ADAM3A revealed by...",1,5,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL4091,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE21420,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM535581,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghld,P2Y,pgxind-kftx27eg,pgxcs-kftvltis,70736035,0.025,70736035,0.025,0,0,PGX_AM_BS_MedBlast-rea-02,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.876000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,109.2,,,T2M3,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlf,P1Y8M,pgxind-kftx27ei,pgxcs-kftvltj8,2368498857,0.824,1155816975,0.402,1212681882,0.422,PGX_AM_BS_MedBlast-rea-03,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.877000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,85.2,,,T3M1,NCITstage-C27970,Stage III,TNM-C48700,M1 Stage Finding,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlh,P2Y7M,pgxind-kftx27ej,pgxcs-kftvltjq,1154065251,0.401,739105365,0.257,414959886,0.144,PGX_AM_BS_MedBlast-rea-04,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.879000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,86.4,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlm,P10Y,pgxind-kftx27eq,pgxcs-kftvltl5,876023023,0.305,384033490,0.134,491989533,0.171,PGX_AM_BS_MedBlast-rea-07,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.883000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,99.6,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghln,P19Y11M,pgxind-kftx27es,pgxcs-kftvltlm,0,0,0,0,0,0,PGX_AM_BS_MedBlast-rea-08,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.885000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,86.4,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlr,P4Y10M,pgxind-kftx27ew,pgxcs-kftvltmj,279792419,0.097,86594805,0.03,193197614,0.067,PGX_AM_BS_MedBlast-rea-10,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.888000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,32.4,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghls,P9Y4M,pgxind-kftx27ey,pgxcs-kftvltot,2099145892,0.73,982675368,0.342,1116470524,0.388,PGX_AM_BS_MedBlast-rea-11,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.889000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,46.8,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlu,P7Y11M,pgxind-kftx27f0,pgxcs-kftvltpc,598221651,0.208,406308080,0.141,191913571,0.067,PGX_AM_BS_MedBlast-rea-12,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.890000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,40.8,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlx,P7Y6M,pgxind-kftx27f4,pgxcs-kftvltqb,1160065558,0.404,829130424,0.288,330935134,0.115,PGX_AM_BS_MedBlast-rea-14,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.893000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,123.6,,,T2M3,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlz,P4Y4M,pgxind-kftx27f6,pgxcs-kftvltqs,146594864,0.051,86594805,0.03,60000059,0.021,PGX_AM_BS_MedBlast-rea-15,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.895000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,9.6,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad65,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm2,P11Y4M,pgxind-kftx27fa,pgxcs-kftvltrp,517831046,0.18,517831046,0.18,0,0,PGX_AM_BS_MedBlast-rea-17,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.897000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,98.4,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad66,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm4,P9Y11M,pgxind-kftx27fc,pgxcs-kftvlts6,1007457758,0.35,544622419,0.189,462835339,0.161,PGX_AM_BS_MedBlast-rea-18,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.899000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,70.8,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad67,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm5,P8Y10M,pgxind-kftx27fe,pgxcs-kftvltsn,193006172,0.067,193006172,0.067,0,0,PGX_AM_BS_MedBlast-rea-19,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.900000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,81.6,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad68,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm7,P6Y1M,pgxind-kftx27fg,pgxcs-kftvltt4,1302310718,0.453,830933970,0.289,471376748,0.164,PGX_AM_BS_MedBlast-rea-20,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.902000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,108,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad69,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm9,P15Y4M,pgxind-kftx27fi,pgxcs-kftvlttl,781833098,0.272,203773406,0.071,578059692,0.201,PGX_AM_BS_MedBlast-rea-21,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.903000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,61.2,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghma,P16Y1M,pgxind-kftx27fj,pgxcs-kftvltu2,382735186,0.133,167338804,0.058,215396382,0.075,PGX_AM_BS_MedBlast-rea-22,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.905000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,55.2,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghmd,P4Y8M,pgxind-kftx27fn,pgxcs-kftvltv0,759632318,0.264,223279862,0.078,536352456,0.187,PGX_AM_BS_MedBlast-rea-24,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.908000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,98.4,,,T3M1,NCITstage-C27970,Stage III,TNM-C48700,M1 Stage Finding,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghmf,P12Y6M,pgxind-kftx27fp,pgxcs-kftvltvi,778048582,0.271,403266541,0.14,374782041,0.13,PGX_AM_BS_MedBlast-rea-25,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.909000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,48,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghmh,P6Y,pgxind-kftx27fs,pgxcs-kftvltvz,283579231,0.099,130054800,0.045,153524431,0.053,PGX_AM_BS_MedBlast-rea-26,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.911000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,69.6,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghmi,P11Y10M,pgxind-kftx27ft,pgxcs-kftvltwh,694225518,0.241,255812634,0.089,438412884,0.152,PGX_AM_BS_MedBlast-rea-27,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.912000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",0,86.4,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abde1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmy5,P24Y,pgxind-kftx2dwh,pgxcs-kftvnf7j,57752982,0.02,33514042,0.012,24238940,0.008,PGX_AM_BS_Medblast-pfi-1M23,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.898000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,84,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyi,P46Y,pgxind-kftx2dwx,pgxcs-kftvnfb8,355710898,0.124,315510858,0.11,40200040,0.014,PGX_AM_BS_Medblast-pfi-2M17,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.909000,geo:GSE8634,,0,68,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyk,P32Y,pgxind-kftx2dwz,pgxcs-kftvnfbp,117400117,0.041,110600110,0.038,6800007,0.002,PGX_AM_BS_Medblast-pfi-2M3,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.911000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,92,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdeb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyl,P19Y,pgxind-kftx2dx1,pgxcs-kftvnfc5,12772289,0.004,672277,0,12100012,0.004,PGX_AM_BS_Medblast-pfi-2M6,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.912000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,72,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abded,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyp,P24Y,pgxind-kftx2dx5,pgxcs-kftvnfd3,271966294,0.095,174815627,0.061,97150667,0.034,PGX_AM_BS_MedBlast-pfi-5M1,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.915000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,61,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyq,P26Y,pgxind-kftx2dx7,pgxcs-kftvnfdk,1388106294,0.483,480810379,0.167,907295915,0.316,PGX_AM_BS_MedBlast-pfi-5M10,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.917000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,12,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmys,P27Y,pgxind-kftx2dx9,pgxcs-kftvnfe1,80423626,0.028,20603171,0.007,59820455,0.021,PGX_AM_BS_MedBlast-pfi-5M12,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.918000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,16,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdf0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyu,P44Y,pgxind-kftx2dxb,pgxcs-kftvnfei,313924951,0.109,274441489,0.095,39483462,0.014,PGX_AM_BS_MedBlast-pfi-5M13,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.920000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,38,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyv,P27Y,pgxind-kftx2dxd,pgxcs-kftvnfey,896732100,0.312,534402702,0.186,362329398,0.126,PGX_AM_BS_MedBlast-pfi-5M14,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.921000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,16,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdf2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyx,P27Y,pgxind-kftx2dxf,pgxcs-kftvnfff,152594002,0.053,42548822,0.015,110045180,0.038,PGX_AM_BS_MedBlast-pfi-5M15,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.923000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,55,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmz0,P18Y,pgxind-kftx2dxj,pgxcs-kftvnfgc,121879560,0.042,121500487,0.042,379073,0,PGX_AM_BS_MedBlast-pfi-5M17,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.925000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,28,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmz2,P46Y,pgxind-kftx2dxm,pgxcs-kftvnfgt,1066038589,0.371,919972826,0.32,146065763,0.051,PGX_AM_BS_MedBlast-pfi-5M18,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.927000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmz7,P20Y,pgxind-kftx2dxs,pgxcs-kftvnfi7,1893123,0.001,350929,0,1542194,0.001,PGX_AM_BS_MedBlast-pfi-5M3,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.931000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,36,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmz8,P25Y,pgxind-kftx2dxu,pgxcs-kftvnfio,658413078,0.229,383234573,0.133,275178505,0.096,PGX_AM_BS_MedBlast-pfi-5M4,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.933000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,27,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdfa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmza,P19Y,pgxind-kftx2dxw,pgxcs-kftvnfj5,267051375,0.093,267051375,0.093,0,0,PGX_AM_BS_MedBlast-pfi-5M5,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.934000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,84,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdfb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmzc,P18Y,pgxind-kftx2dxy,pgxcs-kftvnfjl,2817719,0.001,2817719,0.001,0,0,PGX_AM_BS_MedBlast-pfi-5M6,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.936000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,55,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdfc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmzd,P18Y,pgxind-kftx2dy0,pgxcs-kftvnfk2,270104901,0.094,214168671,0.074,55936230,0.019,PGX_AM_BS_MedBlast-pfi-5M7,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.937000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,48,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdfe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmzh,P48Y,pgxind-kftx2dy4,pgxcs-kftvnfl0,500912563,0.174,362028808,0.126,138883755,0.048,PGX_AM_BS_MedBlast-pfi-5M9,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.940000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,46,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac89a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqej,P11Y,pgxind-kftx2i7n,pgxcs-kftvoguu,435013147,0.151,298813011,0.104,136200136,0.047,PGX_AM_BS_19378321_LFS-rie-01,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.704000,PMID:19378321,"Rieber J, Remke M et al. (2009): Novel oncogene amplifications in tumors from...",0,36,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac8da,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqhe,P6Y7M,pgxind-kftx2ib9,pgxcs-kftvohry,81155607,0.028,18423487,0.006,62732120,0.022,PGX_AM_BS_19270706_MBL-nor-MDT-MB-004,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.791000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,176,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac8db,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqhf,P6Y7M,pgxind-kftx2ibb,pgxcs-kftvohsf,976849548,0.34,721683229,0.251,255166319,0.089,PGX_AM_BS_19270706_MBL-nor-MDT-MB-005,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.793000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,1,,,M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqhm,P3Y2M,pgxind-kftx2ibj,pgxcs-kftvohuc,511208157,0.178,456833811,0.159,54374346,0.019,PGX_AM_BS_19270706_MBL-nor-MDT-MB-009,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.798000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,124,,,M0,,,,,,,,,,,,geo:GSE14437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqiw,P4Y11M,pgxind-kftx2id4,pgxcs-kftvoi7r,889198852,0.309,502425885,0.175,386772967,0.135,PGX_AM_BS_19270706_MBL-nor-MDT-MB-038,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.837000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,111,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac907,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqjg,P5Y11M,pgxind-kftx2idt,pgxcs-kftvoidi,816110655,0.284,129624290,0.045,686486365,0.239,PGX_AM_BS_19270706_MBL-nor-MDT-MB-050,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.854000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,147,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac929,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [biphasic tumour, with nodular and non nodular content]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgql0,P5Y5M,pgxind-kftx2ifq,pgxcs-kftvoiw4,216876143,0.075,53805160,0.019,163070983,0.057,PGX_AM_BS_19270706_MBL-nor-MDT-MB-103,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.901000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,61,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac955,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular component makes up about 50 of the tumour],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqmz,,pgxind-kftx2ii7,pgxcs-kftvojha,565012415,0.197,404536234,0.141,160476181,0.056,PGX_AM_BS_19270706_MBL-nor-MDT-MB-150,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.962000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,59,,,M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac98b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqpf,P5Y,pgxind-kftx2il8,pgxcs-kftvok9k,503059352,0.175,268733725,0.093,234325627,0.082,PGX_AM_BS_19270706_MBL-nor-MDT-MB-207,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.036000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,139,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac98d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma with neuronal and glial differentiation,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqpi,P4Y2M,pgxind-kftx2ilc,pgxcs-kftvokai,338642830,0.118,0,0,338642830,0.118,PGX_AM_BS_19270706_MBL-nor-MDT-MB-209,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.039000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,150,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac98e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqpk,P12Y5M,pgxind-kftx2ile,pgxcs-kftvokb0,251800326,0.088,177297562,0.062,74502764,0.026,PGX_AM_BS_19270706_MBL-nor-MDT-MB-210,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.040000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,94,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac9a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma with neuronal differentiation,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqqj,P6Y8M,pgxind-kftx2imk,pgxcs-kftvokl2,703380547,0.245,400283153,0.139,303097394,0.105,PGX_AM_BS_19270706_MBL-nor-MDT-MB-208,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.069000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,121,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca20,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqw6,P8Y,pgxind-kftx2itm,pgxcs-kftvomb5,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pfi-1M13,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.244000,geo:GSE8634,,0,87,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca21,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqw8,P10Y,pgxind-kftx2ito,pgxcs-kftvombm,434724581,0.151,398934347,0.139,35790234,0.012,PGX_AM_BS_MedBlast-pfi-1M14,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.245000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,78,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca22,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqw9,P13Y,pgxind-kftx2itq,pgxcs-kftvomc3,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pfi-1M15,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.246000,geo:GSE8634,,0,87,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca23,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwb,P11Y,pgxind-kftx2its,pgxcs-kftvomck,170092863,0.059,170092863,0.059,0,0,PGX_AM_BS_MedBlast-pfi-1M16,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.248000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,83,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca29,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwl,P12Y,pgxind-kftx2iu4,pgxcs-kftvomfh,328902401,0.114,226911734,0.079,101990667,0.035,PGX_AM_BS_MedBlast-pfi-1M22,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.257000,geo:GSE8634,,0,85,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwt,P8Y,pgxind-kftx2iue,pgxcs-kftvomhv,497951593,0.173,103043830,0.036,394907763,0.137,PGX_AM_BS_MedBlast-pfi-1M32,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.263000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,74,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca2f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwv,P12Y,pgxind-kftx2iug,pgxcs-kftvomic,2657017613,0.924,1265049513,0.44,1391968100,0.484,PGX_AM_BS_MedBlast-pfi-1M33,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.265000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,65,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwx,P12Y,pgxind-kftx2iuj,pgxcs-kftvomiu,172781530,0.06,170582403,0.059,2199127,0.001,PGX_AM_BS_MedBlast-pfi-1M4,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.266000,geo:GSE8634,,0,84,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwy,P8Y,pgxind-kftx2iul,pgxcs-kftvomlm,947710864,0.33,337717437,0.117,609993427,0.212,PGX_AM_BS_MedBlast-pfi-1M6,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.268000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,88,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca33,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqx1,P1Y,pgxind-kftx2iup,pgxcs-kftvommn,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pfi-1M8,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.271000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,72,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca35,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqx5,P16Y,pgxind-kftx2iut,pgxcs-kftvomnl,742392171,0.258,440315753,0.153,302076418,0.105,PGX_AM_BS_MedBlast-pfi-2M12,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.273000,geo:GSE8634,,0,38,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqx6,P3Y,pgxind-kftx2iuv,pgxcs-kftvomo3,81343413,0.028,21665278,0.008,59678135,0.021,PGX_AM_BS_MedBlast-pfi-2M13,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.275000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,48,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxa,P7Y,pgxind-kftx2iuz,pgxcs-kftvomp1,1437899063,0.5,925669679,0.322,512229384,0.178,PGX_AM_BS_MedBlast-pfi-2M15,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.278000,geo:GSE8634,,0,56,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxb,P9Y,pgxind-kftx2iv1,pgxcs-kftvompj,986394966,0.343,570190434,0.198,416204532,0.145,PGX_AM_BS_MedBlast-pfi-2M16,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.279000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,71,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxe,P13Y,pgxind-kftx2iv5,pgxcs-kftvomqh,151309928,0.053,91165267,0.032,60144661,0.021,PGX_AM_BS_MedBlast-pfi-2M19,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.282000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,56,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxg,P10Y,pgxind-kftx2iv7,pgxcs-kftvomqz,291696974,0.101,267759080,0.093,23937894,0.008,PGX_AM_BS_MedBlast-pfi-2M2,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.283000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,62,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxj,P7Y,pgxind-kftx2ivb,pgxcs-kftvomry,553794880,0.193,94835358,0.033,458959522,0.16,PGX_AM_BS_MedBlast-pfi-2M21,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.286000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,72,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca3f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxl,P11Y,pgxind-kftx2ivd,pgxcs-kftvomsf,2418969,0.001,2418969,0.001,0,0,PGX_AM_BS_MedBlast-pfi-2M22,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.287000,geo:GSE8634,,0,68,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxn,P10Y,pgxind-kftx2ivf,pgxcs-kftvomsw,784049163,0.273,458435905,0.159,325613258,0.113,PGX_AM_BS_MedBlast-pfi-2M4,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.289000,geo:GSE8634,,0,71,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxo,P5Y,pgxind-kftx2ivh,pgxcs-kftvomtd,667064028,0.232,376373665,0.131,290690363,0.101,PGX_AM_BS_MedBlast-pfi-2M5,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.290000,geo:GSE8634,,0,55,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxq,P4Y,pgxind-kftx2ivj,pgxcs-kftvomtu,858505773,0.299,175127595,0.061,683378178,0.238,PGX_AM_BS_MedBlast-pfi-2M7,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.292000,geo:GSE8634,,0,48,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxv,P10Y,pgxind-kftx2ivp,pgxcs-kftvomva,1306326582,0.454,645392293,0.224,660934289,0.23,PGX_AM_BS_MedBlast-pfi-3M2,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.296000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,12,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqy0,P9Y,pgxind-kftx2ivv,pgxcs-kftvomwp,202324000,0.07,123374068,0.043,78949932,0.027,PGX_AM_BS_MedBlast-pfi-3M6,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.300000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,24,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqy9,P14Y,pgxind-kftx2iw5,pgxcs-kftvomz3,1087728669,0.378,565154072,0.197,522574597,0.182,PGX_AM_BS_MedBlast-pfi-4M43,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.307000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,24,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqym,P8Y,pgxind-kftx2iwl,pgxcs-kftvon2y,178761884,0.062,170582403,0.059,8179481,0.003,PGX_AM_BS_MedBlast-pfi-4M8,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.318000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,16,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqyp,P5Y,pgxind-kftx2iwp,pgxcs-kftvon3x,1168810061,0.407,648085359,0.225,520724702,0.181,PGX_AM_BS_MedBlast-pfi-M1000,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.321000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,29,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqyr,P4Y,pgxind-kftx2iwr,pgxcs-kftvon4e,220620958,0.077,142638488,0.05,77982470,0.027,PGX_AM_BS_MedBlast-pfi-M1001,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.323000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqyu,P11Y,pgxind-kftx2iww,pgxcs-kftvon5d,168835815,0.059,168835815,0.059,0,0,PGX_AM_BS_MedBlast-pfi-M1015,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.325000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,36,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqyw,P13Y,pgxind-kftx2iwy,pgxcs-kftvon5u,76294312,0.027,16149651,0.006,60144661,0.021,PGX_AM_BS_MedBlast-pfi-M1017,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.327000,geo:GSE8634,,0,38,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqz7,P3Y,pgxind-kftx2ixc,pgxcs-kftvon98,76737330,0.027,16592669,0.006,60144661,0.021,PGX_AM_BS_MedBlast-pfi-M246,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.337000,geo:GSE8634,,0,22,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca69,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzi,P3Y,pgxind-kftx2ixq,pgxcs-kftvoncm,1399445518,0.487,632422672,0.22,767022846,0.267,PGX_AM_BS_MedBlast-pfi-M516,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.346000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,92,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzk,P13Y,pgxind-kftx2ixs,pgxcs-kftvond4,249919943,0.087,191513322,0.067,58406621,0.02,PGX_AM_BS_MedBlast-pfi-M518,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.348000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,86,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzq,P4Y,pgxind-kftx2iy0,pgxcs-kftvonf1,550618938,0.192,130542475,0.045,420076463,0.146,PGX_AM_BS_MedBlast-pfi-M564,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.353000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,85,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzs,P8Y,pgxind-kftx2iy2,pgxcs-kftvonfi,745442572,0.259,274279263,0.095,471163309,0.164,PGX_AM_BS_MedBlast-pfi-M575,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.355000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,100,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca70,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzu,P8Y,pgxind-kftx2iy4,pgxcs-kftvonfz,379248244,0.132,166789357,0.058,212458887,0.074,PGX_AM_BS_MedBlast-pfi-M599,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.356000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,66,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca71,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzv,P5Y,pgxind-kftx2iy6,pgxcs-kftvongh,93844841,0.033,16306441,0.006,77538400,0.027,PGX_AM_BS_MedBlast-pfi-M601,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.358000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,92,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca72,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzx,P5Y,pgxind-kftx2iy8,pgxcs-kftvongy,382768214,0.133,237861192,0.083,144907022,0.05,PGX_AM_BS_MedBlast-pfi-M612,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.359000,geo:GSE8634,,0,76,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca75,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr02,P9Y,pgxind-kftx2iye,pgxcs-kftvonie,71031225,0.025,13524009,0.005,57507216,0.02,PGX_AM_BS_MedBlast-pfi-M639,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.363000,geo:GSE8634,,0,72,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca7a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0a,P10Y,pgxind-kftx2iyo,pgxcs-kftvonks,1018281743,0.354,480974003,0.167,537307740,0.187,PGX_AM_BS_MedBlast-pfi-M667,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.370000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,92,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca7e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0h,P4Y,pgxind-kftx2iyx,pgxcs-kftvonmp,377959457,0.131,159460776,0.055,218498681,0.076,PGX_AM_BS_MedBlast-pfi-M751,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.376000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,78,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca7f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0i,P2Y,pgxind-kftx2iyz,pgxcs-kftvonn7,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pfi-M772,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.377000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,143,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca80,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0k,P15Y,pgxind-kftx2iz1,pgxcs-kftvonnn,340182005,0.118,38744343,0.013,301437662,0.105,PGX_AM_BS_MedBlast-pfi-M879,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.379000,geo:GSE8634,,0,79,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca82,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0n,P14Y,pgxind-kftx2iz5,pgxcs-kftvonom,426544596,0.148,187171344,0.065,239373252,0.083,PGX_AM_BS_MedBlast-pfi-M987,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.382000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,32,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca83,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0p,P6Y,pgxind-kftx2iz7,pgxcs-kftvonp3,1493054282,0.519,696942447,0.242,796111835,0.277,PGX_AM_BS_MedBlast-pfi-M997,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.383000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,43,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acad4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4c,P7Y7M,pgxind-kftx2j3t,pgxcs-kftvooup,145892504,0.051,0,0,145892504,0.051,PGX_AM_BS_19197950_MB100.1297,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.497000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,99.7,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acad7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4h,P6Y10M,pgxind-kftx2j3z,pgxcs-kftvoow7,120774863,0.042,51400051,0.018,69374812,0.024,PGX_AM_BS_19197950_MB103.1321,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.501000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,124.1,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acadc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4p,P8Y,pgxind-kftx2j49,pgxcs-kftvooyl,241498265,0.084,176521262,0.061,64977003,0.023,PGX_AM_BS_19197950_MB108.1326,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.508000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,4,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acadd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4r,P5Y3M,pgxind-kftx2j4b,pgxcs-kftvooz2,268335074,0.093,135738774,0.047,132596300,0.046,PGX_AM_BS_19197950_MB109.1388,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.509000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,74.5,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acadf,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4u,P0Y9M,pgxind-kftx2j4f,pgxcs-kftvop25,0,0,0,0,0,0,PGX_AM_BS_19197950_MB111.1390,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.512000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,106.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acae0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4w,P11Y6M,pgxind-kftx2j4h,pgxcs-kftvop2n,252996419,0.088,0,0,252996419,0.088,PGX_AM_BS_19197950_MB112.1391,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.514000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,74.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acae4,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr52,P12Y3M,pgxind-kftx2j4p,pgxcs-kftvop4l,163306143,0.057,163306143,0.057,0,0,PGX_AM_BS_19197950_MB116.1397,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.519000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,69.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acae6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr55,P9Y7M,pgxind-kftx2j4t,pgxcs-kftvop5j,383726620,0.133,124030194,0.043,259696426,0.09,PGX_AM_BS_19197950_MB118.1399,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.522000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,95.1,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acae7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr57,P7Y9M,pgxind-kftx2j4v,pgxcs-kftvop60,627462136,0.218,589940674,0.205,37521462,0.013,PGX_AM_BS_19197950_MB119.1400,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.523000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,89.6,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acae8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr58,P9Y,pgxind-kftx2j4x,pgxcs-kftvop6i,0,0,0,0,0,0,PGX_AM_BS_19197950_MB120.1410,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.525000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,27.6,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaea,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5c,P7Y1M,pgxind-kftx2j51,pgxcs-kftvop7g,672789789,0.234,304483446,0.106,368306343,0.128,PGX_AM_BS_19197950_MB122.1441,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.527000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,75,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaec,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5f,P10Y2M,pgxind-kftx2j55,pgxcs-kftvop8e,125651659,0.044,43227298,0.015,82424361,0.029,PGX_AM_BS_19197950_MB124.1443,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.530000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,59.5,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acaee,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5i,P1Y1M,pgxind-kftx2j59,pgxcs-kftvop9d,9500009,0.003,0,0,9500009,0.003,PGX_AM_BS_19197950_MB126.1437,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.533000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,95.2,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaef,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5k,P5Y8M,pgxind-kftx2j5b,pgxcs-kftvop9u,0,0,0,0,0,0,PGX_AM_BS_19197950_MB127.1537,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.534000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,78.7,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5l,P6Y6M,pgxind-kftx2j5d,pgxcs-kftvopaa,82133717,0.029,68694787,0.024,13438930,0.005,PGX_AM_BS_19197950_MB128.1538,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.535000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,74.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acaf5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5u,P13Y3M,pgxind-kftx2j5o,pgxcs-kftvopco,296059856,0.103,175006154,0.061,121053702,0.042,PGX_AM_BS_19197950_MB133.5881,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.542000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,98.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5v,P11Y,pgxind-kftx2j5q,pgxcs-kftvopd6,100996269,0.035,22100022,0.008,78896247,0.027,PGX_AM_BS_19197950_MB134.5882,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.544000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,90.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr60,P7Y9M,pgxind-kftx2j5w,pgxcs-kftvopel,315982203,0.11,94793625,0.033,221188578,0.077,PGX_AM_BS_19197950_MB137.5885,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.548000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,84,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acafa,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr62,P6Y1M,pgxind-kftx2j5y,pgxcs-kftvopf3,46200045,0.016,16100016,0.006,30100029,0.01,PGX_AM_BS_19197950_MB138.5886,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.549000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,110,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acafc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr65,P7Y9M,pgxind-kftx2j62,pgxcs-kftvopg1,409642093,0.142,70900070,0.025,338742023,0.118,PGX_AM_BS_19197950_MB140.5971,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.552000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,114.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acafd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr66,P18Y,pgxind-kftx2j64,pgxcs-kftvopgj,0,0,0,0,0,0,PGX_AM_BS_19197950_MB141.5943,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.553000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,61.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acafe,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr68,P8Y8M,pgxind-kftx2j66,pgxcs-kftvoph0,117324396,0.041,22100022,0.008,95224374,0.033,PGX_AM_BS_19197950_MB142.5944,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.555000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,86.3,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb00,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6b,P14Y5M,pgxind-kftx2j6a,pgxcs-kftvophy,84974828,0.03,22100022,0.008,62874806,0.022,PGX_AM_BS_19197950_MB144.6024,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.557000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,72.2,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb01,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6d,P11Y3M,pgxind-kftx2j6c,pgxcs-kftvopif,131085251,0.046,117585238,0.041,13500013,0.005,PGX_AM_BS_19197950_MB145.5950,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.558000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,73.4,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb02,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6f,P8Y2M,pgxind-kftx2j6e,pgxcs-kftvopiw,503343445,0.175,425643368,0.148,77700077,0.027,PGX_AM_BS_19197950_MB146.6025,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.560000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,69.8,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb06,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6l,P6Y4M,pgxind-kftx2j6m,pgxcs-kftvopkt,68274811,0.024,22100022,0.008,46174789,0.016,PGX_AM_BS_19197950_MB23.703,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.565000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,113.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb08,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6o,P10Y4M,pgxind-kftx2j6q,pgxcs-kftvopls,694968889,0.242,180827434,0.063,514141455,0.179,PGX_AM_BS_19197950_MB30.704,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.568000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,176.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb0b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6t,P5Y3M,pgxind-kftx2j6w,pgxcs-kftvopn8,177549896,0.062,12649733,0.004,164900163,0.057,PGX_AM_BS_19197950_MB36.4735,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.572000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,123.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb0c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6v,P8Y9M,pgxind-kftx2j6y,pgxcs-kftvopnp,494923170,0.172,54427309,0.019,440495861,0.153,PGX_AM_BS_19197950_MB37.707,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.573000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,172,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb0d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6w,P3Y,pgxind-kftx2j70,pgxcs-kftvopo6,783944587,0.273,415887461,0.145,368057126,0.128,PGX_AM_BS_19197950_MB39.708,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.575000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,153.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb0e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6y,P14Y6M,pgxind-kftx2j72,pgxcs-kftvopon,347342030,0.121,48100047,0.017,299241983,0.104,PGX_AM_BS_19197950_MB41.709,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.576000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,167.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb10,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr71,P12Y3M,pgxind-kftx2j76,pgxcs-kftvoppm,556995496,0.194,243281862,0.085,313713634,0.109,PGX_AM_BS_19197950_MB44.711,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.579000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,155,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb12,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr74,P12Y,pgxind-kftx2j7a,pgxcs-kftvopqk,1074912251,0.374,67427321,0.023,1007484930,0.35,PGX_AM_BS_19197950_MB50.713,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.582000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,129,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb14,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr78,P11Y,pgxind-kftx2j7e,pgxcs-kftvoprj,207170208,0.072,0,0,207170208,0.072,PGX_AM_BS_19197950_MB67.715,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.584000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,115.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb19,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7g,P9Y,pgxind-kftx2j7p,pgxcs-kftvopty,508949060,0.177,217852603,0.076,291096457,0.101,PGX_AM_BS_19197950_MB72.720,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.591000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,87,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb1a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7h,P15Y4M,pgxind-kftx2j7r,pgxcs-kftvopuf,0,0,0,0,0,0,PGX_AM_BS_19197950_MB73.721,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.593000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,165.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb1e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7o,P12Y9M,pgxind-kftx2j7z,pgxcs-kftvopwd,201006179,0.07,170806150,0.059,30200029,0.011,PGX_AM_BS_19197950_MB77.725,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.598000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,121.2,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb24,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7y,P6Y,pgxind-kftx2j8b,pgxcs-kftvopz8,221432830,0.077,92157958,0.032,129274872,0.045,PGX_AM_BS_19197950_MB83.1281,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.606000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,29.2,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb25,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr80,P12Y2M,pgxind-kftx2j8d,pgxcs-kftvopzp,396022095,0.138,267897689,0.093,128124406,0.045,PGX_AM_BS_19197950_MB84b.1282,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.608000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,115,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb2a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr87,P11Y2M,pgxind-kftx2j8n,pgxcs-kftvoq24,126089425,0.044,37100037,0.013,88989388,0.031,PGX_AM_BS_19197950_MB89.1287,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.615000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,108.8,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb2e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr8e,P14Y1M,pgxind-kftx2j8v,pgxcs-kftvoq41,66472232,0.023,28097451,0.01,38374781,0.013,PGX_AM_BS_19197950_MB94.1292,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.620000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,73.8,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad73e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv3g,P12Y,pgxind-kftx2o2p,pgxcs-kftvpx9x,503553822,0.175,0,0,503553822,0.175,PGX_AM_BS_18056178_MB-lo-J1002,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.877000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,117,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad742,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv3n,P24Y,pgxind-kftx2o2y,pgxcs-kftvpxbv,158543169,0.055,21732444,0.008,136810725,0.048,PGX_AM_BS_18056178_MB-lo-J1007,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.882000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,113,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad74e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv46,P13Y,pgxind-kftx2o3m,pgxcs-kftvpxjk,134655814,0.047,203295,0,134452519,0.047,PGX_AM_BS_18056178_MB-lo-J1025,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.900000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,37,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad74f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv48,P10Y,pgxind-kftx2o3o,pgxcs-kftvpxk1,85612124,0.03,22200022,0.008,63412102,0.022,PGX_AM_BS_18056178_MB-lo-J1026,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.902000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,40,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad750,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medullomyoblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4a,P21Y,pgxind-kftx2o3q,pgxcs-kftvpxkj,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-J1054,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.903000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad752,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4d,P13Y,pgxind-kftx2o3u,pgxcs-kftvpxlh,722402278,0.251,376864980,0.131,345537298,0.12,PGX_AM_BS_18056178_MB-lo-J1115,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.906000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad753,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4f,P13Y,pgxind-kftx2o3w,pgxcs-kftvpxlz,284697967,0.099,103527357,0.036,181170610,0.063,PGX_AM_BS_18056178_MB-lo-J319,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.907000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad760,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv50,P10Y10M,pgxind-kftx2o4n,pgxcs-kftvpxs9,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-MD24,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.925000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,27,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad763,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv55,P5Y6M,pgxind-kftx2o4t,pgxcs-kftvpxtr,600114880,0.209,0,0,600114880,0.209,PGX_AM_BS_18056178_MB-lo-MD36,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.929000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,46,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad764,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv56,P12Y7M,pgxind-kftx2o4v,pgxcs-kftvpxu8,1009913761,0.351,502430150,0.175,507483611,0.177,PGX_AM_BS_18056178_MB-lo-MD37,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.931000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,51,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad767,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5b,P9Y4M,pgxind-kftx2o51,pgxcs-kftvpxvo,82396104,0.029,22200022,0.008,60196082,0.021,PGX_AM_BS_18056178_MB-lo-MD43,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.935000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,64,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad768,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5d,P5Y4M,pgxind-kftx2o53,pgxcs-kftvpxw5,510620888,0.178,170806150,0.059,339814738,0.118,PGX_AM_BS_18056178_MB-lo-MD44,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.936000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,66,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad769,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5e,P3Y6M,pgxind-kftx2o55,pgxcs-kftvpxwm,113008192,0.039,52900052,0.018,60108140,0.021,PGX_AM_BS_18056178_MB-lo-MD45,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.938000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,68,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad76a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5g,P13Y,pgxind-kftx2o57,pgxcs-kftvpxx4,327631378,0.114,139061695,0.048,188569683,0.066,PGX_AM_BS_18056178_MB-lo-MD49,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.939000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,74,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad76b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5h,P10Y,pgxind-kftx2o59,pgxcs-kftvpxxl,455882543,0.159,307510665,0.107,148371878,0.052,PGX_AM_BS_18056178_MB-lo-MD50,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.941000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,79,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad76c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv5j,P1Y8M,pgxind-kftx2o5b,pgxcs-kftvpxy2,522796647,0.182,0,0,522796647,0.182,PGX_AM_BS_18056178_MB-lo-MD52,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.942000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,80,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adde7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8n,P5Y1M,pgxind-kftx2qqv,pgxcs-kftvql6j,670588300,0.233,585989212,0.204,84599088,0.029,PGX_AM_BS_MedBlFav_cli_01,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.249000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,90,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adde8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8p,P6Y10M,pgxind-kftx2qqx,pgxcs-kftvql71,1624548404,0.565,509097130,0.177,1115451274,0.388,PGX_AM_BS_MedBlFav_cli_02,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.251000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,96,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adde9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8r,P8Y7M,pgxind-kftx2qqz,pgxcs-kftvql7i,164276167,0.057,111635114,0.039,52641053,0.018,PGX_AM_BS_MedBlFav_cli_03,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.252000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,87,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8s,P10Y5M,pgxind-kftx2qr1,pgxcs-kftvql7z,227076825,0.079,169362150,0.059,57714675,0.02,PGX_AM_BS_MedBlFav_cli_04,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.253000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,90,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8w,P9Y4M,pgxind-kftx2qr5,pgxcs-kftvql8y,325393753,0.113,64430489,0.022,260963264,0.091,PGX_AM_BS_MedBlFav_cli_06,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.256000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,66,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx8z,P6Y11M,pgxind-kftx2qr9,pgxcs-kftvql9w,498134031,0.173,287700819,0.1,210433212,0.073,PGX_AM_BS_MedBlFav_cli_08,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.259000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,74,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addf3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx98,P5Y4M,pgxind-kftx2qrj,pgxcs-kftvqlcb,913016719,0.318,565762814,0.197,347253905,0.121,PGX_AM_BS_MedBlFav_cli_13,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.265000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,57,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx99,P17Y11M,pgxind-kftx2qrl,pgxcs-kftvqlcs,274316835,0.095,24936028,0.009,249380807,0.087,PGX_AM_BS_MedBlFav_cli_14,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.267000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,73,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx9b,P4Y6M,pgxind-kftx2qrn,pgxcs-kftvqld9,667997718,0.232,476357521,0.166,191640197,0.067,PGX_AM_BS_MedBlFav_cli_15,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.268000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,90,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx9c,P3Y2M,pgxind-kftx2qrp,pgxcs-kftvqldr,58527039,0.02,0,0,58527039,0.02,PGX_AM_BS_MedBlFav_cli_16,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.270000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,125,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx9f,P10Y10M,pgxind-kftx2qrt,pgxcs-kftvqleq,0,0,0,0,0,0,PGX_AM_BS_MedBlFav_cli_18,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.272000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,19,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx9h,P9Y5M,pgxind-kftx2qrv,pgxcs-kftvqlf7,0,0,0,0,0,0,PGX_AM_BS_MedBlFav_cli_19,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.274000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,60,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae174,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyoz,P4Y1M,pgxind-kftx2s5w,pgxcs-kftvqxx4,612075176,0.213,370163888,0.129,241911288,0.084,PGX_AM_BS_MedBlast-deb-MB106,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.503000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,84,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae177,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyp4,P8Y4M,pgxind-kftx2s62,pgxcs-kftvqxyj,288655866,0.1,232081067,0.081,56574799,0.02,PGX_AM_BS_MedBlast-deb-MB112,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.507000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,19,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae178,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, with desmoplasia]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyp6,P10Y,pgxind-kftx2s64,pgxcs-kftvqxz1,469329991,0.163,167338804,0.058,301991187,0.105,PGX_AM_BS_MedBlast-deb-MB115,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.509000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,94,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae17a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyp9,P5Y6M,pgxind-kftx2s68,pgxcs-kftvqxzz,1165031349,0.405,764298478,0.266,400732871,0.139,PGX_AM_BS_MedBlast-deb-MB129,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.511000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,24,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae184,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypp,P6Y5M,pgxind-kftx2s6s,pgxcs-kftvqy4u,586082263,0.204,292088440,0.102,293993823,0.102,PGX_AM_BS_MedBlast-deb-MB229,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.526000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,65,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae187,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypu,P9Y,pgxind-kftx2s6y,pgxcs-kftvqy69,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MB309,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.530000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,55,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae189,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypy,P5Y1M,pgxind-kftx2s72,pgxcs-kftvqy77,282642946,0.098,153390432,0.053,129252514,0.045,PGX_AM_BS_MedBlast-deb-MB376,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.533000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,47,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae18b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyq1,P11Y6M,pgxind-kftx2s76,pgxcs-kftvqy86,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB383,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.536000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,46,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae192,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqd,P3Y1M,pgxind-kftx2s7l,pgxcs-kftvqybk,720970012,0.251,574069866,0.2,146900146,0.051,PGX_AM_BS_MedBlast-deb-MB647,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.546000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,26,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae194,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqg,P8Y7M,pgxind-kftx2s7p,pgxcs-kftvqyek,401415893,0.14,342598680,0.119,58817213,0.02,PGX_AM_BS_MedBlast-deb-MB651,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.549000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,27,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae196,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqk,P4Y2M,pgxind-kftx2s7t,pgxcs-kftvqyfl,916595578,0.319,664857482,0.231,251738096,0.088,PGX_AM_BS_MedBlast-deb-MB664,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.551000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae197,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [with neuronal, ganglionic and malanotic differentiation]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyql,P2Y7M,pgxind-kftx2s7v,pgxcs-kftvqyg3,114133349,0.04,48127303,0.017,66006046,0.023,PGX_AM_BS_MedBlast-deb-MB731,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.553000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae198,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [with focal nodularity and focal large cells],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqn,P6Y10M,pgxind-kftx2s7x,pgxcs-kftvqygk,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MB817,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.554000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae19c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqt,P18Y,pgxind-kftx2s85,pgxcs-kftvqyii,610996943,0.213,34327289,0.012,576669654,0.201,PGX_AM_BS_MedBlast-deb-MB953,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.560000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,12,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [intermediary],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyr0,P10Y10M,pgxind-kftx2s8d,pgxcs-kftvqykf,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MM05,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.565000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,53,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyr3,P9Y4M,pgxind-kftx2s8h,pgxcs-kftvqyld,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MM08,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.568000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,64,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [intermediary],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyr6,P5Y6M,pgxind-kftx2s8l,pgxcs-kftvqymc,1407938070,0.49,804077489,0.28,603860581,0.21,PGX_AM_BS_MedBlast-deb-MM10,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.571000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,46,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyr8,P8Y2M,pgxind-kftx2s8o,pgxcs-kftvqymt,560608172,0.195,405893461,0.141,154714711,0.054,PGX_AM_BS_MedBlast-deb-MM11,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.572000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,42,,,T3M1,NCITstage-C27970,Stage III,TNM-C48700,M1 Stage Finding,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrd,P12Y11M,pgxind-kftx2s8u,pgxcs-kftvqyo9,464385911,0.162,134722108,0.047,329663803,0.115,PGX_AM_BS_MedBlast-deb-MM15,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.576000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,74,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1aa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrg,P5Y4M,pgxind-kftx2s8y,pgxcs-kftvqyp8,312762825,0.109,170806150,0.059,141956675,0.049,PGX_AM_BS_MedBlast-deb-MM22,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.579000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,66,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1ac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrj,P3Y6M,pgxind-kftx2s92,pgxcs-kftvqyq6,476788796,0.166,252406231,0.088,224382565,0.078,PGX_AM_BS_MedBlast-deb-MM26,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.582000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,68,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1af,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyro,P1Y8M,pgxind-kftx2s98,pgxcs-kftvqyrm,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MM35,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.586000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,80,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrs,P9Y11M,pgxind-kftx2s9c,pgxcs-kftvqysk,549187105,0.191,301320537,0.105,247866568,0.086,PGX_AM_BS_MedBlast-deb-MM39,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.589000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,79,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyru,P7Y5M,pgxind-kftx2s9e,pgxcs-kftvqyt2,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MM40,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.590000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,35,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1b3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrv,P10Y10M,pgxind-kftx2s9g,pgxcs-kftvqytj,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MM42,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.592000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,27,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyry,P12Y7M,pgxind-kftx2s9k,pgxcs-kftvqyuh,963971432,0.335,496371031,0.173,467600401,0.163,PGX_AM_BS_MedBlast-deb-MM44,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.594000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,51,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1b6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgys0,P2Y7M,pgxind-kftx2s9m,pgxcs-kftvqyuz,1572786228,0.547,678582893,0.236,894203335,0.311,PGX_AM_BS_MedBlast-deb-MM45,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.596000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8f4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13m,P10Y11M,pgxind-kftx2v5j,pgxcs-kftvrotb,789635247,0.275,318724995,0.111,470910252,0.164,PGX_AM_BS_MedBlast-pan-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.558000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,134.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8f5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13o,P14Y11M,pgxind-kftx2v5l,pgxcs-kftvrott,312618991,0.109,291818970,0.102,20800021,0.007,PGX_AM_BS_MedBlast-pan-02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.559000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,64.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae8f7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13s,P2Y11M,pgxind-kftx2v5p,pgxcs-kftvrour,86949895,0.03,86949895,0.03,0,0,PGX_AM_BS_MedBlast-pan-04,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.562000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,166.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8fc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh140,P11Y10M,pgxind-kftx2v5z,pgxcs-kftvrox5,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-09,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.569000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,176.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae8fe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh144,P3Y10M,pgxind-kftx2v64,pgxcs-kftvroy4,452089542,0.157,440489530,0.153,11600012,0.004,PGX_AM_BS_MedBlast-pan-11,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.572000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,123.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae900,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh147,P14Y,pgxind-kftx2v68,pgxcs-kftvroz2,652194224,0.227,417255411,0.145,234938813,0.082,PGX_AM_BS_MedBlast-pan-13,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.574000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,72,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae902,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14a,P6Y11M,pgxind-kftx2v6c,pgxcs-kftvrp00,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-15,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.577000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,138,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae903,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14c,P10Y11M,pgxind-kftx2v6e,pgxcs-kftvrp0h,228033623,0.079,228033623,0.079,0,0,PGX_AM_BS_MedBlast-pan-16,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.579000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,126,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae904,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14e,P5Y5M,pgxind-kftx2v6g,pgxcs-kftvrp0z,195090473,0.068,78094796,0.027,116995677,0.041,PGX_AM_BS_MedBlast-pan-17,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.580000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,150,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae905,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14f,P5Y4M,pgxind-kftx2v6i,pgxcs-kftvrp1g,200494918,0.07,130194849,0.045,70300069,0.024,PGX_AM_BS_MedBlast-pan-18,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.581000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,129.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae906,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14h,P11Y8M,pgxind-kftx2v6k,pgxcs-kftvrp1x,28830712,0.01,28830712,0.01,0,0,PGX_AM_BS_MedBlast-pan-19,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.583000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,118.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae908,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14k,P9Y11M,pgxind-kftx2v6o,pgxcs-kftvrp2v,831055480,0.289,648359130,0.226,182696350,0.064,PGX_AM_BS_MedBlast-pan-21,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.585000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,158.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae909,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14m,P6Y2M,pgxind-kftx2v6q,pgxcs-kftvrp3c,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-22,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.587000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,104.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae90b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14p,P4Y6M,pgxind-kftx2v6u,pgxcs-kftvrp4b,759905959,0.264,316509350,0.11,443396609,0.154,PGX_AM_BS_MedBlast-pan-24,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.589000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,97.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae90d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14s,P6Y7M,pgxind-kftx2v6y,pgxcs-kftvrp5a,472274287,0.164,300052691,0.104,172221596,0.06,PGX_AM_BS_MedBlast-pan-26,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.592000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,124.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae90e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14u,P3Y10M,pgxind-kftx2v70,pgxcs-kftvrp5r,629196838,0.219,335909931,0.117,293286907,0.102,PGX_AM_BS_MedBlast-pan-27,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.594000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,114,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae910,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14x,P5Y2M,pgxind-kftx2v74,pgxcs-kftvrp6q,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-29,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.596000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,88.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae911,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14z,P5Y5M,pgxind-kftx2v77,pgxcs-kftvrp77,319201659,0.111,217677280,0.076,101524379,0.035,PGX_AM_BS_MedBlast-pan-30,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.598000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,104.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae914,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh154,P3Y1M,pgxind-kftx2v7d,pgxcs-kftvrp8m,929236697,0.323,124022258,0.043,805214439,0.28,PGX_AM_BS_MedBlast-pan-33,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.602000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,76.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae915,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh155,P10Y,pgxind-kftx2v7f,pgxcs-kftvrp93,904500513,0.315,541289408,0.188,363211105,0.126,PGX_AM_BS_MedBlast-pan-34,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.603000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",0,82.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0209,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, left hemisphere]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh956,P4Y,pgxind-kftx3576,pgxcs-kftvu6lb,701153567,0.244,264247367,0.092,436906200,0.152,PGX_AM_BS_MedBl-mic-PN01_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.437000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b020a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, vermis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh957,P17Y,pgxind-kftx3578,pgxcs-kftvu6lv,1386658111,0.482,393632861,0.137,993025250,0.345,PGX_AM_BS_MedBl-mic-PN02_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.438000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b020e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, vermis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95e,P4Y,pgxind-kftx357g,pgxcs-kftvu6nu,1338612465,0.466,644991623,0.224,693620842,0.241,PGX_AM_BS_MedBl-mic-PN09_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.444000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b020f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [Fossa posterior],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95g,P15Y,pgxind-kftx357i,pgxcs-kftvu6ob,1374464935,0.478,623007123,0.217,751457812,0.261,PGX_AM_BS_MedBl-mic-PN10_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.445000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0210,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, right hemisphere]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95h,P7Y,pgxind-kftx357k,pgxcs-kftvu6ot,622717612,0.217,192194910,0.067,430522702,0.15,PGX_AM_BS_MedBl-mic-PN52_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.447000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0212,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95k,P3Y,pgxind-kftx357o,pgxcs-kftvu6ps,2006593073,0.698,573047127,0.199,1433545946,0.499,PGX_AM_BS_MedBl-mic-PN54_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.450000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0214,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [Relapse in cerebellum and myelum],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95o,P4Y,pgxind-kftx357s,pgxcs-kftvu6qv,2226561579,0.774,634253993,0.221,1592307586,0.554,PGX_AM_BS_MedBl-mic-PN61_2,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.452000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0216,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95r,P11Y,pgxind-kftx357w,pgxcs-kftvu6ru,590806071,0.205,375409689,0.131,215396382,0.075,PGX_AM_BS_MedBl-mic-PN64_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.455000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0217,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, midline and hypophysis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95s,P14Y,pgxind-kftx357y,pgxcs-kftvu6sb,254613575,0.089,22200022,0.008,232413553,0.081,PGX_AM_BS_MedBl-mic-PN65_1,,4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.456000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",0,30,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0512,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M1]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha47,P13Y,pgxind-kftx36f2,pgxcs-kftvuhiu,494061139,0.172,258441266,0.09,235619873,0.082,PGX_AM_BS_11770900_MB-ebe-LCMbl-06,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.508000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,35,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0513,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M1]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha48,P24Y,pgxind-kftx36f4,pgxcs-kftvuhjb,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-07,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.510000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,64,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0515,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M0]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4c,P12Y,pgxind-kftx36f8,pgxcs-kftvuhk9,597269130,0.208,154913909,0.054,442355221,0.154,PGX_AM_BS_11770900_MB-ebe-LCMbl-09,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.513000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,72,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0516,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M0]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4d,P12Y,pgxind-kftx36fa,pgxcs-kftvuhkr,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-10,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.514000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,11,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0517,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, recurrence, stage M4]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4f,P8Y,pgxind-kftx36fc,pgxcs-kftvuhl8,222490501,0.077,86594805,0.03,135895696,0.047,PGX_AM_BS_11770900_MB-ebe-LCMbl-11,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.515000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,31,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0518,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M4]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4g,P2Y,pgxind-kftx36fe,pgxcs-kftvuhlo,234938813,0.082,0,0,234938813,0.082,PGX_AM_BS_11770900_MB-ebe-LCMbl-12,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.517000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,132,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0519,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M0]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4i,P21Y,pgxind-kftx36fg,pgxcs-kftvuhm6,132704338,0.046,107854778,0.038,24849560,0.009,PGX_AM_BS_11770900_MB-ebe-LCMbl-13,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.518000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,1,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b051b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, primary, stage M0]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4l,P9Y,pgxind-kftx36fk,pgxcs-kftvuhn5,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-15,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.521000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,1,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd83,P7Y,pgxind-kftx3aal,pgxcs-kftvvgf2,311956673,0.109,207081825,0.072,104874848,0.036,PGX_AM_BS_11154805_MB-gil-166,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.937000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,108,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd84,P10Y,pgxind-kftx3aan,pgxcs-kftvvgfj,0,0,0,0,0,0,PGX_AM_BS_11154805_MB-gil-167,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.938000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,120,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd86,P5Y,pgxind-kftx3aap,pgxcs-kftvvgg1,0,0,0,0,0,0,PGX_AM_BS_11154805_MB-gil-24,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.940000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,84,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0ec8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd8e,P12Y,pgxind-kftx3aaz,pgxcs-kftvvgif,422209361,0.147,365634562,0.127,56574799,0.02,PGX_AM_BS_11154805_MB-gil-622,,5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.947000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,84,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1551,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfcg,P1Y,pgxind-kftx3cwy,pgxcs-kftvw41c,771022798,0.268,271864363,0.095,499158435,0.174,PGX_AM_BS_Medblast-4,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.262000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1553,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfck,P7Y,pgxind-kftx3cx2,pgxcs-kftvw42a,96600096,0.034,96600096,0.034,0,0,PGX_AM_BS_Medblast-6,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.265000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1698,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrd,P19Y10M,pgxind-kftx3df5,pgxcs-kftvw8pt,1602110785,0.557,911883394,0.317,690227391,0.24,PGX_AM_BS_PNET-nic-01,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.712000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,57.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b1699,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfre,P14Y4M,pgxind-kftx3df7,pgxcs-kftvw8qa,870772184,0.303,655375802,0.228,215396382,0.075,PGX_AM_BS_PNET-nic-02,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.714000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,105.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrr,P6Y7M,pgxind-kftx3dfn,pgxcs-kftvw8u6,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-09,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.725000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,33.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrt,P3Y4M,pgxind-kftx3dfp,pgxcs-kftvw8un,397578053,0.138,72914629,0.025,324663424,0.113,PGX_AM_BS_PNET-nic-10,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.726000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,75.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrv,P24Y10M,pgxind-kftx3dfr,pgxcs-kftvw8v5,212572377,0.074,22200022,0.008,190372355,0.066,PGX_AM_BS_PNET-nic-11,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.728000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,3.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16ba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medullomyoblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfsx,P14Y1M,pgxind-kftx3dh2,pgxcs-kftvw96b,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-33,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.759000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,123.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16cc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhftr,P6Y,pgxind-kftx3di3,pgxcs-kftvw9f6,491193084,0.171,170806150,0.059,320386934,0.111,PGX_AM_BS_PNET-rus-I-21-PP6,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.783000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16cd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfts,P5Y,pgxind-kftx3di5,pgxcs-kftvw9fn,287671980,0.1,111722085,0.039,175949895,0.061,PGX_AM_BS_PNET-rus-I-22-PP7,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.785000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfuc,P12Y,pgxind-kftx3dit,pgxcs-kftvw9lk,0,0,0,0,0,0,PGX_AM_BS_PNET-rus-I-32-PM14,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.801000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16da,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfue,P14Y,pgxind-kftx3div,pgxcs-kftvw9o0,1420942743,0.494,318311002,0.111,1102631741,0.384,PGX_AM_BS_PNET-rus-I-33-PM18,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.803000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfuh,P8Y,pgxind-kftx3diz,pgxcs-kftvw9p0,689542319,0.24,207813961,0.072,481728358,0.168,PGX_AM_BS_PNET-rus-I-36-PM29,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.806000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16dd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfui,P7Y,pgxind-kftx3dj1,pgxcs-kftvw9pi,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_PNET-rus-I-37-PM30,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.807000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfum,P2Y,pgxind-kftx3dj5,pgxcs-kftvw9qh,0,0,0,0,0,0,PGX_AM_BS_PNET-rus-I-39-PM32,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.810000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aab1d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [p53 mut., Li-Fraumeni syndrome]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftva6a7,P0Y6M,pgxind-kftx26j0,pgxcs-kftvllqs,2345039951,0.816,1116074997,0.388,1228964954,0.427,PGX_AM_BS_9600210_MedBl-p53-1,{},6.78,51.22,Point,DEU,Dusseldorf,Germany,"Dusseldorf, Germany",51.22,6.78,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.081000,PMID:9600210,"Reifenberger J, Janssen G et al. (1998): Primitive neuroectodermal tumors of the cerebral...",1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aab1e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [p53 mut., Li-Fraumeni syndrome]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftva6a8,P5Y,pgxind-kftx26j2,pgxcs-kftvllra,1876775350,0.653,838317781,0.292,1038457569,0.361,PGX_AM_BS_9600210_MedBl-p53-2,{},6.78,51.22,Point,DEU,Dusseldorf,Germany,"Dusseldorf, Germany",51.22,6.78,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.083000,PMID:9600210,"Reifenberger J, Janssen G et al. (1998): Primitive neuroectodermal tumors of the cerebral...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aad55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlc,P4Y6M,pgxind-kftx27ee,pgxcs-kftvltib,538535559,0.187,247021947,0.086,291513612,0.101,PGX_AM_BS_MedBlast-rea-01,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.874000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,46.8,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghli,P3Y7M,pgxind-kftx27el,pgxcs-kftvltk7,750951668,0.261,293293275,0.102,457658393,0.159,PGX_AM_BS_MedBlast-rea-05,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.880000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,34.8,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlk,P2Y6M,pgxind-kftx27eo,pgxcs-kftvltko,2494472444,0.868,1395434691,0.485,1099037753,0.382,PGX_AM_BS_MedBlast-rea-06,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.882000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,110.4,,,T4M3,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlp,P8Y11M,pgxind-kftx27eu,pgxcs-kftvltm2,297999826,0.104,93497516,0.033,204502310,0.071,PGX_AM_BS_MedBlast-rea-09,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.886000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,26.4,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghlv,P4Y4M,pgxind-kftx27f2,pgxcs-kftvltpt,611464038,0.213,351283056,0.122,260180982,0.09,PGX_AM_BS_MedBlast-rea-13,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.892000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,40.8,,,T2M3,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad64,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghm0,P8Y6M,pgxind-kftx27f8,pgxcs-kftvltr8,201390480,0.07,86594805,0.03,114795675,0.04,PGX_AM_BS_MedBlast-rea-16,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.896000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,44.4,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aad6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghmc,P10Y1M,pgxind-kftx27fl,pgxcs-kftvltuj,0,0,0,0,0,0,PGX_AM_BS_MedBlast-rea-23,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.906000,PMID:9307291,"Reardon DA, Michalkiewicz E et al. (1997): Extensive genomic abnormalities in childhood medulloblastoma...",1,45.6,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab6a7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgklx,P0Y6M,pgxind-kftx2b2l,pgxcs-kftvmq6l,172649892,0.06,32900032,0.011,139749860,0.049,PGX_AM_BS_22616618_MDS-tas-02,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:10.258000,PMID:22616618,"Tassano E, Tavella E et al. (2012): New recurrent chromosome change in pediatric...",1,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abddd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmxy,P23Y,pgxind-kftx2dw9,pgxcs-kftvnf5p,1571255,0.001,1571255,0.001,0,0,PGX_AM_BS_Medblast-pfi-1M1,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.892000,geo:GSE8634,,1,110,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmy3,P18Y,pgxind-kftx2dwf,pgxcs-kftvnf73,255813635,0.089,192938829,0.067,62874806,0.022,PGX_AM_BS_Medblast-pfi-1M2,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.896000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,8,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmy8,P28Y,pgxind-kftx2dwl,pgxcs-kftvnf8h,804783183,0.28,369741609,0.129,435041574,0.151,PGX_AM_BS_Medblast-pfi-1M29,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.901000,geo:GSE8634,,1,23,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abde4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmya,P38Y,pgxind-kftx2dwn,pgxcs-kftvnf8x,387706455,0.135,176018431,0.061,211688024,0.074,PGX_AM_BS_MedBlast-pfi-1M31,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.902000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,24,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyd,P33Y,pgxind-kftx2dwr,pgxcs-kftvnf9v,0,0,0,0,0,0,PGX_AM_BS_Medblast-pfi-1M9,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.905000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,58,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyf,P18Y,pgxind-kftx2dwt,pgxcs-kftvnfab,676559795,0.235,388155676,0.135,288404119,0.1,PGX_AM_BS_Medblast-pfi-2M1,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.906000,geo:GSE8634,,1,43,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdf3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmyz,P24Y,pgxind-kftx2dxh,pgxcs-kftvnffv,268842272,0.094,105640158,0.037,163202114,0.057,PGX_AM_BS_MedBlast-pfi-5M16,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.924000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgmz3,P29Y,pgxind-kftx2dxo,pgxcs-kftvnfh9,1335826659,0.465,819426763,0.285,516399896,0.18,PGX_AM_BS_MedBlast-pfi-5M19,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.929000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,45,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8c6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqgh,P7Y4M,pgxind-kftx2ia4,pgxcs-kftvohfy,617532418,0.215,389253686,0.135,228278732,0.079,PGX_AM_BS_19270706_MBL-nor-MDT-MB-007,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.764000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,14,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqh9,P6Y5M,pgxind-kftx2ib3,pgxcs-kftvohqi,712765425,0.248,17876511,0.006,694888914,0.242,PGX_AM_BS_19270706_MBL-nor-MDT-MB-001,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.787000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,14,,,M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqhb,P3Y8M,pgxind-kftx2ib5,pgxcs-kftvohqz,1083307507,0.377,635624551,0.221,447682956,0.156,PGX_AM_BS_19270706_MBL-nor-MDT-MB-002,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.789000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqhc,P5Y6M,pgxind-kftx2ib7,pgxcs-kftvohrh,435226786,0.151,211940163,0.074,223286623,0.078,PGX_AM_BS_19270706_MBL-nor-MDT-MB-003,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.790000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,64,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac927,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [moderate anaplasia],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqkw,P4Y6M,pgxind-kftx2ifm,pgxcs-kftvoisv,330701163,0.115,139489088,0.049,191212075,0.067,PGX_AM_BS_19270706_MBL-nor-MDT-MB-101,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.898000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,33,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac98f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, midline]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqpm,P2Y7M,pgxind-kftx2ilg,pgxcs-kftvokbh,0,0,0,0,0,0,PGX_AM_BS_19270706_MBL-nor-MDT-MB-211,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.041000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,5,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca24,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwd,P10Y,pgxind-kftx2itu,pgxcs-kftvomd1,76410076,0.027,16588941,0.006,59821135,0.021,PGX_AM_BS_MedBlast-pfi-1M17,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.249000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,22,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca25,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwe,P16Y,pgxind-kftx2itw,pgxcs-kftvomdi,449291604,0.156,46959995,0.016,402331609,0.14,PGX_AM_BS_MedBlast-pfi-1M18,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.251000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,8,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca28,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwj,P8Y,pgxind-kftx2iu2,pgxcs-kftvomf0,890832282,0.31,374531968,0.13,516300314,0.18,PGX_AM_BS_MedBlast-pfi-1M21,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.255000,geo:GSE8634,,1,124,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqwo,P5Y,pgxind-kftx2iu8,pgxcs-kftvomgg,235597667,0.082,175986516,0.061,59611151,0.021,PGX_AM_BS_MedBlast-pfi-1M25,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.259000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,3,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqx3,P3Y,pgxind-kftx2iur,pgxcs-kftvomn4,34802119,0.012,34802119,0.012,0,0,PGX_AM_BS_MedBlast-pfi-2M10,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.272000,geo:GSE8634,,1,17,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqx8,P3Y,pgxind-kftx2iux,pgxcs-kftvomok,1586771192,0.552,1275082924,0.444,311688268,0.108,PGX_AM_BS_MedBlast-pfi-2M14,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.276000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,15,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqxd,P14Y,pgxind-kftx2iv3,pgxcs-kftvomq0,1387835787,0.483,822470390,0.286,565365397,0.197,PGX_AM_BS_MedBlast-pfi-2M18,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.280000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,53,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqy2,P1Y,pgxind-kftx2ivx,pgxcs-kftvomx6,537096430,0.187,91973462,0.032,445122968,0.155,PGX_AM_BS_MedBlast-pfi-4M1,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.301000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqy3,P11Y,pgxind-kftx2ivz,pgxcs-kftvomxo,340647942,0.118,150413817,0.052,190234125,0.066,PGX_AM_BS_MedBlast-pfi-4M23,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.303000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,27,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqyi,P8Y,pgxind-kftx2iwh,pgxcs-kftvon20,2164964427,0.753,1095830426,0.381,1069134001,0.372,PGX_AM_BS_MedBlast-pfi-4M67,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.316000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,22,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqz5,P2Y,pgxind-kftx2ixa,pgxcs-kftvon8q,15318933,0.005,0,0,15318933,0.005,PGX_AM_BS_MedBlast-pfi-M242,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.335000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,57,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqz9,P1Y,pgxind-kftx2ixe,pgxcs-kftvon9p,242467088,0.084,0,0,242467088,0.084,PGX_AM_BS_MedBlast-pfi-M248,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.338000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,18,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca64,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqza,P4Y,pgxind-kftx2ixg,pgxcs-kftvona6,242568808,0.084,208424985,0.072,34143823,0.012,PGX_AM_BS_MedBlast-pfi-M250,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.339000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,39,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca68,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzh,P3Y,pgxind-kftx2ixo,pgxcs-kftvonc5,42660972,0.015,36419683,0.013,6241289,0.002,PGX_AM_BS_MedBlast-pfi-M501,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.345000,geo:GSE8634,,1,11,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgqzn,P3Y,pgxind-kftx2ixw,pgxcs-kftvone2,977498812,0.34,134709587,0.047,842789225,0.293,PGX_AM_BS_MedBlast-pfi-M557,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.351000,geo:GSE8634,,1,58,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca74,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr00,P2Y,pgxind-kftx2iyc,pgxcs-kftvonhx,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pfi-M626,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.362000,geo:GSE8634,,1,55,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca76,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr03,P6Y,pgxind-kftx2iyg,pgxcs-kftvoniv,499787111,0.174,193964404,0.067,305822707,0.106,PGX_AM_BS_MedBlast-pfi-M645,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.365000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,45,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca78,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr07,P6Y,pgxind-kftx2iyk,pgxcs-kftvonjt,177473014,0.062,82902468,0.029,94570546,0.033,PGX_AM_BS_MedBlast-pfi-M665,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.368000,geo:GSE8634,,1,9,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca7b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0c,P3Y,pgxind-kftx2iyr,pgxcs-kftvonl9,339176945,0.118,104582500,0.036,234594445,0.082,PGX_AM_BS_MedBlast-pfi-M702,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.372000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,9,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca7c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0d,P7Y,pgxind-kftx2iyt,pgxcs-kftvonlq,347381499,0.121,215961417,0.075,131420082,0.046,PGX_AM_BS_MedBlast-pfi-M704,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.373000,geo:GSE8634,,1,65,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca7d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr0f,P3Y,pgxind-kftx2iyv,pgxcs-kftvonm7,1605004626,0.558,991989195,0.345,613015431,0.213,PGX_AM_BS_MedBlast-pfi-M738,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.375000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,7,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acad3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4a,P7Y5M,pgxind-kftx2j3r,pgxcs-kftvoou7,614881358,0.214,207650015,0.072,407231343,0.142,PGX_AM_BS_19197950_MB10.585,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.495000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,41.2,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acad5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4e,P5Y7M,pgxind-kftx2j3v,pgxcs-kftvoov7,394413714,0.137,96600095,0.034,297813619,0.104,PGX_AM_BS_19197950_MB101.1319,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.498000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,44,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acad6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4f,P9Y,pgxind-kftx2j3x,pgxcs-kftvoovp,639591511,0.222,297777850,0.104,341813661,0.119,PGX_AM_BS_19197950_MB102.1320,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.500000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,32.8,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acad8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4i,P9Y6M,pgxind-kftx2j41,pgxcs-kftvoowp,84974828,0.03,22100022,0.008,62874806,0.022,PGX_AM_BS_19197950_MB104.1322,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.502000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,64.1,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acada,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4m,P4Y2M,pgxind-kftx2j45,pgxcs-kftvooxn,351881639,0.122,95985217,0.033,255896422,0.089,PGX_AM_BS_19197950_MB106.1324,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.505000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,19.6,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acadb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4n,P10Y5M,pgxind-kftx2j47,pgxcs-kftvooy4,358199294,0.125,344760364,0.12,13438930,0.005,PGX_AM_BS_19197950_MB107.1325,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.506000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,12.8,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acae1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr4x,P11Y3M,pgxind-kftx2j4j,pgxcs-kftvop34,607259623,0.211,210424887,0.073,396834736,0.138,PGX_AM_BS_19197950_MB113.1392,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.515000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,8.7,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acae9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5a,P5Y10M,pgxind-kftx2j4z,pgxcs-kftvop6z,101074843,0.035,0,0,101074843,0.035,PGX_AM_BS_19197950_MB121.14017,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.526000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,31.6,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acaed,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5g,P3Y6M,pgxind-kftx2j57,pgxcs-kftvop8v,264707497,0.092,37627292,0.013,227080205,0.079,PGX_AM_BS_19197950_MB125.1444,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.531000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,14.4,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5q,P10Y11M,pgxind-kftx2j5k,pgxcs-kftvopbq,84974828,0.03,22100022,0.008,62874806,0.022,PGX_AM_BS_19197950_MB131.5422,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.539000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,65.5,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5x,P2Y9M,pgxind-kftx2j5s,pgxcs-kftvopdn,101174843,0.035,22100022,0.008,79074821,0.028,PGX_AM_BS_19197950_MB135.5883,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.545000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,17.1,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acaf8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr5y,P5Y,pgxind-kftx2j5u,pgxcs-kftvope4,476261133,0.166,290739524,0.101,185521609,0.065,PGX_AM_BS_19197950_MB136.5884,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.546000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,38.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acafb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr63,P8Y4M,pgxind-kftx2j60,pgxcs-kftvopfk,92674835,0.032,29800029,0.01,62874806,0.022,PGX_AM_BS_19197950_MB139.6334,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.551000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,37.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb05,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6k,P5Y,pgxind-kftx2j6k,pgxcs-kftvopkc,0,0,0,0,0,0,PGX_AM_BS_19197950_MB21.702,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.564000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,78.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb07,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6n,P11Y,pgxind-kftx2j6o,pgxcs-kftvopla,117189417,0.041,0,0,117189417,0.041,PGX_AM_BS_19197950_MB27.6331,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.566000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,37.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb09,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6q,P5Y1M,pgxind-kftx2j6s,pgxcs-kftvopm9,228264043,0.079,56561725,0.02,171702318,0.06,PGX_AM_BS_19197950_MB32.705,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.569000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,44,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb0a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr6s,P9Y8M,pgxind-kftx2j6u,pgxcs-kftvopmq,266295047,0.093,49827304,0.017,216467743,0.075,PGX_AM_BS_19197950_MB33.706,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.571000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,15.8,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb0f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr70,P2Y11M,pgxind-kftx2j74,pgxcs-kftvopp5,764165191,0.266,44427298,0.015,719737893,0.25,PGX_AM_BS_19197950_MB43.710,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.577000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,17.9,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb11,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr73,P6Y4M,pgxind-kftx2j78,pgxcs-kftvopq3,65502063,0.023,15527270,0.005,49974793,0.017,PGX_AM_BS_19197950_MB46.712,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.580000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,17,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb13,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr76,P7Y1M,pgxind-kftx2j7c,pgxcs-kftvopr2,394485013,0.137,33900034,0.012,360584979,0.125,PGX_AM_BS_19197950_MB66.6332,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.583000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,20.9,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb15,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr79,P3Y4M,pgxind-kftx2j7g,pgxcs-kftvops0,398452868,0.139,107520892,0.037,290931976,0.101,PGX_AM_BS_19197950_MB68.716,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.586000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,26.7,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb1d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7m,P3Y11M,pgxind-kftx2j7x,pgxcs-kftvopvv,372490727,0.13,54027308,0.019,318463419,0.111,PGX_AM_BS_19197950_MB76.724,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.597000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,11.3,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb1f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7q,P8Y10M,pgxind-kftx2j81,pgxcs-kftvopwu,445323123,0.155,54427309,0.019,390895814,0.136,PGX_AM_BS_19197950_MB78.695,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.599000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,97.3,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb20,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medullomyoblastoma/medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr7r,P3Y,pgxind-kftx2j83,pgxcs-kftvopxb,190574932,0.066,32800032,0.011,157774900,0.055,PGX_AM_BS_19197950_MB79.1276,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.601000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,14.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb26,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr81,P10Y3M,pgxind-kftx2j8f,pgxcs-kftvoq06,274113652,0.095,193938830,0.067,80174822,0.028,PGX_AM_BS_19197950_MB85.1283,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.609000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,10.3,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb28,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr84,P7Y3M,pgxind-kftx2j8j,pgxcs-kftvoq15,370603938,0.129,77057943,0.027,293545995,0.102,PGX_AM_BS_19197950_MB87a.1318,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.612000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,49.8,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb29,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr86,P9Y6M,pgxind-kftx2j8l,pgxcs-kftvoq1n,132074873,0.046,9600010,0.003,122474863,0.043,PGX_AM_BS_19197950_MB88.1286,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.613000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,63.9,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb2b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr89,P8Y1M,pgxind-kftx2j8p,pgxcs-kftvoq2l,27200027,0.009,0,0,27200027,0.009,PGX_AM_BS_19197950_MB90.1288,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.616000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,33.9,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb2c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr8b,P4Y11M,pgxind-kftx2j8r,pgxcs-kftvoq32,363006335,0.126,2100002,0.001,360906333,0.126,PGX_AM_BS_19197950_MB91.1289,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.617000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,3.2,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb30,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr8h,P3Y8M,pgxind-kftx2j8z,pgxcs-kftvoq50,104974848,0.037,27100027,0.009,77874821,0.027,PGX_AM_BS_19197950_MB96.1294,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.623000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,42.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb32,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgr8k,P8Y3M,pgxind-kftx2j93,pgxcs-kftvoq5y,279914063,0.097,0,0,279914063,0.097,PGX_AM_BS_19197950_MB99.1296,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.625000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,22.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acef7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,medulloblstoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgsg1,P19Y,pgxind-kftx2krl,pgxcs-kftvp3np,583498920,0.203,233898571,0.081,349600349,0.122,PGX_AM_BS_18769486_MB0255,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:18.955000,PMID:18769486,"Kool M, Koster J et al. (2008): Integrated genomics identifies five medulloblastoma subtypes...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad754,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4g,P0Y7M,pgxind-kftx2o3y,pgxcs-kftvpxmg,169406149,0.059,110306090,0.038,59100059,0.021,PGX_AM_BS_18056178_MB-lo-MD01,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.909000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,11,,,T4M1,NCITstage-C27971,Stage IV,TNM-C48700,M1 Stage Finding,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad755,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4i,P8Y10M,pgxind-kftx2o40,pgxcs-kftvpxmx,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-MD02,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.910000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,5,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad756,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4j,P6Y,pgxind-kftx2o42,pgxcs-kftvpxnf,885345085,0.308,398446448,0.139,486898637,0.169,PGX_AM_BS_18056178_MB-lo-MD03,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.912000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,7,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad757,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4l,P5Y4M,pgxind-kftx2o44,pgxcs-kftvpxnx,220868520,0.077,93497516,0.033,127371004,0.044,PGX_AM_BS_18056178_MB-lo-MD04,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.913000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,7,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad758,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4n,P0Y7M,pgxind-kftx2o47,pgxcs-kftvpxoe,886149148,0.308,308601848,0.107,577547300,0.201,PGX_AM_BS_18056178_MB-lo-MD06,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.914000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,9,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad759,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4o,P6Y5M,pgxind-kftx2o49,pgxcs-kftvpxow,739978337,0.257,356360965,0.124,383617372,0.133,PGX_AM_BS_18056178_MB-lo-MD07,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.916000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,14,,,T1M0,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4q,P8Y,pgxind-kftx2o4b,pgxcs-kftvpxpd,136913845,0.048,2461326,0.001,134452519,0.047,PGX_AM_BS_18056178_MB-lo-MD09,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.917000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4r,P3Y10M,pgxind-kftx2o4d,pgxcs-kftvpxpu,149364904,0.052,14004499,0.005,135360405,0.047,PGX_AM_BS_18056178_MB-lo-MD10,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.919000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4t,P8Y2M,pgxind-kftx2o4f,pgxcs-kftvpxqc,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-MD11,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.920000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,19,,,T2M1,NCITstage-C28054,Stage II,TNM-C48700,M1 Stage Finding,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgv4v,P14Y5M,pgxind-kftx2o4h,pgxcs-kftvpxqt,930640110,0.324,630224856,0.219,300415254,0.104,PGX_AM_BS_18056178_MB-lo-MD13,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.921000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,26,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addf0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx93,P7Y5M,pgxind-kftx2qrd,pgxcs-kftvqlav,0,0,0,0,0,0,PGX_AM_BS_MedBlFav_cli_10,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.261000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",1,53,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00addf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgx94,P5Y6M,pgxind-kftx2qrf,pgxcs-kftvqlbc,215726750,0.075,97042629,0.034,118684121,0.041,PGX_AM_BS_MedBlFav_cli_11,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.263000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",1,4,,,M2M3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae17c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypc,P13Y11M,pgxind-kftx2s6c,pgxcs-kftvqy0z,264326402,0.092,95151492,0.033,169174910,0.059,PGX_AM_BS_MedBlast-deb-MB139,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.514000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,38,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae181,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypk,P1Y4M,pgxind-kftx2s6m,pgxcs-kftvqy3d,2748371498,0.956,1393439018,0.485,1354932480,0.471,PGX_AM_BS_MedBlast-deb-MB180,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.522000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,5,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae183,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypn,P6Y7M,pgxind-kftx2s6q,pgxcs-kftvqy4d,656109845,0.228,169645040,0.059,486464805,0.169,PGX_AM_BS_MedBlast-deb-MB218,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.524000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,50,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae185,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgypr,P12Y4M,pgxind-kftx2s6u,pgxcs-kftvqy5b,886320247,0.308,476263308,0.166,410056939,0.143,PGX_AM_BS_MedBlast-deb-MB235,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.527000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,50,,,M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae186,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyps,P1Y8M,pgxind-kftx2s6w,pgxcs-kftvqy5s,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB246,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.528000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,19,,,M2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae19e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyqw,P6Y1M,pgxind-kftx2s89,pgxcs-kftvqyjh,695900730,0.242,409011947,0.142,286888783,0.1,PGX_AM_BS_MedBlast-deb-MM02,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.562000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,16,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [intermediary],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyr5,,pgxind-kftx2s8j,pgxcs-kftvqylu,1740953450,0.606,1008492241,0.351,732461209,0.255,PGX_AM_BS_MedBlast-deb-MM09,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.569000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,9,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1a9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyre,P6Y,pgxind-kftx2s8w,pgxcs-kftvqyoq,789573295,0.275,348419743,0.121,441153552,0.153,PGX_AM_BS_MedBlast-deb-MM17,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.577000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,7,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1ae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrm,P14Y5M,pgxind-kftx2s96,pgxcs-kftvqyr5,525589660,0.183,425868136,0.148,99721524,0.035,PGX_AM_BS_MedBlast-deb-MM34,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.584000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,26,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgyrq,P6Y5M,pgxind-kftx2s9a,pgxcs-kftvqys3,816508241,0.284,583411841,0.203,233096400,0.081,PGX_AM_BS_MedBlast-deb-MM37,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.587000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,14,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [classic],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgys3,P38Y2M,pgxind-kftx2s9q,pgxcs-kftvqyvy,1527151394,0.531,731749067,0.255,795402327,0.277,PGX_AM_BS_MedBlast-deb-MM47,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.599000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,7,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8f6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13q,P7Y8M,pgxind-kftx2v5n,pgxcs-kftvroua,362298632,0.126,156252539,0.054,206046093,0.072,PGX_AM_BS_MedBlast-pan-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.561000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8f8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [infant],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13u,P0Y7M,pgxind-kftx2v5r,pgxcs-kftvrov8,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.563000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,9.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8f9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [infant],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13v,P0Y7M,pgxind-kftx2v5t,pgxcs-kftvrovq,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.565000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8fa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13x,P6Y6M,pgxind-kftx2v5v,pgxcs-kftvrow7,438076404,0.152,281780081,0.098,156296323,0.054,PGX_AM_BS_MedBlast-pan-07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.566000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,151.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae8fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh13z,P6Y6M,pgxind-kftx2v5x,pgxcs-kftvrowo,624298000,0.217,408901618,0.142,215396382,0.075,PGX_AM_BS_MedBlast-pan-08,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.567000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,40.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae8fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh142,P3Y6M,pgxind-kftx2v61,pgxcs-kftvroxn,150124828,0.052,95124773,0.033,55000055,0.019,PGX_AM_BS_MedBlast-pan-10,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.570000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,26.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae8ff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh145,P7Y4M,pgxind-kftx2v66,pgxcs-kftvroyl,109474851,0.038,52900052,0.018,56574799,0.02,PGX_AM_BS_MedBlast-pan-12,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.573000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,129.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae901,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [infant],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh149,P0Y8M,pgxind-kftx2v6a,pgxcs-kftvrozj,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-14,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.576000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,7.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae907,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14i,P6Y4M,pgxind-kftx2v6m,pgxcs-kftvrp2e,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-20,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.584000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,31.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae90a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14n,P3Y5M,pgxind-kftx2v6s,pgxcs-kftvrp3u,0,0,0,0,0,0,PGX_AM_BS_MedBlast-pan-23,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.588000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,7.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae90c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14q,P9Y4M,pgxind-kftx2v6w,pgxcs-kftvrp4s,561035508,0.195,438192404,0.152,122843104,0.043,PGX_AM_BS_MedBlast-pan-25,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.591000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,7.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae90f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh14v,P6Y4M,pgxind-kftx2v72,pgxcs-kftvrp69,494462799,0.172,279066417,0.097,215396382,0.075,PGX_AM_BS_MedBlast-pan-28,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.595000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,54,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae912,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [standard risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh150,P4Y1M,pgxind-kftx2v79,pgxcs-kftvrp7o,265338902,0.092,0,0,265338902,0.092,PGX_AM_BS_MedBlast-pan-31,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.599000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,13.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae913,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh152,P11Y2M,pgxind-kftx2v7b,pgxcs-kftvrp85,214047356,0.074,84697507,0.029,129349849,0.045,PGX_AM_BS_MedBlast-pan-32,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.600000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae916,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [poor risk],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh157,P4Y2M,pgxind-kftx2v7h,pgxcs-kftvrp9k,542896876,0.189,65527320,0.023,477369556,0.166,PGX_AM_BS_MedBlast-pan-35,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:28.605000,PMID:16000568,"Pan E, Pellarin M et al. (2005): Isochromosome 17q is a negative prognostic...",1,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af384,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh4hi,P12Y,pgxind-kftx2ze7,pgxcs-kftvsqjj,436542641,0.152,221738858,0.077,214803783,0.075,PGX_AM_BS_MedBl-ton-M11,{},114.16,22.29,Point,CHN,Hong Kong,China,"Hong Kong, China",22.29,114.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:32.306000,PMID:14758948,"Tong CY, Hui AB et al. (2004): Detection of oncogene amplifications in medulloblastomas...",1,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af386,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh4hm,P11Y,pgxind-kftx2zeb,pgxcs-kftvsqki,330395607,0.115,51900051,0.018,278495556,0.097,PGX_AM_BS_MedBl-ton-M13,{},114.16,22.29,Point,CHN,Hong Kong,China,"Hong Kong, China",22.29,114.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:32.308000,PMID:14758948,"Tong CY, Hui AB et al. (2004): Detection of oncogene amplifications in medulloblastomas...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b020b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [4th Ventricle and spinal canal],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh959,P2Y6M,pgxind-kftx357a,pgxcs-kftvu6md,358754706,0.125,96949632,0.034,261805074,0.091,PGX_AM_BS_MedBl-mic-PN03_1,,4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.439000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,3,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b020c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, vermis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95b,P10Y,pgxind-kftx357c,pgxcs-kftvu6mu,1601049140,0.557,355478613,0.124,1245570527,0.433,PGX_AM_BS_MedBl-mic-PN06_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.441000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b020d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, vermis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95c,P9Y,pgxind-kftx357e,pgxcs-kftvu6nd,0,0,0,0,0,0,PGX_AM_BS_MedBl-mic-PN08_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.442000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0211,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, vermis]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95j,P6Y,pgxind-kftx357m,pgxcs-kftvu6pa,995237081,0.346,369009241,0.128,626227840,0.218,PGX_AM_BS_MedBl-mic-PN53_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.448000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0213,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, left hemisphere]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95m,P9Y,pgxind-kftx357q,pgxcs-kftvu6qc,843213158,0.293,314339777,0.109,528873381,0.184,PGX_AM_BS_MedBl-mic-PN56_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.451000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0215,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Medulloblastoma [cerebellum, midline and hemispheres and myelum]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvh95p,P5Y,pgxind-kftx357u,pgxcs-kftvu6rc,270451987,0.094,90927345,0.032,179524642,0.062,PGX_AM_BS_MedBl-mic-PN63_1,{},4.9,52.37,Point,NLD,Amsterdam,Netherlands,"Amsterdam, The Netherlands",52.37,4.9,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.454000,PMID:11990307,"Michiels EM, Weiss MM et al. (2002): Genetic alterations in childhood medulloblastoma analyzed...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0514,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [classic, recurrence, stage M2]",NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvha4a,P15Y,pgxind-kftx36f6,pgxcs-kftvuhjs,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-08,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.511000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,82,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [cell line],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd89,P3Y5M,pgxind-kftx3aat,pgxcs-kftvvggz,377780631,0.131,22200022,0.008,355580609,0.124,PGX_AM_BS_11154805_MB-gil-341,,5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.943000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",1,9.6,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhd8d,P6Y,pgxind-kftx3aax,pgxcs-kftvvghy,72874815,0.025,0,0,72874815,0.025,PGX_AM_BS_11154805_MB-gil-620,,5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.945000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",1,60,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b1264,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvheee,P6Y,pgxind-kftx3br4,pgxcs-kftvvtkt,387195233,0.135,157967868,0.055,229227365,0.08,PGX_AM_BS_10882752_PNET-fru-05,{},-97.37,41.43,Point,USA,Columbus,United States of America,"Columbus, United States",41.43,-97.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:43.217000,PMID:10882752,"Fr√ºhwald MC, O'Dorisio MS et al. (2000): Gene amplification in PNETs/medulloblastomas: mapping of...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b154e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfcb,P8Y,pgxind-kftx3cws,pgxcs-kftvw3zv,626678881,0.218,254103767,0.088,372575114,0.13,PGX_AM_BS_Medblast-1,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.258000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b154f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfcd,P14Y,pgxind-kftx3cwu,pgxcs-kftvw40d,507332514,0.176,450757715,0.157,56574799,0.02,PGX_AM_BS_Medblast-2,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.259000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1550,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfcf,P1Y,pgxind-kftx3cww,pgxcs-kftvw40u,1237506650,0.43,563441571,0.196,674065079,0.234,PGX_AM_BS_Medblast-3,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.261000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1552,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pediatric medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfci,P8Y,pgxind-kftx3cx0,pgxcs-kftvw41t,196295755,0.068,0,0,196295755,0.068,PGX_AM_BS_Medblast-5,{},131.47,34.19,Point,JPN,Yamaguchi-shi,Japan,"Yamaguchi-shi, Japan",34.19,131.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.263000,PMID:10545819,"Nishizaki T, Harada K et al. (1999): Genetic alterations in pediatric medulloblastomas detected...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b169a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrg,P8Y6M,pgxind-kftx3df9,pgxcs-kftvw8qs,426851930,0.148,217421464,0.076,209430466,0.073,PGX_AM_BS_PNET-nic-03,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.715000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,39.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b169b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfri,P0Y8M,pgxind-kftx3dfb,pgxcs-kftvw8r9,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-04,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.717000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,3.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b169c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrj,P1Y7M,pgxind-kftx3dfd,pgxcs-kftvw8rr,200619976,0.07,91727508,0.032,108892468,0.038,PGX_AM_BS_PNET-nic-05,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.718000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,3.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b169d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrl,P6Y4M,pgxind-kftx3dff,pgxcs-kftvw8s8,300030833,0.104,167338804,0.058,132692029,0.046,PGX_AM_BS_PNET-nic-06,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.719000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,16.8,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b169e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrm,P9Y10M,pgxind-kftx3dfh,pgxcs-kftvw8sp,124702283,0.043,68127484,0.024,56574799,0.02,PGX_AM_BS_PNET-nic-07,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.721000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,20.4,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b169f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfro,P6Y6M,pgxind-kftx3dfj,pgxcs-kftvw8t7,507895606,0.177,193399870,0.067,314495736,0.109,PGX_AM_BS_PNET-nic-08r1,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.722000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,61.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrq,P6Y6M,pgxind-kftx3dfl,pgxcs-kftvw8to,600223113,0.209,285727377,0.099,314495736,0.109,PGX_AM_BS_PNET-nic-08r2,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.723000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,61.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfrw,P4Y10M,pgxind-kftx3dft,pgxcs-kftvw8vm,479683721,0.167,142041953,0.049,337641768,0.117,PGX_AM_BS_PNET-nic-12,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.729000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,1.2,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfry,P30Y4M,pgxind-kftx3dfv,pgxcs-kftvw8w4,870864068,0.303,419066425,0.146,451797643,0.157,PGX_AM_BS_PNET-nic-13,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.730000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,39.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfs0,P32Y2M,pgxind-kftx3dfy,pgxcs-kftvw8wm,250150057,0.087,250150057,0.087,0,0,PGX_AM_BS_PNET-nic-14,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.732000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfs1,P5Y4M,pgxind-kftx3dg0,pgxcs-kftvw8x3,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-15,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.733000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,18,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfs3,P0Y4M,pgxind-kftx3dg2,pgxcs-kftvw8xk,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-16,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.734000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,1,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16a9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfs5,P0Y8M,pgxind-kftx3dg4,pgxcs-kftvw8y2,156060174,0.054,49691482,0.017,106368692,0.037,PGX_AM_BS_PNET-nic-17,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.736000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,15.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16cb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhftp,P20Y,pgxind-kftx3di1,pgxcs-kftvw9eo,353777489,0.123,106527522,0.037,247249967,0.086,PGX_AM_BS_PNET-rus-I-20-PP5,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.782000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16ce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhftu,P0Y6M,pgxind-kftx3di7,pgxcs-kftvw9g6,0,0,0,0,0,0,PGX_AM_BS_PNET-rus-I-23-PP8,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.786000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16d0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhftx,P8Y,pgxind-kftx3dib,pgxcs-kftvw9h5,399323820,0.139,230931756,0.08,168392064,0.059,PGX_AM_BS_PNET-rus-I-24-PM27,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.789000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [metastasis],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfua,P3Y,pgxind-kftx3dir,pgxcs-kftvw9l2,1167108805,0.406,857912330,0.298,309196475,0.108,PGX_AM_BS_PNET-rus-I-31-PM13,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.800000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16e1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfup,P3Y,pgxind-kftx3dj9,pgxcs-kftvw9rf,1181831887,0.411,810759094,0.282,371072793,0.129,PGX_AM_BS_PNET-rus-I-40-PM33,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.813000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16e2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfur,P13Y,pgxind-kftx3djb,pgxcs-kftvw9rx,754909183,0.263,418766265,0.146,336142918,0.117,PGX_AM_BS_PNET-rus-I-41-PM34,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.814000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16e3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [infratentorial],NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvhfut,P11Y,pgxind-kftx3djd,pgxcs-kftvw9sf,481130949,0.167,234341404,0.082,246789545,0.086,PGX_AM_BS_PNET-rus-I-42-PM35,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.815000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5c86608309d374f2dc37d972,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6f,P6Y8M,pgxind-kftx4ipa,pgxcs-kftwb4gc,129459771,0.045,87685750,0.03,41774021,0.015,PGX_AM_BS_MedBlast-lo-MD01,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.031000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,11,,,T4M1,NCITstage-C27971,Stage IV,TNM-C48700,M1 Stage Finding,TNM-C48732,T4 Stage Finding,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d973,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6h,P6Y,pgxind-kftx4ipc,pgxcs-kftwb4gt,388542907,0.135,238493730,0.083,150049177,0.052,PGX_AM_BS_MedBlast-lo-MD03,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.033000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,7,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d974,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6i,P8Y4M,pgxind-kftx4ipe,pgxcs-kftwb4hb,0,0,0,0,0,0,PGX_AM_BS_MedBlast-lo-MD04,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.034000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,7,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d975,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6k,P5Y10M,pgxind-kftx4ipg,pgxcs-kftwb4hu,251557861,0.087,106539079,0.037,145018782,0.05,PGX_AM_BS_MedBlast-lo-MD06,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.036000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,9,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5c86608309d374f2dc37d976,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6l,P10Y2M,pgxind-kftx4ipi,pgxcs-kftwb4ib,210061851,0.073,188973556,0.066,21088295,0.007,PGX_AM_BS_MedBlast-lo-MD07,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.037000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,14,,,T1M0,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d977,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6n,P8Y,pgxind-kftx4ipk,pgxcs-kftwb4it,0,0,0,0,0,0,PGX_AM_BS_MedBlast-lo-MD09,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.038000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,18,,,M0,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d978,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6p,P11Y4M,pgxind-kftx4ipm,pgxcs-kftwb4ja,17905166,0.006,5317434,0.002,12587732,0.004,PGX_AM_BS_MedBlast-lo-MD10,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.040000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,18,,,M0,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d979,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6q,P9Y8M,pgxind-kftx4ipo,pgxcs-kftwb4js,0,0,0,0,0,0,PGX_AM_BS_MedBlast-lo-MD11,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.041000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,19,,,T2M1,NCITstage-C28054,Stage II,TNM-C48700,M1 Stage Finding,TNM-C48724,T2 Stage Finding,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608309d374f2dc37d97a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvis6s,P18Y2M,pgxind-kftx4ipq,pgxcs-kftwb4k9,129949795,0.045,102413221,0.036,27536574,0.01,PGX_AM_BS_MedBlast-lo-MD13,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.043000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,26,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf5e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9ln,P23Y,pgxind-kftx6bl6,pgxcs-kftwpzou,0,0,0,0,0,0,PGX_AM_BS_GSM213833,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.479000,geo:GSM213833,,1,110,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL5685,,,,,,,,,geo:gse,geo:GSE8634,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf5f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9lp,P18Y,pgxind-kftx6bl8,pgxcs-kftwpzp5,247363650,0.086,184006402,0.064,63357248,0.022,PGX_AM_BS_GSM213834,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.480000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,8,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213834,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf64,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9lx,P33Y,pgxind-kftx6bli,pgxcs-kftwpzqo,0,0,0,0,0,0,PGX_AM_BS_GSM213839,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.485000,geo:GSM213839,,1,58,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE8634,,,,,,,,,geo:gpl,geo:GPL5685,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf6c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9ma,P16Y,pgxind-kftx6bly,pgxcs-kftwpzt6,267779562,0.093,47062782,0.016,220716780,0.077,PGX_AM_BS_GSM213847,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.494000,geo:GPL5685,,1,8,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213847,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf6f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9mf,P8Y,pgxind-kftx6bm4,pgxcs-kftwpzu4,580235985,0.202,276810997,0.096,303424988,0.106,PGX_AM_BS_GSM213850,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.497000,geo:GSM213850,,1,124,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf81,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9n8,P3Y,pgxind-kftx6bn5,pgxcs-kftwpzzr,29203036,0.01,29203036,0.01,0,0,PGX_AM_BS_GSM213868,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.516000,geo:GSE8634,,1,17,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213868,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf88,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9nk,P14Y,pgxind-kftx6bnj,pgxcs-kftwq01y,1027152865,0.357,623317645,0.217,403835220,0.14,PGX_AM_BS_GSM213875,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.524000,geo:GSM213875,,1,53,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf8d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9ns,P2Y,pgxind-kftx6bnt,pgxcs-kftwq03i,0,0,0,0,0,0,PGX_AM_BS_GSM213880,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.529000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,57,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,geo:gsm,geo:GSM213880,,,,,,,,,,,,,,,,,F
5dc184fb09d374f6dd84bf91,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9nz,P3Y,pgxind-kftx6bo1,pgxcs-kftwq04s,38724537,0.013,38724537,0.013,0,0,PGX_AM_BS_GSM213884,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.533000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,11,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213884,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf94,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9o3,P3Y,pgxind-kftx6bo7,pgxcs-kftwq05q,658360852,0.229,135946759,0.047,522414093,0.182,PGX_AM_BS_GSM213887,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.536000,geo:GSM213887,,1,58,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE8634,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gpl,geo:GPL5685,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf9b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9of,P2Y,pgxind-kftx6bol,pgxcs-kftwq07x,29971610,0.01,29971610,0.01,0,0,PGX_AM_BS_GSM213894,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.544000,geo:GPL5685,,1,55,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213894,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf9d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9oi,P6Y,pgxind-kftx6bop,pgxcs-kftwq08j,500606481,0.174,195637806,0.068,304968675,0.106,PGX_AM_BS_GSM213896,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.546000,geo:GPL5685,,1,45,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213896,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf9e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9ok,P6Y,pgxind-kftx6bos,pgxcs-kftwq08v,175475111,0.061,79576216,0.028,95898895,0.033,PGX_AM_BS_GSM213897,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.547000,geo:GSM213897,,1,9,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfa0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9on,P3Y,pgxind-kftx6bow,pgxcs-kftwq09h,345420766,0.12,103243464,0.036,242177302,0.084,PGX_AM_BS_GSM213899,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.549000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213899,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bfa1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9op,P7Y,pgxind-kftx6boy,pgxcs-kftwq09s,350179285,0.122,215506703,0.075,134672582,0.047,PGX_AM_BS_GSM213900,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.550000,geo:GSE8634,,1,65,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM213900,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bfa2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9or,P3Y,pgxind-kftx6bp0,pgxcs-kftwq0a3,1358654697,0.473,769582138,0.268,589072559,0.205,PGX_AM_BS_GSM213901,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.551000,geo:GSM213901,,1,7,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bfbe,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9q0,P24Y,pgxind-kftx6bqk,pgxcs-kftwpzl2,274307119,0.095,105657048,0.037,168650071,0.059,PGX_AM_BS_20479417_MedBlast-pfi-5M16,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.581000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,26,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bfc1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma,NCIT:C3222,Medulloblastoma,icdom-94703,"Medulloblastoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvk9q5,P29Y,pgxind-kftx6bqq,pgxcs-kftwpzm0,1343453164,0.467,822612433,0.286,520840731,0.181,PGX_AM_BS_20479417_MedBlast-pfi-5M19,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.584000,geo:GPL5685,,1,45,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",geo:gpl,,,,,,,,,,arraymap import,,,pubmed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaeba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1n,P3Y6M,pgxind-kftx27y4,pgxcs-kftvlycl,0,0,0,0,0,0,PGX_AM_BS_9006325_NB-pla-01,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.375000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,39,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaebb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1p,P0Y6M,pgxind-kftx27y6,pgxcs-kftvlyd2,1215572923,0.423,261282601,0.091,954290322,0.332,PGX_AM_BS_9006325_NB-pla-02,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.377000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,36,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaebc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1q,P1Y2M,pgxind-kftx27y8,pgxcs-kftvlydj,1286661224,0.448,575938204,0.2,710723020,0.247,PGX_AM_BS_9006325_NB-pla-03,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.378000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,51,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaebd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1s,P0Y8M,pgxind-kftx27ya,pgxcs-kftvlye0,1384171980,0.481,1023636816,0.356,360535164,0.125,PGX_AM_BS_9006325_NB-pla-04,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.380000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,39,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaebe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1u,P3Y4M,pgxind-kftx27yc,pgxcs-kftvlyeh,1255051097,0.437,674921905,0.235,580129192,0.202,PGX_AM_BS_9006325_NB-pla-05,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.381000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,63,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaebf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1v,P1Y7M,pgxind-kftx27ye,pgxcs-kftvlyey,1093391526,0.38,213531584,0.074,879859942,0.306,PGX_AM_BS_9006325_NB-pla-06,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.383000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,116,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1x,P0Y2M,pgxind-kftx27yg,pgxcs-kftvlyfe,1253471684,0.436,498207377,0.173,755264307,0.263,PGX_AM_BS_9006325_NB-pla-07,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.384000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,51,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi1z,P1Y4M,pgxind-kftx27yi,pgxcs-kftvlyht,1272310223,0.443,801471642,0.279,470838581,0.164,PGX_AM_BS_9006325_NB-pla-08,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.386000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,42,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi20,P1Y11M,pgxind-kftx27yk,pgxcs-kftvlyib,1250186656,0.435,1034790274,0.36,215396382,0.075,PGX_AM_BS_9006325_NB-pla-09,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.387000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,27,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi22,P0Y5M,pgxind-kftx27ym,pgxcs-kftvlyis,114727242,0.04,71352456,0.025,43374786,0.015,PGX_AM_BS_9006325_NB-pla-10,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.389000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,27,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi23,P1Y5M,pgxind-kftx27yo,pgxcs-kftvlyj9,457160576,0.159,140821112,0.049,316339464,0.11,PGX_AM_BS_9006325_NB-pla-11,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.390000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,28,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi25,P0Y8M,pgxind-kftx27yr,pgxcs-kftvlyjq,0,0,0,0,0,0,PGX_AM_BS_9006325_NB-pla-12,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.391000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,48,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi28,P1Y4M,pgxind-kftx27yv,pgxcs-kftvlyko,1060657697,0.369,487662186,0.17,572995511,0.199,PGX_AM_BS_9006325_NB-pla-14,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.394000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,72,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaeca,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2d,P1Y6M,pgxind-kftx27z1,pgxcs-kftvlym2,423956121,0.147,361520094,0.126,62436027,0.022,PGX_AM_BS_9006325_NB-pla-17,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.398000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,18,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaecb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2f,P1Y4M,pgxind-kftx27z3,pgxcs-kftvlymj,1297374157,0.451,332748277,0.116,964625880,0.336,PGX_AM_BS_9006325_NB-pla-18,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.400000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,45,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaecc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2h,P1Y2M,pgxind-kftx27z5,pgxcs-kftvlyn0,199628060,0.069,96236060,0.033,103392000,0.036,PGX_AM_BS_9006325_NB-pla-19,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.401000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,52,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2s,P0Y4M,pgxind-kftx27zj,pgxcs-kftvlyqa,793673995,0.276,395735120,0.138,397938875,0.138,PGX_AM_BS_9006325_NB-pla-26,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.411000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2u,P0Y1M,pgxind-kftx27zl,pgxcs-kftvlyqq,0,0,0,0,0,0,PGX_AM_BS_9006325_NB-pla-27,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.412000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,74,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2v,P0Y6M,pgxind-kftx27zn,pgxcs-kftvlyr7,877393938,0.305,639797534,0.223,237596404,0.083,PGX_AM_BS_9006325_NB-pla-28,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.414000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,52,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2x,P0Y2M,pgxind-kftx27zp,pgxcs-kftvlyro,885974328,0.308,169209217,0.059,716765111,0.249,PGX_AM_BS_9006325_NB-pla-29,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.416000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",0,47,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac403,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxh,P1Y2M,pgxind-kftx2gd7,pgxcs-kftvo0mr,306235068,0.107,55168642,0.019,251066426,0.087,PGX_AM_BS_20003513_NBL-1401,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.080000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,67,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac405,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxl,P2Y4M,pgxind-kftx2gdc,pgxcs-kftvo0nq,83674826,0.029,4900005,0.002,78774821,0.027,PGX_AM_BS_20003513_NBL-1445,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.083000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,121,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac407,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxo,P4Y2M,pgxind-kftx2gdg,pgxcs-kftvo0oo,399381612,0.139,183697605,0.064,215684007,0.075,PGX_AM_BS_20003513_NBL-1558,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.085000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,112,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac409,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxr,P2Y10M,pgxind-kftx2gdk,pgxcs-kftvo0pm,418806670,0.146,137491159,0.048,281315511,0.098,PGX_AM_BS_20003513_NBL-1641,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.088000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,104,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxt,P1Y4M,pgxind-kftx2gdm,pgxcs-kftvo0q3,1332444286,0.463,0,0,1332444286,0.463,PGX_AM_BS_20003513_NBL-1684,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.090000,geo:GSE14109,,0,101,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxx,P4Y,pgxind-kftx2gds,pgxcs-kftvo0rk,71517688,0.025,58617675,0.02,12900013,0.004,PGX_AM_BS_20003513_NBL-1864,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.094000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,43,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy1,P3Y,pgxind-kftx2gdw,pgxcs-kftvo0sj,891977930,0.31,418218855,0.145,473759075,0.165,PGX_AM_BS_20003513_NBL-1889,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.097000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,82,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac410,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy2,P3Y4M,pgxind-kftx2gdy,pgxcs-kftvo0t0,757445987,0.263,302450109,0.105,454995878,0.158,PGX_AM_BS_20003513_NBL-1893,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.098000,geo:GSE14109,,0,45,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac412,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy5,P1Y4M,pgxind-kftx2ge2,pgxcs-kftvo0u0,343093204,0.119,228068812,0.079,115024392,0.04,PGX_AM_BS_20003513_NBL-1905,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.101000,geo:GSE14109,,0,80,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac415,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoya,P1Y5M,pgxind-kftx2ge8,pgxcs-kftvo0vh,1397881673,0.486,951818372,0.331,446063301,0.155,PGX_AM_BS_20003513_NBL-2035,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.105000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,66,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac416,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyc,P3Y10M,pgxind-kftx2gea,pgxcs-kftvo0vy,1430945169,0.498,7600008,0.003,1423345161,0.495,PGX_AM_BS_20003513_NBL-2056,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.107000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,76,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac418,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyf,P4Y7M,pgxind-kftx2gef,pgxcs-kftvo0ww,664987864,0.231,242992021,0.085,421995843,0.147,PGX_AM_BS_20003513_NBL-2140,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.109000,geo:GSE14109,,0,62,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac419,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyh,P1Y11M,pgxind-kftx2geh,pgxcs-kftvo0xd,1643601362,0.572,733723159,0.255,909878203,0.316,PGX_AM_BS_20003513_NBL-2362,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.111000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,43,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac41a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyi,P2Y8M,pgxind-kftx2gej,pgxcs-kftvo0xu,165680888,0.058,118306098,0.041,47374790,0.016,PGX_AM_BS_20003513_NBL-2425,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.112000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",0,39,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac41d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyn,P1Y10M,pgxind-kftx2gep,pgxcs-kftvo0z9,137531509,0.048,78913834,0.027,58617675,0.02,PGX_AM_BS_20003513_NBL-789,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.116000,geo:GSE14109,,0,164,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvmx,P0Y1M,pgxind-kftx2or4,pgxcs-kftvq3bj,2469984310,0.859,1192247437,0.415,1277736873,0.444,PGX_AM_BS_Nbl-mic-AD-114,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.476000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvni,P3Y8M,pgxind-kftx2oru,pgxcs-kftvq3ht,512126121,0.178,118827372,0.041,393298749,0.137,PGX_AM_BS_Nbl-mic-AD-100,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.494000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,128.4,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8fc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnk,P4Y7M,pgxind-kftx2orw,pgxcs-kftvq3ia,632296794,0.22,100370102,0.035,531926692,0.185,PGX_AM_BS_Nbl-mic-AD-101,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.495000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,87.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnm,P0Y4M,pgxind-kftx2ory,pgxcs-kftvq3is,1106897443,0.385,584351794,0.203,522545649,0.182,PGX_AM_BS_Nbl-mic-AD-102,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.497000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,51.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad903,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnv,P0Y8M,pgxind-kftx2osb,pgxcs-kftvq3nt,2433680518,0.846,1561550848,0.543,872129670,0.303,PGX_AM_BS_Nbl-mic-AD-108,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.505000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,51.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad906,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo0,P2Y1M,pgxind-kftx2osh,pgxcs-kftvq3pa,241749776,0.084,99400099,0.035,142349677,0.05,PGX_AM_BS_Nbl-mic-AD-115,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.509000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,42,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo7,P0Y1M,pgxind-kftx2osp,pgxcs-kftvq3r7,1761916401,0.613,617577346,0.215,1144339055,0.398,PGX_AM_BS_Nbl-mic-AD-119,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.515000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,57.6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo9,P0Y,pgxind-kftx2osr,pgxcs-kftvq3rp,1440414399,0.501,1202817995,0.418,237596404,0.083,PGX_AM_BS_Nbl-mic-AD-120,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.517000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,52.8,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoa,P0Y2M,pgxind-kftx2ost,pgxcs-kftvq3s7,0,0,0,0,0,0,PGX_AM_BS_Nbl-mic-AD-123,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.518000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,45.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad911,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoi,P13Y10M,pgxind-kftx2ot3,pgxcs-kftvq3um,1067019513,0.371,557401974,0.194,509617539,0.177,PGX_AM_BS_Nbl-mic-AD-129,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.525000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,140.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad913,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvol,P0Y10M,pgxind-kftx2ot7,pgxcs-kftvq3vk,806388210,0.28,727613389,0.253,78774821,0.027,PGX_AM_BS_Nbl-mic-AD-131,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.528000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,42,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad914,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvon,P0Y8M,pgxind-kftx2ot9,pgxcs-kftvq3w2,1679055970,0.584,896109977,0.312,782945993,0.272,PGX_AM_BS_Nbl-mic-AD-132,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.529000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,37.2,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad915,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvop,P0Y10M,pgxind-kftx2otb,pgxcs-kftvq3wk,449753050,0.156,341363643,0.119,108389407,0.038,PGX_AM_BS_Nbl-mic-AD-134,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.530000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,67.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad916,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoq,P0Y6M,pgxind-kftx2otd,pgxcs-kftvq3x2,545320654,0.19,466545833,0.162,78774821,0.027,PGX_AM_BS_Nbl-mic-AD-135,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.532000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,28.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad918,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvot,P0Y1M,pgxind-kftx2otg,pgxcs-kftvq3y0,1188608807,0.413,951012403,0.331,237596404,0.083,PGX_AM_BS_Nbl-mic-AD-143,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.535000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad919,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvov,P2Y11M,pgxind-kftx2oti,pgxcs-kftvq3yi,249610956,0.087,167700166,0.058,81910790,0.028,PGX_AM_BS_Nbl-mic-AD-144,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.536000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,66,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoy,P1Y10M,pgxind-kftx2otm,pgxcs-kftvq3zg,137574880,0.048,49000049,0.017,88574831,0.031,PGX_AM_BS_Nbl-mic-AD-166,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.539000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,15.6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp0,P2Y4M,pgxind-kftx2otp,pgxcs-kftvq3zy,1870485405,0.651,1278567720,0.445,591917685,0.206,PGX_AM_BS_Nbl-mic-AD-172,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.540000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,8.4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp1,P0Y,pgxind-kftx2otr,pgxcs-kftvq40f,2670340763,0.929,1638098422,0.57,1032242341,0.359,PGX_AM_BS_Nbl-mic-AH-1,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.542000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,86.4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp3,P0Y11M,pgxind-kftx2ott,pgxcs-kftvq40w,1309160680,0.455,824640896,0.287,484519784,0.169,PGX_AM_BS_Nbl-mic-AD-176,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.543000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,10.8,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad920,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp6,P0Y,pgxind-kftx2otw,pgxcs-kftvq41v,9900010,0.003,0,0,9900010,0.003,PGX_AM_BS_Nbl-mic-AD-186,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.546000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,99.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad923,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpb,P0Y4M,pgxind-kftx2ou2,pgxcs-kftvq43b,872178925,0.303,0,0,872178925,0.303,PGX_AM_BS_Nbl-mic-AD-59,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.550000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,97.2,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad924,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpd,P2Y2M,pgxind-kftx2ou4,pgxcs-kftvq43s,335048885,0.117,123152507,0.043,211896378,0.074,PGX_AM_BS_Nbl-mic-AD-63,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.551000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,33.6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad925,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpe,P0Y10M,pgxind-kftx2ou6,pgxcs-kftvq44a,1421902832,0.495,754218401,0.262,667684431,0.232,PGX_AM_BS_Nbl-mic-AD-71,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.553000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,114,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad927,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpi,P0Y4M,pgxind-kftx2oua,pgxcs-kftvq459,1507174930,0.524,962911767,0.335,544263163,0.189,PGX_AM_BS_Nbl-mic-AD-74,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.556000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,61.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad929,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpl,P0Y6M,pgxind-kftx2oue,pgxcs-kftvq468,2008490381,0.699,1014289223,0.353,994201158,0.346,PGX_AM_BS_Nbl-mic-AD-76,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.559000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,15.6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpn,P5Y2M,pgxind-kftx2oug,pgxcs-kftvq46r,543366247,0.189,161852546,0.056,381513701,0.133,PGX_AM_BS_Nbl-mic-AD-77,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.560000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,80.4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpv,P0Y,pgxind-kftx2our,pgxcs-kftvq498,888661207,0.309,298217504,0.104,590443703,0.205,PGX_AM_BS_Nbl-mic-AD-85,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.567000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,73.2,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad930,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpw,P1Y5M,pgxind-kftx2out,pgxcs-kftvq49p,1013992642,0.353,586135913,0.204,427856729,0.149,PGX_AM_BS_Nbl-mic-AD-86,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.568000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,50.4,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad932,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpz,P0Y8M,pgxind-kftx2oux,pgxcs-kftvq4ap,430266133,0.15,286241526,0.1,144024607,0.05,PGX_AM_BS_Nbl-mic-AD-89,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.571000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,51.6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad934,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq3,P2Y7M,pgxind-kftx2ov1,pgxcs-kftvq4bq,437441186,0.152,344066351,0.12,93374835,0.032,PGX_AM_BS_Nbl-mic-AD-173,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.574000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,10.8,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad935,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq4,P0Y7M,pgxind-kftx2ov3,pgxcs-kftvq4c7,273542352,0.095,166417782,0.058,107124570,0.037,PGX_AM_BS_Nbl-mic-AH-10,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.575000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,75.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad936,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq6,P2Y7M,pgxind-kftx2ov5,pgxcs-kftvq4cp,0,0,0,0,0,0,PGX_AM_BS_Nbl-mic-AH-11,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.577000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,45.6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad937,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq7,P3Y10M,pgxind-kftx2ov7,pgxcs-kftvq4d7,971536867,0.338,657038677,0.229,314498190,0.109,PGX_AM_BS_Nbl-mic-AH-12,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.578000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,57.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad938,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq9,P1Y2M,pgxind-kftx2ov9,pgxcs-kftvq4do,2250283844,0.783,1187844594,0.413,1062439250,0.37,PGX_AM_BS_Nbl-mic-AH-13,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.579000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,72,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad939,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqb,P3Y4M,pgxind-kftx2ovb,pgxcs-kftvq4e8,1613948581,0.561,736349364,0.256,877599217,0.305,PGX_AM_BS_Nbl-mic-AH-14,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.581000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,62.4,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqc,P1Y4M,pgxind-kftx2ovd,pgxcs-kftvq4eq,1397013584,0.486,766685584,0.267,630328000,0.219,PGX_AM_BS_Nbl-mic-AH-15,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.582000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,73.2,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqe,P1Y4M,pgxind-kftx2ovf,pgxcs-kftvq4f8,383439271,0.133,304664450,0.106,78774821,0.027,PGX_AM_BS_Nbl-mic-AH-18,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.584000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,52.8,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqf,P0Y5M,pgxind-kftx2ovh,pgxcs-kftvq4fq,1552513391,0.54,961881619,0.335,590631772,0.205,PGX_AM_BS_Nbl-mic-AH-19,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.585000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,45.6,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqh,P1Y2M,pgxind-kftx2ovj,pgxcs-kftvq4g8,1697094264,0.59,1274230986,0.443,422863278,0.147,PGX_AM_BS_Nbl-mic-AH-2,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.586000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,63.6,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqk,P0Y4M,pgxind-kftx2ovn,pgxcs-kftvq4h7,1092460593,0.38,709725407,0.247,382735186,0.133,PGX_AM_BS_Nbl-mic-AH-21,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.589000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,55.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad940,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqm,P2Y1M,pgxind-kftx2ovp,pgxcs-kftvq4ho,1611752187,0.561,949236872,0.33,662515315,0.23,PGX_AM_BS_Nbl-mic-AH-22,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.591000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,52.8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad941,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqo,P0Y11M,pgxind-kftx2ovr,pgxcs-kftvq4i6,193874935,0.067,100200099,0.035,93674836,0.033,PGX_AM_BS_Nbl-mic-AH-35,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.592000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,57.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad942,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqp,P0Y7M,pgxind-kftx2ovt,pgxcs-kftvq4in,2125031754,0.739,1082046679,0.376,1042985075,0.363,PGX_AM_BS_Nbl-mic-AH-38,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.594000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,51.6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad943,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqr,P0Y4M,pgxind-kftx2ovv,pgxcs-kftvq4j5,1282465819,0.446,844131515,0.294,438334304,0.152,PGX_AM_BS_Nbl-mic-AH-41,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.595000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,57.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad944,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqt,P0Y6M,pgxind-kftx2ovx,pgxcs-kftvq4jn,1112765682,0.387,875169278,0.304,237596404,0.083,PGX_AM_BS_Nbl-mic-AH-43,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.597000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,103.2,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad945,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqu,P0Y1M,pgxind-kftx2ovz,pgxcs-kftvq4k7,276224554,0.096,161500161,0.056,114724393,0.04,PGX_AM_BS_Nbl-mic-AH-5,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.598000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,19.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad946,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqw,P0Y,pgxind-kftx2ow1,pgxcs-kftvq4ko,509788816,0.177,272192412,0.095,237596404,0.083,PGX_AM_BS_Nbl-mic-AH-6,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.599000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,69.6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad947,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqy,P3Y1M,pgxind-kftx2ow3,pgxcs-kftvq4l6,182274924,0.063,84700084,0.029,97574840,0.034,PGX_AM_BS_Nbl-mic-AH-7,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.601000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,76.8,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad948,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqz,P0Y1M,pgxind-kftx2ow5,pgxcs-kftvq4lo,785835207,0.273,357978478,0.125,427856729,0.149,PGX_AM_BS_Nbl-mic-AH-9,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.602000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",0,55.2,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae34f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzai,P4Y6M,pgxind-kftx2swi,pgxcs-kftvr4kp,182009694,0.063,49317665,0.017,132692029,0.046,PGX_AM_BS_NB-nog-01,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.552000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,38.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae350,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzak,P1Y6M,pgxind-kftx2swk,pgxcs-kftvr4l7,1121730036,0.39,400354355,0.139,721375681,0.251,PGX_AM_BS_NB-nog-02,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.553000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,38.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae352,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzan,P2Y,pgxind-kftx2swo,pgxcs-kftvr4m6,431610295,0.15,299992439,0.104,131617856,0.046,PGX_AM_BS_NB-nog-04,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.556000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,39.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae353,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzap,P3Y1M,pgxind-kftx2swq,pgxcs-kftvr4mo,298768571,0.104,0,0,298768571,0.104,PGX_AM_BS_NB-nog-05,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.557000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,32.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae357,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzaw,P3Y8M,pgxind-kftx2swx,pgxcs-kftvr4ol,98470400,0.034,27800027,0.01,70670373,0.025,PGX_AM_BS_NB-nog-14,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.562000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,18.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae35a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb1,P4Y4M,pgxind-kftx2sx2,pgxcs-kftvr4q1,732406526,0.255,391267331,0.136,341139195,0.119,PGX_AM_BS_NB-nog-17,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.567000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,18.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae35b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb3,P4Y2M,pgxind-kftx2sx4,pgxcs-kftvr4qi,604256564,0.21,143010394,0.05,461246170,0.16,PGX_AM_BS_NB-nog-19,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.568000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,21.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae35d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb6,P9Y,pgxind-kftx2sx7,pgxcs-kftvr4rh,573887960,0.2,117700117,0.041,456187843,0.159,PGX_AM_BS_NB-nog-21,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.571000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,16.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae35e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb8,P2Y5M,pgxind-kftx2sx9,pgxcs-kftvr4ry,225766399,0.079,119500118,0.042,106266281,0.037,PGX_AM_BS_NB-nog-22,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.572000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,17.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae360,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbb,P5Y1M,pgxind-kftx2sxd,pgxcs-kftvr4sy,176242332,0.061,21517638,0.007,154724694,0.054,PGX_AM_BS_NB-nog-24,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.575000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,29.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae365,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbj,P3Y6M,pgxind-kftx2sxm,pgxcs-kftvr4ve,86252471,0.03,81552467,0.028,4700004,0.002,PGX_AM_BS_NB-nog-29,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.582000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,21.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae368,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"neuroblastoma, NOS",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbo,P3Y5M,pgxind-kftx2sxs,pgxcs-kftvr4wu,427992153,0.149,190400188,0.066,237591965,0.083,PGX_AM_BS_NB-nog-33,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.586000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,12.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae36a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbr,P2Y4M,pgxind-kftx2sxv,pgxcs-kftvr4xs,1569007905,0.546,113217729,0.039,1455790176,0.506,PGX_AM_BS_NB-nog-35,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.589000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,13.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae36e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbx,P3Y6M,pgxind-kftx2sy2,pgxcs-kftvr4zq,413700949,0.144,167970169,0.058,245730780,0.085,PGX_AM_BS_NB-nog-40,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.595000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,18.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae36f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbz,P1Y2M,pgxind-kftx2sy3,pgxcs-kftvr509,134066308,0.047,27800027,0.01,106266281,0.037,PGX_AM_BS_NB-nog-41,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.596000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,5.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae372,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc4,P2Y,pgxind-kftx2sy9,pgxcs-kftvr51p,167774909,0.058,71200070,0.025,96574839,0.034,PGX_AM_BS_NB-nog-45,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.600000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,16.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae373,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc5,P2Y4M,pgxind-kftx2syb,pgxcs-kftvr528,168327422,0.059,168327422,0.059,0,0,PGX_AM_BS_NB-nog-47,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.602000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,16.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae374,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"neuroblastoma, NOS",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc7,P11Y,pgxind-kftx2syd,pgxcs-kftvr52q,1054358115,0.367,169443987,0.059,884914128,0.308,PGX_AM_BS_NB-nog-48,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.604000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,12.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae375,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc8,P6Y,pgxind-kftx2syf,pgxcs-kftvr538,0,0,0,0,0,0,PGX_AM_BS_NB-nog-50,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.605000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,5.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae376,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzca,P3Y4M,pgxind-kftx2syh,pgxcs-kftvr53q,549049204,0.191,81552467,0.028,467496737,0.163,PGX_AM_BS_NB-nog-51,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.606000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,3.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae378,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzcd,P3Y4M,pgxind-kftx2syk,pgxcs-kftvr54o,765576076,0.266,435565024,0.152,330011052,0.115,PGX_AM_BS_NB-nog-54,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.609000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,6.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae379,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzcf,P2Y7M,pgxind-kftx2sym,pgxcs-kftvr556,0,0,0,0,0,0,PGX_AM_BS_NB-nog-55,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.610000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,4.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae37c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzck,P1Y6M,pgxind-kftx2sys,pgxcs-kftvr56m,200072364,0.07,143497565,0.05,56574799,0.02,PGX_AM_BS_NB-nog-59,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.615000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,0.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae37d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzcl,P2Y8M,pgxind-kftx2syu,pgxcs-kftvr573,772023673,0.269,119500118,0.042,652523555,0.227,PGX_AM_BS_NB-nog-61,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.616000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,1.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae37f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzco,P1Y4M,pgxind-kftx2syy,pgxcs-kftvr582,561383587,0.195,0,0,561383587,0.195,PGX_AM_BS_NB-nog-63,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.619000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,9.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb0e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 3, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wf,P6Y1M,pgxind-kftx32ed,pgxcs-kftvthk6,458852416,0.16,0,0,458852416,0.16,PGX_AM_BS_NB711-sta-25,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.972000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,42,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb0f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 1, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wh,P0Y10M,pgxind-kftx32ef,pgxcs-kftvthkq,95600096,0.033,31800032,0.011,63800064,0.022,PGX_AM_BS_NB711-sta-26,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.973000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,36,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb11,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [differentiating, 2, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wk,P0Y10M,pgxind-kftx32ej,pgxcs-kftvthlo,0,0,0,0,0,0,PGX_AM_BS_NB711-sta-30,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.976000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,36,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb12,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wl,P1Y11M,pgxind-kftx32el,pgxcs-kftvthm5,176621601,0.061,26400027,0.009,150221574,0.052,PGX_AM_BS_NB711-sta-31a,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.977000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,17,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb15,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4s, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wq,P0Y5M,pgxind-kftx32er,pgxcs-kftvthnl,1065479731,0.371,134452519,0.047,931027212,0.324,PGX_AM_BS_NB711-sta-32,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.982000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb16,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6ws,P2Y5M,pgxind-kftx32et,pgxcs-kftvtho2,504655561,0.176,35100035,0.012,469555526,0.163,PGX_AM_BS_NB711-sta-34,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.983000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb17,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Cervicothoracic]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wu,P2Y5M,pgxind-kftx32ev,pgxcs-kftvthok,120300120,0.042,28700029,0.01,91600091,0.032,PGX_AM_BS_NB711-sta-35,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.985000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb18,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 2a, Thoracic]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wv,P0Y1M,pgxind-kftx32ex,pgxcs-kftvthp1,1089815995,0.379,0,0,1089815995,0.379,PGX_AM_BS_NB711-sta-36,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.986000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,12,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb19,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Thoracoabdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wx,P1Y10M,pgxind-kftx32ez,pgxcs-kftvthpj,488888600,0.17,24100024,0.008,464788576,0.162,PGX_AM_BS_NB711-sta-37,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.988000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb1a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6wz,P0Y7M,pgxind-kftx32f1,pgxcs-kftvthq1,504655561,0.176,35100035,0.012,469555526,0.163,PGX_AM_BS_NB711-sta-39,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.989000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb1b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [poorly differentiated, 4, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6x0,P4Y6M,pgxind-kftx32f3,pgxcs-kftvthqi,400966107,0.139,52952438,0.018,348013669,0.121,PGX_AM_BS_NB711-sta-40,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.990000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afb1c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Neuroblastoma [NOS, 4, Abdominal]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvh6x2,P4Y7M,pgxind-kftx32f5,pgxcs-kftvthqz,53500053,0.019,26400027,0.009,27100026,0.009,PGX_AM_BS_NB711-sta-41,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:34.992000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbl,,pgxind-kftx37xi,pgxcs-kftvuv34,1447467822,0.503,979994257,0.341,467473565,0.163,PGX_AM_BS_NBL-Meta-100,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.840000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbm,P0Y,pgxind-kftx37xk,pgxcs-kftvuv3l,685704258,0.239,298077356,0.104,387626902,0.135,PGX_AM_BS_NBL-Meta-101,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.841000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,6,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbo,P0Y,pgxind-kftx37xm,pgxcs-kftvuv43,581315810,0.202,185597607,0.065,395718203,0.138,PGX_AM_BS_NBL-Meta-102,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.843000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,10,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbq,P0Y,pgxind-kftx37xo,pgxcs-kftvuv4k,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-103,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.844000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,22,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2A],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbr,P0Y,pgxind-kftx37xq,pgxcs-kftvuv51,775795253,0.27,479581174,0.167,296214079,0.103,PGX_AM_BS_NBL-Meta-104,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.845000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,47,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08da,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbt,P0Y,pgxind-kftx37xs,pgxcs-kftvuv5i,1170740863,0.407,391838685,0.136,778902178,0.271,PGX_AM_BS_NBL-Meta-105,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.847000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,83,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08db,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2B],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbv,P0Y,pgxind-kftx37xu,pgxcs-kftvuv60,1302033446,0.453,892445731,0.31,409587715,0.142,PGX_AM_BS_NBL-Meta-106,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.848000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,7,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbw,P0Y,pgxind-kftx37xw,pgxcs-kftvuv6h,433607616,0.151,233113986,0.081,200493630,0.07,PGX_AM_BS_NBL-Meta-107,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.850000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,61,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08dd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbby,P0Y,pgxind-kftx37xy,pgxcs-kftvuv6y,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-108,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.851000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,40,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc1,,pgxind-kftx37y2,pgxcs-kftvuv7x,2033613438,0.707,1421473595,0.494,612139843,0.213,PGX_AM_BS_NBL-Meta-11,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.854000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,49,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc3,P5Y,pgxind-kftx37y4,pgxcs-kftvuv8e,250474991,0.087,196000194,0.068,54474797,0.019,PGX_AM_BS_NBL-Meta-110,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.855000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,17,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc4,P0Y,pgxind-kftx37y6,pgxcs-kftvuv8x,467893168,0.163,218312197,0.076,249580971,0.087,PGX_AM_BS_NBL-Meta-111,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.856000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,19,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc6,P0Y,pgxind-kftx37y8,pgxcs-kftvuv9e,478010398,0.166,195213949,0.068,282796449,0.098,PGX_AM_BS_NBL-Meta-112,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.858000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,52,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc7,P1Y,pgxind-kftx37yb,pgxcs-kftvuv9v,629347308,0.219,288116710,0.1,341230598,0.119,PGX_AM_BS_NBL-Meta-113,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.859000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,30,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcp,P3Y6M,pgxind-kftx37yx,pgxcs-kftvuvfa,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-123,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.874000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,39,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcr,,pgxind-kftx37yz,pgxcs-kftvuvfr,1229258071,0.428,868722907,0.302,360535164,0.125,PGX_AM_BS_NBL-Meta-124,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.876000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,39,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcs,P1Y2M,pgxind-kftx37z1,pgxcs-kftvuvg8,1105803177,0.385,395080157,0.137,710723020,0.247,PGX_AM_BS_NBL-Meta-125,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.877000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,51,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcu,,pgxind-kftx37z3,pgxcs-kftvuvgq,1093104215,0.38,154913909,0.054,938190306,0.326,PGX_AM_BS_NBL-Meta-126,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.879000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcv,,pgxind-kftx37z5,pgxcs-kftvuvh7,540752221,0.188,0,0,540752221,0.188,PGX_AM_BS_NBL-Meta-127,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.880000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,46,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcx,,pgxind-kftx37z7,pgxcs-kftvuvho,1643635434,0.572,784245624,0.273,859389810,0.299,PGX_AM_BS_NBL-Meta-128,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.882000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcz,,pgxind-kftx37z9,pgxcs-kftvuvi7,1376969486,0.479,767071608,0.267,609897878,0.212,PGX_AM_BS_NBL-Meta-129,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.883000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,30,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd0,P5Y6M,pgxind-kftx37zb,pgxcs-kftvuvip,262288760,0.091,154913909,0.054,107374851,0.037,PGX_AM_BS_NBL-Meta-13,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.884000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,46,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd2,,pgxind-kftx37zd,pgxcs-kftvuvj6,1147804505,0.399,304664450,0.106,843140055,0.293,PGX_AM_BS_NBL-Meta-130,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.886000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,24,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd3,P1Y1M,pgxind-kftx37zf,pgxcs-kftvuvjn,707165916,0.246,288711465,0.1,418454451,0.146,PGX_AM_BS_NBL-Meta-131,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.887000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,18,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd5,,pgxind-kftx37zh,pgxcs-kftvuvk5,1117209346,0.389,441722220,0.154,675487126,0.235,PGX_AM_BS_NBL-Meta-132,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.889000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,13,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08f9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd7,P1Y,pgxind-kftx37zj,pgxcs-kftvuvkm,1342640307,0.467,922640480,0.321,419999827,0.146,PGX_AM_BS_NBL-Meta-133,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.890000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,20,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08fa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbd8,P3Y10M,pgxind-kftx37zl,pgxcs-kftvuvl6,353607277,0.123,0,0,353607277,0.123,PGX_AM_BS_NBL-Meta-134,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.891000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,49,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbda,P1Y10M,pgxind-kftx37zn,pgxcs-kftvuvln,1424681898,0.496,649793105,0.226,774888793,0.27,PGX_AM_BS_NBL-Meta-135,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.893000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,49,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08fc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdb,,pgxind-kftx37zp,pgxcs-kftvuvm5,1110303600,0.386,677876932,0.236,432426668,0.15,PGX_AM_BS_NBL-Meta-136,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.894000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,33,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdd,,pgxind-kftx37zs,pgxcs-kftvuvmm,1463354513,0.509,543424413,0.189,919930100,0.32,PGX_AM_BS_NBL-Meta-137,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.896000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,14,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08fe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbde,P1Y2M,pgxind-kftx37zu,pgxcs-kftvuvn4,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-138,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.897000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,39,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdg,P4Y1M,pgxind-kftx37zw,pgxcs-kftvuvnm,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-139,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.898000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,13,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0900,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdi,P1Y5M,pgxind-kftx37zy,pgxcs-kftvuvo4,613766325,0.213,0,0,613766325,0.213,PGX_AM_BS_NBL-Meta-14,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.900000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,117,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0901,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdj,P8Y,pgxind-kftx3800,pgxcs-kftvuvol,578916004,0.201,149452534,0.052,429463470,0.149,PGX_AM_BS_NBL-Meta-140,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.901000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,47,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0902,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdl,,pgxind-kftx3802,pgxcs-kftvuvp4,1627838171,0.566,661357879,0.23,966480292,0.336,PGX_AM_BS_NBL-Meta-141,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.902000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,41,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0903,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdm,P1Y4M,pgxind-kftx3804,pgxcs-kftvuvpm,1772655806,0.617,729670731,0.254,1042985075,0.363,PGX_AM_BS_NBL-Meta-142,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.904000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,41,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0904,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdo,,pgxind-kftx3806,pgxcs-kftvuvq4,946943556,0.329,388510504,0.135,558433052,0.194,PGX_AM_BS_NBL-Meta-143,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.905000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,10,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0905,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdq,P1Y5M,pgxind-kftx3808,pgxcs-kftvuvql,1387478442,0.483,784245624,0.273,603232818,0.21,PGX_AM_BS_NBL-Meta-144,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.907000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,41,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0906,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdr,P1Y2M,pgxind-kftx380a,pgxcs-kftvuvr3,1642653815,0.571,1103498527,0.384,539155288,0.188,PGX_AM_BS_NBL-Meta-145,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.908000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,1,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0907,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdt,P1Y7M,pgxind-kftx380c,pgxcs-kftvuvrn,1093391526,0.38,213531584,0.074,879859942,0.306,PGX_AM_BS_NBL-Meta-146,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.910000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,116,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0908,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdv,,pgxind-kftx380e,pgxcs-kftvuvs4,1253471684,0.436,498207377,0.173,755264307,0.263,PGX_AM_BS_NBL-Meta-147,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.911000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,51,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0909,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdw,,pgxind-kftx380g,pgxcs-kftvuvsl,1265710216,0.44,794871635,0.276,470838581,0.164,PGX_AM_BS_NBL-Meta-148,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.913000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,42,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdy,P1Y11M,pgxind-kftx380i,pgxcs-kftvuvt3,1209786615,0.421,994390233,0.346,215396382,0.075,PGX_AM_BS_NBL-Meta-149,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.914000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,27,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbdz,,pgxind-kftx380k,pgxcs-kftvuvtk,1152982818,0.401,373170878,0.13,779811940,0.271,PGX_AM_BS_NBL-Meta-15,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.916000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,60,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe1,,pgxind-kftx380m,pgxcs-kftvuvu3,101127229,0.035,57752443,0.02,43374786,0.015,PGX_AM_BS_NBL-Meta-150,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.917000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,27,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe3,P1Y5M,pgxind-kftx380o,pgxcs-kftvuvuk,432160551,0.15,115821087,0.04,316339464,0.11,PGX_AM_BS_NBL-Meta-151,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.918000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,28,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe6,,pgxind-kftx380s,pgxcs-kftvuvvl,846618695,0.294,494879196,0.172,351739499,0.122,PGX_AM_BS_NBL-Meta-153,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.921000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,24,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0910,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe7,P1Y,pgxind-kftx380u,pgxcs-kftvuvw2,1225820607,0.426,767726571,0.267,458094036,0.159,PGX_AM_BS_NBL-Meta-154,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.923000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,54,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0911,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe9,P1Y10M,pgxind-kftx380w,pgxcs-kftvuvwk,831954003,0.289,154913909,0.054,677040094,0.235,PGX_AM_BS_NBL-Meta-155,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.924000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,58,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0913,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbec,,pgxind-kftx3810,pgxcs-kftvuvxj,1395798207,0.485,544889659,0.19,850908548,0.296,PGX_AM_BS_NBL-Meta-157,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.927000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,20,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0914,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbee,,pgxind-kftx3812,pgxcs-kftvuvy0,1455147728,0.506,459578359,0.16,995569369,0.346,PGX_AM_BS_NBL-Meta-158,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.928000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,32,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0915,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbef,P2Y,pgxind-kftx3814,pgxcs-kftvuvyi,859479252,0.299,395735120,0.138,463744132,0.161,PGX_AM_BS_NBL-Meta-159,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.930000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,18,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0916,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbeh,P3Y,pgxind-kftx3816,pgxcs-kftvuvz1,765205133,0.266,497822537,0.173,267382596,0.093,PGX_AM_BS_NBL-Meta-16,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.931000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,67,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0917,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbej,P3Y4M,pgxind-kftx3818,pgxcs-kftvuvzj,1449359049,0.504,624221855,0.217,825137194,0.287,PGX_AM_BS_NBL-Meta-160,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.932000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,13,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0919,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbem,P1Y4M,pgxind-kftx381d,pgxcs-kftvuw2n,1060657697,0.369,487662186,0.17,572995511,0.199,PGX_AM_BS_NBL-Meta-162,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.935000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,72,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbep,,pgxind-kftx381h,pgxcs-kftvuw3o,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-164,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.938000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,48,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbes,P2Y,pgxind-kftx381l,pgxcs-kftvuw4n,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-166,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.941000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,48,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbeu,,pgxind-kftx381n,pgxcs-kftvuw55,1410660476,0.491,336235061,0.117,1074425415,0.374,PGX_AM_BS_NBL-Meta-167,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.942000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,12,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbev,P1Y10M,pgxind-kftx381p,pgxcs-kftvuw5n,1352957537,0.471,577511825,0.201,775445712,0.27,PGX_AM_BS_NBL-Meta-168,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.944000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,26,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0921,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbez,P1Y,pgxind-kftx381t,pgxcs-kftvuw6o,467020229,0.162,0,0,467020229,0.162,PGX_AM_BS_NBL-Meta-17,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.947000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,71,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0922,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf0,P13Y,pgxind-kftx381v,pgxcs-kftvuw76,1927993913,0.671,893150435,0.311,1034843478,0.36,PGX_AM_BS_NBL-Meta-170,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.948000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,123,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0923,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf2,P1Y4M,pgxind-kftx381x,pgxcs-kftvuw7o,1297374157,0.451,332748277,0.116,964625880,0.336,PGX_AM_BS_NBL-Meta-171,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.950000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,45,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfd,,pgxind-kftx382b,pgxcs-kftvuwb2,849489041,0.295,0,0,849489041,0.295,PGX_AM_BS_NBL-Meta-178,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.959000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfg,,pgxind-kftx382f,pgxcs-kftvuwc2,317896483,0.111,51800051,0.018,266096432,0.093,PGX_AM_BS_NBL-Meta-18,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.962000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,108,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfi,P5Y1M,pgxind-kftx382h,pgxcs-kftvuwck,1473044407,0.512,641090404,0.223,831954003,0.289,PGX_AM_BS_NBL-Meta-180,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.963000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfl,,pgxind-kftx382l,pgxcs-kftvuwdm,1540453387,0.536,225839141,0.079,1314614246,0.457,PGX_AM_BS_NBL-Meta-182,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.966000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0930,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfn,P2Y8M,pgxind-kftx382n,pgxcs-kftvuwe3,178796682,0.062,0,0,178796682,0.062,PGX_AM_BS_NBL-Meta-183,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.967000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0934,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbft,P3Y11M,pgxind-kftx382v,pgxcs-kftvuwg1,214733331,0.075,108467050,0.038,106266281,0.037,PGX_AM_BS_NBL-Meta-187,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.973000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0937,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfy,P0Y,pgxind-kftx3831,pgxcs-kftvuwhi,973206318,0.339,0,0,973206318,0.339,PGX_AM_BS_NBL-Meta-19,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.977000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,119,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg3,P5Y,pgxind-kftx3837,pgxcs-kftvuwiy,514745252,0.179,233731188,0.081,281014064,0.098,PGX_AM_BS_NBL-Meta-192,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.981000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg7,,pgxind-kftx383c,pgxcs-kftvuwjx,936874379,0.326,169209217,0.059,767665162,0.267,PGX_AM_BS_NBL-Meta-194,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.984000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,47,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg8,,pgxind-kftx383e,pgxcs-kftvuwkf,704463811,0.245,466867407,0.162,237596404,0.083,PGX_AM_BS_NBL-Meta-195,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.986000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,52,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbga,P1Y,pgxind-kftx383g,pgxcs-kftvuwkv,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-196,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.987000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,74,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgb,,pgxind-kftx383i,pgxcs-kftvuwlc,793673995,0.276,395735120,0.138,397938875,0.138,PGX_AM_BS_NBL-Meta-197,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.989000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0941,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgf,P0Y,pgxind-kftx383m,pgxcs-kftvuwmb,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-199,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.991000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0943,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgi,P15Y5M,pgxind-kftx383q,pgxcs-kftvuwna,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-20,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.994000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,92,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0945,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgl,P0Y,pgxind-kftx383t,pgxcs-kftvuwo8,241724519,0.084,35500035,0.012,206224484,0.072,PGX_AM_BS_NBL-Meta-201,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.997000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,23,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0946,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgn,,pgxind-kftx383v,pgxcs-kftvuwoq,1661504798,0.578,640017978,0.223,1021486820,0.355,PGX_AM_BS_NBL-Meta-202,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.998000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,66,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0947,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgo,,pgxind-kftx383x,pgxcs-kftvuwp8,1560069498,0.543,947929655,0.33,612139843,0.213,PGX_AM_BS_NBL-Meta-203,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.999000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,47,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0948,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgq,,pgxind-kftx383z,pgxcs-kftvuwpp,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-204,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.001000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,35,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0949,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgs,,pgxind-kftx3841,pgxcs-kftvuwq7,1481105559,0.515,572350854,0.199,908754705,0.316,PGX_AM_BS_NBL-Meta-21,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.002000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,88,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgt,,pgxind-kftx3844,pgxcs-kftvuwqo,1053698888,0.367,345128655,0.12,708570233,0.246,PGX_AM_BS_NBL-Meta-22,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.004000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,54,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgv,,pgxind-kftx3846,pgxcs-kftvuwr6,620111813,0.216,43600043,0.015,576511770,0.201,PGX_AM_BS_NBL-Meta-23,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.005000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,80,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgw,,pgxind-kftx3848,pgxcs-kftvuwrn,427279647,0.149,159587022,0.056,267692625,0.093,PGX_AM_BS_NBL-Meta-24,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.006000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,108,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0950,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh3,P3Y,pgxind-kftx384g,pgxcs-kftvuwtk,385956889,0.134,187064332,0.065,198892557,0.069,PGX_AM_BS_NBL-Meta-28,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.012000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,84,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0951,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh5,,pgxind-kftx384i,pgxcs-kftvuwu1,1055711567,0.367,311909906,0.108,743801661,0.259,PGX_AM_BS_NBL-Meta-29,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.013000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,66,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0953,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh8,P2Y1M,pgxind-kftx384m,pgxcs-kftvuwv0,201349736,0.07,94500094,0.033,106849642,0.037,PGX_AM_BS_NBL-Meta-30,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.016000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,42.5,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0954,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbha,,pgxind-kftx384o,pgxcs-kftvuwvi,354277989,0.123,236877871,0.082,117400118,0.041,PGX_AM_BS_NBL-Meta-31,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.017000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,149,,,T2,NCITstage-C27970,Stage III,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0955,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhb,P1Y8M,pgxind-kftx384q,pgxcs-kftvuwvz,278572443,0.097,228297650,0.079,50274793,0.017,PGX_AM_BS_NBL-Meta-32,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.019000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,83,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0957,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhe,P2Y7M,pgxind-kftx384u,pgxcs-kftvuwwx,607496422,0.211,159421130,0.055,448075292,0.156,PGX_AM_BS_NBL-Meta-34,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.021000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,111,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0958,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhg,P5Y5M,pgxind-kftx384w,pgxcs-kftvuwxe,534666238,0.186,207352591,0.072,327313647,0.114,PGX_AM_BS_NBL-Meta-35,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.023000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,40,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbho,P1Y11M,pgxind-kftx3856,pgxcs-kftvuwzt,201174942,0.07,60900060,0.021,140274882,0.049,PGX_AM_BS_NBL-Meta-4,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.030000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,58,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0960,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbht,P3Y5M,pgxind-kftx385c,pgxcs-kftvux19,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-42,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.034000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,90,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0962,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhw,P1Y5M,pgxind-kftx385g,pgxcs-kftvux27,134374876,0.047,84100083,0.029,50274793,0.017,PGX_AM_BS_NBL-Meta-44,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.036000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,116,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0963,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhy,P2Y11M,pgxind-kftx385i,pgxcs-kftvux2p,136600135,0.048,117500116,0.041,19100019,0.007,PGX_AM_BS_NBL-Meta-45,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.038000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,66,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0964,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhz,P2Y8M,pgxind-kftx385k,pgxcs-kftvux36,385998658,0.134,216102320,0.075,169896338,0.059,PGX_AM_BS_NBL-Meta-46,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.039000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,104,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0965,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi1,P14Y10M,pgxind-kftx385m,pgxcs-kftvux3n,348411501,0.121,172117787,0.06,176293714,0.061,PGX_AM_BS_NBL-Meta-47,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.040000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,27.5,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0966,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi3,P1Y7M,pgxind-kftx385o,pgxcs-kftvux45,140474882,0.049,84700084,0.029,55774798,0.019,PGX_AM_BS_NBL-Meta-48,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.042000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,80,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0967,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi4,P2Y10M,pgxind-kftx385r,pgxcs-kftvux4n,605848424,0.211,0,0,605848424,0.211,PGX_AM_BS_NBL-Meta-49,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.043000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,86,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0968,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi6,P0Y,pgxind-kftx385t,pgxcs-kftvux55,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-5,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.045000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,96,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0969,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi7,P4Y,pgxind-kftx385v,pgxcs-kftvux5n,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-50,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.046000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,38,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbi9,,pgxind-kftx385x,pgxcs-kftvux65,2151734740,0.748,952295630,0.331,1199439110,0.417,PGX_AM_BS_NBL-Meta-51,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.048000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,11,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbib,P1Y5M,pgxind-kftx385z,pgxcs-kftvux6n,1177594045,0.41,494879196,0.172,682714849,0.237,PGX_AM_BS_NBL-Meta-52,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.049000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,5,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbic,P1Y7M,pgxind-kftx3861,pgxcs-kftvux74,1161684338,0.404,565530029,0.197,596154309,0.207,PGX_AM_BS_NBL-Meta-53,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.050000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,10,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbie,,pgxind-kftx3863,pgxcs-kftvux7m,854711951,0.297,575519776,0.2,279192175,0.097,PGX_AM_BS_NBL-Meta-54,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.052000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,9,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbig,,pgxind-kftx3865,pgxcs-kftvux83,606870847,0.211,236924776,0.082,369946071,0.129,PGX_AM_BS_NBL-Meta-55,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.053000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,12,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b096f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbih,P1Y4M,pgxind-kftx3867,pgxcs-kftvuxai,1326198160,0.461,544570678,0.189,781627482,0.272,PGX_AM_BS_NBL-Meta-56,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.055000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,15,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0970,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 1],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbij,,pgxind-kftx3869,pgxcs-kftvuxb1,2316426498,0.806,1105433457,0.384,1210993041,0.421,PGX_AM_BS_NBL-Meta-57,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.056000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,11,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0971,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbik,P2Y2M,pgxind-kftx386b,pgxcs-kftvuxbk,618071475,0.215,190214746,0.066,427856729,0.149,PGX_AM_BS_NBL-Meta-58,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.058000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,21,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0972,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbim,P8Y,pgxind-kftx386d,pgxcs-kftvuxc1,739831446,0.257,292795852,0.102,447035594,0.155,PGX_AM_BS_NBL-Meta-59,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.059000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,14,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0973,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2A],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbio,P1Y,pgxind-kftx386f,pgxcs-kftvuxcj,1189287773,0.414,761431044,0.265,427856729,0.149,PGX_AM_BS_NBL-Meta-6,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.061000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,78,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0974,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbip,,pgxind-kftx386h,pgxcs-kftvuxd1,417963526,0.145,227967169,0.079,189996357,0.066,PGX_AM_BS_NBL-Meta-60,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.062000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,15,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0975,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbir,P2Y7M,pgxind-kftx386j,pgxcs-kftvuxdi,167074909,0.058,84700084,0.029,82374825,0.029,PGX_AM_BS_NBL-Meta-61,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.064000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,43,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0976,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbit,P1Y,pgxind-kftx386l,pgxcs-kftvuxe0,225477013,0.078,154427408,0.054,71049605,0.025,PGX_AM_BS_NBL-Meta-62,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.065000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,19,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0977,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbiu,P4Y,pgxind-kftx386n,pgxcs-kftvuxei,884566897,0.308,278384207,0.097,606182690,0.211,PGX_AM_BS_NBL-Meta-63,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.066000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,41,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0979,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbiy,P4Y11M,pgxind-kftx386r,pgxcs-kftvuxfj,903575421,0.314,238825357,0.083,664750064,0.231,PGX_AM_BS_NBL-Meta-65,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.069000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,7,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbiz,P4Y11M,pgxind-kftx386t,pgxcs-kftvuxg0,418615660,0.146,57752443,0.02,360863217,0.126,PGX_AM_BS_NBL-Meta-66,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.070000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,82,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj4,P1Y7M,pgxind-kftx386z,pgxcs-kftvuxhg,1444205828,0.502,526905360,0.183,917300468,0.319,PGX_AM_BS_NBL-Meta-69,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.075000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,88,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj5,P1Y2M,pgxind-kftx3871,pgxcs-kftvuxhy,303488222,0.106,105417722,0.037,198070500,0.069,PGX_AM_BS_NBL-Meta-7,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.076000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,58,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0982,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjc,P10Y2M,pgxind-kftx3879,pgxcs-kftvuxjw,439074435,0.153,84700084,0.029,354374351,0.123,PGX_AM_BS_NBL-Meta-73,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.081000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,13,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0983,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbje,,pgxind-kftx387b,pgxcs-kftvuxkf,808445552,0.281,729670731,0.254,78774821,0.027,PGX_AM_BS_NBL-Meta-74,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.083000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0984,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjf,P5Y6M,pgxind-kftx387d,pgxcs-kftvuxkx,624353848,0.217,406755754,0.141,217598094,0.076,PGX_AM_BS_NBL-Meta-75,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.084000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0985,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjh,P4Y4M,pgxind-kftx387f,pgxcs-kftvuxlf,781049162,0.272,365095042,0.127,415954120,0.145,PGX_AM_BS_NBL-Meta-76,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.086000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0989,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2B],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjn,,pgxind-kftx387o,pgxcs-kftvuxnd,904565837,0.315,502124652,0.175,402441185,0.14,PGX_AM_BS_NBL-Meta-8,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.091000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,55,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjq,,pgxind-kftx387s,pgxcs-kftvuxoc,363145797,0.126,191921163,0.067,171224634,0.06,PGX_AM_BS_NBL-Meta-81,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.094000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjs,,pgxind-kftx387u,pgxcs-kftvuxou,142569603,0.05,60900060,0.021,81669543,0.028,PGX_AM_BS_NBL-Meta-82,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.095000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,75,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjv,,pgxind-kftx387y,pgxcs-kftvuxps,794418643,0.276,494879196,0.172,299539447,0.104,PGX_AM_BS_NBL-Meta-84,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.098000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,74,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjx,,pgxind-kftx3880,pgxcs-kftvuxq9,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-85,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.099000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,90,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0991,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk0,,pgxind-kftx3884,pgxcs-kftvuxr8,1614250210,0.561,271196111,0.094,1343054099,0.467,PGX_AM_BS_NBL-Meta-87,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.102000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,78,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0992,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk2,,pgxind-kftx3886,pgxcs-kftvuxrq,972266752,0.338,193070194,0.067,779196558,0.271,PGX_AM_BS_NBL-Meta-88,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.103000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,67,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0993,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk3,,pgxind-kftx3888,pgxcs-kftvuxs8,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-89,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.105000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,58,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0994,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk5,,pgxind-kftx388a,pgxcs-kftvuxsp,2185257027,0.76,1368663379,0.476,816593648,0.284,PGX_AM_BS_NBL-Meta-9,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.106000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,54,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0995,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk6,,pgxind-kftx388c,pgxcs-kftvuxt6,1223153410,0.425,524151515,0.182,699001895,0.243,PGX_AM_BS_NBL-Meta-90,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.108000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,49,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0996,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk8,,pgxind-kftx388e,pgxcs-kftvuxtn,1171502076,0.407,198295758,0.069,973206318,0.339,PGX_AM_BS_NBL-Meta-91,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.109000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,46,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0997,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbk9,,pgxind-kftx388g,pgxcs-kftvuxu5,2423061835,0.843,1153390153,0.401,1269671682,0.442,PGX_AM_BS_NBL-Meta-92,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.110000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0998,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkb,,pgxind-kftx388i,pgxcs-kftvuxum,315107230,0.11,139514696,0.049,175592534,0.061,PGX_AM_BS_NBL-Meta-93,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.112000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,70,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b099a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkf,,pgxind-kftx388m,pgxcs-kftvuxvl,1283804054,0.447,593617931,0.206,690186123,0.24,PGX_AM_BS_NBL-Meta-95,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.115000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b099b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkg,,pgxind-kftx388o,pgxcs-kftvuxw3,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-96,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.116000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,23,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b099c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbki,,pgxind-kftx388q,pgxcs-kftvuxwk,2276571112,0.792,810189762,0.282,1466381350,0.51,PGX_AM_BS_NBL-Meta-97,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.118000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b099d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkj,,pgxind-kftx388s,pgxcs-kftvuxx1,1382807798,0.481,933806996,0.325,449000802,0.156,PGX_AM_BS_NBL-Meta-98,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.119000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,7,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b099e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkl,,pgxind-kftx388u,pgxcs-kftvuxxj,1643511059,0.572,878328468,0.306,765182591,0.266,PGX_AM_BS_NBL-Meta-99,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.120000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",0,5,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi27,P1Y4M,pgxind-kftx27yt,pgxcs-kftvlyk7,1565734195,0.545,653863602,0.227,911870593,0.317,PGX_AM_BS_9006325_NB-pla-13,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.393000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,21,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2a,P3Y11M,pgxind-kftx27yx,pgxcs-kftvlyl5,992001889,0.345,849137341,0.295,142864548,0.05,PGX_AM_BS_9006325_NB-pla-15,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.396000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaec9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2b,P1Y10M,pgxind-kftx27yz,pgxcs-kftvlyll,554079927,0.193,141927557,0.049,412152370,0.143,PGX_AM_BS_9006325_NB-pla-16,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.397000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaecd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2i,P2Y1M,pgxind-kftx27z7,pgxcs-kftvlynh,898480418,0.313,577511825,0.201,320968593,0.112,PGX_AM_BS_9006325_NB-pla-20,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.403000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaece,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2k,P1Y8M,pgxind-kftx27z9,pgxcs-kftvlyny,240339259,0.084,84700084,0.029,155639175,0.054,PGX_AM_BS_9006325_NB-pla-21,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.404000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaecf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2m,P5Y7M,pgxind-kftx27zb,pgxcs-kftvlyoe,898577138,0.313,618112539,0.215,280464599,0.098,PGX_AM_BS_9006325_NB-pla-22,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.405000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2n,P0Y5M,pgxind-kftx27zd,pgxcs-kftvlyov,258380980,0.09,46500046,0.016,211880934,0.074,PGX_AM_BS_9006325_NB-pla-23,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.407000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,41,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2p,P0Y4M,pgxind-kftx27zf,pgxcs-kftvlypc,849424930,0.295,139997562,0.049,709427368,0.247,PGX_AM_BS_9006325_NB-pla-24,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.408000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c0727983b2e00aaed2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgi2q,P0Y6M,pgxind-kftx27zh,pgxcs-kftvlypt,0,0,0,0,0,0,PGX_AM_BS_9006325_NB-pla-25,,-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:07.410000,PMID:9006325,"Plantaz D, Mohapatra G et al. (1997): Gain of chromosome 17 is the...",1,8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab8a6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Cerebral neuroblastoma [cerebral region     midline, frontal lobe]",NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl95,P4Y11M,pgxind-kftx2buv,pgxcs-kftvmx4q,500652012,0.174,185192463,0.064,315459549,0.11,PGX_AM_BS_21798848_PNET-mil-25,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.974000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,9,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abea0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn6u,P5Y,pgxind-kftx2e7b,pgxcs-kftvnht8,433665499,0.151,189701051,0.066,243964448,0.085,PGX_AM_BS_20406844_NB-buc-CHOP1220,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.171000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7h,P12Y8M,pgxind-kftx2e83,pgxcs-kftvnhzr,609076501,0.212,95702214,0.033,513374287,0.179,PGX_AM_BS_20406844_NB-buc-CHOP1551,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.191000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeaf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7i,P12Y7M,pgxind-kftx2e85,pgxcs-kftvni08,17404361,0.006,17404361,0.006,0,0,PGX_AM_BS_20406844_NB-buc-CHOP1585,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.192000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeb1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7m,P6Y2M,pgxind-kftx2e89,pgxcs-kftvni16,601334504,0.209,306527470,0.107,294807034,0.103,PGX_AM_BS_20406844_NB-buc-CHOP1638,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.195000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeb3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7p,P1Y4M,pgxind-kftx2e8d,pgxcs-kftvni27,104580706,0.036,97511118,0.034,7069588,0.002,PGX_AM_BS_20406844_NB-buc-CHOP1643,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.198000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeb6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7u,P4Y,pgxind-kftx2e8j,pgxcs-kftvni3m,604793155,0.21,226032202,0.079,378760953,0.132,PGX_AM_BS_20406844_NB-buc-CHOP1667,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.202000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeb8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7x,P4Y6M,pgxind-kftx2e8n,pgxcs-kftvni4k,454179412,0.158,86546543,0.03,367632869,0.128,PGX_AM_BS_20406844_NB-buc-CHOP1699,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.205000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeb9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn7z,P1Y,pgxind-kftx2e8p,pgxcs-kftvni50,290886459,0.101,233820983,0.081,57065476,0.02,PGX_AM_BS_20406844_NB-buc-CHOP1710,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.206000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn80,P6Y7M,pgxind-kftx2e8r,pgxcs-kftvni5i,314528567,0.109,204370036,0.071,110158531,0.038,PGX_AM_BS_20406844_NB-buc-CHOP1729,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.207000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abec0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn8a,P10Y11M,pgxind-kftx2e94,pgxcs-kftvni8b,403398986,0.14,206173526,0.072,197225460,0.069,PGX_AM_BS_20406844_NB-buc-CHOP1830,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.216000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abec3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn8f,P14Y5M,pgxind-kftx2e9a,pgxcs-kftvni9q,42011383,0.015,41491351,0.014,520032,0,PGX_AM_BS_20406844_NB-buc-CHOP1851,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.220000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abec5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn8i,P0Y7M,pgxind-kftx2e9e,pgxcs-kftvniao,56626320,0.02,54178518,0.019,2447802,0.001,PGX_AM_BS_20406844_NB-buc-CHOP1894,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.223000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abed2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn93,P1Y6M,pgxind-kftx2ea5,pgxcs-kftvnigr,0,0,0,0,0,0,PGX_AM_BS_20406844_NB-buc-CHOP2057,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.240000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abee1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgn9s,P1Y10M,pgxind-kftx2eb0,pgxcs-kftvnipu,246932257,0.086,96631463,0.034,150300794,0.052,PGX_AM_BS_20406844_NB-buc-CHOP2172,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.261000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnaa,P7Y7M,pgxind-kftx2ebm,pgxcs-kftvniv0,594651348,0.207,266356515,0.093,328294833,0.114,PGX_AM_BS_20406844_NB-buc-CHOP258,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.277000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnaf,P1Y8M,pgxind-kftx2ebt,pgxcs-kftvniwf,111402319,0.039,106889105,0.037,4513214,0.002,PGX_AM_BS_20406844_NB-buc-CHOP28,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.281000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abef1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnai,P3Y,pgxind-kftx2ebx,pgxcs-kftvnixe,97812319,0.034,97275645,0.034,536674,0,PGX_AM_BS_20406844_NB-buc-CHOP300,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.284000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abef7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnas,P3Y6M,pgxind-kftx2ec9,pgxcs-kftvnj07,565474723,0.197,103705849,0.036,461768874,0.161,PGX_AM_BS_20406844_NB-buc-COG1100,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.292000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abef8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnat,P1Y,pgxind-kftx2ecb,pgxcs-kftvnj0o,196078297,0.068,69122372,0.024,126955925,0.044,PGX_AM_BS_20406844_NB-buc-COG1126,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.294000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abef9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnav,P0Y11M,pgxind-kftx2ecd,pgxcs-kftvnj15,357517497,0.124,156280136,0.054,201237361,0.07,PGX_AM_BS_20406844_NB-buc-COG1128,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.295000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abefb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnay,P3Y7M,pgxind-kftx2ech,pgxcs-kftvnj23,278043797,0.097,228399879,0.079,49643918,0.017,PGX_AM_BS_20406844_NB-buc-COG1173,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.298000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abefc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnb0,P3Y8M,pgxind-kftx2ecj,pgxcs-kftvnj2k,326707110,0.114,114418529,0.04,212288581,0.074,PGX_AM_BS_20406844_NB-buc-COG1194,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.299000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abeff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnb5,P1Y5M,pgxind-kftx2ecp,pgxcs-kftvnj3y,52916297,0.018,51323849,0.018,1592448,0.001,PGX_AM_BS_20406844_NB-buc-CHOP2238,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.303000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf03,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbb,P14Y7M,pgxind-kftx2ecx,pgxcs-kftvnj5t,199610043,0.069,76398696,0.027,123211347,0.043,PGX_AM_BS_20406844_NB-buc-COG157,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.309000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf04,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbd,P3Y11M,pgxind-kftx2ecz,pgxcs-kftvnj6a,406184987,0.141,236698258,0.082,169486729,0.059,PGX_AM_BS_20406844_NB-buc-COG283,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.310000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf06,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbg,P2Y8M,pgxind-kftx2ed3,pgxcs-kftvnj78,457925774,0.159,224776416,0.078,233149358,0.081,PGX_AM_BS_20406844_NB-buc-COG355,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.313000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf07,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbi,P0Y5M,pgxind-kftx2ed5,pgxcs-kftvnj7o,244292669,0.085,84621386,0.029,159671283,0.056,PGX_AM_BS_20406844_NB-buc-COG430,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.315000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf09,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbl,P4Y1M,pgxind-kftx2ed9,pgxcs-kftvnj8m,301951310,0.105,141014790,0.049,160936520,0.056,PGX_AM_BS_20406844_NB-buc-COG493,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.317000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf0a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbn,P6Y,pgxind-kftx2edb,pgxcs-kftvnj93,329757209,0.115,195382547,0.068,134374662,0.047,PGX_AM_BS_20406844_NB-buc-OLHSC195,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.319000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf0d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbr,P1Y1M,pgxind-kftx2edi,pgxcs-kftvnjai,385127814,0.134,253099144,0.088,132028670,0.046,PGX_AM_BS_20406844_NB-buc-OLHSC214,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.323000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf10,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnbw,P5Y11M,pgxind-kftx2edo,pgxcs-kftvnjbw,619888489,0.216,337280159,0.117,282608330,0.098,PGX_AM_BS_20406844_NB-buc-OLHSC237,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.327000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf15,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnc4,P3Y7M,pgxind-kftx2edy,pgxcs-kftvnje9,424341599,0.148,176372212,0.061,247969387,0.086,PGX_AM_BS_20406844_NB-buc-OLHSC272,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.334000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf19,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgncb,P5Y4M,pgxind-kftx2ee6,pgxcs-kftvnjg5,13554114,0.005,8261863,0.003,5292251,0.002,PGX_AM_BS_20406844_NB-buc-OLHSC310,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.339000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf1e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgncj,P2Y11M,pgxind-kftx2eeg,pgxcs-kftvnjih,561325428,0.195,91484359,0.032,469841069,0.163,PGX_AM_BS_20406844_NB-buc-OLHSC404,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.347000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf1f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgncl,P2Y11M,pgxind-kftx2eei,pgxcs-kftvnjix,519281605,0.181,137345448,0.048,381936157,0.133,PGX_AM_BS_20406844_NB-buc-ROI45,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.348000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf27,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgncy,P5Y10M,pgxind-kftx2eey,pgxcs-kftvnjmp,593704309,0.207,179044865,0.062,414659444,0.144,PGX_AM_BS_20406844_NB-buc-OLHSC474,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.359000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnd4,P4Y10M,pgxind-kftx2ef6,pgxcs-kftvnjok,130792897,0.045,41249246,0.014,89543651,0.031,PGX_AM_BS_20406844_NB-buc-ROI11,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.365000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnd6,P2Y1M,pgxind-kftx2ef9,pgxcs-kftvnjp1,3160616,0.001,1567972,0.001,1592644,0.001,PGX_AM_BS_20406844_NB-buc-ROI14,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.366000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnd8,P3Y4M,pgxind-kftx2efb,pgxcs-kftvnjpi,491049972,0.171,251284945,0.087,239765027,0.083,PGX_AM_BS_20406844_NB-buc-ROI17,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.368000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnd9,P3Y,pgxind-kftx2efd,pgxcs-kftvnjry,254977938,0.089,61868163,0.022,193109775,0.067,PGX_AM_BS_20406844_NB-buc-ROI22,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.369000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf2f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgndb,P7Y2M,pgxind-kftx2eff,pgxcs-kftvnjsh,25739121,0.009,1182358,0,24556763,0.009,PGX_AM_BS_20406844_NB-buc-ROI23,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.371000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgndc,P2Y5M,pgxind-kftx2efh,pgxcs-kftvnjsz,189387993,0.066,105401402,0.037,83986591,0.029,PGX_AM_BS_20406844_NB-buc-ROI35,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.372000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgnde,P4Y6M,pgxind-kftx2efj,pgxcs-kftvnjth,183306715,0.064,58087449,0.02,125219266,0.044,PGX_AM_BS_20406844_NB-buc-ROI40,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.373000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgndj,P2Y1M,pgxind-kftx2efp,pgxcs-kftvnjux,152561722,0.053,115582519,0.04,36979203,0.013,PGX_AM_BS_20406844_NB-buc-ROI43,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.378000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgndr,P0Y8M,pgxind-kftx2efz,pgxcs-kftvnjxe,164029534,0.057,107799517,0.037,56230017,0.02,PGX_AM_BS_20406844_NB-buc-ROI58,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.385000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgndt,P4Y5M,pgxind-kftx2eg1,pgxcs-kftvnjxv,270820719,0.094,199093496,0.069,71727223,0.025,PGX_AM_BS_20406844_NB-buc-ROI6,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:13.386000,PMID:20406844,"Buckley PG, Alcock L et al. (2010): Chromosomal and microRNA expression patterns reveal...",1,,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac400,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxd,P3Y11M,pgxind-kftx2gd1,pgxcs-kftvo0la,1169277820,0.407,788776188,0.274,380501632,0.132,PGX_AM_BS_20003513_NBL-1243,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.075000,geo:GSE14109,,1,20,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac401,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxe,P5Y8M,pgxind-kftx2gd3,pgxcs-kftvo0ls,318275840,0.111,167215206,0.058,151060634,0.053,PGX_AM_BS_20003513_NBL-1276,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.077000,geo:GSE14109,,1,24,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac404,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxj,P3Y2M,pgxind-kftx2gd9,pgxcs-kftvo0n9,621575843,0.216,151779952,0.053,469795891,0.163,PGX_AM_BS_20003513_NBL-1439,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.081000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,9,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac406,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxm,P4Y2M,pgxind-kftx2gde,pgxcs-kftvo0o7,651050829,0.226,198304677,0.069,452746152,0.157,PGX_AM_BS_20003513_NBL-1506,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.084000,geo:GSE14109,,1,30,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac408,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxp,P2Y2M,pgxind-kftx2gdi,pgxcs-kftvo0p5,105992465,0.037,0,0,105992465,0.037,PGX_AM_BS_20003513_NBL-1560,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.087000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,12,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxu,P3Y10M,pgxind-kftx2gdo,pgxcs-kftvo0ql,355753934,0.124,211621181,0.074,144132753,0.05,PGX_AM_BS_20003513_NBL-1699,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.091000,geo:GSE14109,,1,16,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxw,P2Y11M,pgxind-kftx2gdq,pgxcs-kftvo0r2,108592468,0.038,0,0,108592468,0.038,PGX_AM_BS_20003513_NBL-1768,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.093000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,17,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac40e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoxz,P4Y,pgxind-kftx2gdu,pgxcs-kftvo0s1,399381612,0.139,183697605,0.064,215684007,0.075,PGX_AM_BS_20003513_NBL-1869,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.095000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,1,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac411,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy4,P3Y1M,pgxind-kftx2ge0,pgxcs-kftvo0ti,779931870,0.271,84952470,0.03,694979400,0.242,PGX_AM_BS_20003513_NBL-1900,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.099000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,24,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac413,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy7,P6Y11M,pgxind-kftx2ge4,pgxcs-kftvo0ui,1196645288,0.416,739714811,0.257,456930477,0.159,PGX_AM_BS_20003513_NBL-1965,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.102000,geo:GSE14109,,1,34,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac414,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoy9,P1Y10M,pgxind-kftx2ge6,pgxcs-kftvo0uz,1507641887,0.524,83200082,0.029,1424441805,0.495,PGX_AM_BS_20003513_NBL-1995,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.104000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,21,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac417,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoye,P2Y4M,pgxind-kftx2gec,pgxcs-kftvo0wf,545275263,0.19,273229103,0.095,272046160,0.095,PGX_AM_BS_20003513_NBL-2100,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.108000,geo:GSE14109,,1,11,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac41b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNpos],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyk,P1Y1M,pgxind-kftx2gel,pgxcs-kftvo0yb,620037503,0.216,502771211,0.175,117266292,0.041,PGX_AM_BS_20003513_NBL-2704,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.114000,geo:GSE14109,,1,7,,,,,,,,,,,,,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac41e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [ampMYCNneg],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoyp,P2Y10M,pgxind-kftx2ger,pgxcs-kftvo0zq,670957525,0.233,209552593,0.073,461404932,0.16,PGX_AM_BS_20003513_NBL-806,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:15.118000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,6,,,,,,,,,,,,,,,geo:GSE14109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8fe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnn,P5Y5M,pgxind-kftx2os0,pgxcs-kftvq3j9,591596979,0.206,189352573,0.066,402244406,0.14,PGX_AM_BS_Nbl-mic-AD-103,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.498000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,111.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad8ff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnp,P5Y4M,pgxind-kftx2os3,pgxcs-kftvq3ls,1688309692,0.587,1021091032,0.355,667218660,0.232,PGX_AM_BS_Nbl-mic-AD-104,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.499000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,3.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad900,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnq,P2Y8M,pgxind-kftx2os5,pgxcs-kftvq3ma,1181843560,0.411,971618888,0.338,210224672,0.073,PGX_AM_BS_Nbl-mic-AD-105,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.501000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,8.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad901,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvns,P9Y6M,pgxind-kftx2os7,pgxcs-kftvq3mt,1194181460,0.415,537914667,0.187,656266793,0.228,PGX_AM_BS_Nbl-mic-AD-106,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.502000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,27.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad902,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnu,P1Y7M,pgxind-kftx2os9,pgxcs-kftvq3nb,307024770,0.107,115900115,0.04,191124655,0.066,PGX_AM_BS_Nbl-mic-AD-107,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.504000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,7.2,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad904,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvnx,P2Y4M,pgxind-kftx2osd,pgxcs-kftvq3ob,528284355,0.184,151621123,0.053,376663232,0.131,PGX_AM_BS_Nbl-mic-AD-110,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.506000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,32.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad907,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo2,P2Y7M,pgxind-kftx2osj,pgxcs-kftvq3pr,701196516,0.244,186121157,0.065,515075359,0.179,PGX_AM_BS_Nbl-mic-AD-116,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.511000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,111.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad908,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo3,P3Y11M,pgxind-kftx2osl,pgxcs-kftvq3q8,1550023619,0.539,886555135,0.308,663468484,0.231,PGX_AM_BS_Nbl-mic-AD-117,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.512000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,22.8,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad909,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvo5,P0Y,pgxind-kftx2osn,pgxcs-kftvq3qq,0,0,0,0,0,0,PGX_AM_BS_Nbl-mic-AD-118,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.514000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,7.2,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoc,P2Y10M,pgxind-kftx2osv,pgxcs-kftvq3sp,236296403,0.082,103900103,0.036,132396300,0.046,PGX_AM_BS_Nbl-mic-AD-125,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.519000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,37.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvod,P4Y10M,pgxind-kftx2osx,pgxcs-kftvq3t6,438973126,0.153,172121142,0.06,266851984,0.093,PGX_AM_BS_Nbl-mic-AD-126,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.521000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,21.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad90f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvof,P2Y10M,pgxind-kftx2osz,pgxcs-kftvq3tn,1838780571,0.64,1092324552,0.38,746456019,0.26,PGX_AM_BS_Nbl-mic-AD-127,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.522000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,27.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad910,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvoh,P1Y5M,pgxind-kftx2ot1,pgxcs-kftvq3u5,0,0,0,0,0,0,PGX_AM_BS_Nbl-mic-AD-128,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.523000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad912,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvok,P2Y7M,pgxind-kftx2ot5,pgxcs-kftvq3v3,0,0,0,0,0,0,PGX_AM_BS_Nbl-mic-AD-130,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.526000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad917,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvos,P5Y,pgxind-kftx2ote,pgxcs-kftvq3xj,366718759,0.128,275650083,0.096,91068676,0.032,PGX_AM_BS_Nbl-mic-AD-140,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.533000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,32.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvox,P3Y,pgxind-kftx2otk,pgxcs-kftvq3yz,896704329,0.312,165408751,0.058,731295578,0.254,PGX_AM_BS_Nbl-mic-AD-165,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.537000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad91f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp5,P3Y5M,pgxind-kftx2otu,pgxcs-kftvq41e,341866048,0.119,63752449,0.022,278113599,0.097,PGX_AM_BS_Nbl-mic-AD-177,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.544000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,19.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad921,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp8,P2Y4M,pgxind-kftx2oty,pgxcs-kftvq42c,193606172,0.067,101806081,0.035,91800091,0.032,PGX_AM_BS_Nbl-mic-AD-187,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.547000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,13.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad922,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvp9,P7Y11M,pgxind-kftx2ou0,pgxcs-kftvq42t,835422820,0.291,287113268,0.1,548309552,0.191,PGX_AM_BS_Nbl-mic-AD-188,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.549000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad926,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpg,P7Y8M,pgxind-kftx2ou8,pgxcs-kftvq44r,891799474,0.31,412131467,0.143,479668007,0.167,PGX_AM_BS_Nbl-mic-AD-73,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.554000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,15.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad928,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpj,P2Y5M,pgxind-kftx2ouc,pgxcs-kftvq45q,567788874,0.197,348192488,0.121,219596386,0.076,PGX_AM_BS_Nbl-mic-AD-75,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.557000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpo,P1Y,pgxind-kftx2oui,pgxcs-kftvq479,155674899,0.054,99400099,0.035,56274800,0.02,PGX_AM_BS_Nbl-mic-AD-78,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.561000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,14.4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpq,P2Y8M,pgxind-kftx2ouk,pgxcs-kftvq47q,1684709178,0.586,379153805,0.132,1305555373,0.454,PGX_AM_BS_Nbl-mic-AD-79,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.563000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,93.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpr,P3Y,pgxind-kftx2oum,pgxcs-kftvq489,441772048,0.154,264647408,0.092,177124640,0.062,PGX_AM_BS_Nbl-mic-AD-80,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.564000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,15.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad92e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpt,P2Y1M,pgxind-kftx2oup,pgxcs-kftvq48q,418439918,0.146,199715238,0.069,218724680,0.076,PGX_AM_BS_Nbl-mic-AD-83,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.565000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,9.6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad931,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvpy,P1Y11M,pgxind-kftx2ouv,pgxcs-kftvq4a7,636740053,0.221,56200056,0.02,580539997,0.202,PGX_AM_BS_Nbl-mic-AD-88,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.570000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,18,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad933,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvq1,P4Y10M,pgxind-kftx2ouz,pgxcs-kftvq4b8,1794021613,0.624,804745222,0.28,989276391,0.344,PGX_AM_BS_Nbl-mic-AD-90,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.572000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,25.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad93e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgvqj,P0Y7M,pgxind-kftx2ovl,pgxcs-kftvq4gp,179404418,0.062,124736089,0.043,54668329,0.019,PGX_AM_BS_Nbl-mic-AH-20,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:22.588000,PMID:17823929,"Michels E, Vandesompele J et al. (2007): ArrayCGH-based classification of neuroblastoma into genomic...",1,31.2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae354,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzar,P2Y,pgxind-kftx2swr,pgxcs-kftvr4n5,269993799,0.094,27800027,0.01,242193772,0.084,PGX_AM_BS_NB-nog-07,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.558000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,6.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae355,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzas,P1Y2M,pgxind-kftx2swt,pgxcs-kftvr4nm,252630510,0.088,37706017,0.013,214924493,0.075,PGX_AM_BS_NB-nog-09,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.560000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,9.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae356,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [undifferentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzau,P3Y,pgxind-kftx2swv,pgxcs-kftvr4o3,290115999,0.101,0,0,290115999,0.101,PGX_AM_BS_NB-nog-10,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.561000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,0.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae359,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzaz,P5Y2M,pgxind-kftx2sx0,pgxcs-kftvr4pj,977328936,0.34,301721272,0.105,675607664,0.235,PGX_AM_BS_NB-nog-16,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.565000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,2.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae35c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb4,P3Y4M,pgxind-kftx2sx5,pgxcs-kftvr4qz,0,0,0,0,0,0,PGX_AM_BS_NB-nog-20,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.570000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,10.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae35f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzb9,P1Y4M,pgxind-kftx2sxb,pgxcs-kftvr4sf,89200089,0.031,27800027,0.01,61400062,0.021,PGX_AM_BS_NB-nog-23,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.574000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,24.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae361,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbc,P6Y7M,pgxind-kftx2sxf,pgxcs-kftvr4tg,378266554,0.132,246500246,0.086,131766308,0.046,PGX_AM_BS_NB-nog-25,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.576000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae362,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbe,P1Y6M,pgxind-kftx2sxg,pgxcs-kftvr4ty,476530915,0.166,226095785,0.079,250435130,0.087,PGX_AM_BS_NB-nog-26,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.578000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,23.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae367,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbm,P3Y8M,pgxind-kftx2sxq,pgxcs-kftvr4wc,708873637,0.247,207752591,0.072,501121046,0.174,PGX_AM_BS_NB-nog-32,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.585000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,17.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae36d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbw,P1Y4M,pgxind-kftx2sy0,pgxcs-kftvr4z9,0,0,0,0,0,0,PGX_AM_BS_NB-nog-38,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.593000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,0.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae370,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [differentiating],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc0,P14Y5M,pgxind-kftx2sy5,pgxcs-kftvr50q,654895316,0.228,0,0,654895316,0.228,PGX_AM_BS_NB-nog-43,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.597000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,5.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae371,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [poorly differentiated],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzc2,P1Y11M,pgxind-kftx2sy7,pgxcs-kftvr518,267696434,0.093,27800027,0.01,239896407,0.083,PGX_AM_BS_NB-nog-44,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.599000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,14.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b08d3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbh,P7Y11M,pgxind-kftx37xe,pgxcs-kftvuv21,555162859,0.193,359066496,0.125,196096363,0.068,PGX_AM_BS_NBL-Meta-1,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.837000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,32,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08d4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbj,P2Y1M,pgxind-kftx37xg,pgxcs-kftvuv2l,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-10,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.838000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08de,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbbz,P2Y,pgxind-kftx37y0,pgxcs-kftvuv7g,341997887,0.119,154913909,0.054,187083978,0.065,PGX_AM_BS_NBL-Meta-109,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.852000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,3,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbc9,P7Y6M,pgxind-kftx37yd,pgxcs-kftvuvac,577125075,0.201,376028707,0.131,201096368,0.07,PGX_AM_BS_NBL-Meta-114,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.861000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,28,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcb,P2Y,pgxind-kftx37yf,pgxcs-kftvuvau,821680910,0.286,521889417,0.182,299791493,0.104,PGX_AM_BS_NBL-Meta-115,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.862000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,11,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcc,P13Y,pgxind-kftx37yh,pgxcs-kftvuvbc,179676841,0.062,123652507,0.043,56024334,0.019,PGX_AM_BS_NBL-Meta-116,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.863000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08e7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbce,P2Y6M,pgxind-kftx37yj,pgxcs-kftvuvbt,154492512,0.054,27800027,0.01,126692485,0.044,PGX_AM_BS_NBL-Meta-117,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.865000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,11,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcj,P4Y10M,pgxind-kftx37yp,pgxcs-kftvuvd9,1214369672,0.422,701812529,0.244,512557143,0.178,PGX_AM_BS_NBL-Meta-12,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.869000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,15,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08eb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbck,P2Y,pgxind-kftx37yr,pgxcs-kftvuvdr,316388812,0.11,261914015,0.091,54474797,0.019,PGX_AM_BS_NBL-Meta-120,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.870000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcm,P18Y,pgxind-kftx37yt,pgxcs-kftvuvea,1032058909,0.359,549584429,0.191,482474480,0.168,PGX_AM_BS_NBL-Meta-121,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.872000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b08ed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbcn,P3Y5M,pgxind-kftx37yv,pgxcs-kftvuves,716159941,0.249,264895987,0.092,451263954,0.157,PGX_AM_BS_NBL-Meta-122,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.873000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,13,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b090e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbe4,P0Y,pgxind-kftx380q,pgxcs-kftvuvv2,511639549,0.178,253997675,0.088,257641874,0.09,PGX_AM_BS_NBL-Meta-152,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.920000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,9,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0912,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 2],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbeb,,pgxind-kftx380y,pgxcs-kftvuvx1,123974865,0.043,60900060,0.021,63074805,0.022,PGX_AM_BS_NBL-Meta-156,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.925000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,12,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0918,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbek,P3Y11M,pgxind-kftx381b,pgxcs-kftvuw25,1215515865,0.423,1037551282,0.361,177964583,0.062,PGX_AM_BS_NBL-Meta-161,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.934000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,4,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhben,P1Y4M,pgxind-kftx381f,pgxcs-kftvuw36,1410820286,0.491,498949693,0.174,911870593,0.317,PGX_AM_BS_NBL-Meta-163,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.937000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,21,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b091c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhber,P1Y10M,pgxind-kftx381j,pgxcs-kftvuw45,608479980,0.212,151727567,0.053,456752413,0.159,PGX_AM_BS_NBL-Meta-165,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.939000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,20,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0920,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbex,,pgxind-kftx381r,pgxcs-kftvuw64,113774855,0.04,46500046,0.016,67274809,0.023,PGX_AM_BS_NBL-Meta-169,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.945000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,3,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0924,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf3,P1Y8M,pgxind-kftx381z,pgxcs-kftvuw85,223939242,0.078,84700084,0.029,139239158,0.048,PGX_AM_BS_NBL-Meta-172,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.951000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0925,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf5,P5Y7M,pgxind-kftx3821,pgxcs-kftvuw8n,902777145,0.314,639312561,0.222,263464584,0.092,PGX_AM_BS_NBL-Meta-173,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.952000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0926,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf7,,pgxind-kftx3823,pgxcs-kftvuw95,414478558,0.144,185097607,0.064,229380951,0.08,PGX_AM_BS_NBL-Meta-174,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.954000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,41,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0927,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbf8,P3Y4M,pgxind-kftx3825,pgxcs-kftvuw9m,336066042,0.117,57752443,0.02,278313599,0.097,PGX_AM_BS_NBL-Meta-175,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.955000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,6,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0928,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfa,P7Y,pgxind-kftx3827,pgxcs-kftvuwa3,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-176,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.956000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,16,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0929,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfc,P5Y,pgxind-kftx3829,pgxcs-kftvuwal,1047470226,0.364,487867989,0.17,559602237,0.195,PGX_AM_BS_NBL-Meta-177,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.958000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,40,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbff,P2Y5M,pgxind-kftx382d,pgxcs-kftvuwbk,1974751829,0.687,1385596767,0.482,589155062,0.205,PGX_AM_BS_NBL-Meta-179,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.961000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b092e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfk,P1Y8M,pgxind-kftx382j,pgxcs-kftvuwd1,351503264,0.122,184538821,0.064,166964443,0.058,PGX_AM_BS_NBL-Meta-181,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.965000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,15,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0931,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfo,,pgxind-kftx382p,pgxcs-kftvuwek,198174940,0.069,124300124,0.043,73874816,0.026,PGX_AM_BS_NBL-Meta-184,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.969000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,16,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0932,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfq,P1Y7M,pgxind-kftx382r,pgxcs-kftvuwf2,545162946,0.19,0,0,545162946,0.19,PGX_AM_BS_NBL-Meta-185,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.970000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0935,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfv,P2Y10M,pgxind-kftx382x,pgxcs-kftvuwgj,607316090,0.211,403891425,0.14,203424665,0.071,PGX_AM_BS_NBL-Meta-188,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.974000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,17,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0936,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbfx,P4Y10M,pgxind-kftx382z,pgxcs-kftvuwh0,1782803888,0.62,1057125109,0.368,725678779,0.252,PGX_AM_BS_NBL-Meta-189,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.976000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,34,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0938,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg0,P3Y5M,pgxind-kftx3833,pgxcs-kftvuwhz,242667115,0.084,27800027,0.01,214867088,0.075,PGX_AM_BS_NBL-Meta-190,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.979000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,15,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0939,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg2,P3Y10M,pgxind-kftx3835,pgxcs-kftvuwih,277533384,0.097,84706064,0.029,192827320,0.067,PGX_AM_BS_NBL-Meta-191,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.980000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b093b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbg5,,pgxind-kftx3839,pgxcs-kftvuwjf,854224935,0.297,144797567,0.05,709427368,0.247,PGX_AM_BS_NBL-Meta-193,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.983000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0940,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgd,,pgxind-kftx383k,pgxcs-kftvuwlu,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-198,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.990000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0942,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgg,P5Y6M,pgxind-kftx383o,pgxcs-kftvuwms,390743049,0.136,155179956,0.054,235563093,0.082,PGX_AM_BS_NBL-Meta-2,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.992000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0944,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgk,,pgxind-kftx383s,pgxcs-kftvuwnr,82000081,0.029,34400034,0.012,47600047,0.017,PGX_AM_BS_NBL-Meta-200,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:39.995000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,7,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbgy,,pgxind-kftx384a,pgxcs-kftvuws4,338362654,0.118,103423841,0.036,234938813,0.082,PGX_AM_BS_NBL-Meta-25,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.008000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,74,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh0,,pgxind-kftx384c,pgxcs-kftvuwsl,490296484,0.171,393282729,0.137,97013755,0.034,PGX_AM_BS_NBL-Meta-26,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.009000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,1.5,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b094f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh1,P1Y8M,pgxind-kftx384e,pgxcs-kftvuwt3,392692006,0.137,0,0,392692006,0.137,PGX_AM_BS_NBL-Meta-27,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.010000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,21,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0952,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbh6,P5Y10M,pgxind-kftx384k,pgxcs-kftvuwuk,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-3,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.015000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0956,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhd,P8Y5M,pgxind-kftx384s,pgxcs-kftvuwwg,1003119482,0.349,37752423,0.013,965367059,0.336,PGX_AM_BS_NBL-Meta-33,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.020000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0959,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhi,P2Y8M,pgxind-kftx384y,pgxcs-kftvuwxw,0,0,0,0,0,0,PGX_AM_BS_NBL-Meta-36,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.024000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,38,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhj,P3Y11M,pgxind-kftx3850,pgxcs-kftvuwyd,292306405,0.102,154913909,0.054,137392496,0.048,PGX_AM_BS_NBL-Meta-37,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.025000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhl,P4Y10M,pgxind-kftx3852,pgxcs-kftvuwyu,1117880821,0.389,614484897,0.214,503395924,0.175,PGX_AM_BS_NBL-Meta-38,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.027000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,25,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhm,P5Y4M,pgxind-kftx3854,pgxcs-kftvuwzb,1904397333,0.662,1051487200,0.366,852910133,0.297,PGX_AM_BS_NBL-Meta-39,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.028000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,3,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhq,P4Y10M,pgxind-kftx3858,pgxcs-kftvux0b,373793421,0.13,169668755,0.059,204124666,0.071,PGX_AM_BS_NBL-Meta-40,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.031000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,21,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b095f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhr,P4Y1M,pgxind-kftx385a,pgxcs-kftvux0s,56324519,0.02,25149745,0.009,31174774,0.011,PGX_AM_BS_NBL-Meta-41,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.032000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,20,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0961,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbhu,P2Y8M,pgxind-kftx385e,pgxcs-kftvux1q,451555651,0.157,327080784,0.114,124474867,0.043,PGX_AM_BS_NBL-Meta-43,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.035000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0978,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbiw,P1Y11M,pgxind-kftx386p,pgxcs-kftvuxf0,951259948,0.331,230666543,0.08,720593405,0.251,PGX_AM_BS_NBL-Meta-64,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.068000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,1,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj1,P4Y4M,pgxind-kftx386v,pgxcs-kftvuxgh,896145168,0.312,51797475,0.018,844347693,0.294,PGX_AM_BS_NBL-Meta-67,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.072000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,18,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 3],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj2,P4Y4M,pgxind-kftx386x,pgxcs-kftvuxgz,896145168,0.312,51797475,0.018,844347693,0.294,PGX_AM_BS_NBL-Meta-68,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.073000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,18,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b097f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj7,P1Y7M,pgxind-kftx3873,pgxcs-kftvuxif,121774863,0.042,46500046,0.016,75274817,0.026,PGX_AM_BS_NBL-Meta-70,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.077000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0980,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbj9,P3Y2M,pgxind-kftx3875,pgxcs-kftvuxix,212754594,0.074,96552481,0.034,116202113,0.04,PGX_AM_BS_NBL-Meta-71,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.079000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0986,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbji,P2Y7M,pgxind-kftx387i,pgxcs-kftvuxlx,180574921,0.063,117500116,0.041,63074805,0.022,PGX_AM_BS_NBL-Meta-77,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.087000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,22,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0987,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjk,P3Y6M,pgxind-kftx387k,pgxcs-kftvuxme,474659773,0.165,141717757,0.049,332942016,0.116,PGX_AM_BS_NBL-Meta-78,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.088000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0988,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjm,P5Y1M,pgxind-kftx387m,pgxcs-kftvuxmw,601606884,0.209,334421758,0.116,267185126,0.093,PGX_AM_BS_NBL-Meta-79,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.090000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjp,P1Y8M,pgxind-kftx387q,pgxcs-kftvuxnv,173224636,0.06,0,0,173224636,0.06,PGX_AM_BS_NBL-Meta-80,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.092000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,7,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b098d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbju,,pgxind-kftx387w,pgxcs-kftvuxpb,132295691,0.046,46500046,0.016,85795645,0.03,PGX_AM_BS_NBL-Meta-83,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.096000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,17,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0990,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbjy,,pgxind-kftx3882,pgxcs-kftvuxqr,494581520,0.172,317363620,0.11,177217900,0.062,PGX_AM_BS_NBL-Meta-86,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.101000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cc727983b2e00b0999,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,neuroblastoma [stage 4S],NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C72.9,"Nervous system, NOS",pgxbs-kftvhbkd,,pgxind-kftx388k,pgxcs-kftvuxv3,1009507414,0.351,644233200,0.224,365274214,0.127,PGX_AM_BS_NBL-Meta-94,,3.72,51.05,Point,BEL,Gent,Belgium,"Gent, Belgium",51.05,3.72,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:40.113000,PMID:11464905,"Vandesompele J, Speleman F et al. (2001): Multicentre analysis of patterns of DNA...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5c865b6609d374f2dc2be00e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaq2,P6Y4M,pgxind-kftx3xlc,pgxcs-kftw5tyj,465987591,0.162,210710792,0.073,255276799,0.089,PGX_AM_BS_GSM313859,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.022000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,52,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313859,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be012,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaq8,P9Y2M,pgxind-kftx3xll,pgxcs-kftw5u0g,222629250,0.077,124605690,0.043,98023560,0.034,PGX_AM_BS_GSM313863,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.027000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,61,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313863,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be018,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaqi,P5Y10M,pgxind-kftx3xlx,pgxcs-kftw5u3d,140613195,0.049,1901739,0.001,138711456,0.048,PGX_AM_BS_GSM313869,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.036000,geo:GSE12494,,1,,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313869,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be022,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaqy,P4Y10M,pgxind-kftx3xmh,pgxcs-kftw5u88,121468206,0.042,101351980,0.035,20116226,0.007,PGX_AM_BS_GSM313879,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.050000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,43,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313879,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be023,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviar0,P4Y10M,pgxind-kftx3xmj,pgxcs-kftw5u8q,311519795,0.108,185059256,0.064,126460539,0.044,PGX_AM_BS_GSM313880,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.052000,geo:GSM313880,,1,37,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be024,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviar1,P10Y4M,pgxind-kftx3xml,pgxcs-kftw5u98,83630179,0.029,53117207,0.018,30512972,0.011,PGX_AM_BS_GSM313881,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.053000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,26,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313881,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be025,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviar3,P6Y,pgxind-kftx3xmn,pgxcs-kftw5u9q,75513131,0.026,39778920,0.014,35734211,0.012,PGX_AM_BS_GSM313882,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.054000,geo:GSE12494,,1,10,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313882,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be026,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviar5,P11Y8M,pgxind-kftx3xmp,pgxcs-kftw5ua8,40147114,0.014,2604,0,40144510,0.014,PGX_AM_BS_GSM313883,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.056000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,50,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313883,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be02a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarb,P14Y,pgxind-kftx3xmx,pgxcs-kftw5uc8,859138976,0.299,366893933,0.128,492245043,0.171,PGX_AM_BS_GSM313887,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.062000,geo:GPL3718,,1,96,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313887,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be02c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarf,P9Y,pgxind-kftx3xn1,pgxcs-kftw5ud8,862217495,0.3,284204183,0.099,578013312,0.201,PGX_AM_BS_GSM313889,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.065000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313889,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be02d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarg,P10Y,pgxind-kftx3xn3,pgxcs-kftw5udq,646374299,0.225,213373353,0.074,433000946,0.151,PGX_AM_BS_GSM313890,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.066000,geo:GSE12494,,1,110,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313890,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be02e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviari,P13Y,pgxind-kftx3xn5,pgxcs-kftw5ue8,167658889,0.058,29578961,0.01,138079928,0.048,PGX_AM_BS_GSM313891,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.068000,geo:GSM313891,,1,25,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.38,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5c865b6609d374f2dc2be02f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviark,P4Y4M,pgxind-kftx3xn7,pgxcs-kftw5uep,2599099,0.001,2426179,0.001,172920,0,PGX_AM_BS_GSM313892,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.069000,geo:GSM313892,,1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6609d374f2dc2be030,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarl,P8Y,pgxind-kftx3xn9,pgxcs-kftw5uf6,210065,0,14445,0,195620,0,PGX_AM_BS_GSM313893,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.071000,geo:GSM313893,,1,32,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be033,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarq,P4Y,pgxind-kftx3xnf,pgxcs-kftw5ugn,344822588,0.12,122055421,0.042,222767167,0.077,PGX_AM_BS_GSM313896,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.075000,geo:GSM313896,,1,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be035,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviart,P22Y,pgxind-kftx3xnk,pgxcs-kftw5uhm,289629892,0.101,126230765,0.044,163399127,0.057,PGX_AM_BS_GSM313898,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.078000,geo:GSM313898,,1,84,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be037,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviarx,P8Y,pgxind-kftx3xno,pgxcs-kftw5uil,2795138,0.001,348307,0,2446831,0.001,PGX_AM_BS_GSM313900,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.081000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,28,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313900,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be038,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviary,P4Y,pgxind-kftx3xnq,pgxcs-kftw5uj2,3457419,0.001,187337,0,3270082,0.001,PGX_AM_BS_GSM313901,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.082000,geo:GSM313901,,1,23,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be039,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvias0,P5Y,pgxind-kftx3xns,pgxcs-kftw5ujj,196265,0,43127,0,153138,0,PGX_AM_BS_GSM313902,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.084000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,35,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313902,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be03d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvias7,P12Y4M,pgxind-kftx3xo0,pgxcs-kftw5ulg,265032931,0.092,164616669,0.057,100416262,0.035,PGX_AM_BS_GSM313906,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.089000,geo:GSE12494,,1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313906,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be03e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvias8,P5Y4M,pgxind-kftx3xo2,pgxcs-kftw5uly,51522883,0.018,11152213,0.004,40370670,0.014,PGX_AM_BS_GSM313907,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.091000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313907,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be03f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasa,P5Y,pgxind-kftx3xo5,pgxcs-kftw5umf,202245767,0.07,155624671,0.054,46621096,0.016,PGX_AM_BS_GSM313908,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.092000,geo:GSM313908,,1,27,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.16,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be040,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasc,P7Y8M,pgxind-kftx3xo7,pgxcs-kftw5umx,2685304,0.001,306378,0,2378926,0.001,PGX_AM_BS_GSM313909,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.093000,geo:GSM313909,,1,35,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be041,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviase,P14Y2M,pgxind-kftx3xo9,pgxcs-kftw5une,2852902,0.001,63386,0,2789516,0.001,PGX_AM_BS_GSM313910,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.095000,geo:GSM313910,,1,27,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be046,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasm,P15Y8M,pgxind-kftx3xoj,pgxcs-kftw5v3i,487881224,0.17,20224922,0.007,467656302,0.163,PGX_AM_BS_GSM313938,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.102000,geo:GSM313938,,1,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be049,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasr,P10Y2M,pgxind-kftx3xop,pgxcs-kftw5ur9,884066,0,316,0,883750,0,PGX_AM_BS_GSM313918,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.106000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313918,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.44,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be04a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviass,P8Y,pgxind-kftx3xos,pgxcs-kftw5urq,247967777,0.086,30925603,0.011,217042174,0.075,PGX_AM_BS_GSM313919,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.107000,geo:GPL3718,,1,24,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313919,,,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be04c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasw,P7Y8M,pgxind-kftx3xow,pgxcs-kftw5usp,640708786,0.223,905648,0,639803138,0.223,PGX_AM_BS_GSM313921,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.110000,geo:GSM313921,,1,9,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be04d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviasx,P14Y2M,pgxind-kftx3xoy,pgxcs-kftw5ut7,44206196,0.015,351920,0,43854276,0.015,PGX_AM_BS_GSM313922,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.112000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,36,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313922,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be04f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviat0,P7Y4M,pgxind-kftx3xp2,pgxcs-kftw5uu5,286083299,0.1,137834868,0.048,148248431,0.052,PGX_AM_BS_GSM313924,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.114000,geo:GSM313924,,1,23,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be050,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviat2,P6Y10M,pgxind-kftx3xp4,pgxcs-kftw5uum,1929822,0.001,5649,0,1924173,0.001,PGX_AM_BS_GSM313925,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.116000,geo:GSM313925,,1,19,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be052,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviat6,P13Y4M,pgxind-kftx3xp8,pgxcs-kftw5uvk,601690593,0.209,173744086,0.06,427946507,0.149,PGX_AM_BS_GSM313927,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.119000,geo:GPL3718,,1,65,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313927,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be053,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviat7,P11Y8M,pgxind-kftx3xpa,pgxcs-kftw5uw2,46796532,0.016,284618,0,46511914,0.016,PGX_AM_BS_GSM313928,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.120000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313928,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.16,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be054,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviat9,P3Y8M,pgxind-kftx3xpc,pgxcs-kftw5uwj,2373653,0.001,2340786,0.001,32867,0,PGX_AM_BS_GSM313929,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.121000,geo:GSM313929,,1,23,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be055,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviata,P4Y2M,pgxind-kftx3xpe,pgxcs-kftw5ux0,100540,0,3062,0,97478,0,PGX_AM_BS_GSM313930,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.123000,geo:GSE12494,,1,10,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313930,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be056,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatc,P13Y,pgxind-kftx3xpg,pgxcs-kftw5uxi,279501,0,126363,0,153138,0,PGX_AM_BS_GSM313931,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.124000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,26,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313931,,,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.14,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be058,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatf,P11Y4M,pgxind-kftx3xpk,pgxcs-kftw5uyg,254807645,0.089,38126458,0.013,216681187,0.075,PGX_AM_BS_GSM313933,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.127000,geo:GPL3718,,1,105,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313933,,,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be05a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatj,P6Y8M,pgxind-kftx3xpo,pgxcs-kftw5uzf,1551569,0.001,1505089,0.001,46480,0,PGX_AM_BS_GSM313935,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.130000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,13,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313935,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be05b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatk,P2Y10M,pgxind-kftx3xpq,pgxcs-kftw5uzx,2609754,0.001,1728522,0.001,881232,0,PGX_AM_BS_GSM313936,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.131000,geo:GSE12494,,1,11,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313936,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be05c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatm,P5Y8M,pgxind-kftx3xps,pgxcs-kftw5v2z,276086831,0.096,65479571,0.023,210607260,0.073,PGX_AM_BS_GSM313937,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.133000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,11,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313937,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be05d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatn,P8Y8M,pgxind-kftx3xpv,pgxcs-kftw5upt,236378,0,170959,0,65419,0,PGX_AM_BS_GSM313915,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.134000,geo:GSE12494,,1,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313915,,,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6709d374f2dc2be05e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviatp,P17Y2M,pgxind-kftx3xpx,pgxcs-kftw5v40,584286369,0.203,308703342,0.107,275583027,0.096,PGX_AM_BS_GSM313939,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.135000,geo:GSM313939,,1,89,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be067,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviau4,P4Y8M,pgxind-kftx3xqf,pgxcs-kftw5v8f,20497552,0.007,21992,0,20475560,0.007,PGX_AM_BS_GSM313948,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.148000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,26,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313948,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be068,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviau5,P7Y,pgxind-kftx3xqh,pgxcs-kftw5v8x,321763464,0.112,144332132,0.05,177431332,0.062,PGX_AM_BS_GSM313949,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.150000,geo:GSM313949,,1,15,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be06a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviau9,P0Y10M,pgxind-kftx3xql,pgxcs-kftw5v9w,156278174,0.054,110467992,0.038,45810182,0.016,PGX_AM_BS_GSM313951,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.152000,geo:GSM313951,,1,7,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be06c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauc,P8Y4M,pgxind-kftx3xqp,pgxcs-kftw5vav,120251105,0.042,78782904,0.027,41468201,0.014,PGX_AM_BS_GSM313953,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.155000,geo:GSM313953,,1,13,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be06d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaue,P6Y,pgxind-kftx3xqr,pgxcs-kftw5vbc,197044010,0.069,134132240,0.047,62911770,0.022,PGX_AM_BS_GSM313954,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.157000,geo:GSM313954,,1,35,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be06e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauf,P5Y4M,pgxind-kftx3xqt,pgxcs-kftw5vbu,342401355,0.119,220662758,0.077,121738597,0.042,PGX_AM_BS_GSM313955,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.158000,geo:GPL3718,,1,8,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313955,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be06f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauh,P9Y4M,pgxind-kftx3xqv,pgxcs-kftw5vcb,215306979,0.075,66501890,0.023,148805089,0.052,PGX_AM_BS_GSM313956,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.159000,geo:GSM313956,,1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be070,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauj,P8Y4M,pgxind-kftx3xqx,pgxcs-kftw5vct,169134352,0.059,117151930,0.041,51982422,0.018,PGX_AM_BS_GSM313957,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.161000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313957,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be071,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauk,P6Y2M,pgxind-kftx3xqz,pgxcs-kftw5vda,305410790,0.106,268044110,0.093,37366680,0.013,PGX_AM_BS_GSM313958,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.162000,geo:GSM313958,,1,63,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.4,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be074,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaup,P9Y10M,pgxind-kftx3xr5,pgxcs-kftw5vet,8187233,0.003,2402660,0.001,5784573,0.002,PGX_AM_BS_GSM313961,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.166000,geo:GSE12494,,1,29,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313961,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be075,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaur,P9Y8M,pgxind-kftx3xr7,pgxcs-kftw5vfb,240580642,0.084,35059091,0.012,205521551,0.071,PGX_AM_BS_GSM313962,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.168000,geo:GSM313962,,1,16,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be077,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauu,P11Y,pgxind-kftx3xrb,pgxcs-kftw5vga,123465308,0.043,113963483,0.04,9501825,0.003,PGX_AM_BS_GSM313964,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.171000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,7,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313964,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be078,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauw,P5Y,pgxind-kftx3xrd,pgxcs-kftw5vgs,647633134,0.225,356531840,0.124,291101294,0.101,PGX_AM_BS_GSM313965,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.172000,geo:GSM313965,,1,13,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.2,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be079,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauy,P5Y4M,pgxind-kftx3xrf,pgxcs-kftw5vh9,269677903,0.094,91411728,0.032,178266175,0.062,PGX_AM_BS_GSM313966,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.173000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313966,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.02,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5c865b6809d374f2dc2be07a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviauz,P1Y,pgxind-kftx3xrh,pgxcs-kftw5vhr,130013759,0.045,94614922,0.033,35398837,0.012,PGX_AM_BS_GSM313967,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.175000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,32,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313967,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be07b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav1,P9Y4M,pgxind-kftx3xrj,pgxcs-kftw5vi8,199006874,0.069,155062832,0.054,43944042,0.015,PGX_AM_BS_GSM313968,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.176000,geo:GPL3718,,1,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313968,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be07c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav3,P5Y4M,pgxind-kftx3xrl,pgxcs-kftw5viq,3188977,0.001,2564015,0.001,624962,0,PGX_AM_BS_GSM313969,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.178000,geo:GSM313969,,1,14,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.16,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be07d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav4,P4Y4M,pgxind-kftx3xrn,pgxcs-kftw5vj7,115017330,0.04,79743521,0.028,35273809,0.012,PGX_AM_BS_GSM313970,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.179000,geo:GPL3718,,1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313970,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be07e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav6,P9Y,pgxind-kftx3xrp,pgxcs-kftw5vjp,227404010,0.079,186630440,0.065,40773570,0.014,PGX_AM_BS_GSM313971,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.180000,geo:GPL3718,,1,26,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313971,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be07f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav7,P6Y10M,pgxind-kftx3xrr,pgxcs-kftw5vk7,213245401,0.074,103427683,0.036,109817718,0.038,PGX_AM_BS_GSM313972,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.182000,geo:GSM313972,,1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gse,geo:GSE12494,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be080,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviav9,P12Y2M,pgxind-kftx3xrt,pgxcs-kftw5vkp,268140646,0.093,120045393,0.042,148095253,0.052,PGX_AM_BS_GSM313973,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.183000,geo:GSE12494,,1,4,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313973,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.14,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be085,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviavi,,pgxind-kftx3xs3,pgxcs-kftw5vn5,83206937,0.029,327210,0,82879727,0.029,PGX_AM_BS_GSM313978,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.190000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313978,,,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be086,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviavj,P1Y8M,pgxind-kftx3xs5,pgxcs-kftw5vnn,59175711,0.021,11938748,0.004,47236963,0.016,PGX_AM_BS_GSM313979,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.191000,geo:GSM313979,,1,2,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be087,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviavl,P3Y4M,pgxind-kftx3xs7,pgxcs-kftw5vo4,3969242,0.001,1600951,0.001,2368291,0.001,PGX_AM_BS_GSM313980,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.193000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,5,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313980,,,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be088,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviavn,P0Y10M,pgxind-kftx3xs9,pgxcs-kftw5vol,244644984,0.085,160212,0,244484772,0.085,PGX_AM_BS_GSM313981,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.194000,geo:GPL3718,,1,1,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313981,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6809d374f2dc2be089,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviavo,P1Y8M,pgxind-kftx3xsb,pgxcs-kftw5vp3,242391398,0.084,244862,0,242146536,0.084,PGX_AM_BS_GSM313982,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.196000,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",1,,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313982,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be094,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaw6,P3Y4M,pgxind-kftx3xsy,pgxcs-kftw5vuf,1078600,0,17053,0,1061547,0,PGX_AM_BS_GSM313993,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.211000,geo:GSE12494,,1,18,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313993,,,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be099,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviawe,P3Y4M,pgxind-kftx3xt8,pgxcs-kftw5vwt,107783567,0.037,55107344,0.019,52676223,0.018,PGX_AM_BS_GSM313998,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.218000,geo:GSE12494,,1,6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM313998,,,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.24,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be09b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviawi,P2Y,pgxind-kftx3xtc,pgxcs-kftw5vxs,100031834,0.035,321068,0,99710766,0.035,PGX_AM_BS_GSM314000,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.221000,geo:GSM314000,,1,48,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be09f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviawo,P19Y4M,pgxind-kftx3xtk,pgxcs-kftw5vzp,129817096,0.045,238569,0,129578527,0.045,PGX_AM_BS_GSM314004,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.226000,geo:GSM314004,,1,50,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be0a0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviawq,P4Y,pgxind-kftx3xtm,pgxcs-kftw5w07,494537936,0.172,325267116,0.113,169270820,0.059,PGX_AM_BS_GSM314005,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.228000,geo:GPL3718,,1,11,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE12494,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM314005,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be0a1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviawr,P7Y8M,pgxind-kftx3xto,pgxcs-kftw5w0o,2474082,0.001,85526,0,2388556,0.001,PGX_AM_BS_GSM314006,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.229000,geo:GSM314006,,1,12,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.4,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5c865b6909d374f2dc2be0bb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftviaxy,P11Y10M,pgxind-kftx3xv5,pgxcs-kftw5wqg,381326201,0.133,109060810,0.038,272265391,0.095,PGX_AM_BS_GSM333819,,139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:45:19.266000,geo:GSM333819,,1,3,,,T4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:18923524,"Chen Y, Takita J et al. (2008): Oncogenic mutations of ALK kinase in...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE12494,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL3718,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0027,Han Chinese,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,
5dc17fba09d374f6dd7ea1e3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk0ux,P12Y2M,pgxind-kftx60jp,pgxcs-kftwo1m6,40799017,0.014,676143,0,40122874,0.014,PGX_AM_BS_GSM354006,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:27.931000,geo:GSM354006,,1,20,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL2873,,,,,,,,,,,,,,,,,
5dc184d609d374f6dd84b3c6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9f7,P10Y4M,pgxind-kftx6bd6,pgxcs-kftwpy3d,345249306,0.12,194147435,0.068,151101871,0.053,PGX_AM_BS_GSM353512,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.320000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,6,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM353512,,,,,,,,,,,,,,,,,
5dc184d609d374f6dd84b3ec,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fa,P11Y8M,pgxind-kftx6bda,pgxcs-kftwpy45,137261806,0.048,37826956,0.013,99434850,0.035,PGX_AM_BS_GSM353575,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.322000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,24,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM353575,,,,,,,,,,,,,,,,,
5dc184d709d374f6dd84b422,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9ff,P4Y8M,pgxind-kftx6bdg,pgxcs-kftwpy5c,133594571,0.046,92477066,0.032,41117505,0.014,PGX_AM_BS_GSM353597,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.326000,geo:GSM353597,,1,9,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,
5dc184d709d374f6dd84b448,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fi,P5Y8M,pgxind-kftx6bdk,pgxcs-kftwpy64,234931554,0.082,178692366,0.062,56239188,0.02,PGX_AM_BS_GSM353599,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.328000,geo:GSE14109,,1,30,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM353599,,,,,,,,,,,,,,,,,
5dc184d809d374f6dd84b478,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fl,P3Y8M,pgxind-kftx6bdo,pgxcs-kftwpy6w,1337319,0,51041,0,1286278,0,PGX_AM_BS_GSM353979,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.330000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,12,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14109,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5477,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM353979,,,,,,,,,,,,,,,,,
5dc184d809d374f6dd84b4ad,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fq,P11Y4M,pgxind-kftx6bdu,pgxcs-kftwpy83,1041628,0,0,0,1041628,0,PGX_AM_BS_GSM353982,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.334000,geo:GSM353982,,1,16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,
5dc184d909d374f6dd84b4be,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fs,P11Y2M,pgxind-kftx6bdw,pgxcs-kftwpy8h,1236241,0,488,0,1235753,0,PGX_AM_BS_GSM353985,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.335000,geo:GSE14109,,1,17,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5477,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,,,,geo:gsm,geo:GSM353985,,,,,,,,,,,,,,,,,
5dc184d909d374f6dd84b4d9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9fv,P4Y,pgxind-kftx6be0,pgxcs-kftwpy99,154015853,0.054,69195833,0.024,84820020,0.03,PGX_AM_BS_GSM353987,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.338000,geo:GSM353987,,1,1,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14109,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5477,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,
5dc184da09d374f6dd84b4fd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9g0,P3Y10M,pgxind-kftx6be6,pgxcs-kftwpyaf,183944505,0.064,62659776,0.022,121284729,0.042,PGX_AM_BS_GSM353990,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.341000,geo:GSM353990,,1,24,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14109,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5477,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,
5dc184da09d374f6dd84b519,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9g2,P15Y2M,pgxind-kftx6be8,pgxcs-kftwpyat,62871291,0.022,51041,0,62820250,0.022,PGX_AM_BS_GSM353993,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.343000,geo:GSM353993,,1,34,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL5477,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,pubmed,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",,,,,,,,,,,,,,,,
5dc184da09d374f6dd84b538,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9g3,P9Y4M,pgxind-kftx6bea,pgxcs-kftwpyb7,37317571,0.013,22946791,0.008,14370780,0.005,PGX_AM_BS_GSM353996,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.344000,geo:GSM353996,,1,21,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL5477,,,,,,,,,,,,,,,,,
5dc184da09d374f6dd84b567,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9g7,P5Y4M,pgxind-kftx6bee,pgxcs-kftwpybz,195091138,0.068,171003915,0.059,24087223,0.008,PGX_AM_BS_GSM353998,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.346000,geo:GSM353998,,1,11,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14109,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gpl,geo:GPL5477,,,,,,,,,,,,,,,,,
5dc184db09d374f6dd84b59d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,neuroblastoma,NCIT:C3270,Neuroblastoma,icdom-95003,"Neuroblastoma, NOS",icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvk9gd,P1Y10M,pgxind-kftx6bem,pgxcs-kftwpydk,82008848,0.029,1858962,0.001,80149886,0.028,PGX_AM_BS_GSM354003,{},8.92,44.43,Point,ITA,Genoa,Italy,"Genoa, Italy",44.43,8.92,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:46:36.351000,PMID:20003513,"Scaruffi P, Stigliani S et al. (2009): Transcribed-Ultra Conserved Region expression is associated...",1,7,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14109,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5477,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,pgxcohort-carriocordo2021heterogeneity,Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021),,,geo:gsm,geo:GSM354003,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf70,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [temporal],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgng8,P14Y,pgxind-kftx2ej3,pgxcs-kftvnknb,351138294,0.122,62100062,0.022,289038232,0.101,PGX_AM_BS_20192643_PB-far-13,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.461000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf71,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [temporal],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgnga,P5Y,pgxind-kftx2ej5,pgxcs-kftvnkns,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-14,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.462000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf76,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [frontal],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgngi,P7Y,pgxind-kftx2ejf,pgxcs-kftvnkq6,185104886,0.064,185104886,0.064,0,0,PGX_AM_BS_20192643_PB-far-19,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.470000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb7f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgp,P3Y,pgxind-kftx2ps7,pgxcs-kftvqcl8,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G02,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.401000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb80,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgq,P48Y,pgxind-kftx2ps9,pgxcs-kftvqclp,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G03,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.403000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb81,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgs,P41Y,pgxind-kftx2psb,pgxcs-kftvqcm6,354258667,0.123,147723282,0.051,206535385,0.072,PGX_AM_BS_17390041_GBM-tah-G04,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.404000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb82,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgu,P39Y,pgxind-kftx2psd,pgxcs-kftvqcmn,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G05,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.405000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb83,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgv,P48Y,pgxind-kftx2psf,pgxcs-kftvqcn5,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G06,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.407000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb84,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgx,P41Y,pgxind-kftx2psh,pgxcs-kftvqcnm,270735041,0.094,270735041,0.094,0,0,PGX_AM_BS_17390041_GBM-tah-G07,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.408000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb85,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgz,P29Y,pgxind-kftx2psj,pgxcs-kftvqco3,509552408,0.177,247699756,0.086,261852652,0.091,PGX_AM_BS_17390041_GBM-tah-G08,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.409000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb86,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwh0,P45Y,pgxind-kftx2psl,pgxcs-kftvqcok,272314828,0.095,272314828,0.095,0,0,PGX_AM_BS_17390041_GBM-tah-G09,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.411000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb89,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwh5,P31Y,pgxind-kftx2pst,pgxcs-kftvqcq2,499204998,0.174,0,0,499204998,0.174,PGX_AM_BS_17390041_GBM-tah-G12,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.415000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb8a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwh7,P32Y,pgxind-kftx2psv,pgxcs-kftvqcqk,409236389,0.142,208514765,0.073,200721624,0.07,PGX_AM_BS_17390041_GBM-tah-G13,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.417000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcd3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgww3,P32Y,pgxind-kftx2qbh,pgxcs-kftvqhbs,322432495,0.112,293932467,0.102,28500028,0.01,PGX_AM_BS_OligoAstro-tro-O14,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.869000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgww5,P32Y,pgxind-kftx2qbj,pgxcs-kftvqhc9,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_OligoAstro-tro-O15,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.870000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcd5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgww7,P40Y,pgxind-kftx2qbl,pgxcs-kftvqhcq,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_OligoAstro-tro-O16,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.871000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwb,P53Y,pgxind-kftx2qbr,pgxcs-kftvqhe6,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_OligoAstro-tro-O20,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.876000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcda,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwf,P54Y,pgxind-kftx2qbv,pgxcs-kftvqhf5,206217822,0.072,206217822,0.072,0,0,PGX_AM_BS_OligoAstro-tro-O22,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.878000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcdb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwg,P35Y,pgxind-kftx2qbx,pgxcs-kftvqhfn,203917820,0.071,154417771,0.054,49500049,0.017,PGX_AM_BS_OligoAstro-tro-O23,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.880000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcdc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwi,P8Y,pgxind-kftx2qbz,pgxcs-kftvqhg4,121053702,0.042,0,0,121053702,0.042,PGX_AM_BS_OligoAstro-tro-O73,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.881000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcdd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwj,P34Y,pgxind-kftx2qc1,pgxcs-kftvqhgl,252560851,0.088,252560851,0.088,0,0,PGX_AM_BS_OligoAstro-tro-O74,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.882000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcdf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwn,P54Y,pgxind-kftx2qc5,pgxcs-kftvqhhk,313239354,0.109,154417771,0.054,158821583,0.055,PGX_AM_BS_OligoAstro-tro-O76,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.885000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwo,P25Y,pgxind-kftx2qc7,pgxcs-kftvqhi2,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_OligoAstro-tro-O77,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.886000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwq,P54Y,pgxind-kftx2qc9,pgxcs-kftvqhij,389356584,0.135,230535001,0.08,158821583,0.055,PGX_AM_BS_OligoAstro-tro-O78,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.888000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwr,P48Y,pgxind-kftx2qcb,pgxcs-kftvqhj1,0,0,0,0,0,0,PGX_AM_BS_OligoAstro-tro-O8,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.889000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf74,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [hemisphere],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgngf,P6Y,pgxind-kftx2ejb,pgxcs-kftvnkp7,673420716,0.234,376220420,0.131,297200296,0.103,PGX_AM_BS_20192643_PB-far-17,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.467000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf75,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [parietal],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgngh,P7Y,pgxind-kftx2ejd,pgxcs-kftvnkpp,391444630,0.136,34327289,0.012,357117341,0.124,PGX_AM_BS_20192643_PB-far-18,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.468000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf77,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligodendroglioma [lateral ventricle],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgngk,P8Y,pgxind-kftx2ejh,pgxcs-kftvnkqn,870274172,0.303,561424143,0.195,308850029,0.107,PGX_AM_BS_20192643_PB-far-20,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.471000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb7e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwgn,P35Y,pgxind-kftx2ps5,pgxcs-kftvqckr,319719166,0.111,133797556,0.047,185921610,0.065,PGX_AM_BS_17390041_GBM-tah-G01,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.400000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb87,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwh2,P43Y,pgxind-kftx2psp,pgxcs-kftvqcp2,257917411,0.09,229417383,0.08,28500028,0.01,PGX_AM_BS_17390041_GBM-tah-G10,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.412000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb88,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma,NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwh3,P57Y,pgxind-kftx2psr,pgxcs-kftvqcpj,456024222,0.159,206217822,0.072,249806400,0.087,PGX_AM_BS_17390041_GBM-tah-G11rec,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.414000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgww8,P59Y,pgxind-kftx2qbn,pgxcs-kftvqhd7,701591380,0.244,0,0,701591380,0.244,PGX_AM_BS_OligoAstro-tro-O17,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.873000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcd7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwa,P63Y,pgxind-kftx2qbp,pgxcs-kftvqhdp,442775597,0.154,442775597,0.154,0,0,PGX_AM_BS_OligoAstro-tro-O19,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.874000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,170,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwd,P51Y,pgxind-kftx2qbt,pgxcs-kftvqheo,237756771,0.083,237756771,0.083,0,0,PGX_AM_BS_OligoAstro-tro-O21,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.877000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligodendroglioma [WHO II],NCIT:C3288,Oligodendroglioma,icdom-94503,"Oligodendroglioma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgwwl,P48Y,pgxind-kftx2qc3,pgxcs-kftvqhh3,494284104,0.172,335462521,0.117,158821583,0.055,PGX_AM_BS_OligoAstro-tro-O75,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.884000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0233,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh972,P16Y,pgxind-kftx359j,pgxcs-kftvu762,190260325,0.066,114143095,0.04,76117230,0.026,PGX_AM_BS_Epend-car-01,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.495000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,178,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b023b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh97e,P23Y,pgxind-kftx35a0,pgxcs-kftvu79z,1150038929,0.4,203266212,0.071,946772717,0.329,PGX_AM_BS_Epend-car-09,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.506000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0240,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh97m,P15Y,pgxind-kftx35aa,pgxcs-kftvu7eh,1256191553,0.437,0,0,1256191553,0.437,PGX_AM_BS_Epend-car-14,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.513000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,114,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0241,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh97o,P24Y,pgxind-kftx35ac,pgxcs-kftvu7ey,1256191553,0.437,0,0,1256191553,0.437,PGX_AM_BS_Epend-car-15,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.515000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0244,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh97t,P44Y,pgxind-kftx35ai,pgxcs-kftvu7gf,1021846571,0.355,0,0,1021846571,0.355,PGX_AM_BS_Epend-car-18,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.519000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,101,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0252,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh98g,P28Y,pgxind-kftx35bb,pgxcs-kftvu7na,842847582,0.293,0,0,842847582,0.293,PGX_AM_BS_Epend-car-32,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.539000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0254,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh98j,P18Y,pgxind-kftx35bf,pgxcs-kftvu7o9,1053487040,0.366,729720884,0.254,323766156,0.113,PGX_AM_BS_Epend-car-34,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.541000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0255,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh98l,P58Y,pgxind-kftx35bh,pgxcs-kftvu7oq,0,0,0,0,0,0,PGX_AM_BS_Epend-car-35,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.543000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0259,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [medullary],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C71.7,brain stem,pgxbs-kftvh98r,P25Y,pgxind-kftx35bp,pgxcs-kftvu7qq,1846984956,0.642,0,0,1846984956,0.642,PGX_AM_BS_Epend-car-39,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.549000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b025a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh98t,P41Y,pgxind-kftx35br,pgxcs-kftvu7r9,1414651862,0.492,183489038,0.064,1231162824,0.428,PGX_AM_BS_Epend-car-40,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.550000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b025b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh98v,P49Y,pgxind-kftx35bt,pgxcs-kftvu7rr,491681903,0.171,402854560,0.14,88827343,0.031,PGX_AM_BS_Epend-car-41,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.552000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0262,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh997,P44Y,pgxind-kftx35c8,pgxcs-kftvu7v5,138518825,0.048,138518825,0.048,0,0,PGX_AM_BS_Epend-car-48,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.561000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0265,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh99c,P31Y,pgxind-kftx35ce,pgxcs-kftvu7wm,931278953,0.324,0,0,931278953,0.324,PGX_AM_BS_Epend-car-51,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.566000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0270,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh99t,P35Y,pgxind-kftx35d0,pgxcs-kftvu81x,901989102,0.314,499448125,0.174,402540977,0.14,PGX_AM_BS_Epend-car-62,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.581000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b027e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [medullary],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C71.7,brain stem,pgxbs-kftvh9ag,P48Y,pgxind-kftx35ds,pgxcs-kftvu88n,1123901349,0.391,0,0,1123901349,0.391,PGX_AM_BS_Epend-car-76,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.600000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0286,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh9au,P32Y,pgxind-kftx35e9,pgxcs-kftvu8ch,276366285,0.096,276366285,0.096,0,0,PGX_AM_BS_Epend-car-84,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.611000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b023e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh97j,P65Y,pgxind-kftx35a6,pgxcs-kftvu7dh,0,0,0,0,0,0,PGX_AM_BS_Epend-car-12,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.511000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0249,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,myxopapillary ependymoma [filum terminale],NCIT:C3697,Myxopapillary Ependymoma,icdom-93941,Myxopapillary ependymoma,icdot-C72.0,Spinal cord,pgxbs-kftvh981,P50Y,pgxind-kftx35as,pgxcs-kftvu7iv,721793880,0.251,0,0,721793880,0.251,PGX_AM_BS_Epend-car-23,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.526000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,331,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab899,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8k,P1Y,pgxind-kftx2bu5,pgxcs-kftvmwwl,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-11,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.957000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,24,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe, parietal]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl93,P4Y5M,pgxind-kftx2but,pgxcs-kftvmx27,715989994,0.249,262169513,0.091,453820481,0.158,PGX_AM_BS_21798848_PNET-mil-24,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.973000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,22,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8ab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9d,P7Y1M,pgxind-kftx2bv6,pgxcs-kftvmx7e,1801581120,0.627,906010465,0.315,895570655,0.312,PGX_AM_BS_21798848_PNET-mil-31,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.982000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,83,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8ae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region   parietal],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9i,P10Y,pgxind-kftx2bvc,pgxcs-kftvmx8v,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-35,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.986000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,52,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8b0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     parietal],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9l,P10Y7M,pgxind-kftx2bvg,pgxcs-kftvmx9t,751413116,0.261,0,0,751413116,0.261,PGX_AM_BS_21798848_PNET-mil-37,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.989000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,27,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8b4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9r,P12Y,pgxind-kftx2bvn,pgxcs-kftvmxbq,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-41,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.994000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8b5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9t,P15Y10M,pgxind-kftx2bvp,pgxcs-kftvmxc9,701575124,0.244,567763538,0.197,133811586,0.047,PGX_AM_BS_21798848_PNET-mil-43,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.996000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,15,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac440,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp09,P2Y7M,pgxind-kftx2ggo,pgxcs-kftvo1fl,104810551,0.036,37163873,0.013,67646678,0.024,PGX_AM_BS_19962671_PNET-li-PNET13,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.164000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac459,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp1e,P2Y7M,pgxind-kftx2gi2,pgxcs-kftvo1t8,317335324,0.11,235060730,0.082,82274594,0.029,PGX_AM_BS_19962671_PNET-li-PNET47,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.199000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",0,134,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c6727983b2e00ad9ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvyi,P3Y,pgxind-kftx2p5l,pgxcs-kftvq6yz,382378883,0.133,95679735,0.033,286699148,0.1,PGX_AM_BS_17592618_PNET6,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.841000,geo:GSE8736,,0,80,,,M0,,,,,,,,,,,,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab898,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8i,P1Y,pgxind-kftx2bu3,pgxcs-kftvmww5,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-10,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.955000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,41,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab89a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region - posterior fossa],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8l,P1Y7M,pgxind-kftx2bu7,pgxcs-kftvmwx2,669187022,0.233,112563617,0.039,556623405,0.194,PGX_AM_BS_21798848_PNET-mil-12,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.958000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,11,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab89b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe, temporal lobe]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8n,P1Y7M,pgxind-kftx2bu9,pgxcs-kftvmwxj,1063476445,0.37,0,0,1063476445,0.37,PGX_AM_BS_21798848_PNET-mil-14,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.959000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,20,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab89c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8p,P1Y8M,pgxind-kftx2bub,pgxcs-kftvmwy0,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-15,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.961000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab89e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8s,P1Y11M,pgxind-kftx2buf,pgxcs-kftvmwyy,311884283,0.108,185335205,0.064,126549078,0.044,PGX_AM_BS_21798848_PNET-mil-17,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.963000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,7,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab89f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8u,P2Y,pgxind-kftx2buh,pgxcs-kftvmwzf,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-18,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.965000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [with true rosettes, cerebral region]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8v,P2Y2M,pgxind-kftx2buj,pgxcs-kftvmwzv,278770217,0.097,27795502,0.01,250974715,0.087,PGX_AM_BS_21798848_PNET-mil-19,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.966000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe, parietal]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl8y,P3Y,pgxind-kftx2bun,pgxcs-kftvmx0t,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-21,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.969000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,16,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl90,P3Y1M,pgxind-kftx2bup,pgxcs-kftvmx1a,675475073,0.235,0,0,675475073,0.235,PGX_AM_BS_21798848_PNET-mil-22,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.970000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,6,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8a4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe, parietal]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl92,P4Y2M,pgxind-kftx2bur,pgxcs-kftvmx1q,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-23,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.972000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,24,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl96,P5Y1M,pgxind-kftx2bux,pgxcs-kftvmx58,109272849,0.038,3492198,0.001,105780651,0.037,PGX_AM_BS_21798848_PNET-mil-27,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.976000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8a8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe, parietal]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl98,P5Y11M,pgxind-kftx2buz,pgxcs-kftvmx5p,331408308,0.115,252633487,0.088,78774821,0.027,PGX_AM_BS_21798848_PNET-mil-28,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.977000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,5,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab8a9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region     temporal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9a,P6Y5M,pgxind-kftx2bv1,pgxcs-kftvmx66,864138112,0.301,0,0,864138112,0.301,PGX_AM_BS_21798848_PNET-mil-29,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.979000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,17,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8aa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9b,P7Y,pgxind-kftx2bv4,pgxcs-kftvmx6o,649324885,0.226,69779858,0.024,579545027,0.202,PGX_AM_BS_21798848_PNET-mil-30,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.980000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,20,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8ac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9e,P8Y11M,pgxind-kftx2bv8,pgxcs-kftvmx7x,682558334,0.237,209253863,0.073,473304471,0.165,PGX_AM_BS_21798848_PNET-mil-33,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.983000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,71,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8b1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [cerebral region   frontal lobe],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9m,P11Y8M,pgxind-kftx2bvi,pgxcs-kftvmxaa,225526153,0.078,179948856,0.063,45577297,0.016,PGX_AM_BS_21798848_PNET-mil-38,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.990000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,30,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab8b3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Central nervous system primitive neuroectodermal tumor [cerebral region   hemispheric, lateral ventricle]",NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgl9q,P11Y10M,pgxind-kftx2bvm,pgxcs-kftvmxba,883519212,0.307,432408518,0.15,451110694,0.157,PGX_AM_BS_21798848_PNET-mil-40,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.993000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac299,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.7,brain stem,pgxbs-kl8hk351,P5Y1M,pgxind-kl8hk375,pgxcs-kftvnvo3,277537793,0.097,140562543,0.049,136975250,0.048,PGX_AM_BS_20142589-zar-DIPG01,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.586000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.34,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0494,,pgxcs-kftwqh6m,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac29a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.7,brain stem,pgxbs-kftvgoh3,P0Y,pgxind-kftx2fss,pgxcs-kftvnvok,31737817,0.011,22171578,0.008,9566239,0.003,DIPG_BS_0890,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:14.587000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.03,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20142589-zar-DIPG02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac441,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp0a,P1Y,pgxind-kftx2ggq,pgxcs-kftvo1g2,447291027,0.156,7916874,0.003,439374153,0.153,PGX_AM_BS_19962671_PNET-li-PNET14,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.166000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,0.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac443,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp0e,P2Y7M,pgxind-kftx2ggu,pgxcs-kftvo1h0,105641839,0.037,37996716,0.013,67645123,0.024,PGX_AM_BS_19962671_PNET-li-PNET18,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.168000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac444,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp0f,P3Y,pgxind-kftx2ggw,pgxcs-kftvo1hh,35856064,0.012,29999629,0.01,5856435,0.002,PGX_AM_BS_19962671_PNET-li-PNET19,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.170000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac446,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp0i,P11Y,pgxind-kftx2gh0,pgxcs-kftvo1if,627795656,0.218,152817517,0.053,474978139,0.165,PGX_AM_BS_19962671_PNET-li-PNET20,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.172000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac447,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp0k,P9Y7M,pgxind-kftx2gh2,pgxcs-kftvo1iw,552747537,0.192,446044212,0.155,106703325,0.037,PGX_AM_BS_19962671_PNET-li-PNET22,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.174000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac451,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp11,P13Y,pgxind-kftx2ghm,pgxcs-kftvo1ni,550972915,0.192,336088615,0.117,214884300,0.075,PGX_AM_BS_19962671_PNET-li-PNET4,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.188000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac452,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp12,P2Y6M,pgxind-kftx2gho,pgxcs-kftvo1nz,212521715,0.074,188147335,0.065,24374380,0.008,PGX_AM_BS_19962671_PNET-li-PNET40,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.189000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,0.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac453,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp14,P14Y1M,pgxind-kftx2ghq,pgxcs-kftvo1og,441198355,0.153,194191846,0.068,247006509,0.086,PGX_AM_BS_19962671_PNET-li-PNET41,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.191000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,57,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac454,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp15,P3Y2M,pgxind-kftx2ghs,pgxcs-kftvo1ox,549280075,0.191,67852474,0.024,481427601,0.167,PGX_AM_BS_19962671_PNET-li-PNET42,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.192000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,10,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac455,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp17,P1Y6M,pgxind-kftx2ghu,pgxcs-kftvo1pe,286629334,0.1,43019834,0.015,243609500,0.085,PGX_AM_BS_19962671_PNET-li-PNET43,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.193000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac456,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp19,P11Y,pgxind-kftx2ghw,pgxcs-kftvo1pu,67295455,0.023,67295455,0.023,0,0,PGX_AM_BS_19962671_PNET-li-PNET44,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.195000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,21,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac457,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp1b,P14Y11M,pgxind-kftx2ghy,pgxcs-kftvo1qb,704218630,0.245,68289472,0.024,635929158,0.221,PGX_AM_BS_19962671_PNET-li-PNET45,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.196000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,23,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac458,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp1c,P2Y1M,pgxind-kftx2gi0,pgxcs-kftvo1sp,539313924,0.188,283774327,0.099,255539597,0.089,PGX_AM_BS_19962671_PNET-li-PNET46,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.197000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac45a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgp1f,P1Y,pgxind-kftx2gi4,pgxcs-kftvo1tq,26783562,0.009,25719010,0.009,1064552,0,PGX_AM_BS_19962671_PNET-li-PNET48,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.200000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c4727983b2e00acb17,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgr7d,P4Y2M,pgxind-kftx2j7l,pgxcs-kftvopsz,290317442,0.101,134700135,0.047,155617307,0.054,PGX_AM_BS_19197950_MB70.718,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:17.588000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,7.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb1b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgr7j,P4Y3M,pgxind-kftx2j7t,pgxcs-kftvopux,376809780,0.131,122824800,0.043,253984980,0.088,PGX_AM_BS_19197950_MB74.722,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:17.594000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,25.2,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb27,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [brain stem],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.7,brain stem,pgxbs-kftvgr83,P3Y11M,pgxind-kftx2j8h,pgxcs-kftvoq0o,752652563,0.262,86352471,0.03,666300092,0.232,PGX_AM_BS_19197950_MB86.1284,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:17.610000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,13.4,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9e8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvy7,P1Y,pgxind-kftx2p58,pgxcs-kftvq6w4,0,0,0,0,0,0,PGX_AM_BS_17592618_PNET1,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.832000,geo:GSE8736,,1,31,,,M0,,,,,,,,,,,,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9e9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvy9,P3Y,pgxind-kftx2p5a,pgxcs-kftvq6wl,440608176,0.153,22100022,0.008,418508154,0.146,PGX_AM_BS_17592618_PNET10,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.834000,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",1,14,,,M0,,,,,,,,,,,,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9ea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvyb,P7Y,pgxind-kftx2p5c,pgxcs-kftvq6x2,45800045,0.016,19100019,0.007,26700026,0.009,PGX_AM_BS_17592618_PNET2,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.835000,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",1,11,,,M0,,,,,,,,,,,,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9eb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvyd,P11Y,pgxind-kftx2p5e,pgxcs-kftvq6xj,325994570,0.113,177944702,0.062,148049868,0.051,PGX_AM_BS_17592618_PNET3,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.836000,geo:GSE8736,,1,104,,,,,,,,,,,,,,,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad9ec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvye,P6Y,pgxind-kftx2p5h,pgxcs-kftvq6y0,499875165,0.174,248533482,0.086,251341683,0.087,PGX_AM_BS_17592618_PNET4,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.838000,geo:GSE8736,,1,15,,,,,,,,,,,,,,,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9ed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvyg,P2Y,pgxind-kftx2p5j,pgxcs-kftvq6yi,8200008,0.003,4900005,0.002,3300003,0.001,PGX_AM_BS_17592618_PNET5,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.839000,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",1,17,,,,,,,,,,,,,,,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad9f1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgvyn,P7Y,pgxind-kftx2p5r,pgxcs-kftvq70f,519225307,0.181,519225307,0.181,0,0,PGX_AM_BS_17592618_PNET9,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:22.845000,geo:GSE8736,,1,16,,,M0,,,,,,,,,,,,PMID:17592618,"Pfister S, Remke M et al. (2007): Supratentorial primitive neuroectodermal tumors of the...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16eb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive Neuroectodermal Tumor [supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvhfv6,P13Y,pgxind-kftx3djt,pgxcs-kftvw9w9,392787708,0.137,0,0,392787708,0.137,PGX_AM_BS_PNET-rus-S-10-PM20,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:44.826000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfae,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pa,P1Y,pgxind-kftx6bpo,pgxcs-kftwq0dt,0,0,0,0,0,0,PGX_AM_BS_GSM216695,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.564000,geo:GSM216695,,1,31,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc184fb09d374f6dd84bfaf,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pc,P7Y,pgxind-kftx6bpq,pgxcs-kftwq0e5,34453185,0.012,11711571,0.004,22741614,0.008,PGX_AM_BS_GSM216696,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.565000,geo:GSM216696,,1,11,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfb0,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pd,P11Y,pgxind-kftx6bps,pgxcs-kftwq0eg,272282989,0.095,143329762,0.05,128953227,0.045,PGX_AM_BS_GSM216697,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.566000,geo:GSE8736,,1,104,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,geo:gsm,geo:GSM216697,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc184fb09d374f6dd84bfb1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pf,P6Y,pgxind-kftx6bpu,pgxcs-kftwq0er,433290850,0.151,239362914,0.083,193927936,0.067,PGX_AM_BS_GSM216698,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.567000,geo:GPL5685,,1,15,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8736,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,geo:gsm,geo:GSM216698,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfb2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pg,P2Y,pgxind-kftx6bpw,pgxcs-kftwq0f2,0,0,0,0,0,0,PGX_AM_BS_GSM216699,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.568000,geo:GSM216699,,1,17,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8736,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfb6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9pn,P7Y,pgxind-kftx6bq4,pgxcs-kftwq0gb,348887507,0.121,348887507,0.121,0,0,PGX_AM_BS_GSM216703,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.572000,geo:GSM216703,,1,16,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8736,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc184fb09d374f6dd84bfb7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,primitive neuroepidermal tumor [PNET; supratentorial],NCIT:C3716,Primitive Neuroectodermal Tumor,icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.0,cerebrum,pgxbs-kftvk9po,P3Y,pgxind-kftx6bq6,pgxcs-kftwq0gn,423591280,0.147,17452158,0.006,406139122,0.141,PGX_AM_BS_GSM216704,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:46:36.574000,geo:GSM216704,,1,14,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8736,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad365,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvb,P49Y,pgxind-kftx2mj8,pgxcs-kftvpjfn,616041376,0.214,147434918,0.051,468606458,0.163,PGX_AM_BS_OlfNB-gul-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.516000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,192,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad367,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtve,P38Y,pgxind-kftx2mjc,pgxcs-kftvpjgn,197964472,0.069,129514683,0.045,68449789,0.024,PGX_AM_BS_OlfNB-gul-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.518000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad368,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvg,P40Y,pgxind-kftx2mje,pgxcs-kftvpjh4,72043051,0.025,27400027,0.01,44643024,0.016,PGX_AM_BS_OlfNB-gul-05,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.520000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,149,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad369,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvi,P27Y,pgxind-kftx2mjg,pgxcs-kftvpjhl,1150209620,0.4,630625371,0.219,519584249,0.181,PGX_AM_BS_OlfNB-gul-06,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.521000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,119,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad36a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvj,P61Y,pgxind-kftx2mji,pgxcs-kftvpji4,680287040,0.237,458759111,0.16,221527929,0.077,PGX_AM_BS_OlfNB-gul-07,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.523000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,106,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad36b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvl,P27Y,pgxind-kftx2mjk,pgxcs-kftvpjim,791874203,0.275,367267885,0.128,424606318,0.148,PGX_AM_BS_OlfNB-gul-08,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.524000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,59,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad36c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvm,P40Y,pgxind-kftx2mjm,pgxcs-kftvpjj3,1076417185,0.374,544094118,0.189,532323067,0.185,PGX_AM_BS_OlfNB-gul-09,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.526000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,57,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad36f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvr,P44Y,pgxind-kftx2mjs,pgxcs-kftvpjkj,42500042,0.015,11900011,0.004,30600031,0.011,PGX_AM_BS_OlfNB-gul-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.530000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad370,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvt,P60Y,pgxind-kftx2mju,pgxcs-kftvpjl1,272315444,0.095,47400048,0.016,224915396,0.078,PGX_AM_BS_OlfNB-gul-15,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.531000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",0,6,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad356,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtun,P62Y,pgxind-kftx2mid,pgxcs-kftvpj8h,1277913576,0.444,634109799,0.221,643803777,0.224,PGX_AM_BS_OlfNB-gul-12,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.495000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",1,35,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad364,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtv9,P50Y,pgxind-kftx2mj6,pgxcs-kftvpjf6,414317549,0.144,158602737,0.055,255714812,0.089,PGX_AM_BS_OlfNB-gul-01,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.514000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",1,156,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad366,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Olfactory neuroblastoma,NCIT:C3789,Olfactory Neuroblastoma,icdom-95223,Olfactory neuroblastoma,icdot-C72.2,Olfactory nerve,pgxbs-kftvgtvd,P53Y,pgxind-kftx2mja,pgxcs-kftvpjg4,852078927,0.296,494935532,0.172,357143395,0.124,PGX_AM_BS_OlfNB-gul-03,,24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001579,olfactory nerve,{},2020-09-10 17:44:20.517000,PMID:18408657,"Guled M, Myllykangas S et al. (2008): Array comparative genomic hybridization analysis of...",1,20,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae351,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma,NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzam,P5Y1M,pgxind-kftx2swm,pgxcs-kftvr4lo,309571453,0.108,27800027,0.01,281771426,0.098,PGX_AM_BS_NB-nog-03,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.554000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,25.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae364,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma [D],NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbh,P1Y5M,pgxind-kftx2sxk,pgxcs-kftvr4ux,0,0,0,0,0,0,PGX_AM_BS_NB-nog-28,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.581000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,22.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae366,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma [D],NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbk,P2Y6M,pgxind-kftx2sxo,pgxcs-kftvr4vv,0,0,0,0,0,0,PGX_AM_BS_NB-nog-30,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.583000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,21.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae36c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma [D],NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbu,P3Y1M,pgxind-kftx2sxy,pgxcs-kftvr4yr,137392496,0.048,0,0,137392496,0.048,PGX_AM_BS_NB-nog-37,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.592000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,20.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae37b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma [N],NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzci,P2Y10M,pgxind-kftx2syq,pgxcs-kftvr564,244330777,0.085,27800027,0.01,216530750,0.075,PGX_AM_BS_NB-nog-58,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.613000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,0,7.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afb10,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Ganglioneuroblastoma [nodular, atypical, 2a, Abdominal]",NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C47.9,peripheral nervs incl. Autonomous,pgxbs-kftvh6wi,P3Y,pgxind-kftx32eh,pgxcs-kftvthl7,247260382,0.086,29500029,0.01,217760353,0.076,PGX_AM_BS_NB711-sta-27,,-6.25,53.33,Point,IRL,Dublin,Ireland,"Dublin, Ireland",53.33,-6.25,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:34.975000,PMID:12645651,"Stallings RL, Howard J et al. (2003): Are gains of chromosomal regions 7q...",0,24,,,T2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae36b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ganglioneuroblastoma [D],NCIT:C3790,Ganglioneuroblastoma,icdom-94903,Ganglioneuroblastoma,icdot-C72.9,"Nervous system, NOS",pgxbs-kftvgzbt,P4Y1M,pgxind-kftx2sxw,pgxcs-kftvr4ya,235972588,0.082,0,0,235972588,0.082,PGX_AM_BS_NB-nog-36,{},-0.38,39.47,Point,ESP,Valencia,Spain,"Valencia, Spain",39.47,-0.38,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001016,nervous system,{},2020-09-10 17:44:26.591000,PMID:16756886,Noguera Salv√° R et al. (2006): [Genomic profile in high risk neuroblastoma...,1,4.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma,NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi7z,P33Y,pgxind-kftx285x,pgxcs-kftvm098,0,0,0,0,0,0,PGX_AM_BS_8800093_GBM-Boerman-F5,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.570000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [glioma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi84,P33Y,pgxind-kftx2863,pgxcs-kftvm0am,0,0,0,0,0,0,PGX_AM_BS_8800093_GBM-Boerman-G5,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.574000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [sarcoma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi8b,P33Y,pgxind-kftx286b,pgxcs-kftvm0cj,0,0,0,0,0,0,PGX_AM_BS_8800093_GBM-Boerman-S5,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.580000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma,NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi7t,P60Y,pgxind-kftx285o,pgxcs-kftvm07c,548667340,0.191,283250090,0.099,265417250,0.092,PGX_AM_BS_8800093_GBM-Boerman-F1,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.565000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma,NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi7u,P67Y,pgxind-kftx285q,pgxcs-kftvm07t,651686371,0.227,245614821,0.085,406071550,0.141,PGX_AM_BS_8800093_GBM-Boerman-F2,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.566000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma,NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi7w,P41Y,pgxind-kftx285s,pgxcs-kftvm08b,542134738,0.189,91700091,0.032,450434647,0.157,PGX_AM_BS_8800093_GBM-Boerman-F3,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.567000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aaf44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma,NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi7y,P67Y,pgxind-kftx285v,pgxcs-kftvm08r,249921673,0.087,0,0,249921673,0.087,PGX_AM_BS_8800093_GBM-Boerman-F4,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.569000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [glioma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi81,P60Y,pgxind-kftx285z,pgxcs-kftvm09p,360519206,0.125,201697623,0.07,158821583,0.055,PGX_AM_BS_8800093_GBM-Boerman-G1,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.572000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [glioma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi83,P67Y,pgxind-kftx2861,pgxcs-kftvm0a5,539686259,0.188,257914833,0.09,281771426,0.098,PGX_AM_BS_8800093_GBM-Boerman-G2,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.573000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [sarcoma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi86,P60Y,pgxind-kftx2865,pgxcs-kftvm0b3,442071673,0.154,283250090,0.099,158821583,0.055,PGX_AM_BS_8800093_GBM-Boerman-S1,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.576000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [sarcoma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi87,P67Y,pgxind-kftx2867,pgxcs-kftvm0bl,550932111,0.192,392110528,0.136,158821583,0.055,PGX_AM_BS_8800093_GBM-Boerman-S2,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.577000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aaf4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliosarcoma [sarcoma component],NCIT:C3796,Gliosarcoma,icdom-94423,Gliosarcoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgi89,P67Y,pgxind-kftx2869,pgxcs-kftvm0c2,0,0,0,0,0,0,PGX_AM_BS_8800093_GBM-Boerman-S4,{},-70.98,43.3,Point,USA,Rochester,United States of America,"Rochester, United States",43.3,-70.98,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:07.579000,PMID:8800093,"Boerman RH, Anderl K et al. (1996): The glial and mesenchymal elements of...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac253,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Retroperitoneum],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodw,P64Y,pgxind-kftx2fou,pgxcs-kftvnur2,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-023,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.486000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac254,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodx,P41Y,pgxind-kftx2fow,pgxcs-kftvnuri,1937835042,0.674,951076918,0.331,986758124,0.343,PGX_AM_BS_20159821_MPNST-bre-024,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.487000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac258,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe4,P15Y,pgxind-kftx2fp4,pgxcs-kftvnutf,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-034,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.493000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoea,P50Y,pgxind-kftx2fpc,pgxcs-kftvnuvc,1009805081,0.351,120236424,0.042,889568657,0.309,PGX_AM_BS_20159821_MPNST-bre-040,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.498000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoec,P14Y,pgxind-kftx2fpe,pgxcs-kftvnuvs,1163881456,0.405,586567547,0.204,577313909,0.201,PGX_AM_BS_20159821_MPNST-bre-043,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.500000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Knee]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoef,P45Y,pgxind-kftx2fpi,pgxcs-kftvnuwr,532438858,0.185,390043997,0.136,142394861,0.05,PGX_AM_BS_20159821_MPNST-bre-046,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.503000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac261,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoej,P27Y,pgxind-kftx2fpm,pgxcs-kftvnuxp,217731742,0.076,201431726,0.07,16300016,0.006,PGX_AM_BS_20159821_MPNST-bre-049,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.505000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac262,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Leg],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoek,P30Y,pgxind-kftx2fpo,pgxcs-kftvnuy6,1254288828,0.436,423375067,0.147,830913761,0.289,PGX_AM_BS_20159821_MPNST-bre-050,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.507000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac266,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoer,P24Y,pgxind-kftx2fpw,pgxcs-kftvnv02,1491366828,0.519,825593611,0.287,665773217,0.232,PGX_AM_BS_20159821_MPNST-bre-056,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.513000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac269,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Shoulder]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoew,P20Y,pgxind-kftx2fq2,pgxcs-kftvnv1h,835898392,0.291,609102445,0.212,226795947,0.079,PGX_AM_BS_20159821_MPNST-bre-060,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.517000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Under arm],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoex,P59Y,pgxind-kftx2fq4,pgxcs-kftvnv1y,1099256834,0.382,876843898,0.305,222412936,0.077,PGX_AM_BS_20159821_MPNST-bre-061,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.519000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac277,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Axilla],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofi,P40Y,pgxind-kftx2fqu,pgxcs-kftvnv84,1267780766,0.441,194785694,0.068,1072995072,0.373,PGX_AM_BS_20159821_MPNST-bre-087,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.538000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofq,P30Y,pgxind-kftx2fr4,pgxcs-kftvnvai,198170501,0.069,121195682,0.042,76974819,0.027,PGX_AM_BS_20159821_MPNST-bre-116,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.545000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",0,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac250,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodq,P26Y,pgxind-kftx2foo,pgxcs-kftvnupl,1329127181,0.462,307514884,0.107,1021612297,0.355,PGX_AM_BS_20159821_MPNST-bre-013,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.481000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac251,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgods,P19Y,pgxind-kftx2foq,pgxcs-kftvnuq2,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-020,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.483000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,186,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac252,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodu,P18Y,pgxind-kftx2fos,pgxcs-kftvnuqj,1636953920,0.569,725961202,0.253,910992718,0.317,PGX_AM_BS_20159821_MPNST-bre-021,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.484000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac255,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodz,P22Y,pgxind-kftx2foy,pgxcs-kftvnus0,1165492623,0.405,135327390,0.047,1030165233,0.358,PGX_AM_BS_20159821_MPNST-bre-026,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.489000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac256,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe0,P33Y,pgxind-kftx2fp0,pgxcs-kftvnusg,2763479032,0.961,1140622209,0.397,1622856823,0.564,PGX_AM_BS_20159821_MPNST-bre-029,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.490000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac257,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe2,P77Y,pgxind-kftx2fp2,pgxcs-kftvnusy,1104109901,0.384,446385191,0.155,657724710,0.229,PGX_AM_BS_20159821_MPNST-bre-032,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.492000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac259,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Pelvis],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe5,P42Y,pgxind-kftx2fp5,pgxcs-kftvnutw,1851316984,0.644,604400129,0.21,1246916855,0.434,PGX_AM_BS_20159821_MPNST-bre-035,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.494000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe7,P34Y,pgxind-kftx2fp8,pgxcs-kftvnuud,2832113038,0.985,1257209528,0.437,1574903510,0.548,PGX_AM_BS_20159821_MPNST-bre-037,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.496000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe9,P71Y,pgxind-kftx2fpa,pgxcs-kftvnuuu,197338834,0.069,12600013,0.004,184738821,0.064,PGX_AM_BS_20159821_MPNST-bre-038,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.497000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoee,P17Y,pgxind-kftx2fpg,pgxcs-kftvnuwa,2617449835,0.91,989113185,0.344,1628336650,0.566,PGX_AM_BS_20159821_MPNST-bre-044,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.501000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac260,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoeh,P35Y,pgxind-kftx2fpk,pgxcs-kftvnux8,1486291449,0.517,644670186,0.224,841621263,0.293,PGX_AM_BS_20159821_MPNST-bre-048,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.504000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac263,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoem,P73Y,pgxind-kftx2fpq,pgxcs-kftvnuyn,1984268799,0.69,489597598,0.17,1494671201,0.52,PGX_AM_BS_20159821_MPNST-bre-051,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.508000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac264,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Proximal arm],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoeo,P37Y,pgxind-kftx2fps,pgxcs-kftvnuz4,863649586,0.3,659825104,0.23,203824482,0.071,PGX_AM_BS_20159821_MPNST-bre-052,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.510000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac265,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoep,P15Y,pgxind-kftx2fpu,pgxcs-kftvnuzl,811243086,0.282,494740890,0.172,316502196,0.11,PGX_AM_BS_20159821_MPNST-bre-053,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.511000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac267,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Intrathoracic]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoet,P24Y,pgxind-kftx2fpy,pgxcs-kftvnv0j,1489346799,0.518,494635615,0.172,994711184,0.346,PGX_AM_BS_20159821_MPNST-bre-057,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.514000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac26b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoez,P62Y,pgxind-kftx2fq6,pgxcs-kftvnv2f,1323499107,0.46,471638913,0.164,851860194,0.296,PGX_AM_BS_20159821_MPNST-bre-063,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.520000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thoracic wall]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof1,P26Y,pgxind-kftx2fq8,pgxcs-kftvnv2w,1437003163,0.5,557693347,0.194,879309816,0.306,PGX_AM_BS_20159821_MPNST-bre-064,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.522000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Right shoulder]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof2,P53Y,pgxind-kftx2fqa,pgxcs-kftvnv3e,1350313022,0.47,810871505,0.282,539441517,0.188,PGX_AM_BS_20159821_MPNST-bre-065,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.523000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof4,P28Y,pgxind-kftx2fqc,pgxcs-kftvnv3v,1540858905,0.536,635641927,0.221,905216978,0.315,PGX_AM_BS_20159821_MPNST-bre-067,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.525000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof6,P41Y,pgxind-kftx2fqe,pgxcs-kftvnv4c,1407853388,0.49,769905657,0.268,637947731,0.222,PGX_AM_BS_20159821_MPNST-bre-068,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.526000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac270,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Mediastinum],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof7,P73Y,pgxind-kftx2fqg,pgxcs-kftvnv4s,2510212230,0.873,1444256608,0.502,1065955622,0.371,PGX_AM_BS_20159821_MPNST-bre-070,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.528000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac271,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof9,P29Y,pgxind-kftx2fqi,pgxcs-kftvnv5a,366871444,0.128,183232624,0.064,183638820,0.064,PGX_AM_BS_20159821_MPNST-bre-074,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.529000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac272,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofb,P26Y,pgxind-kftx2fqk,pgxcs-kftvnv5r,248896417,0.087,90521516,0.031,158374901,0.055,PGX_AM_BS_20159821_MPNST-bre-077,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.531000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac273,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofc,P21Y,pgxind-kftx2fqm,pgxcs-kftvnv68,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-079,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.532000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac275,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Mediastinum]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoff,P52Y,pgxind-kftx2fqq,pgxcs-kftvnv76,1958473088,0.681,680007220,0.237,1278465868,0.445,PGX_AM_BS_20159821_MPNST-bre-083,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.535000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac276,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofh,P42Y,pgxind-kftx2fqs,pgxcs-kftvnv7n,2496649693,0.868,1151180206,0.4,1345469487,0.468,PGX_AM_BS_20159821_MPNST-bre-086,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.536000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac278,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofk,P32Y,pgxind-kftx2fqw,pgxcs-kftvnv8l,2312561261,0.804,946983195,0.329,1365578066,0.475,PGX_AM_BS_20159821_MPNST-bre-088,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.539000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac27b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Back],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofp,P54Y,pgxind-kftx2fr2,pgxcs-kftvnva1,196600196,0.068,196600196,0.068,0,0,PGX_AM_BS_20159821_MPNST-bre-115,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.544000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofs,P79Y,pgxind-kftx2fr6,pgxcs-kftvnvay,1099762116,0.383,128240240,0.045,971521876,0.338,PGX_AM_BS_20159821_MPNST-bre-117,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.547000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofu,P11Y,pgxind-kftx2fr8,pgxcs-kftvnvbf,93117817,0.032,61943043,0.022,31174774,0.011,PGX_AM_BS_20159821_MPNST-bre-118,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.548000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac27f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Lung],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofv,P32Y,pgxind-kftx2fra,pgxcs-kftvnvbw,479964775,0.167,187162556,0.065,292802219,0.102,PGX_AM_BS_20159821_MPNST-bre-120,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.550000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac28b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgogf,P25Y,pgxind-kftx2fry,pgxcs-kftvnvhj,1830651586,0.637,654808603,0.228,1175842983,0.409,PGX_AM_BS_20159821_MPNST-bre-080,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.566000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac290,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgogn,P45Y,pgxind-kftx2fs8,pgxcs-kftvnvjv,382244997,0.133,197906177,0.069,184338820,0.064,PGX_AM_BS_20159821_MPNST-bre-091,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.573000,PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",1,123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad64b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Glioma, mixed",NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgush,P34Y,pgxind-kftx2np3,pgxcs-kftvptw3,906049230,0.315,553149109,0.192,352900121,0.123,PGX_AM_BS_18077431_ber_AMG1,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:21.534000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,70.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c5727983b2e00ad64c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Glioma, mixed",NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgusj,P40Y,pgxind-kftx2np5,pgxcs-kftvptwl,873707698,0.304,659028147,0.229,214679551,0.075,PGX_AM_BS_18077431_ber_AMG2,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:21.536000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,24.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad65a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgut6,P42Y,pgxind-kftx2npy,pgxcs-kftvpu3d,431898102,0.15,336796520,0.117,95101582,0.033,PGX_AM_BS_18077431_ber_LGOA1,{},-71.11,42.38,Point,USA,Cambridge,United States of America,"Cambridge, United States",42.38,-71.11,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:21.556000,PMID:18077431,"Beroukhim R, Getz G et al. (2007): Assessing the significance of chromosomal aberrations...",0,125.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adb8d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic astrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwhb,P63Y,pgxind-kftx2pt2,pgxcs-kftvqcs0,360834644,0.126,224882123,0.078,135952521,0.047,PGX_AM_BS_17390041_GBM-tah-G16,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.421000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb8e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic astrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwhd,P35Y,pgxind-kftx2pt4,pgxcs-kftvqcsh,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G17,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.422000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adc15,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic astrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwni,P47Y,pgxind-kftx2q0r,pgxcs-kftvqeox,1541267020,0.536,478926211,0.167,1062340809,0.37,PGX_AM_BS_17367075_GBM-tak-04,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.607000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcbd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv4,P64Y,pgxind-kftx2qa9,pgxcs-kftvqgz4,1292574009,0.45,1292574009,0.45,0,0,PGX_AM_BS_OligoAstro-tro-AOA15,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.838000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcbf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv7,P74Y,pgxind-kftx2qad,pgxcs-kftvqh03,0,0,0,0,0,0,PGX_AM_BS_OligoAstro-tro-AOA44,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.841000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcc2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvc,P60Y,pgxind-kftx2qaj,pgxcs-kftvqh1l,223886427,0.078,223886427,0.078,0,0,PGX_AM_BS_OligoAstro-tro-AOA80,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.845000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcc4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvf,P62Y,pgxind-kftx2qan,pgxcs-kftvqh2l,230670232,0.08,206217822,0.072,24452410,0.009,PGX_AM_BS_OligoAstro-tro-AOA82,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.848000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvh,P37Y,pgxind-kftx2qap,pgxcs-kftvqh4z,414101173,0.144,414101173,0.144,0,0,PGX_AM_BS_OligoAstro-tro-AOA83,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.849000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvi,P33Y,pgxind-kftx2qar,pgxcs-kftvqh5g,105000103,0.037,61400060,0.021,43600043,0.015,PGX_AM_BS_OligoAstro-tro-AOA84,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.851000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcc7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvk,P42Y,pgxind-kftx2qat,pgxcs-kftvqh5y,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_OligoAstro-tro-AOA85,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.852000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvn,P54Y,pgxind-kftx2qax,pgxcs-kftvqh6y,259336239,0.09,172314728,0.06,87021511,0.03,PGX_AM_BS_OligoAstro-tro-AOA87,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.855000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcca,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvp,P48Y,pgxind-kftx2qaz,pgxcs-kftvqh7f,127203530,0.044,127203530,0.044,0,0,PGX_AM_BS_OligoAstro-tro-AOA88,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.856000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adccc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvs,P43Y,pgxind-kftx2qb3,pgxcs-kftvqh8e,258288707,0.09,154749688,0.054,103539019,0.036,PGX_AM_BS_OligoAstro-tro-AOA90,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.859000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adccf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvx,P36Y,pgxind-kftx2qb9,pgxcs-kftvqh9u,74617691,0.026,30117647,0.01,44500044,0.015,PGX_AM_BS_OligoAstro-tro-AOA96,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.863000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgww0,P41Y,pgxind-kftx2qbd,pgxcs-kftvqhat,164792524,0.057,154417771,0.054,10374753,0.004,PGX_AM_BS_OligoAstro-tro-AOA98,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.866000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcd2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgww2,P40Y,pgxind-kftx2qbf,pgxcs-kftvqhba,381683993,0.133,300262487,0.104,81421506,0.028,PGX_AM_BS_OligoAstro-tro-AOA99,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.867000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adce4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma [WHO II],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwwv,P61Y,pgxind-kftx2qcg,pgxcs-kftvqhjz,451349475,0.157,186427787,0.065,264921688,0.092,PGX_AM_BS_OligoAstro-tro-OA2,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.892000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma [WHO II],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwww,P10Y,pgxind-kftx2qci,pgxcs-kftvqhkg,0,0,0,0,0,0,PGX_AM_BS_OligoAstro-tro-OA43,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.893000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,329,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adce6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma [WHO II],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwwy,P18Y,pgxind-kftx2qck,pgxcs-kftvqhkx,0,0,0,0,0,0,PGX_AM_BS_OligoAstro-tro-OA44,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.895000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma [WHO II],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwwz,P41Y,pgxind-kftx2qcm,pgxcs-kftvqhle,344632517,0.12,344632517,0.12,0,0,PGX_AM_BS_OligoAstro-tro-OA45,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.896000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",0,102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae9df,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvh1e8,P51Y,pgxind-kftx2viv,pgxcs-kftvrs4f,283121707,0.098,124300124,0.043,158821583,0.055,PGX_AM_BS_AnOlAst-mar-1,{},13.74,51.05,Point,DEU,Dresden,Germany,"Dresden, Germany",51.05,13.74,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:28.880000,PMID:15925987,"Martinez R, Schackert HK et al. (2005): Comparative genetic analysis of metachronous anaplastic...",0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c0e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [high grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhcct,P54Y,pgxind-kftx397n,pgxcs-kftvv6og,1881685121,0.654,1218048982,0.424,663636139,0.231,PGX_AM_BS_OA-N127,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:40.978000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,8,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c12,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [high grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhccz,P48Y,pgxind-kftx397v,pgxcs-kftvv6qf,432593567,0.15,374841124,0.13,57752443,0.02,PGX_AM_BS_OA-N167,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:40.984000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,7,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c1e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [high grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhcdj,P67Y,pgxind-kftx398j,pgxcs-kftvv6w9,1373546207,0.478,743233466,0.259,630312741,0.219,PGX_AM_BS_OA-T14,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,10.09.20 17:44,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,74,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb8b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwh8,P34Y,pgxind-kftx2psy,pgxcs-kftvqcr1,752391799,0.262,404728712,0.141,347663087,0.121,PGX_AM_BS_17390041_GBM-tah-G14,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.418000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adb8c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic astrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwha,P38Y,pgxind-kftx2pt0,pgxcs-kftvqcrj,0,0,0,0,0,0,PGX_AM_BS_17390041_GBM-tah-G15,{},29.08,40.19,Point,TUR,Bursa,Turkey,"Bursa, Turkey",40.19,29.08,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.419000,PMID:17390041,"Yakut T, Gutenberg A et al. (2007): Correlation of chromosomal imbalances by comparative...",1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adc13,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwnf,P77Y,pgxind-kftx2q0n,pgxcs-kftvqem2,1415384805,0.492,741301823,0.258,674082982,0.234,PGX_AM_BS_17367075_GBM-tak-02,{},139.69,35.69,Point,JPN,Tokyo,Japan,"Tokyo, Japan",35.69,139.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.604000,PMID:17367075,"Takahashi S, Hirose Y et al. (2007): Chromosome arm 1q gain associated with...",1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcba,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwuz,P39Y,pgxind-kftx2qa2,pgxcs-kftvqgxo,211645244,0.074,211645244,0.074,0,0,PGX_AM_BS_OligoAstro-tro-AOA100,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.834000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcbb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv0,P55Y,pgxind-kftx2qa4,pgxcs-kftvqgy5,539902549,0.188,340363714,0.118,199538835,0.069,PGX_AM_BS_OligoAstro-tro-AOA13,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.836000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcbc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv2,P38Y,pgxind-kftx2qa6,pgxcs-kftvqgyn,279638868,0.097,69486273,0.024,210152595,0.073,PGX_AM_BS_OligoAstro-tro-AOA14,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.837000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcbe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv5,P25Y,pgxind-kftx2qab,pgxcs-kftvqgzm,436844188,0.152,358044110,0.125,78800078,0.027,PGX_AM_BS_OligoAstro-tro-AOA18,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.840000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwv9,P38Y,pgxind-kftx2qaf,pgxcs-kftvqh0l,0,0,0,0,0,0,PGX_AM_BS_OligoAstro-tro-AOA46,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.842000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwva,P50Y,pgxind-kftx2qah,pgxcs-kftvqh13,413672841,0.144,133797556,0.047,279875285,0.097,PGX_AM_BS_OligoAstro-tro-AOA7,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.844000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvd,P43Y,pgxind-kftx2qal,pgxcs-kftvqh23,415208995,0.144,311935082,0.108,103273913,0.036,PGX_AM_BS_OligoAstro-tro-AOA81,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.847000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcc8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvl,P28Y,pgxind-kftx2qav,pgxcs-kftvqh6h,443902281,0.154,443902281,0.154,0,0,PGX_AM_BS_OligoAstro-tro-AOA86,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.853000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adccb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvq,P25Y,pgxind-kftx2qb1,pgxcs-kftvqh7x,186919034,0.065,28097451,0.01,158821583,0.055,PGX_AM_BS_OligoAstro-tro-AOA89,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.857000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adccd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvu,P30Y,pgxind-kftx2qb5,pgxcs-kftvqh8v,472549798,0.164,472549798,0.164,0,0,PGX_AM_BS_OligoAstro-tro-AOA94,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.860000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00adcce,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvv,P47Y,pgxind-kftx2qb7,pgxcs-kftvqh9d,871092466,0.303,871092466,0.303,0,0,PGX_AM_BS_OligoAstro-tro-AOA95,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.862000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adcd0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,anaplastic oligoastrocytoma [WHO III],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwvy,P49Y,pgxind-kftx2qbb,pgxcs-kftvqhab,184517801,0.064,184517801,0.064,0,0,PGX_AM_BS_OligoAstro-tro-AOA97,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.865000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00adce3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,oligoastrocytoma [WHO II],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvgwwt,P70Y,pgxind-kftx2qcd,pgxcs-kftvqhji,384036846,0.134,166597588,0.058,217439258,0.076,PGX_AM_BS_OligoAstro-tro-OA10,{},7.1,50.73,Point,DEU,Bonn,Germany,"Bonn, Germany",50.73,7.1,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:23.891000,PMID:17285580,"Trost D, Ehrler M et al. (2007): Identification of genomic aberrations associated with...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c0a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [high grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhccm,P59Y,pgxind-kftx397e,pgxcs-kftvv6mj,589402268,0.205,376685071,0.131,212717197,0.074,PGX_AM_BS_OA-N101,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:40.972000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,6,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c11,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [low grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhccy,P72Y,pgxind-kftx397t,pgxcs-kftvv6px,121721546,0.042,0,0,121721546,0.042,PGX_AM_BS_OA-N163,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:40.982000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,24,NCITgrade-C14161,Low Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c1b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Oligoastrocytoma [high grade],NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, NOS",pgxbs-kftvhcde,P49Y,pgxind-kftx398d,pgxcs-kftvv6us,392119237,0.136,233297654,0.081,158821583,0.055,PGX_AM_BS_OA-N65,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:40.996000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",1,5,NCITgrade-C14158,High Grade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc180ed09d374f6dd7f92e5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Anaplastic oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, nos",pgxbs-kftvk2t4,P22Y8M,pgxind-kftx62xy,pgxcs-kftwohde,691680109,0.241,583903481,0.203,107776628,0.037,PGX_AM_BS_GSM487847,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.687000,geo:GSM487847,,1,9.6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE19578,,,,,,,,,,,,,,,,,
5dc1837e09d374f6dd82fb56,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Anaplastic oligoastrocytoma,NCIT:C3903,Mixed Glioma,icdom-93823,Mixed glioma,icdot-C71.9,"brain, nos",pgxbs-kftvk71s,P22Y8M,pgxind-kftx684g,pgxcs-kftwph79,824321195,0.287,584286804,0.203,240034391,0.083,PGX_AM_BS_GSM487925,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.050000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,9.6,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM487925,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00b0234,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh973,P1Y10M,pgxind-kftx359l,pgxcs-kftvu76j,0,0,0,0,0,0,PGX_AM_BS_Epend-car-02,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.496000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0236,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh976,P12Y,pgxind-kftx359p,pgxcs-kftvu77h,261344699,0.091,0,0,261344699,0.091,PGX_AM_BS_Epend-car-04,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.499000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b024a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh983,P9Y10M,pgxind-kftx35au,pgxcs-kftvu7jc,0,0,0,0,0,0,PGX_AM_BS_Epend-car-24,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.527000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b024b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh984,P14Y,pgxind-kftx35ax,pgxcs-kftvu7ju,0,0,0,0,0,0,PGX_AM_BS_Epend-car-25,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.529000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0253,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, medullary]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.7,brain stem,pgxbs-kftvh98h,P45Y,pgxind-kftx35bd,pgxcs-kftvu7ns,0,0,0,0,0,0,PGX_AM_BS_Epend-car-33,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:37.540000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0256,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh98m,P6Y11M,pgxind-kftx35bj,pgxcs-kftvu7p7,1390662108,0.484,0,0,1390662108,0.484,PGX_AM_BS_Epend-car-36,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.544000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b026c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh99n,P32Y,pgxind-kftx35cs,pgxcs-kftvu7zz,588916003,0.205,133797556,0.047,455118447,0.158,PGX_AM_BS_Epend-car-58,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.575000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b026f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, filum terminale]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C72.0,Spinal cord,pgxbs-kftvh99s,P40Y,pgxind-kftx35cy,pgxcs-kftvu81h,0,0,0,0,0,0,PGX_AM_BS_Epend-car-61,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:37.580000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0275,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9a2,P2Y,pgxind-kftx35da,pgxcs-kftvu84c,0,0,0,0,0,0,PGX_AM_BS_Epend-car-67,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.588000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,110,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0276,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, supratentorial]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvh9a3,P9Y10M,pgxind-kftx35dc,pgxcs-kftvu84t,412807844,0.144,412807844,0.144,0,0,PGX_AM_BS_Epend-car-68,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.589000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0277,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9a5,P2Y,pgxind-kftx35de,pgxcs-kftvu85a,0,0,0,0,0,0,PGX_AM_BS_Epend-car-69,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.591000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b027c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9ad,P8Y10M,pgxind-kftx35do,pgxcs-kftvu87o,808599138,0.281,0,0,808599138,0.281,PGX_AM_BS_Epend-car-74,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.597000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b027f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, supratentorial]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvh9ai,P5Y11M,pgxind-kftx35du,pgxcs-kftvu894,0,0,0,0,0,0,PGX_AM_BS_Epend-car-77,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.601000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0285,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9as,P8Y7M,pgxind-kftx35e7,pgxcs-kftvu8bz,0,0,0,0,0,0,PGX_AM_BS_Epend-car-83,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.610000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac44b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvgp0r,P4Y,pgxind-kftx2gha,pgxcs-kftvo1kq,595928742,0.207,162356130,0.056,433572612,0.151,PGX_AM_BS_19962671_PNET-li-PNET3,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.179000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac450,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvgp0z,P0Y7M,pgxind-kftx2ghk,pgxcs-kftvo1n2,271492843,0.094,21949439,0.008,249543404,0.087,PGX_AM_BS_19962671_PNET-li-PNET39,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.186000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c3727983b2e00ac45b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvgp1h,P1Y7M,pgxind-kftx2gi6,pgxcs-kftvo1u7,3411884,0.001,3154373,0.001,257511,0,PGX_AM_BS_19962671_PNET-li-PNET5,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:15.201000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae447,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoblastoma [upper cerebellar vermis],NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvgzln,P2Y4M,pgxind-kftx2ta3,pgxcs-kftvr7zj,450642942,0.157,208449170,0.073,242193772,0.084,PGX_AM_BS_16718352_EB-ric-02,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:26.889000,PMID:16718352,Rickert CH et al. (2006) Cytogenetic features of ependymoblastomas.,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae448,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoblastoma,NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.9,"Brain, NOS",pgxbs-kftvgzlo,P2Y4M,pgxind-kftx2ta5,pgxcs-kftvr800,640857688,0.223,398663916,0.139,242193772,0.084,PGX_AM_BS_16718352_EB-ric-03,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.890000,PMID:16718352,Rickert CH et al. (2006) Cytogenetic features of ependymoblastomas.,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae449,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,ependymoblastoma,NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,Cerebellum,pgxbs-kftvgzlq,P3Y5M,pgxind-kftx2ta7,pgxcs-kftvr80h,463578785,0.161,259076475,0.09,204502310,0.071,PGX_AM_BS_16718352_EB-ric-04,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:26.892000,PMID:16718352,Rickert CH et al. (2006) Cytogenetic features of ependymoblastomas.,1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0237,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh978,P13Y,pgxind-kftx359r,pgxcs-kftvu77z,642653404,0.224,0,0,642653404,0.224,PGX_AM_BS_Epend-car-05,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.501000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0239,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh97b,P7Y10M,pgxind-kftx359w,pgxcs-kftvu78z,173577148,0.06,50627305,0.018,122949843,0.043,PGX_AM_BS_Epend-car-07,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.503000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0245,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh97u,P3Y11M,pgxind-kftx35ak,pgxcs-kftvu7gx,0,0,0,0,0,0,PGX_AM_BS_Epend-car-19,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.520000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0247,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, supratentorial]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvh97y,P48Y,pgxind-kftx35ao,pgxcs-kftvu7hx,172732614,0.06,49691482,0.017,123041132,0.043,PGX_AM_BS_Epend-car-21,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.523000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b024c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh986,P15Y,pgxind-kftx35az,pgxcs-kftvu7kb,0,0,0,0,0,0,PGX_AM_BS_Epend-car-26,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.530000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0269,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, supratentorial]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvh99i,P40Y,pgxind-kftx35cm,pgxcs-kftvu7yj,0,0,0,0,0,0,PGX_AM_BS_Epend-car-55,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.571000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b027a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9aa,P6Y11M,pgxind-kftx35dk,pgxcs-kftvu86p,92458103,0.032,13791447,0.005,78666656,0.027,PGX_AM_BS_Epend-car-72,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.595000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b027d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9af,P6Y5M,pgxind-kftx35dq,pgxcs-kftvu885,170649890,0.059,0,0,170649890,0.059,PGX_AM_BS_Epend-car-75,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.599000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0280,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, supratentorial]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.0,cerebrum,pgxbs-kftvh9ak,P59Y,pgxind-kftx35dw,pgxcs-kftvu89l,1746760148,0.608,57227473,0.02,1689532675,0.588,PGX_AM_BS_Epend-car-78,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:37.603000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0283,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"ependymoma [anaplastic, posterior fossa]",NCIT:C4049,Anaplastic Ependymoma,icdom-93923,"Ependymoma, anaplastic",icdot-C71.6,cerebellum,pgxbs-kftvh9ap,P44Y,pgxind-kftx35e3,pgxcs-kftvu8b1,1504260266,0.523,787520339,0.274,716739927,0.249,PGX_AM_BS_Epend-car-81,{},-1.4,50.9,Point,GBR,Southampton,United Kingdom,"Southampton, United Kingdom",50.9,-1.4,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:37.607000,PMID:11953826,"Carter M, Nicholson J et al. (2002): Genetic abnormalities detected in ependymomas by...",1,402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3d6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,gliomatosis cerebri [infratentorial],NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.6,cerebellum,pgxbs-kftvgovh,P9Y9M,pgxind-kftx2gao,pgxcs-kftvnzzo,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN3180,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.019000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0m,P73Y5M,pgxind-kftx2qh4,pgxcs-kftvqiq3,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.006000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,41.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0o,P23Y10M,pgxind-kftx2qh6,pgxcs-kftvqiqk,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.008000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,81.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add3d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0v,P30Y11M,pgxind-kftx2qhf,pgxcs-kftvqisi,146100145,0.051,105800105,0.037,40300040,0.014,PGX_AM_BS_GliCer-war-10,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.013000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx11,P58Y6M,pgxind-kftx2qhn,pgxcs-kftvqiuf,428574790,0.149,137403540,0.048,291171250,0.101,PGX_AM_BS_GliCer-war-14,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.019000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx13,P45Y1M,pgxind-kftx2qhp,pgxcs-kftvqiuw,445832618,0.155,344632517,0.12,101200101,0.035,PGX_AM_BS_GliCer-war-15,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.020000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,162.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx15,P75Y8M,pgxind-kftx2qhr,pgxcs-kftvqive,399419246,0.139,179797602,0.063,219621644,0.076,PGX_AM_BS_GliCer-war-16,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.021000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",0,10.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0g,P19Y7M,pgxind-kftx2qgx,pgxcs-kftvqio6,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.001000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,32.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add35,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0i,P29Y,pgxind-kftx2qgz,pgxcs-kftvqion,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.002000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,82.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0j,P33Y4M,pgxind-kftx2qh1,pgxcs-kftvqip4,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.003000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,23.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0l,P38Y,pgxind-kftx2qh2,pgxcs-kftvqipm,0,0,0,0,0,0,PGX_AM_BS_GliCer-war-04,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.005000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,40.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0q,P63Y10M,pgxind-kftx2qh8,pgxcs-kftvqir2,136286287,0.047,0,0,136286287,0.047,PGX_AM_BS_GliCer-war-07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.009000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,82.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0r,P78Y2M,pgxind-kftx2qha,pgxcs-kftvqirj,160121585,0.056,0,0,160121585,0.056,PGX_AM_BS_GliCer-war-08,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.010000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0t,P87Y2M,pgxind-kftx2qhd,pgxcs-kftvqis0,146094864,0.051,146094864,0.051,0,0,PGX_AM_BS_GliCer-war-09,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.012000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0x,P67Y1M,pgxind-kftx2qhh,pgxcs-kftvqisz,356403757,0.124,356403757,0.124,0,0,PGX_AM_BS_GliCer-war-11,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.015000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add3f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx0y,P84Y1M,pgxind-kftx2qhj,pgxcs-kftvqitg,314219160,0.109,133797556,0.047,180421604,0.063,PGX_AM_BS_GliCer-war-12,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.016000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx10,P54Y10M,pgxind-kftx2qhl,pgxcs-kftvqitx,500877214,0.174,161197584,0.056,339679630,0.118,PGX_AM_BS_GliCer-war-13,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.017000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx16,P27Y4M,pgxind-kftx2qht,pgxcs-kftvqivv,458270303,0.159,417970263,0.145,40300040,0.014,PGX_AM_BS_GliCer-war-17,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.023000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,73.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx18,P47Y4M,pgxind-kftx2qhv,pgxcs-kftvqiwc,494129661,0.172,164058186,0.057,330071475,0.115,PGX_AM_BS_GliCer-war-18,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.024000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00add46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx1a,P45Y8M,pgxind-kftx2qhx,pgxcs-kftvqiwu,465899442,0.162,170800170,0.059,295099272,0.103,PGX_AM_BS_GliCer-war-19,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.025000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx1b,P26Y7M,pgxind-kftx2qhz,pgxcs-kftvqixb,731117134,0.254,162414740,0.056,568702394,0.198,PGX_AM_BS_GliCer-war-20,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.027000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx1d,P56Y11M,pgxind-kftx2qi1,pgxcs-kftvqixt,734714286,0.256,284495844,0.099,450218442,0.157,PGX_AM_BS_GliCer-war-21,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.028000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,17.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00add49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Gliomatosis cerebri,NCIT:C4318,Gliomatosis Cerebri,icdom-93813,Gliomatosis cerebri,icdot-C71.9,"brain, NOS",pgxbs-kftvgx1e,P59Y8M,pgxind-kftx2qi3,pgxcs-kftvqiya,756545691,0.263,129197551,0.045,627348140,0.218,PGX_AM_BS_GliCer-war-22,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:24.030000,PMID:17228264,"Ware ML, Hirose Y et al. (2007) Genetic aberrations in gliomatosis cerebri.",1,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abd82,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,fibrillary astrocytoma,NCIT:C4322,Fibrillary Astrocytoma,icdom-94203,Fibrillary astrocytoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgmtt,P65Y,pgxind-kftx2dr5,pgxcs-kftvndx4,319467008,0.111,319467008,0.111,0,0,PGX_AM_BS_20591577_AT-jin-11,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:12.756000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd83,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,fibrillary astrocytoma,NCIT:C4322,Fibrillary Astrocytoma,icdom-94203,Fibrillary astrocytoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgmtv,P44Y,pgxind-kftx2dr6,pgxcs-kftvndxl,390882099,0.136,390882099,0.136,0,0,PGX_AM_BS_20591577_AT-jin-12,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:12.758000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd85,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,fibrillary astrocytoma,NCIT:C4322,Fibrillary Astrocytoma,icdom-94203,Fibrillary astrocytoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgmty,P52Y,pgxind-kftx2dra,pgxcs-kftvndyj,686999737,0.239,686999737,0.239,0,0,PGX_AM_BS_20591577_AT-jin-14,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:12.761000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",0,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abd89,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,fibrillary astrocytoma,NCIT:C4322,Fibrillary Astrocytoma,icdom-94203,Fibrillary astrocytoma,icdot-C71.9,"brain, NOS",pgxbs-kftvgmu5,P36Y,pgxind-kftx2dri,pgxcs-kftvne0d,248658115,0.086,22200022,0.008,226458093,0.079,PGX_AM_BS_20591577_AT-jin-18,{},117.18,39.14,Point,CHN,Tianjin,China,"Tianjin, China",39.14,117.18,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:12.766000,PMID:20591577,"Jin S, Sun C, Yu S et al. (2010): Chromosome DNA imbalances in human astrocytic...",1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3c4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pleomorphic xanthoastrocytoma [supratentorial],NCIT:C4323,Pleomorphic Xanthoastrocytoma,icdom-94243,Pleomorphic xanthoastrocytoma,icdot-C71.0,cerebrum,pgxbs-kftvgouo,P13Y,pgxind-kftx2g9o,pgxcs-kftvnzra,92206071,0.032,92206071,0.032,0,0,PGX_AM_BS_20052518_PA-war-IN2587,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.995000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abe1d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Anaplastic pleomorphic xanthoastrocytoma,NCIT:C4323,Pleomorphic Xanthoastrocytoma,icdom-94243,Pleomorphic xanthoastrocytoma,icdot-C71.0,Cerebrum,pgxbs-kftvgn0v,P7Y,pgxind-kftx2dzv,pgxcs-kftvnfzj,14632261,0.005,653022,0,13979239,0.005,DIPG_BS_0422,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:12.985000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,1.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_20479398-pau-HGG072,,,geo:GSE19578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5dc180ee09d374f6dd7f9361,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Anaplastic pleomorphic xanthoastrocytoma,NCIT:C4323,Pleomorphic Xanthoastrocytoma,icdom-94243,Pleomorphic xanthoastrocytoma,icdot-C71.9,"brain, nos",pgxbs-kftvk2tc,P7Y,pgxind-kftx62y8,pgxcs-kftwohex,14951474,0.005,389985,0,14561489,0.005,PGX_AM_BS_GSM487852,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:29.692000,geo:GSM487852,,1,21,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE19578,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",,,,,,,,,,,,,,,,
5dc1837f09d374f6dd82fbbf,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Anaplastic pleomorphic xanthoastrocytoma,NCIT:C4323,Pleomorphic Xanthoastrocytoma,icdom-94243,Pleomorphic xanthoastrocytoma,icdot-C71.9,"brain, nos",pgxbs-kftvk720,P7Y,pgxind-kftx684q,pgxcs-kftwph8t,410514,0,380272,0,30242,0,PGX_AM_BS_GSM487930,,-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:34.056000,PMID:20479398,"Paugh BS, Qu C, Jones C et al. (2010): Integrated molecular genetic profiling of pediatric...",1,21,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE19578,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM487930,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00b0396,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9n6,P0Y5M,pgxind-kftx35to,pgxcs-kftvuc5p,2614721442,0.909,1283135462,0.446,1331585980,0.463,PGX_AM_BS_ChorPlex-35,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.984000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,57,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0397,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9n8,P0Y10M,pgxind-kftx35tq,pgxcs-kftvuc66,512766205,0.178,13791447,0.005,498974758,0.174,PGX_AM_BS_ChorPlex-36,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.986000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,4,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b039a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nc,P1Y,pgxind-kftx35tw,pgxcs-kftvuc7p,0,0,0,0,0,0,PGX_AM_BS_ChorPlex-39,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.990000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,20,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b039c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9ng,P2Y5M,pgxind-kftx35u0,pgxcs-kftvucab,2163354302,0.752,1169961243,0.407,993393059,0.346,PGX_AM_BS_ChorPlex-41,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.993000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,75,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b039d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nh,P3Y4M,pgxind-kftx35u2,pgxcs-kftvucat,1163094783,0.405,419089098,0.146,744005685,0.259,PGX_AM_BS_ChorPlex-42,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.994000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,17,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b039f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nl,P8Y,pgxind-kftx35u6,pgxcs-kftvucbu,1153265159,0.401,717643300,0.25,435621859,0.152,PGX_AM_BS_ChorPlex-44,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.997000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,72,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b03a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9no,P10Y,pgxind-kftx35ua,pgxcs-kftvucct,0,0,0,0,0,0,PGX_AM_BS_ChorPlex-47,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,10.09.20 17:44,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,12,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac89d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma,NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C72.0,Spinal cord,pgxbs-kftvgqeo,P11Y,pgxind-kftx2i7t,pgxcs-kftvogwb,0,0,0,0,0,0,PGX_AM_BS_19378321_LFS-rie-04,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002240,spinal cord,{},2020-09-10 17:44:16.708000,PMID:19378321,"Rieber J, Remke M et al. (2009): Novel oncogene amplifications in tumors from...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0398,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9n9,P0Y11M,pgxind-kftx35ts,pgxcs-kftvuc6o,215606204,0.075,215606204,0.075,0,0,PGX_AM_BS_ChorPlex-37,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.987000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,13,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0399,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nb,P0Y11M,pgxind-kftx35tu,pgxcs-kftvuc75,1821907190,0.634,903582347,0.314,918324843,0.319,PGX_AM_BS_ChorPlex-38,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.989000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,5,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b039b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9ne,P1Y8M,pgxind-kftx35ty,pgxcs-kftvuc86,1904544607,0.662,1078025420,0.375,826519187,0.287,PGX_AM_BS_ChorPlex-40,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.991000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,7,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b039e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nj,P3Y4M,pgxind-kftx35u4,pgxcs-kftvucbb,978649430,0.34,246408833,0.086,732240597,0.255,PGX_AM_BS_ChorPlex-43,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.996000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,22,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b03a0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus carcinoma [WHO grade III],NCIT:C4715,Choroid Plexus Carcinoma,icdom-93903,Choroid plexus carcinoma,icdot-C71.5,ventricle,pgxbs-kftvh9nm,P9Y,pgxind-kftx35u8,pgxcs-kftvuccb,1573392916,0.547,806514703,0.281,766878213,0.267,PGX_AM_BS_ChorPlex-45,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.998000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,32,NCITgrade-C28079,Grade 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab72c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkrz,P6Y3M,pgxind-kftx2b9x,pgxcs-kftvmrya,12996963,0.005,10164692,0.004,2832271,0.001,PGX_AM_BS_22389665-gri-P14,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.446000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,0.1,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0213,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab72d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgks1,P3Y6M,pgxind-kftx2b9z,pgxcs-kftvmryq,326384688,0.114,154279313,0.054,172105375,0.06,DIPG_BS_0214,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.447000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,2.05,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab72f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgks4,P9Y4M,pgxind-kftx2ba3,pgxcs-kftvmrzn,241596598,0.084,105962063,0.037,135634535,0.047,DIPG_BS_0215,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.450000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,3.41,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab734,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgksd,P12Y,pgxind-kftx2bad,pgxcs-kftvms1y,154798447,0.054,110446,0,154688001,0.054,DIPG_BS_0220,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.457000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,9.23,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab73b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkso,P4Y5M,pgxind-kftx2bas,pgxcs-kftvms56,67425511,0.023,67265075,0.023,160436,0,DIPG_BS_0227,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.467000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,3.35,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab73e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkst,P0Y6M,pgxind-kftx2bay,pgxcs-kftvms6k,521406,0,243090,0,278316,0,PGX_AM_BS_22389665-gri-P34,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.471000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,2.23,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab743,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkt1,P13Y6M,pgxind-kftx2bb8,pgxcs-kftvmsaq,1145118,0,1145118,0,0,0,PGX_AM_BS_22389665-gri-P41,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.477000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,4.53,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0235,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab764,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkuj,P3Y4M,pgxind-kftx2bd1,pgxcs-kftvmsq3,165393656,0.058,48210153,0.017,117183503,0.041,DIPG_BS_0279,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.523000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",0,11.47,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c5727983b2e00ad036,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,chordoid glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.5,ventricle,pgxbs-kftvgsui,P72Y,pgxind-kftx2l95,pgxcs-kftvp83a,25400026,0.009,0,0,25400026,0.009,PGX_AM_BS_ChordGlio-hor-5,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,{},2020-09-10 17:44:19.395000,PMID:18652591,"Horbinski C, Dacic S et al. (2009): Chordoid glioma: a case report and...",0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab64e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse intrinsic pontine glioma [cell line],NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkhv,P6Y,pgxind-kftx2axp,pgxcs-kftvmozn,418114930,0.145,2345807,0.001,415769123,0.145,PGX_AM_BS_22983601-has-DIPGCL,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.134000,PMID:22983601,"Hashizume R, Smirnov I et al. (2012): Characterization of a diffuse intrinsic pontine...",1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab721,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkrh,P8Y,pgxind-kftx2b9b,pgxcs-kftvmrt6,1218380163,0.424,889159575,0.309,329220588,0.115,PGX_AM_BS_22389665-gri-P01,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.431000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0345,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab722,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkrj,P14Y,pgxind-kftx2b9d,pgxcs-kftvmrtn,234423881,0.082,158366199,0.055,76057682,0.026,PGX_AM_BS_22389665-gri-P02,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.432000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0346,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab724,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkrm,P8Y,pgxind-kftx2b9h,pgxcs-kftvmruk,442241976,0.154,309117889,0.108,133124087,0.046,PGX_AM_BS_22389665-gri-P04,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.435000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,3.02,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab726,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkrp,P4Y9M,pgxind-kftx2b9l,pgxcs-kftvmrvh,16016960,0.006,6295595,0.002,9721365,0.003,PGX_AM_BS_22389665-gri-P08,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.438000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.75,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0207,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab730,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgks6,P6Y4M,pgxind-kftx2ba5,pgxcs-kftvms04,457597933,0.159,352194794,0.123,105403139,0.037,DIPG_BS_0216,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.452000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.6,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab731,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgks8,P17Y10M,pgxind-kftx2ba7,pgxcs-kftvms0l,570858882,0.199,335688570,0.117,235170312,0.082,PGX_AM_BS_22389665-gri-P19,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.453000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,7.65,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0217,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab732,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgks9,P15Y3M,pgxind-kftx2ba9,pgxcs-kftvms11,43248943,0.015,32179234,0.011,11069709,0.004,PGX_AM_BS_22389665-gri-P20,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.454000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.49,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0218,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab733,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgksb,P2Y11M,pgxind-kftx2bab,pgxcs-kftvms1i,206317977,0.072,89386758,0.031,116931219,0.041,PGX_AM_BS_22389665-gri-P21,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.456000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.36,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0219,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab735,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkse,P6Y7M,pgxind-kftx2baf,pgxcs-kftvms2f,280109289,0.097,0,0,280109289,0.097,PGX_AM_BS_22389665-gri-P24,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.458000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0221,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab736,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgksg,P4Y7M,pgxind-kftx2bah,pgxcs-kftvms2v,544867,0,183,0,544684,0,PGX_AM_BS_22389665-gri-P25,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.460000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0222,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab738,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgksj,P4Y8M,pgxind-kftx2bal,pgxcs-kftvms3t,289144,0,289144,0,0,0,DIPG_BS_0224,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.462000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,4.16,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab73a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgksm,P13Y7M,pgxind-kftx2baq,pgxcs-kftvms4q,316292630,0.11,286568671,0.1,29723959,0.01,DIPG_BS_0226,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.465000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.62,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab73c,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgksq,P12Y2M,pgxind-kftx2bau,pgxcs-kftvms5n,40348801,0.014,40242151,0.014,106650,0,DIPG_BS_0228,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.468000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.52,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab73f,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgksu,P11Y4M,pgxind-kftx2bb0,pgxcs-kftvms70,843314659,0.293,442602293,0.154,400712366,0.139,DIPG_BS_0232,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.472000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab745,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkt4,P9Y3M,pgxind-kftx2bbc,pgxcs-kftvmsbq,4727962,0.002,0,0,4727962,0.002,DIPG_BS_0237,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.480000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab746,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkt6,P9Y5M,pgxind-kftx2bbe,pgxcs-kftvmsc7,488286847,0.17,333203101,0.116,155083746,0.054,DIPG_BS_0238,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.482000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.59,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab747,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkt7,P12Y8M,pgxind-kftx2bbg,pgxcs-kftvmsco,1197502,0,426025,0,771477,0,PGX_AM_BS_22389665-gri-P46,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.483000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.45,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab748,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkt9,P6Y4M,pgxind-kftx2bbi,pgxcs-kftvmsd4,1796630,0.001,1655536,0.001,141094,0,PGX_AM_BS_22389665-gri-P48,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.485000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.76,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0243,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab749,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgktb,P14Y3M,pgxind-kftx2bbk,pgxcs-kftvmsdl,202550696,0.07,199079290,0.069,3471406,0.001,DIPG_BS_0244,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.486000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.7,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab74a,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgktc,P6Y6M,pgxind-kftx2bbm,pgxcs-kftvmse2,683823007,0.238,673339735,0.234,10483272,0.004,PGX_AM_BS_22389665-gri-P50,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.487000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0245,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab74b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgkte,P4Y7M,pgxind-kftx2bbo,pgxcs-kftvmsej,21034899,0.007,0,0,21034899,0.007,DIPG_BS_0247,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.489000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab74e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgktj,P11Y,pgxind-kftx2bbu,pgxcs-kftvmsfx,88469420,0.031,87895996,0.031,573424,0,DIPG_BS_0251,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.493000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.33,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab752,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgktp,P11Y11M,pgxind-kftx2bc2,pgxcs-kftvmshs,242229711,0.084,231088737,0.08,11140974,0.004,PGX_AM_BS_22389665-gri-P61,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.498000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab756,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgktw,P10Y3M,pgxind-kftx2bc9,pgxcs-kftvmsjm,38930580,0.014,22419945,0.008,16510635,0.006,PGX_AM_BS_22389665-gri-P65,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.504000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.82,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab757,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkty,P8Y,pgxind-kftx2bcb,pgxcs-kftvmsk3,996712,0,996712,0,0,0,PGX_AM_BS_22389665-gri-P68,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.505000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.39,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab759,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgku1,P5Y1M,pgxind-kftx2bcf,pgxcs-kftvmsl0,5244069,0.002,437154,0,4806915,0.002,DIPG_BS_0264,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.508000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.73,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab75b,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgku4,P5Y10M,pgxind-kftx2bcj,pgxcs-kftvmslx,64249291,0.022,775889,0,63473402,0.022,DIPG_BS_0266,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.510000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.4,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab75e,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvgku9,P7Y5M,pgxind-kftx2bcp,pgxcs-kftvmsnb,263277674,0.092,242602701,0.084,20674973,0.007,DIPG_BS_0270,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.515000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,0.9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab761,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkue,P5Y1M,pgxind-kftx2bcv,pgxcs-kftvmsop,122648695,0.043,351785,0,122296910,0.043,DIPG_BS_0275,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.519000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.67,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab763,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkuh,P8Y7M,pgxind-kftx2bcz,pgxcs-kftvmspm,891669,0,476241,0,415428,0,DIPG_BS_0277,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.522000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,2.31,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab766,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkum,P11Y7M,pgxind-kftx2bd5,pgxcs-kftvmsr0,201215,0,1991,0,199224,0,DIPG_BS_0282,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.526000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.01,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab767,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Malignant glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.0,Cerebrum,pgxbs-kftvgkuo,P12Y7M,pgxind-kftx2bd6,pgxcs-kftvmsrh,169040014,0.059,154032164,0.054,15007850,0.005,PGX_AM_BS_22389665-gri-P90,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:10.527000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,1.33,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc1809409d374f6dd7f5d91,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28o,P5Y10M,pgxind-kftx628v,pgxcs-kftwodc8,471728415,0.164,299761529,0.104,171966886,0.06,PGX_AM_BS_GSM466772,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.213000,geo:GSM466772,,1,4.1,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE18828,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0502,Vietnamese,0.46,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,F
5dc1809409d374f6dd7f5d92,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28q,,pgxind-kftx628x,pgxcs-kftwodck,28073845,0.01,19859117,0.007,8214728,0.003,PGX_AM_BS_GSM466773,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.215000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,0.39,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE18828,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM466773,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0005,European,,,,,F
5dc1809409d374f6dd7f5d93,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28s,P6Y8M,pgxind-kftx628z,pgxcs-kftwodcw,784381808,0.273,284739140,0.099,499642668,0.174,PGX_AM_BS_GSM466774,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.215000,geo:GSM466774,,1,11.51,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE18828,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",,,,0.64,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.66,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1809409d374f6dd7f5d94,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28t,P16Y8M,pgxind-kftx6291,pgxcs-kftwodd7,703161783,0.245,355839285,0.124,347322498,0.121,PGX_AM_BS_GSM466775,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.217000,geo:GSE18828,,1,10.16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM466775,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.04,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0005,European,,,,,M
5dc1809409d374f6dd7f5d95,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28v,P9Y,pgxind-kftx6293,pgxcs-kftwoddj,228661652,0.08,206350678,0.072,22310974,0.008,PGX_AM_BS_GSM466776,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.218000,geo:GSM466776,,1,11.64,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE18828,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.18,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.42,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0005,European,,,,,F
5dc1809409d374f6dd7f5d96,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28x,P8Y8M,pgxind-kftx6295,pgxcs-kftwoddu,822224663,0.286,324739611,0.113,497485052,0.173,PGX_AM_BS_GSM466777,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.219000,geo:GSM466777,,1,6,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE18828,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0567,Afro-Caribbean,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,M
5dc1809409d374f6dd7f5d97,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk28y,P5Y,pgxind-kftx6297,pgxcs-kftwode6,576966866,0.201,306555400,0.107,270411466,0.094,PGX_AM_BS_GSM466778,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.220000,geo:GSM466778,,1,6.49,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE18828,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.02,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1809409d374f6dd7f5d98,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk290,P13Y4M,pgxind-kftx6299,pgxcs-kftwodeh,236742361,0.082,235131204,0.082,1611157,0.001,PGX_AM_BS_GSM466779,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.221000,geo:GSM466779,,1,4.92,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL6801,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE18828,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,F
5dc1809409d374f6dd7f5d99,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk292,P16Y6M,pgxind-kftx629b,pgxcs-kftwodet,754652047,0.262,441478789,0.154,313173258,0.109,PGX_AM_BS_GSM466780,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.222000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,10.26,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE18828,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL6801,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM466780,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.18,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,M
5dc1809409d374f6dd7f5d9a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffuse Intrinsic Pontine Glioma,NCIT:C4822,Malignant Glioma,icdom-93803,"Glioma, malignant",icdot-C71.7,brain stem,pgxbs-kftvk293,P12Y10M,pgxind-kftx629d,pgxcs-kftwodf5,570921482,0.199,294726785,0.103,276194697,0.096,PGX_AM_BS_GSM466781,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:46:29.223000,PMID:20142589,"Zarghooni M, Bartels U et al. (2010): Whole-genome profiling of pediatric diffuse intrinsic...",1,2.82,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE18828,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM466781,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0502,Vietnamese,0.4,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0009,East Asian,,,,,M
5bab56c2727983b2e00abdde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmy0,P30Y,pgxind-kftx2dwb,pgxcs-kftvnf65,126146815,0.044,89852975,0.031,36293840,0.013,PGX_AM_BS_Medblast-pfi-1M11,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.894000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,72,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abddf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmy2,P26Y,pgxind-kftx2dwd,pgxcs-kftvnf6m,8801652,0.003,7451397,0.003,1350255,0,PGX_AM_BS_Medblast-pfi-1M12,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.895000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,78,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmyc,P18Y,pgxind-kftx2dwp,pgxcs-kftvnf9e,22294740,0.008,18194736,0.006,4100004,0.001,PGX_AM_BS_Medblast-pfi-1M5,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.903000,geo:GSE8634,,0,96,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmyn,P35Y,pgxind-kftx2dx3,pgxcs-kftvnfcm,426551988,0.148,184358216,0.064,242193772,0.084,PGX_AM_BS_Medblast-pfi-2M8,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.914000,geo:GSE8634,,0,58,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abdf7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmz5,P52Y,pgxind-kftx2dxq,pgxcs-kftvnfhq,1092342899,0.38,372292987,0.129,720049912,0.25,PGX_AM_BS_MedBlast-pfi-5M2,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.930000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",0,58,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf7b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma [hemisphere],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgngq,P13Y,pgxind-kftx2ejp,pgxcs-kftvnksk,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-24,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.477000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf7c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma [hemisphere],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgngs,P7Y,pgxind-kftx2ejr,pgxcs-kftvnkt2,249087241,0.087,50791483,0.018,198295758,0.069,PGX_AM_BS_20192643_PB-far-25,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.478000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac91f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplatic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqkj,P3Y4M,pgxind-kftx2if5,pgxcs-kftvoip1,379492103,0.132,119346173,0.042,260145930,0.09,PGX_AM_BS_19270706_MBL-nor-MDT-MB-074,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.887000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,162,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac926,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqkv,P2Y7M,pgxind-kftx2ifk,pgxcs-kftvoise,158168340,0.055,71502806,0.025,86665534,0.03,PGX_AM_BS_19270706_MBL-nor-MDT-MB-100,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.897000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,63,,,M3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca32,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqx0,P17Y,pgxind-kftx2iun,pgxcs-kftvomm4,1290879093,0.449,873629126,0.304,417249967,0.145,PGX_AM_BS_MedBlast-pfi-1M7,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.269000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,83,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca3d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqxi,P3Y,pgxind-kftx2iv9,pgxcs-kftvomrg,253727084,0.088,36966443,0.013,216760641,0.075,PGX_AM_BS_MedBlast-pfi-2M20,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.285000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,68,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqxs,P5Y,pgxind-kftx2ivl,pgxcs-kftvomuc,233791410,0.081,94028814,0.033,139762596,0.049,PGX_AM_BS_MedBlast-pfi-2M9,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.293000,geo:GSE8634,,0,53,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca66,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqze,P2Y,pgxind-kftx2ixk,pgxcs-kftvonb5,21288344,0.007,21288344,0.007,0,0,PGX_AM_BS_MedBlast-pfi-M490,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.342000,geo:GSE8634,,0,87,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqzm,P1Y,pgxind-kftx2ixu,pgxcs-kftvondl,100337150,0.035,67991120,0.024,32346030,0.011,PGX_AM_BS_MedBlast-pfi-M528,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.349000,geo:GSE8634,,0,97,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca73,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqzz,P1Y,pgxind-kftx2iya,pgxcs-kftvonhg,5930260,0.002,0,0,5930260,0.002,PGX_AM_BS_MedBlast-pfi-M625,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.361000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,84,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acade,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr4s,P2Y7M,pgxind-kftx2j4d,pgxcs-kftvoozj,44400044,0.015,22100022,0.008,22300022,0.008,PGX_AM_BS_19197950_MB110.1389,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.511000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,84.2,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acae2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr4z,P1Y9M,pgxind-kftx2j4l,pgxcs-kftvop3n,0,0,0,0,0,0,PGX_AM_BS_19197950_MB114.1393,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.516000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,94,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaf1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr5n,P7Y2M,pgxind-kftx2j5g,pgxcs-kftvopar,21400021,0.007,16100016,0.006,5300005,0.002,PGX_AM_BS_19197950_MB129.5420,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.537000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,117,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acaf2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr5p,P2Y,pgxind-kftx2j5i,pgxcs-kftvopb9,31500032,0.011,31500032,0.011,0,0,PGX_AM_BS_19197950_MB130.5421,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.538000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,114.6,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb04,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr6i,P6Y11M,pgxind-kftx2j6i,pgxcs-kftvopjv,119372285,0.042,51797475,0.018,67574810,0.024,PGX_AM_BS_19197950_MB148.5889,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.562000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,9.7,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb16,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr7b,P1Y5M,pgxind-kftx2j7i,pgxcs-kftvopsi,0,0,0,0,0,0,PGX_AM_BS_19197950_MB69.717,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.587000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,177.7,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb18,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr7e,P3Y,pgxind-kftx2j7n,pgxcs-kftvoptg,226228101,0.079,0,0,226228101,0.079,PGX_AM_BS_19197950_MB71.719,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.590000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,159.4,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb21,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr7t,P8Y,pgxind-kftx2j85,pgxcs-kftvopxs,746174927,0.26,428887011,0.149,317287916,0.11,PGX_AM_BS_19197950_MB80.1277,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.602000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,67,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb23,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr7w,P3Y5M,pgxind-kftx2j89,pgxcs-kftvopyq,0,0,0,0,0,0,PGX_AM_BS_19197950_MB82.1280,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.605000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,73.9,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acb2d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr8c,P5Y10M,pgxind-kftx2j8t,pgxcs-kftvoq3j,96593526,0.034,0,0,96593526,0.034,PGX_AM_BS_19197950_MB93.1291,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.619000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,71.7,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad744,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv3q,P15Y,pgxind-kftx2o32,pgxcs-kftvpxcu,222372939,0.077,0,0,222372939,0.077,PGX_AM_BS_18056178_MB-lo-J1010,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.885000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,63,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad748,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv3w,P26Y,pgxind-kftx2o3a,pgxcs-kftvpxgn,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-J1019,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.891000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,25,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv4y,P1Y4M,pgxind-kftx2o4l,pgxcs-kftvpxrr,919507022,0.32,101689712,0.035,817817310,0.284,PGX_AM_BS_18056178_MB-lo-MD23,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.924000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,25,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad761,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv51,P6Y,pgxind-kftx2o4p,pgxcs-kftvpxss,567214516,0.197,348196851,0.121,219017665,0.076,PGX_AM_BS_18056178_MB-lo-MD28,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.927000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,35,,,T4M0,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad762,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv53,P2Y4M,pgxind-kftx2o4r,pgxcs-kftvpxta,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-MD35,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.928000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,45,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad765,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv58,P0Y7M,pgxind-kftx2o4x,pgxcs-kftvpxup,94625373,0.033,94625373,0.033,0,0,PGX_AM_BS_18056178_MB-lo-MD38,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.932000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,52,,,T3M1,NCITstage-C27970,Stage III,TNM-C48700,M1 Stage Finding,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad766,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv59,P3Y4M,pgxind-kftx2o4z,pgxcs-kftvpxv7,248995808,0.087,0,0,248995808,0.087,PGX_AM_BS_18056178_MB-lo-MD40,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.934000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,57,,,T4M3,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad76d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv5l,P2Y,pgxind-kftx2o5d,pgxcs-kftvpxyk,0,0,0,0,0,0,PGX_AM_BS_18056178_MB-lo-MD60,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.943000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,24,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addf2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgx96,P14Y,pgxind-kftx2qrh,pgxcs-kftvqlbt,0,0,0,0,0,0,PGX_AM_BS_MedBlFav_cli_12,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.264000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",0,45,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae172,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyov,P8Y6M,pgxind-kftx2s5r,pgxcs-kftvqxw6,165369626,0.058,22200022,0.008,143169604,0.05,PGX_AM_BS_MedBlast-deb-MB101,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.500000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,91,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae176,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyp2,P6Y8M,pgxind-kftx2s60,pgxcs-kftvqxy2,563593233,0.196,167338804,0.058,396254429,0.138,PGX_AM_BS_MedBlast-deb-MB1096,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.506000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae17f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyph,P2Y5M,pgxind-kftx2s6i,pgxcs-kftvqy2f,1351930348,0.47,493694630,0.172,858235718,0.299,PGX_AM_BS_MedBlast-deb-MB162,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.519000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae18e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyq6,P4Y10M,pgxind-kftx2s7d,pgxcs-kftvqy9m,413517945,0.144,120922094,0.042,292595851,0.102,PGX_AM_BS_MedBlast-deb-MB529,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.540000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,35,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae193,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyqf,P3Y5M,pgxind-kftx2s7n,pgxcs-kftvqye2,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB648,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.547000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae195,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyqi,P7Y4M,pgxind-kftx2s7r,pgxcs-kftvqyf2,1633608806,0.568,1010694166,0.352,622914640,0.217,PGX_AM_BS_MedBlast-deb-MB663,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.550000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,23,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae199,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyqo,P10Y2M,pgxind-kftx2s7z,pgxcs-kftvqyh1,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_MedBlast-deb-MB880,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.555000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,13,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae19f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyqy,P11Y10M,pgxind-kftx2s8b,pgxcs-kftvqyjy,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MM04,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.564000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,36,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1a6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyra,P2Y4M,pgxind-kftx2s8q,pgxcs-kftvqynb,288711465,0.1,133797556,0.047,154913909,0.054,PGX_AM_BS_MedBlast-deb-MM13,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.573000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,45,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1a7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyrb,P3Y4M,pgxind-kftx2s8s,pgxcs-kftvqyns,889198140,0.309,448708610,0.156,440489530,0.153,PGX_AM_BS_MedBlast-deb-MM14,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.575000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,57,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1ab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyri,P1Y4M,pgxind-kftx2s90,pgxcs-kftvqypp,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MM24,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.580000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,25,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1ad,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyrl,P6Y1M,pgxind-kftx2s94,pgxcs-kftvqyqn,1037620221,0.361,806123823,0.28,231496398,0.081,PGX_AM_BS_MedBlast-deb-MM33,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.583000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,35,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1b4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyrx,P0Y7M,pgxind-kftx2s9i,pgxcs-kftvqyu0,374506487,0.13,219592578,0.076,154913909,0.054,PGX_AM_BS_MedBlast-deb-MM43,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.593000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,52,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae1b7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgys2,P1Y10M,pgxind-kftx2s9o,pgxcs-kftvqyvg,163474905,0.057,163474905,0.057,0,0,PGX_AM_BS_MedBlast-deb-MM46,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.597000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,16,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af388,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic Medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvh4hp,P8Y,pgxind-kftx2zef,pgxcs-kftvsqli,515390220,0.179,242344059,0.084,273046161,0.095,PGX_AM_BS_MedBl-ton-M15,{},114.16,22.29,Point,CHN,Hong Kong,China,"Hong Kong, China",22.29,114.16,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:32.311000,PMID:14758948,"Tong CY, Hui AB et al. (2004): Detection of oncogene amplifications in medulloblastomas...",0,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b050c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, primary, stage M0]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvha3x,P11Y,pgxind-kftx36eq,pgxcs-kftvuhfz,597631943,0.208,134452519,0.047,463179424,0.161,PGX_AM_BS_11770900_MB-ebe-LCMbl-01A,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.500000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,55,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b050e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, primary, stage M0]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvha40,P26Y,pgxind-kftx36eu,pgxcs-kftvuhgx,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-02,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.503000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b050f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, primary, stage M0]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvha42,P2Y,pgxind-kftx36ew,pgxcs-kftvuhhe,0,0,0,0,0,0,PGX_AM_BS_11770900_MB-ebe-LCMbl-03,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.504000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,9,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0510,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, primary, stage M4]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvha44,P8Y,pgxind-kftx36ey,pgxcs-kftvuhhv,170029353,0.059,164986367,0.057,5042986,0.002,PGX_AM_BS_11770900_MB-ebe-LCMbl-04,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.506000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,15,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0511,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, primary, stage M3]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvha45,P15Y,pgxind-kftx36f0,pgxcs-kftvuhic,826293854,0.287,214407499,0.075,611886355,0.213,PGX_AM_BS_11770900_MB-ebe-LCMbl-05,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.507000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,37,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0ebf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhd80,P3Y,pgxind-kftx3aah,pgxcs-kftvvge4,519497529,0.181,469806047,0.163,49691482,0.017,PGX_AM_BS_11154805_MB-gil-10,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.934000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,84,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhd81,P0Y7M,pgxind-kftx3aaj,pgxcs-kftvvgel,0,0,0,0,0,0,PGX_AM_BS_11154805_MB-gil-1314,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.936000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,84,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0ec9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhd8g,P33Y,pgxind-kftx3ab1,pgxcs-kftvvgix,125085866,0.044,125085866,0.044,0,0,PGX_AM_BS_11154805_MB-gil-968,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.948000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",0,72,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b16ab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfs8,P5Y1M,pgxind-kftx3dg8,pgxcs-kftvw8z1,981841602,0.342,224566277,0.078,757275325,0.263,PGX_AM_BS_PNET-nic-19,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.738000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,76.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16ac,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsa,P11Y2M,pgxind-kftx3dga,pgxcs-kftvw8zi,1230937856,0.428,768291507,0.267,462646349,0.161,PGX_AM_BS_PNET-nic-20,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.740000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,15.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16ad,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsb,P5Y11M,pgxind-kftx3dgc,pgxcs-kftvw900,1103471317,0.384,545542147,0.19,557929170,0.194,PGX_AM_BS_PNET-nic-21,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.741000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,14.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16af,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsf,P12Y8M,pgxind-kftx3dgg,pgxcs-kftvw90y,1020619455,0.355,526258557,0.183,494360898,0.172,PGX_AM_BS_PNET-nic-23,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.744000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,97.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsg,P3Y7M,pgxind-kftx3dgi,pgxcs-kftvw91h,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-24,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.745000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,88.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsl,P22Y10M,pgxind-kftx3dgo,pgxcs-kftvw92x,211913966,0.074,211913966,0.074,0,0,PGX_AM_BS_PNET-nic-26,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.749000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,86.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsn,P7Y4M,pgxind-kftx3dgq,pgxcs-kftvw93f,1656047021,0.576,882138593,0.307,773908428,0.269,PGX_AM_BS_PNET-nic-27,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.751000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,15.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfst,P4Y,pgxind-kftx3dgy,pgxcs-kftvw95c,336690614,0.117,86594805,0.03,250095809,0.087,PGX_AM_BS_PNET-nic-31,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.756000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,10.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abde8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmyh,P47Y,pgxind-kftx2dwv,pgxcs-kftvnfas,0,0,0,0,0,0,PGX_AM_BS_Medblast-pfi-2M11,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.908000,geo:GSE8634,,1,64,,,M0,,,,,,,,,,,,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abdfd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgmzf,P34Y,pgxind-kftx2dy2,pgxcs-kftvnfkj,600253658,0.209,439069735,0.153,161183923,0.056,PGX_AM_BS_MedBlast-pfi-5M8,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.938000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,49,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf7d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma [hemisphere],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgngu,P8Y,pgxind-kftx2ejt,pgxcs-kftvnktk,1295040714,0.45,820728657,0.285,474312057,0.165,PGX_AM_BS_20192643_PB-far-26,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.480000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8dc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplatic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqhh,P2Y2M,pgxind-kftx2ibd,pgxcs-kftvohsw,0,0,0,0,0,0,PGX_AM_BS_19270706_MBL-nor-MDT-MB-006,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.794000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,33,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac920,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplatic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgqkl,P0Y7M,pgxind-kftx2if7,pgxcs-kftvoipj,18061033,0.006,17267487,0.006,793546,0,PGX_AM_BS_19270706_MBL-nor-MDT-MB-075,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.888000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,74,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca81,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr0m,P1Y,pgxind-kftx2iz3,pgxcs-kftvono5,605441965,0.211,17037774,0.006,588404191,0.205,PGX_AM_BS_MedBlast-pfi-M964,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.380000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,8,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acad9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr4k,P1Y,pgxind-kftx2j43,pgxcs-kftvoox6,158219006,0.055,94997518,0.033,63221488,0.022,PGX_AM_BS_19197950_MB105.1323,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.504000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,20.5,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acae5,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr54,P0Y3M,pgxind-kftx2j4r,pgxcs-kftvop52,0,0,0,0,0,0,PGX_AM_BS_19197950_MB117.1398,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.520000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,0.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acaeb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [desmoplastic/nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgr5d,P3Y1M,pgxind-kftx2j53,pgxcs-kftvop7x,666418612,0.232,167238804,0.058,499179808,0.174,PGX_AM_BS_19197950_MB123.1442,,2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.529000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,13.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad75e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [Desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgv4x,P11Y5M,pgxind-kftx2o4j,pgxcs-kftvpxra,109512752,0.038,51800051,0.018,57712701,0.02,PGX_AM_BS_18056178_MB-lo-MD16,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.923000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,39,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00addeb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgx8u,P1Y5M,pgxind-kftx2qr3,pgxcs-kftvql8h,0,0,0,0,0,0,PGX_AM_BS_MedBlFav_cli_05,{},-1.61,54.97,Point,GBR,Newcastle upon Tyne,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97,-1.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:24.255000,PMID:17172831,"Clifford SC, Lusher ME et al. (2006): Wnt/Wingless pathway activation and chromosome 6...",1,24,,,M0M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae17e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, with ganglionic differentiation]",NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgypf,P1Y,pgxind-kftx2s6g,pgxcs-kftvqy1x,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB142,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.517000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,4,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae180,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgypj,P1Y7M,pgxind-kftx2s6k,pgxcs-kftvqy2w,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB164,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.520000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,48,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae188,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgypw,P6Y6M,pgxind-kftx2s70,pgxcs-kftvqy6q,420812122,0.146,197394914,0.069,223417208,0.078,PGX_AM_BS_MedBlast-deb-MB338,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.531000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,35,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae18f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [nodular],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyq8,P10Y4M,pgxind-kftx2s7f,pgxcs-kftvqya3,181613840,0.063,67400067,0.023,114213773,0.04,PGX_AM_BS_MedBlast-deb-MB547,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.541000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,5,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae1a1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvgyr1,P11Y5M,pgxind-kftx2s8f,pgxcs-kftvqykw,412058604,0.143,86594805,0.03,325463799,0.113,PGX_AM_BS_MedBlast-deb-MM07,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.566000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,39,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0ec4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhd88,P8Y,pgxind-kftx3aar,pgxcs-kftvvggi,567847197,0.198,503472391,0.175,64374806,0.022,PGX_AM_BS_11154805_MB-gil-309,,5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.941000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",1,24,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0ec6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhd8b,P13Y,pgxind-kftx3aav,pgxcs-kftvvghg,333825172,0.116,119724958,0.042,214100214,0.074,PGX_AM_BS_11154805_MB-gil-616,,5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:41.944000,PMID:11154805,"Gilhuis HJ, Anderl KL et al. (2000): Comparative genomic hybridization of medulloblastomas and...",1,36,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b16aa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfs6,P9Y4M,pgxind-kftx3dg6,pgxcs-kftvw8yj,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-18,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.737000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,9.6,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16ae,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsd,P5Y4M,pgxind-kftx3dge,pgxcs-kftvw90h,425816959,0.148,129415169,0.045,296401790,0.103,PGX_AM_BS_PNET-nic-22,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.742000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,1.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsi,P19Y7M,pgxind-kftx3dgk,pgxcs-kftvw91y,163823140,0.057,57227473,0.02,106595667,0.037,PGX_AM_BS_PNET-nic-25,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.747000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,54,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsj,P19Y7M,pgxind-kftx3dgm,pgxcs-kftvw92g,153495713,0.053,46900046,0.016,106595667,0.037,PGX_AM_BS_PNET-nic-25r1,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.748000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,54,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfso,P30Y4M,pgxind-kftx3dgs,pgxcs-kftvw93w,106330789,0.037,70994789,0.025,35336000,0.012,PGX_AM_BS_PNET-nic-28,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.752000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,28.8,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfsq,P25Y7M,pgxind-kftx3dgu,pgxcs-kftvw94d,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-29,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.754000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,76.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvhfss,P27Y11M,pgxind-kftx3dgw,pgxcs-kftvw94v,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-30,,-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.755000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,67.2,,,T4M4,NCITstage-C27971,Stage IV,TNM-C48732,T4 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5c86608309d374f2dc37d97b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Medulloblastoma [desmoplastic],NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvis6t,P15Y2M,pgxind-kftx4ips,pgxcs-kftwb4kq,0,0,0,0,0,0,PGX_AM_BS_MedBlast-lo-MD16,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.044000,PMID:17044047,"Lo KC, Rossi MR et al. (2007): Overlay analysis of the oligonucleotide array...",1,39,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc184fb09d374f6dd84bf6b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9m9,P10Y,pgxind-kftx6blw,pgxcs-kftwpzsv,81283830,0.028,17155319,0.006,64128511,0.022,PGX_AM_BS_GSM213846,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.493000,geo:GPL5685,,1,22,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,geo:gsm,geo:GSM213846,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf73,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9ml,P5Y,pgxind-kftx6bmc,pgxcs-kftwpzvd,241051782,0.084,178058914,0.062,62992868,0.022,PGX_AM_BS_GSM213854,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.501000,geo:GSE8634,,1,3,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,geo:gsm,geo:GSM213854,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf78,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9mt,P18Y,pgxind-kftx6bmm,pgxcs-kftwpzwx,521312682,0.181,236541787,0.082,284770895,0.099,PGX_AM_BS_GSM213859,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.506000,geo:GSM213859,,1,43,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf82,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,nodular/desmoplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9na,P47Y,pgxind-kftx6bn7,pgxcs-kftwq002,742109,0,742109,0,0,0,PGX_AM_BS_GSM213869,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.517000,geo:GSE8634,,1,64,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,geo:gsm,geo:GSM213869,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfa6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9ox,P1Y,pgxind-kftx6bp8,pgxcs-kftwq0bc,79237579,0.028,17722167,0.006,61515412,0.021,PGX_AM_BS_GSM213905,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.556000,geo:GPL5685,,1,8,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,geo:gsm,geo:GSM213905,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bfc8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma,NCIT:C4956,Desmoplastic/Nodular Medulloblastoma,icdom-94713,Desmoplastic nodular medulloblastoma,icdot-C71.6,cerebellum,pgxbs-kftvk9qg,P34Y,pgxind-kftx6br4,pgxcs-kftwpzo7,598973428,0.208,444334783,0.155,154638645,0.054,PGX_AM_BS_20479417_MedBlast-pfi-5M8,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.591000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,49,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00b0376,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9lq,P0Y2M,pgxind-kftx35rw,pgxcs-kftvubq6,1661824947,0.578,1126702401,0.392,535122546,0.186,PGX_AM_BS_ChorPlex-01,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.939000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,24,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0377,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9ls,P0Y4M,pgxind-kftx35ry,pgxcs-kftvubqo,0,0,0,0,0,0,PGX_AM_BS_ChorPlex-02,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.941000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,14,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0378,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9lt,P0Y7M,pgxind-kftx35s0,pgxcs-kftvubr5,570107588,0.198,133797556,0.047,436310032,0.152,PGX_AM_BS_ChorPlex-03,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.942000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,57,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0379,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9lv,P0Y10M,pgxind-kftx35s2,pgxcs-kftvubrm,1552539410,0.54,940364177,0.327,612175233,0.213,PGX_AM_BS_ChorPlex-04,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.944000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,14,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b037a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9lw,P0Y11M,pgxind-kftx35s4,pgxcs-kftvubs4,1265063983,0.44,502899464,0.175,762164519,0.265,PGX_AM_BS_ChorPlex-05,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.945000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,70,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b037b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9ly,P1Y,pgxind-kftx35s6,pgxcs-kftvubsm,888764973,0.309,710264795,0.247,178500178,0.062,PGX_AM_BS_ChorPlex-06,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.947000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,12,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b037c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m0,P1Y11M,pgxind-kftx35s8,pgxcs-kftvubt3,741124399,0.258,250463848,0.087,490660551,0.171,PGX_AM_BS_ChorPlex-07,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.948000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,20,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b037d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m1,P11Y,pgxind-kftx35sa,pgxcs-kftvubtl,779286690,0.271,34410018,0.012,744876672,0.259,PGX_AM_BS_ChorPlex-08,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.950000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,42,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b037e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m3,P11Y,pgxind-kftx35sc,pgxcs-kftvubu3,795981572,0.277,218664854,0.076,577316718,0.201,PGX_AM_BS_ChorPlex-09,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.951000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,37,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b037f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m4,P12Y,pgxind-kftx35se,pgxcs-kftvubuk,1435660200,0.499,430236394,0.15,1005423806,0.35,PGX_AM_BS_ChorPlex-10,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.952000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,20,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0380,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m6,P12Y,pgxind-kftx35sg,pgxcs-kftvubv2,753782669,0.262,34410018,0.012,719372651,0.25,PGX_AM_BS_ChorPlex-11,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.954000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,97,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0381,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m8,P12Y,pgxind-kftx35si,pgxcs-kftvubvj,0,0,0,0,0,0,PGX_AM_BS_ChorPlex-12,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.955000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,124,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0382,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9m9,P23Y,pgxind-kftx35sk,pgxcs-kftvubw0,748271336,0.26,375991328,0.131,372280008,0.129,PGX_AM_BS_ChorPlex-13,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.957000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,36,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0383,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mb,P25Y,pgxind-kftx35sm,pgxcs-kftvubwi,589057977,0.205,332093314,0.116,256964663,0.089,PGX_AM_BS_ChorPlex-14,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.958000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,89,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0384,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9md,P26Y,pgxind-kftx35so,pgxcs-kftvubwz,225397008,0.078,0,0,225397008,0.078,PGX_AM_BS_ChorPlex-15,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.959000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,72,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0385,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mf,P27Y,pgxind-kftx35sq,pgxcs-kftvubxh,996017705,0.346,554467032,0.193,441550673,0.154,PGX_AM_BS_ChorPlex-16,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.961000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,7,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0386,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mg,P29Y,pgxind-kftx35ss,pgxcs-kftvubxz,867095972,0.302,373582759,0.13,493513213,0.172,PGX_AM_BS_ChorPlex-17,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.962000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,44,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0387,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mi,P31Y,pgxind-kftx35su,pgxcs-kftvubyg,405891181,0.141,278291054,0.097,127600127,0.044,PGX_AM_BS_ChorPlex-19,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.963000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,20,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0388,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mj,P34Y,pgxind-kftx35sw,pgxcs-kftvubyx,576963954,0.201,37891471,0.013,539072483,0.188,PGX_AM_BS_ChorPlex-20,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.965000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,29,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b038a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mn,P37Y,pgxind-kftx35sz,pgxcs-kftvubzv,908333298,0.316,254887751,0.089,653445547,0.227,PGX_AM_BS_ChorPlex-22,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.967000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,36,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b038b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mo,P38Y,pgxind-kftx35t1,pgxcs-kftvuc0d,533845439,0.186,37891471,0.013,495953968,0.173,PGX_AM_BS_ChorPlex-23,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.969000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,24,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b038c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mq,P39Y,pgxind-kftx35t3,pgxcs-kftvuc0u,742582103,0.258,296867722,0.103,445714381,0.155,PGX_AM_BS_ChorPlex-24,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.970000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,42,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b038d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mr,P44Y,pgxind-kftx35t5,pgxcs-kftvuc1b,390916532,0.136,0,0,390916532,0.136,PGX_AM_BS_ChorPlex-25,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.972000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,69,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b038e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mt,P44Y,pgxind-kftx35t7,pgxcs-kftvuc1t,415578972,0.145,34410018,0.012,381168954,0.133,PGX_AM_BS_ChorPlex-26,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.973000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,50,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b038f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mv,P46Y,pgxind-kftx35ta,pgxcs-kftvuc2a,768307225,0.267,342467884,0.119,425839341,0.148,PGX_AM_BS_ChorPlex-27,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.974000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,17,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0390,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9mw,P58Y,pgxind-kftx35tc,pgxcs-kftvuc2r,767085149,0.267,541184923,0.188,225900226,0.079,PGX_AM_BS_ChorPlex-29,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.976000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,132,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0391,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9my,P59Y,pgxind-kftx35te,pgxcs-kftvuc39,1185064156,0.412,678572487,0.236,506491669,0.176,PGX_AM_BS_ChorPlex-30,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.977000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,36,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0392,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9n0,P62Y,pgxind-kftx35tg,pgxcs-kftvuc3q,838895226,0.292,159189014,0.055,679706212,0.236,PGX_AM_BS_ChorPlex-31,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.979000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,48,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00b0393,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9n1,P66Y,pgxind-kftx35ti,pgxcs-kftvuc48,693785715,0.241,144763743,0.05,549021972,0.191,PGX_AM_BS_ChorPlex-32,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.980000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,25,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0394,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9n3,P71Y,pgxind-kftx35tk,pgxcs-kftvuc4q,574946786,0.2,25391458,0.009,549555328,0.191,PGX_AM_BS_ChorPlex-33,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.982000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,127,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0395,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9n4,P73Y,pgxind-kftx35tm,pgxcs-kftvuc57,251566426,0.088,92566268,0.032,159000158,0.055,PGX_AM_BS_ChorPlex-34,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.983000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",0,43,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00b0389,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Choroid plexus papilloma [grade 1],NCIT:C53686,Atypical Choroid Plexus Papilloma,icdom-93901,Atypical choroid plexus papilloma,icdot-C71.5,ventricle,pgxbs-kftvh9ml,P36Y,pgxind-kftx35sx,pgxcs-kftvubze,697332192,0.243,59801476,0.021,637530716,0.222,PGX_AM_BS_ChorPlex-21,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,,2020-09-10 17:44:37.966000,PMID:11891207,"Rickert CH, Wiestler OD et al. (2002) Chromosomal imbalances in choroid plexus tumors.",1,132,NCITgrade-C28077,Grade 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00acc6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Central nervous system primitive neuroectodermal tumor [ETANTR],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgrmq,P2Y,pgxind-kftx2jqr,pgxcs-kftvoulk,345711492,0.12,89017706,0.031,256693786,0.089,PGX_AM_BS_19057917_PNET-pfi-01,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:18.060000,PMID:19057917,"Pfister S, Remke M et al. (2009): Novel genomic amplification targeting the microRNA...",0,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae327,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgz8q,P17Y6M,pgxind-kftx2sub,pgxcs-kftvr3z7,329136070,0.114,104402351,0.036,224733719,0.078,PGX_AM_BS_MedBlast-mcc-PM03,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.496000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",0,126,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae338,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgz9h,P3Y4M,pgxind-kftx2sva,pgxcs-kftvr47f,565178513,0.197,565178513,0.197,0,0,PGX_AM_BS_MedBlast-mcc-PM21,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.520000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",0,114,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae343,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgz9z,P8Y2M,pgxind-kftx2svv,pgxcs-kftvr4cq,134022267,0.047,134022267,0.047,0,0,PGX_AM_BS_MedBlast-mcc-PM36,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.535000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",0,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae347,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgza6,P2Y8M,pgxind-kftx2sw2,pgxcs-kftvr4en,124172066,0.043,124172066,0.043,0,0,PGX_AM_BS_MedBlast-mcc-PM42,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.540000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",0,169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae34e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgzah,P2Y11M,pgxind-kftx2swg,pgxcs-kftvr4k7,0,0,0,0,0,0,PGX_AM_BS_MedBlast-mcc-PM55,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.550000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",0,148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16b9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ganglioneuroblastoma,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvhfsv,P11Y11M,pgxind-kftx3dh0,pgxcs-kftvw95u,78774821,0.027,22200022,0.008,56574799,0.02,PGX_AM_BS_PNET-nic-32,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.758000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,123.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16bc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvhft0,P2Y7M,pgxind-kftx3dh7,pgxcs-kftvw97a,1123412970,0.391,738127687,0.257,385285283,0.134,PGX_AM_BS_PNET-nic-35,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.762000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",0,68.4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16ed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive Neuroectodermal Tumor [infratentorial],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvhfv9,P31Y,pgxind-kftx3djx,pgxcs-kftvw9x8,194770203,0.068,123631494,0.043,71138709,0.025,PGX_AM_BS_PNET-rus-S-3-SF1729,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.829000,PMID:10421270,"Russo C, Pellarin M et al. (1999): Comparative genomic hybridization in patients with...",0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae337,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgz9g,P23Y1M,pgxind-kftx2sv8,pgxcs-kftvr46y,389844228,0.136,3391202,0.001,386453026,0.134,PGX_AM_BS_MedBlast-mcc-PM20,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.519000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c7727983b2e00ae34b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor [non-pineal],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvgzac,P3Y2M,pgxind-kftx2swa,pgxcs-kftvr4gk,482968439,0.168,39574733,0.014,443393706,0.154,PGX_AM_BS_MedBlast-mcc-PM51,{},0.12,52.21,Point,GBR,Cambridge UK,United Kingdom,"Cambridge UK, United Kingdom",52.21,0.12,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:26.546000,PMID:16783165,"McCabe MG, Ichimura K et al. (2006): High-resolution array-based comparative genomic hybridization of...",1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16bb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvhfsy,P8Y4M,pgxind-kftx3dh5,pgxcs-kftvw96s,2166444113,0.754,1229096990,0.428,937347123,0.326,PGX_AM_BS_PNET-nic-34,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.760000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,7.2,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16bd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvhft2,P6Y5M,pgxind-kftx3dh9,pgxcs-kftvw97s,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-36,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.763000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ce727983b2e00b16be,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvhft3,P1Y1M,pgxind-kftx3dhb,pgxcs-kftvw989,0,0,0,0,0,0,PGX_AM_BS_PNET-nic-37,{},-1.8,51.07,Point,GBR,Salisbury,United Kingdom,"Salisbury, United Kingdom",51.07,-1.8,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:44.765000,PMID:10424732,"Nicholson JC, Ross FM et al. (1999): Comparative genomic hybridization and histological variation...",1,9.6,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5c09067d727983923bb262e8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"brain, nos",pgxbs-khv36qt0,P5Y10M,pgxind-khv36qtg,pgxcs-khv36qtj,395095579,0.13,285457595,0.094,109637984,0.036,PGX_AM_BS_AM20130503HAW-01T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:06.687000,geogpl-GPL6801,,1,0.34,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5c09067d727983923bb262e9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"brain, nos",pgxbs-khv36qvn,,pgxind-khv36qw5,pgxcs-khv36qw8,30365213,0.01,21118964,0.007,9246249,0.003,PGX_AM_BS_AM20130503HAW-02T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:06.743000,geogpl-GPL6801,,1,0.03,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5dc1805d09d374f6dd7f33bc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [medulloepithelioma],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1t3,P9Y2M,pgxind-kftx61ps,pgxcs-kftwo9ny,352438520,0.123,352256884,0.123,181636,0,PGX_AM_BS_GSM353435,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.808000,geo:GSM353435,,1,16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.02,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33bd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1t5,P4Y10M,pgxind-kftx61pu,pgxcs-kftwo9oc,608143471,0.212,163589156,0.057,444554315,0.155,PGX_AM_BS_GSM353436,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.810000,geo:GSM353436,,1,6,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f33be,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1t6,P20Y4M,pgxind-kftx61pw,pgxcs-kftwo9or,559997532,0.195,347024188,0.121,212973344,0.074,PGX_AM_BS_GSM353437,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.811000,geo:GSM353437,,1,9,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.08,SNP2pop 1000 Genomes population,HANCESTRO:0567,Afro-Caribbean,0.28,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f33bf,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1t8,P7Y8M,pgxind-kftx61py,pgxcs-kftwo9p5,8702188,0.003,3601340,0.001,5100848,0.002,PGX_AM_BS_GSM353438,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.812000,geo:GSM353438,,1,7,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.8,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f33c7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1tm,P1Y,pgxind-kftx61qe,pgxcs-kftwo9s9,471170561,0.164,36524683,0.013,434645878,0.151,PGX_AM_BS_GSM353446,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.822000,geo:GPL3718,,1,0.03,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353446,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f33ca,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1tr,P8Y8M,pgxind-kftx61qk,pgxcs-kftwo9th,109325097,0.038,37817357,0.013,71507740,0.025,PGX_AM_BS_GSM353449,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.826000,geo:GSM353449,,1,16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.14,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f33cb,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ts,P3Y,pgxind-kftx61qm,pgxcs-kftwo9tv,34493087,0.012,29250496,0.01,5242591,0.002,PGX_AM_BS_GSM353450,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.827000,geo:GSM353450,,1,1,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.44,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.44,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f33cc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1tu,P11Y,pgxind-kftx61qo,pgxcs-kftwo9u9,653509722,0.227,155510612,0.054,497999110,0.173,PGX_AM_BS_GSM353451,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.829000,geo:GSM353451,,1,12,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0005,European,0.22,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0005,European,,,,,
5dc1805d09d374f6dd7f33cd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1tv,P15Y8M,pgxind-kftx61qq,pgxcs-kftwo9uo,561154702,0.195,450787545,0.157,110367157,0.038,PGX_AM_BS_GSM353452,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.830000,geo:GSM353452,,1,24,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3718,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0567,Afro-Caribbean,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f33d6,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ub,P5Y10M,pgxind-kftx61r9,pgxcs-kftwo9y9,308214466,0.107,40239888,0.014,267974578,0.093,PGX_AM_BS_GSM353461,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.841000,geo:GPL3718,,1,5,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353461,,,,,0.26,SNP2pop 1000 Genomes population,HANCESTRO:0415,Mexican,0.88,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,F
5dc1805d09d374f6dd7f33d7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ud,P7Y,pgxind-kftx61rb,pgxcs-kftwo9yo,716130682,0.249,493776061,0.172,222354621,0.077,PGX_AM_BS_GSM353462,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.842000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,0.06,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353462,,,,,0.26,SNP2pop 1000 Genomes population,HANCESTRO:0415,Mexican,0.88,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,M
5dc1805d09d374f6dd7f33d8,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1uf,P15Y8M,pgxind-kftx61rd,pgxcs-kftwo9z2,443558641,0.154,199747701,0.069,243810940,0.085,PGX_AM_BS_GSM353463,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.843000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,57,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353463,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33d9,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ug,P4Y8M,pgxind-kftx61rf,pgxcs-kftwo9zg,563870460,0.196,73363434,0.026,490507026,0.171,PGX_AM_BS_GSM353464,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.844000,geo:GPL3718,,1,10,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353464,,,,,0.64,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.92,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,F
5dc1805d09d374f6dd7f33da,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ui,P6Y,pgxind-kftx61rh,pgxcs-kftwo9zu,557636448,0.194,311081448,0.108,246555000,0.086,PGX_AM_BS_GSM353465,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.846000,geo:GSM353465,,1,10,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33db,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1uk,P11Y,pgxind-kftx61rj,pgxcs-kftwoa08,69321511,0.024,69216444,0.024,105067,0,PGX_AM_BS_GSM353466,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.847000,geo:GSM353466,,1,21,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0567,Afro-Caribbean,0.06,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33dc,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1um,P23Y2M,pgxind-kftx61rl,pgxcs-kftwoa0m,2771885211,0.964,1754663173,0.61,1017222038,0.354,PGX_AM_BS_GSM353467,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.848000,geo:GSM353467,,1,23,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3718,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33dd,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1un,P2Y10M,pgxind-kftx61rn,pgxcs-kftwoa10,548949460,0.191,289909458,0.101,259040002,0.09,PGX_AM_BS_GSM353468,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.850000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,3,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353468,,,,,0.76,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,1,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33df,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ur,P1Y,pgxind-kftx61rs,pgxcs-kftwoa1s,83215808,0.029,82078627,0.029,1137181,0,PGX_AM_BS_GSM353470,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.852000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,28,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3718,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM353470,,,,,0.1,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.02,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f33ff,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [medulloepithelioma],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1w9,P9Y2M,pgxind-kftx61tk,pgxcs-kftwoae6,364995334,0.127,351767578,0.122,13227756,0.005,PGX_AM_BS_GSM372832,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.891000,geo:GSM372832,,1,16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.16,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.18,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f3400,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wa,P4Y10M,pgxind-kftx61tm,pgxcs-kftwoaek,619816141,0.216,173873520,0.06,445942621,0.155,PGX_AM_BS_GSM372833,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.892000,geo:GSM372833,,1,6,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f3401,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wc,P20Y4M,pgxind-kftx61to,pgxcs-kftwoaey,571122104,0.199,349867864,0.122,221254240,0.077,PGX_AM_BS_GSM372834,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.894000,geo:GSE14087,,1,9,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gse,,,,,,,,,,arraymap import,,,geo:gpl,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372834,,,,,0.26,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.32,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f3402,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1we,P7Y8M,pgxind-kftx61tq,pgxcs-kftwoafc,10987390,0.004,7876621,0.003,3110769,0.001,PGX_AM_BS_GSM372835,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.895000,geo:GSM372835,,1,7,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.5,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.44,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,F
5dc1805d09d374f6dd7f3403,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wf,P7Y,pgxind-kftx61ts,pgxcs-kftwoaor,713815040,0.248,442754618,0.154,271060422,0.094,PGX_AM_BS_GSM372859,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.896000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,0.06,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372859,,,,,0.26,SNP2pop 1000 Genomes population,HANCESTRO:0415,Mexican,0.72,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,M
5dc1805d09d374f6dd7f340a,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wr,P1Y,pgxind-kftx61u6,pgxcs-kftwoaif,480920310,0.167,22578717,0.008,458341593,0.159,PGX_AM_BS_GSM372843,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.905000,geo:GSM372843,,1,0.03,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",,,,0.26,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.3,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f340d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1ww,P8Y8M,pgxind-kftx61uc,pgxcs-kftwoajm,105168958,0.037,38240995,0.013,66927963,0.023,PGX_AM_BS_GSM372846,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.908000,geo:GSM372846,,1,16,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3720,,,,,0.3,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.34,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f340e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wx,P3Y,pgxind-kftx61ue,pgxcs-kftwoak1,34443940,0.012,29385446,0.01,5058494,0.002,PGX_AM_BS_GSM372847,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.910000,geo:GSM372847,,1,1,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3720,,,,,0.24,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.26,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f340f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1wz,P11Y,pgxind-kftx61ug,pgxcs-kftwoakf,655875127,0.228,151733099,0.053,504142028,0.175,PGX_AM_BS_GSM372848,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.911000,geo:GSM372848,,1,12,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3720,,,,,0.22,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.36,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f3410,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1x1,P15Y8M,pgxind-kftx61ui,pgxcs-kftwoakt,579617998,0.202,451629054,0.157,127988944,0.045,PGX_AM_BS_GSM372849,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.912000,geo:GSM372849,,1,24,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3720,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.18,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,
5dc1805d09d374f6dd7f3419,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor [ependymal or ependymoblastic differentiation],NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xg,P5Y10M,pgxind-kftx61v0,pgxcs-kftwoaod,367174655,0.128,93585421,0.033,273589234,0.095,PGX_AM_BS_GSM372858,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.923000,geo:GPL3720,,1,5,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372858,,,,,0.2,SNP2pop 1000 Genomes population,HANCESTRO:0415,Mexican,0.76,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,F
5dc1805d09d374f6dd7f341b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xj,P15Y8M,pgxind-kftx61v5,pgxcs-kftwoap5,434985220,0.151,190622573,0.066,244362647,0.085,PGX_AM_BS_GSM372860,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.926000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,57,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GPL3720,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372860,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.2,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f341c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xl,P4Y8M,pgxind-kftx61v7,pgxcs-kftwoapj,584016378,0.203,96486198,0.034,487530180,0.17,PGX_AM_BS_GSM372861,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.927000,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",1,10,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,pubmed,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372861,,,,,0.42,SNP2pop 1000 Genomes population,HANCESTRO:0421,Puerto Rican,0.8,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0014,Hispanic or Latin American,,,,,F
5dc1805d09d374f6dd7f341d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xm,P6Y,pgxind-kftx61v9,pgxcs-kftwoapx,540870095,0.188,289315332,0.101,251554763,0.087,PGX_AM_BS_GSM372862,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.928000,geo:GSM372862,,1,10,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0.06,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.14,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f341e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xo,P11Y,pgxind-kftx61vb,pgxcs-kftwoat1,67320983,0.023,67320983,0.023,0,0,PGX_AM_BS_GSM372863,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.930000,geo:GSM372863,,1,21,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE14087,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gpl,geo:GPL3720,,,,,0.04,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.12,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f341f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xp,P23Y2M,pgxind-kftx61vd,pgxcs-kftwoatg,2770956416,0.964,1754312315,0.61,1016644101,0.354,PGX_AM_BS_GSM372864,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.931000,geo:GSM372864,,1,23,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0.12,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.22,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f3420,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xr,P2Y10M,pgxind-kftx61vf,pgxcs-kftwoatv,546157005,0.19,287134517,0.1,259022488,0.09,PGX_AM_BS_GSM372865,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.932000,geo:GPL3720,,1,3,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,geo:GSE14087,,geo:gpl,,,,,,,,,,arraymap import,,,geo:gse,pubmed,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gsm,geo:GSM372865,,,,,0.68,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.9,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5dc1805d09d374f6dd7f3422,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Primitive neuroectodermal tumor,NCIT:C5398,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",icdom-94733,"Primitive neuroectodermal tumor, NOS",icdot-C71.9,"Brain, NOS",pgxbs-kftvk1xv,P1Y,pgxind-kftx61vj,pgxcs-kftwoauo,41184455,0.014,40432739,0.014,751716,0,PGX_AM_BS_GSM372867,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:46:28.935000,geo:GSM372867,,1,28,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,PMID:19962671,"Li M, Lee KF, Lu Y et al. (2009): Frequent amplification of a chr19q13.41 microRNA...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gpl,geo:GPL3720,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,geo:gse,geo:GSE14087,,,,,0.02,SNP2pop 1000 Genomes population,HANCESTRO:0568,African American,0.08,SNP2pop 1000 Genomes superpopulation,HANCESTRO:0010,African,,,,,M
5bab56c0727983b2e00aacd6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [fronto-temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfk,P43Y,pgxind-kftx277d,pgxcs-kftvlrsk,0,0,0,0,0,0,PGX_AM_BS_9403731_AC-sal-01,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.698000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aacd8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfo,P38Y,pgxind-kftx277h,pgxcs-kftvlrth,186835366,0.065,0,0,186835366,0.065,PGX_AM_BS_9403731_AC-sal-03,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.701000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",0,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacd9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfq,P13Y,pgxind-kftx277j,pgxcs-kftvlrty,74500073,0.026,0,0,74500073,0.026,PGX_AM_BS_9403731_AC-sal-04,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.702000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aacda,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [cerebellar],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvghfr,P3Y,pgxind-kftx277k,pgxcs-kftvlruf,235313989,0.082,0,0,235313989,0.082,PGX_AM_BS_9403731_AC-sal-05,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:06.704000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",0,73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacdb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghft,P26Y,pgxind-kftx277m,pgxcs-kftvlruv,302305489,0.105,92391525,0.032,209913964,0.073,PGX_AM_BS_9403731_AC-sal-06,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.705000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",0,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgnfz,P13Y,pgxind-kftx2eir,pgxcs-kftvnkkf,118700119,0.041,88600089,0.031,30100030,0.01,PGX_AM_BS_20192643_PB-far-07,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.453000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [vermis],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgng0,P9Y,pgxind-kftx2eit,pgxcs-kftvnkkw,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-08,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.454000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [thalamus],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvgng2,P6Y,pgxind-kftx2eiv,pgxcs-kftvnkle,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-09,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:13.456000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [vermis],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgng3,P6Y,pgxind-kftx2eix,pgxcs-kftvnklw,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-10,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.457000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abf6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [vermis],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgng5,P3Y,pgxind-kftx2eiz,pgxcs-kftvnkmd,86597509,0.03,49700050,0.017,36897459,0.013,PGX_AM_BS_20192643_PB-far-11,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:13.458000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c2727983b2e00abf6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [3rd ventricle],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.5,ventricle,pgxbs-kftvgng7,P3Y,pgxind-kftx2ej1,pgxcs-kftvnkmu,0,0,0,0,0,0,PGX_AM_BS_20192643_PB-far-12,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002082,cardiac ventricle,{},2020-09-10 17:44:13.460000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3a8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse astrocytoma [supratentorial],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgote,P11Y,pgxind-kftx2g82,pgxcs-kftvnze7,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN1145,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.957000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac3c5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,subependymal giant cell astrocytoma [supratentorial],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.0,cerebrum,pgxbs-kftvgoup,P4Y6M,pgxind-kftx2g9q,pgxcs-kftvnzrr,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN2596,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:14.996000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3d4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,pilomyxoid astrocytoma [infratentorial],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgove,P0Y9M,pgxind-kftx2gak,pgxcs-kftvnzyq,0,0,0,0,0,0,PGX_AM_BS_20052518_PA-war-IN3066,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.017000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",0,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaea,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Parietal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6ur,P20Y,pgxind-kftx32cc,pgxcs-kftvth0p,514566374,0.179,217349936,0.076,297216438,0.103,PGX_AM_BS_AstrCyt-II-A-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.921000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,146,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afaec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6uv,P25Y,pgxind-kftx32cg,pgxcs-kftvth1n,181121605,0.063,59500059,0.021,121621546,0.042,PGX_AM_BS_AstrCyt-II-A-05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.924000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,38,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afaed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6uw,P30Y,pgxind-kftx32ci,pgxcs-kftvth25,431574239,0.15,143500142,0.05,288074097,0.1,PGX_AM_BS_AstrCyt-II-A-06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.925000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,88,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afaee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6uy,P30Y,pgxind-kftx32ck,pgxcs-kftvth2m,128221552,0.045,0,0,128221552,0.045,PGX_AM_BS_AstrCyt-II-A-07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.927000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,3,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, pariatal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6v3,P46Y,pgxind-kftx32cq,pgxcs-kftvth41,294935473,0.103,154913909,0.054,140021564,0.049,PGX_AM_BS_AstrCyt-II-A-10,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.931000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,134,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afaf3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6v6,P55Y,pgxind-kftx32cu,pgxcs-kftvth50,179509853,0.062,11493542,0.004,168016311,0.058,PGX_AM_BS_AstrCyt-II-A-12,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.933000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,49,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afaf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6v8,P23Y,pgxind-kftx32cw,pgxcs-kftvth5h,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_AstrCyt-II-A-13,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.935000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,79,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6v9,P33Y,pgxind-kftx32cy,pgxcs-kftvth5y,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_AstrCyt-II-A-14,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.936000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,109,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vb,P33Y,pgxind-kftx32d0,pgxcs-kftvth6i,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_AstrCyt-II-B-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.937000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,22,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6ve,P41Y,pgxind-kftx32d4,pgxcs-kftvth7h,154417771,0.054,154417771,0.054,0,0,PGX_AM_BS_AstrCyt-II-B-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.940000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,20,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afaf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vg,P66Y,pgxind-kftx32d6,pgxcs-kftvth7z,245186448,0.085,245186448,0.085,0,0,PGX_AM_BS_AstrCyt-II-B-04,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.942000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,16,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afafd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Recurrent, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vn,P32Y,pgxind-kftx32de,pgxcs-kftvth9v,187814744,0.065,187814744,0.065,0,0,PGX_AM_BS_AstrCyt-II-C-02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.947000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,25,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afafe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vp,P33Y,pgxind-kftx32dg,pgxcs-kftvthad,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-C-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.949000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,99,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afb00,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vs,P46Y,pgxind-kftx32dk,pgxcs-kftvthbb,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-C-05,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.952000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,75,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb01,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Dorsal medulla]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvh6vt,P13Y,pgxind-kftx32dm,pgxcs-kftvthbs,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-C-06,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,,2020-09-10 17:44:34.953000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,101,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb02,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Occipital lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vv,P13Y,pgxind-kftx32do,pgxcs-kftvthc9,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-C-07,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.955000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,52,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb03,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Temporal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vx,P15Y,pgxind-kftx32dr,pgxcs-kftvthcq,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-D-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.956000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,21,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afb04,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vy,P28Y,pgxind-kftx32dt,pgxcs-kftvthd7,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-D-02,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.957000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,107,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afb05,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Occipital lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6w0,P39Y,pgxind-kftx32dv,pgxcs-kftvthfr,0,0,0,0,0,0,PGX_AM_BS_AstrCyt-II-D-03,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.959000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",0,65,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afc03,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [grade 3-4],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh77g,P73Y,pgxind-kftx32s5,pgxcs-kftvtkzw,601445901,0.209,368166377,0.128,233279524,0.081,PGX_AM_BS_12505254_AsCyt-zub-1,{},12.37,51.34,Point,DEU,Leipzig,Germany,"Leipzig, Germany",51.34,12.37,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:35.311000,PMID:12505254,"Zuber MA, Krupp W et al. (2002): Characterization of chromosomal aberrations in a...",0,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0c13,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvhcd1,P45Y,pgxind-kftx397x,pgxcs-kftvv6qw,140238777,0.049,0,0,140238777,0.049,PGX_AM_BS_OA-N172,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:40.985000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c14,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvhcd2,P38Y,pgxind-kftx397z,pgxcs-kftvv6re,376046769,0.131,376046769,0.131,0,0,PGX_AM_BS_OA-N174,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:40.986000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0c16,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvhcd6,P23Y,pgxind-kftx3982,pgxcs-kftvv6sd,78617696,0.027,78617696,0.027,0,0,PGX_AM_BS_OA-N185,{},5.84,51.81,Point,NLD,Nijmegen,Netherlands,"Nijmegen, The Netherlands",51.81,5.84,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:40.989000,PMID:11329145,"Jeuken JW, Sprenger SH et al. (2001): Subtyping of oligo-astrocytic tumours by comparative...",0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aacd7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [parieto-occipital],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfm,P29Y,pgxind-kftx277f,pgxcs-kftvlrt1,0,0,0,0,0,0,PGX_AM_BS_9403731_AC-sal-02,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.700000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacdc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [frontal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfv,P42Y,pgxind-kftx277o,pgxcs-kftvlrvc,219366358,0.076,0,0,219366358,0.076,PGX_AM_BS_9403731_AC-sal-07,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.706000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacdd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [fronto-basal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfw,P29Y,pgxind-kftx277q,pgxcs-kftvlrvt,460705646,0.16,165091596,0.057,295614050,0.103,PGX_AM_BS_9403731_AC-sal-08,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.707000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacde,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfy,P47Y,pgxind-kftx277s,pgxcs-kftvlrwa,1128817174,0.393,871385547,0.303,257431627,0.09,PGX_AM_BS_9403731_AC-sal-09,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.709000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c0727983b2e00aacdf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghfz,P45Y,pgxind-kftx277u,pgxcs-kftvlrwr,1016308085,0.353,782558317,0.272,233749768,0.081,PGX_AM_BS_9403731_AC-sal-10,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.710000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00aace0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,astrocytoma [temporal],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvghg1,P56Y,pgxind-kftx277w,pgxcs-kftvlrx8,1600607151,0.557,1166471417,0.406,434135734,0.151,PGX_AM_BS_9403731_AC-sal-11,{},23.79,61.5,Point,FIN,Tampere,Finland,"Tampere, Finland",61.5,23.79,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:06.712000,PMID:9403731,"Sallinen SL, Sallinen P et al. (1997): Accumulation of genetic changes is associated...",1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab737,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Diffusely infiltrating astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgksh,P7Y1M,pgxind-kftx2baj,pgxcs-kftvms3c,503863,0,503863,0,0,0,DIPG_BS_0223,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.461000,PMID:22389665,"Puget S, Philippe C et al. (2012): Mesenchymal transition and PDGFRA amplification/mutation are...",1,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,PGX_AM_BS_22389665-gri-P26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab859,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pilocytic astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl5n,P3Y6M,pgxind-kftx2bqk,pgxcs-kftvmw1s,6124383,0.002,1985666,0.001,4138717,0.001,PGX_AM_BS_21931021-pau-BSG006T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.866000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pilocytic astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl5p,P3Y1M,pgxind-kftx2bqm,pgxcs-kftvmw29,4798452,0.002,2084418,0.001,2714034,0.001,PGX_AM_BS_21931021-pau-BSG008T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.867000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pilocytic astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl5u,P12Y4M,pgxind-kftx2bqs,pgxcs-kftvmw3n,33423859,0.012,2299553,0.001,31124306,0.011,PGX_AM_BS_21931021-pau-BSG011T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.872000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab85f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pilocytic astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl5x,P2Y,pgxind-kftx2bqw,pgxcs-kftvmw4l,6423352,0.002,2389346,0.001,4034006,0.001,PGX_AM_BS_21931021-pau-BSG014T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.874000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab862,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Diffusely infiltrating astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl62,P5Y7M,pgxind-kftx2br2,pgxcs-kftvmw5z,37964939,0.013,35146180,0.012,2818759,0.001,PGX_AM_BS_21931021-pau-BSG018T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.879000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,4.3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0917,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab86b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pilocytic astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl6g,P11Y5M,pgxind-kftx2brk,pgxcs-kftvmwa7,444960476,0.155,362888487,0.126,82071989,0.029,PGX_AM_BS_21931021-pau-BSG002T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.892000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab87d,pgxcohort-DIPG,DIPG samples,DUO:0000004,no restriction,Diffusely infiltrating astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgl7a,P8Y5M,pgxind-kftx2bsl,pgxcs-kftvmwin,247934988,0.086,46927745,0.016,201007243,0.07,PGX_AM_BS_21931021-pau-BSG047T,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:10.917000,PMID:21931021,"Paugh BS, Broniscer A et al. (2011): Genome-wide analyses identify recurrent amplifications of...",1,3,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DIPG_BS_0929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c2727983b2e00abf73,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Astrocytoma [brainstem],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.7,brain stem,pgxbs-kftvgngd,P11Y,pgxind-kftx2ej9,pgxcs-kftvnkoq,2066793655,0.719,675547663,0.235,1391245992,0.484,PGX_AM_BS_20192643_PB-far-16,{},-9.13,38.72,Point,PRT,Lisbon,Portugal,"Lisbon, Portugal",38.72,-9.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002298,brainstem,{},2020-09-10 17:44:13.465000,PMID:20192643,"Faria C, Migu√©ns J et al. (2010): Pediatric brain tumors: genetics and clinical...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac3d9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,diffuse astrocytoma [infratentorial],NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.6,cerebellum,pgxbs-kftvgovm,P1Y10M,pgxind-kftx2gav,pgxcs-kftvo012,179715219,0.063,179715219,0.063,0,0,PGX_AM_BS_20052518_PA-war-IN380,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:15.023000,PMID:20052518,"Ward SJ, Karakoula K et al. (2010): Cytogenetic analysis of paediatric astrocytoma using...",1,92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afae8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Pons]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6uo,P19Y,pgxind-kftx32c8,pgxcs-kftvtgzr,332398731,0.116,50627305,0.018,281771426,0.098,PGX_AM_BS_AstrCyt-II-A-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.918000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",1,6,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afafc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Astrocytoma, anaplastic [grade II, Primary, Frontal lobe]",NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, NOS",pgxbs-kftvh6vl,P26Y,pgxind-kftx32dc,pgxcs-kftvth9f,153522968,0.053,0,0,153522968,0.053,PGX_AM_BS_AstrCyt-II-C-01,{},-122.42,37.77,Point,USA,San Francisco,United States of America,"San Francisco, United States",37.77,-122.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,,2020-09-10 17:44:34.946000,PMID:12660025,"Hirose Y, Aldape KD et al. (2003): Grade II astrocytomas are subgrouped by...",1,17,NCITgrade-C28078,Grade 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c09067d727983923bb262f7,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Diffusely infiltrating astrocytoma,NCIT:C60781,Astrocytoma,icdom-94003,"Astrocytoma, NOS",icdot-C71.9,"brain, nos",pgxbs-khv36rug,P12Y2M,pgxind-khv36ruw,pgxcs-khv36rv0,0,0,0,0,0,0,PGX_AM_BS_AM20130503HAW-22T,{},0,0,Point,XXX,,,,0,0,,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-11-23 22:53:07.986000,geogpl-GPL6801,,1,0.59,,,,,,,,,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),,,,,,geo:gpl,,,,,,,,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac928,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [anaplastic],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqky,P2Y1M,pgxind-kftx2ifo,pgxcs-kftvoitc,559323948,0.195,406204214,0.141,153119734,0.053,PGX_AM_BS_19270706_MBL-nor-MDT-MB-102,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.899000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,61,,,M1,,,TNM-C48700,M1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac94e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [moderate to severe anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqmn,P8Y11M,pgxind-kftx2iht,pgxcs-kftvojdy,358568187,0.125,245634110,0.085,112934077,0.039,PGX_AM_BS_19270706_MBL-nor-MDT-MB-118,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.952000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",0,60,,,M3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca1f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqw4,P5Y,pgxind-kftx2itk,pgxcs-kftvoman,1273868068,0.443,676889774,0.235,596978294,0.208,PGX_AM_BS_MedBlast-pfi-1M10,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.242000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,82,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqyf,P15Y,pgxind-kftx2iwd,pgxcs-kftvon10,927932447,0.323,370941271,0.129,556991176,0.194,PGX_AM_BS_MedBlast-pfi-4M63,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.312000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,22,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca59,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqys,P8Y,pgxind-kftx2iwu,pgxcs-kftvon4v,543679471,0.189,106133705,0.037,437545766,0.152,PGX_AM_BS_MedBlast-pfi-M1014,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.324000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",0,23,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb2f,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [large cell/anaplastic],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgr8f,P3Y5M,pgxind-kftx2j8x,pgxcs-kftvoq4i,740642701,0.258,232124908,0.081,508517793,0.177,PGX_AM_BS_19197950_MB95.1293,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.621000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,32.1,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad740,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3k,P9Y,pgxind-kftx2o2u,pgxcs-kftvpxaw,415978191,0.145,93922227,0.033,322055964,0.112,PGX_AM_BS_18056178_MB-lo-J1005,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.879000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad741,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3l,P6Y,pgxind-kftx2o2w,pgxcs-kftvpxbd,382735186,0.133,145138782,0.05,237596404,0.083,PGX_AM_BS_18056178_MB-lo-J1006,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.881000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,111,,,T2M0,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad745,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3s,P2Y,pgxind-kftx2o34,pgxcs-kftvpxdc,333602138,0.116,135306380,0.047,198295758,0.069,PGX_AM_BS_18056178_MB-lo-J1012,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.887000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,62,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad746,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3t,P5Y,pgxind-kftx2o36,pgxcs-kftvpxdt,1022802596,0.356,349351579,0.122,673451017,0.234,PGX_AM_BS_18056178_MB-lo-J1014,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.888000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,35,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad747,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3v,P9Y,pgxind-kftx2o38,pgxcs-kftvpxg5,1209982456,0.421,485894777,0.169,724087679,0.252,PGX_AM_BS_18056178_MB-lo-J1016,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.890000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad74a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv40,P16Y,pgxind-kftx2o3e,pgxcs-kftvpxhm,602651199,0.21,445277098,0.155,157374101,0.055,PGX_AM_BS_18056178_MB-lo-J1021,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.894000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,47,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad74b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv42,P8Y,pgxind-kftx2o3g,pgxcs-kftvpxi3,1541623366,0.536,700723745,0.244,840899621,0.292,PGX_AM_BS_18056178_MB-lo-J1022,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.895000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,98,,,T3M0,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad74d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv45,P19Y,pgxind-kftx2o3k,pgxcs-kftvpxj3,984721609,0.343,414199692,0.144,570521917,0.198,PGX_AM_BS_18056178_MB-lo-J1024,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.898000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",0,37,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae173,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell, with anaplasia and nodularity]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyox,P7Y1M,pgxind-kftx2s5t,pgxcs-kftvqxwn,689005989,0.24,204779844,0.071,484226145,0.168,PGX_AM_BS_MedBlast-deb-MB1041,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.502000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,8,,,T3M2M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae175,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [anaplastic, with focal nodularity]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyp0,P5Y8M,pgxind-kftx2s5y,pgxcs-kftvqxxl,729408727,0.254,596716698,0.208,132692029,0.046,PGX_AM_BS_MedBlast-deb-MB1081,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.504000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae17b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [nodular, with anaplasia]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgypa,P14Y1M,pgxind-kftx2s6a,pgxcs-kftvqy0h,876106183,0.305,481228741,0.167,394877442,0.137,PGX_AM_BS_MedBlast-deb-MB138,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.513000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,63,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae17d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [anaplastic],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgype,P8Y10M,pgxind-kftx2s6e,pgxcs-kftvqy1g,710275086,0.247,450653401,0.157,259621685,0.09,PGX_AM_BS_MedBlast-deb-MB141,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.516000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,85,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae182,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [anaplastic],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgypm,P4Y,pgxind-kftx2s6o,pgxcs-kftvqy3v,1554562639,0.541,1074165993,0.374,480396646,0.167,PGX_AM_BS_MedBlast-deb-MB194,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.523000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,67,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae18a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [large cell],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgypz,P3Y4M,pgxind-kftx2s74,pgxcs-kftvqy7p,1357952114,0.472,553317891,0.192,804634223,0.28,PGX_AM_BS_MedBlast-deb-MB381,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.534000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,49,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae18d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [large cell],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyq4,P10Y,pgxind-kftx2s7a,pgxcs-kftvqy95,468356622,0.163,346599765,0.121,121756857,0.042,PGX_AM_BS_MedBlast-deb-MB505,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.539000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,33,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae190,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [anaplastic, large cell]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyq9,P7Y8M,pgxind-kftx2s7h,pgxcs-kftvqyal,1265736161,0.44,681176977,0.237,584559184,0.203,PGX_AM_BS_MedBlast-deb-MB593,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.543000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,29,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae191,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [mixed nodular, classic, anaplastic]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyqb,P9Y4M,pgxind-kftx2s7j,pgxcs-kftvqyb3,427758463,0.149,58600058,0.02,369158405,0.128,PGX_AM_BS_MedBlast-deb-MB642,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.544000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,26,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae19a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell, with neuroblastic and ependymal differentiation]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyqq,P11Y4M,pgxind-kftx2s81,pgxcs-kftvqyhj,0,0,0,0,0,0,PGX_AM_BS_MedBlast-deb-MB886,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.557000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,10,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae19b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell, with anaplasia]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyqs,P11Y10M,pgxind-kftx2s83,pgxcs-kftvqyi1,466110042,0.162,196524873,0.068,269585169,0.094,PGX_AM_BS_MedBlast-deb-MB894,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.558000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",0,12,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b050d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [moderate anaplastic, recurrence, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha3z,P11Y,pgxind-kftx36es,pgxcs-kftvuhgg,868493030,0.302,132327547,0.046,736165483,0.256,PGX_AM_BS_11770900_MB-ebe-LCMbl-01B,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.502000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,55,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b051c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4n,P5Y,pgxind-kftx36fm,pgxcs-kftvuhnl,876160966,0.305,300052691,0.104,576108275,0.2,PGX_AM_BS_11770900_MB-ebe-LCMbl-16,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.522000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,3,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b051d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4o,P2Y,pgxind-kftx36fo,pgxcs-kftvuho2,332093314,0.116,133797556,0.047,198295758,0.069,PGX_AM_BS_11770900_MB-ebe-LCMbl-17,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.524000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,16,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b051f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4s,P16Y,pgxind-kftx36fs,pgxcs-kftvuhp1,482526909,0.168,231194948,0.08,251331961,0.087,PGX_AM_BS_11770900_MB-ebe-LCMbl-19,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.526000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,7,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0520,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4t,P5Y,pgxind-kftx36fu,pgxcs-kftvuhpi,312896479,0.109,74000073,0.026,238896406,0.083,PGX_AM_BS_11770900_MB-ebe-LCMbl-20,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.528000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,70,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0521,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4v,P8Y,pgxind-kftx36fw,pgxcs-kftvuhpz,380588628,0.132,86594805,0.03,293993823,0.102,PGX_AM_BS_11770900_MB-ebe-LCMbl-21,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.529000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,74,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0522,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4x,P9Y,pgxind-kftx36fy,pgxcs-kftvuhqh,947468854,0.33,293666432,0.102,653802422,0.227,PGX_AM_BS_11770900_MB-ebe-LCMbl-22,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.531000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0523,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [moderate anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4y,P43Y,pgxind-kftx36g0,pgxcs-kftvuhqy,225899645,0.079,0,0,225899645,0.079,PGX_AM_BS_11770900_MB-ebe-LCMbl-23,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.532000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,4,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b0525,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [moderate anaplastic, primary, stage M2]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha51,P18Y,pgxind-kftx36g4,pgxcs-kftvuhrw,592799033,0.206,72827327,0.025,519971706,0.181,PGX_AM_BS_11770900_MB-ebe-LCMbl-25,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.535000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,14,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b052a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell /severe anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha59,P2Y,pgxind-kftx36ge,pgxcs-kftvuhua,374342236,0.13,180092321,0.063,194249915,0.068,PGX_AM_BS_11770900_MB-ebe-LCMbl-30,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.542000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",0,47,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c2727983b2e00abde2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgmy7,P31Y,pgxind-kftx2dwj,pgxcs-kftvnf80,321189071,0.112,34146191,0.012,287042880,0.1,PGX_AM_BS_Medblast-pfi-1M26,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:12.899000,PMID:20479417,"Korshunov A, Remke M et al. (2010): Adult and pediatric medulloblastomas are genetically...",1,49,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00ac8de,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [severe anaplasia ],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqhk,P10Y2M,pgxind-kftx2ibh,pgxcs-kftvohtu,62682765,0.022,55609615,0.019,7073150,0.002,PGX_AM_BS_19270706_MBL-nor-MDT-MB-008,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:16.797000,PMID:19270706,"Northcott PA, Nakahara Y et al. (2009): Multiple recurrent genetic events converge on...",1,47,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca26,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqwg,P4Y,pgxind-kftx2ity,pgxcs-kftvome0,1103975522,0.384,375863736,0.131,728111786,0.253,PGX_AM_BS_MedBlast-pfi-1M19,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.252000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,5,,,M0,,,,,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca27,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqwi,P4Y,pgxind-kftx2iu0,pgxcs-kftvomei,369571737,0.129,18032460,0.006,351539277,0.122,PGX_AM_BS_MedBlast-pfi-1M20,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.254000,geo:GSE8634,,1,10,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca2a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqwn,P7Y,pgxind-kftx2iu6,pgxcs-kftvomfy,430595285,0.15,315013405,0.11,115581880,0.04,PGX_AM_BS_MedBlast-pfi-1M24,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.258000,geo:GSE8634,,1,12,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqwq,P6Y,pgxind-kftx2iua,pgxcs-kftvomgw,326327646,0.114,63343262,0.022,262984384,0.091,PGX_AM_BS_MedBlast-pfi-1M28,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.261000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,4,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,geo:GSE8634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00aca2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqws,P2Y,pgxind-kftx2iuc,pgxcs-kftvomhe,343011266,0.119,20711004,0.007,322300262,0.112,PGX_AM_BS_MedBlast-pfi-1M3,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.262000,geo:GSE8634,,1,9,,,M0,,,,,,,,,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c4727983b2e00aca50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgqye,P2Y,pgxind-kftx2iwb,pgxcs-kftvon0j,255202108,0.089,78916590,0.027,176285518,0.061,PGX_AM_BS_MedBlast-pfi-4M58,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.311000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,23,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acb22,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Medulloblastoma [large cell/anaplastic],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgr7v,P9Y1M,pgxind-kftx2j87,pgxcs-kftvopy9,170817323,0.059,119617272,0.042,51200051,0.018,PGX_AM_BS_19197950_MB81a.1317,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.604000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,14,,,M0,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad73d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3f,P4Y,pgxind-kftx2o2n,pgxcs-kftvpx9g,1447421182,0.503,1045721076,0.364,401700106,0.14,PGX_AM_BS_18056178_MB-lo-J1001,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.875000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad73f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3i,P5Y,pgxind-kftx2o2s,pgxcs-kftvpxaf,357363302,0.124,50627305,0.018,306735997,0.107,PGX_AM_BS_18056178_MB-lo-J1004,,-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.878000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,7,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad743,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [supratentorial],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3o,P9Y,pgxind-kftx2o30,pgxcs-kftvpxcc,1650241420,0.574,677150538,0.236,973090882,0.338,PGX_AM_BS_18056178_MB-lo-J1008,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.884000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,10,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad749,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [supratentorial],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv3y,P6Y,pgxind-kftx2o3c,pgxcs-kftvpxh4,692232004,0.241,385447432,0.134,306784572,0.107,PGX_AM_BS_18056178_MB-lo-J1020,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.893000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,10,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad74c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [supratentorial],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgv43,P11Y,pgxind-kftx2o3i,pgxcs-kftvpxil,366170784,0.127,22200022,0.008,343970762,0.12,PGX_AM_BS_18056178_MB-lo-J1023,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:21.897000,PMID:18056178,"Lo KC, Ma C, Bundy BN et al. (2007): Gain of 1q is a potential...",1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae179,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [large cell],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyp7,P2Y6M,pgxind-kftx2s66,pgxcs-kftvqxzi,130413510,0.045,22200022,0.008,108213488,0.038,PGX_AM_BS_MedBlast-deb-MB118,,-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.510000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,10,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae18c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,medulloblastoma [mixed nodular and anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyq3,P6Y5M,pgxind-kftx2s78,pgxcs-kftvqy8n,724115006,0.252,415070260,0.144,309044746,0.107,PGX_AM_BS_MedBlast-deb-MB431,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.537000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,41,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae19d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [anaplastic, large cell]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvgyqv,P8Y2M,pgxind-kftx2s87,pgxcs-kftvqyiz,1303425175,0.453,793911416,0.276,509513759,0.177,PGX_AM_BS_MedBlast-deb-MB984,{},-95.36,29.76,Point,USA,Houston,United States of America,"Houston, United States",29.76,-95.36,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:25.561000,PMID:16968546,"De Bortoli M, Castellino RC et al. (2006): Medulloblastoma outcome is adversely associated with...",1,9,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cc727983b2e00b051e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [focal moderate anaplastic, primary, stage M2]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha4q,P4Y,pgxind-kftx36fq,pgxcs-kftvuhok,436648929,0.152,0,0,436648929,0.152,PGX_AM_BS_11770900_MB-ebe-LCMbl-18,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.525000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,11,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0524,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [moderate anaplastic, recurrence, stage M2]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha50,P5Y,pgxind-kftx36g2,pgxcs-kftvuhrf,354115965,0.123,50627305,0.018,303488660,0.106,PGX_AM_BS_11770900_MB-ebe-LCMbl-24,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.533000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,7,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0526,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [severe anaplastic, recurrence, stage M2]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha53,P11Y,pgxind-kftx36g6,pgxcs-kftvuhsd,337789635,0.117,49400049,0.017,288389586,0.1,PGX_AM_BS_11770900_MB-ebe-LCMbl-26,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.536000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,27,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0527,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell /severe anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha55,P5Y,pgxind-kftx36g8,pgxcs-kftvuhsu,536186613,0.186,11200011,0.004,524986602,0.183,PGX_AM_BS_11770900_MB-ebe-LCMbl-27,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.538000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,11,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0528,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [severe anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha56,P17Y,pgxind-kftx36ga,pgxcs-kftvuhtb,867718146,0.302,130054800,0.045,737663346,0.257,PGX_AM_BS_11770900_MB-ebe-LCMbl-28,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.539000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,10,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b0529,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [severe anaplastic, primary, stage M2]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha58,P2Y,pgxind-kftx36gc,pgxcs-kftvuhtt,457769351,0.159,0,0,457769351,0.159,PGX_AM_BS_11770900_MB-ebe-LCMbl-29,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.540000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,9,,,T2M2,NCITstage-C28054,Stage II,TNM-C48724,T2 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b052b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [large cell /severe anaplastic, primary, stage M1]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha5b,P2Y,pgxind-kftx36gh,pgxcs-kftvuhur,944288229,0.328,206624883,0.072,737663346,0.257,PGX_AM_BS_11770900_MB-ebe-LCMbl-31,,-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.543000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,1,,,T1M1,NCITstage-C27966,Stage I,TNM-C48700,M1 Stage Finding,TNM-C48720,T1 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cc727983b2e00b052c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"medulloblastoma [severe anaplastic, primary, stage M0]",NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvha5d,P10Y,pgxind-kftx36gj,pgxcs-kftvuhv8,664324892,0.231,184608271,0.064,479716621,0.167,PGX_AM_BS_11770900_MB-ebe-LCMbl-32,{},-76.61,39.29,Point,USA,Baltimore,United States of America,"Baltimore, United States",39.29,-76.61,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:38.545000,PMID:11770900,"Eberhart CG, Kratz JE et al. (2002): Comparative genomic hybridization detects an increased...",1,9,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b1178,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,large cell medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvhe3o,P11Y,pgxind-kftx3bdu,pgxcs-kftvvq8k,582577249,0.203,157669697,0.055,424907552,0.148,PGX_AM_BS_LCMB-01,{},-90.05,35.15,Point,USA,Memphis,United States of America,"Memphis, United States",35.15,-90.05,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:42.894000,PMID:10940769,"Reardon DA, Jenkins JJ et al. (2000): Multiple genomic alterations including N-myc amplification...",1,19,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b149c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Large cell medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvhf47,P6Y,pgxind-kftx3cmy,pgxcs-kftvw1i0,242835047,0.084,0,0,242835047,0.084,PGX_AM_BS_MedBlast-jay,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:44.015000,PMID:10643003,"Jay V, Squire J et al. (1999): Oncogene amplification in medulloblastoma: analysis of...",1,8.5,,,M3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608609d374f2dc37da47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [diffuse moderate anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvis87,P5Y,pgxind-kftx4irj,pgxcs-kftwb4zg,187571666,0.065,42552884,0.015,145018782,0.05,PGX_AM_BS_MedBlast-lo-J1004,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.087000,PMID:17465989,"Lo KC, Rossi MR et al. (2007): Genome wide copy number abnormalities in...",1,7,,,,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608609d374f2dc37da48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [diffuse severe anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvis89,P11Y,pgxind-kftx4irl,pgxcs-kftwb556,25465848,0.009,19632270,0.007,5833578,0.002,PGX_AM_BS_MedBlast-lo-J1023,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.089000,PMID:17465989,"Lo KC, Rossi MR et al. (2007): Genome wide copy number abnormalities in...",1,27,,,,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608609d374f2dc37da49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [diffuse severe anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvis8a,P9Y,pgxind-kftx4irn,pgxcs-kftwb51c,223794661,0.078,125475652,0.044,98319009,0.034,PGX_AM_BS_MedBlast-lo-J1008,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.090000,PMID:17465989,"Lo KC, Rossi MR et al. (2007): Genome wide copy number abnormalities in...",1,10,,,,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608609d374f2dc37da4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [diffuse severe anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvis8c,P6Y,pgxind-kftx4irp,pgxcs-kftwb53q,166682538,0.058,23734781,0.008,142947757,0.05,PGX_AM_BS_MedBlast-lo-J1020,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.092000,PMID:17465989,"Lo KC, Rossi MR et al. (2007): Genome wide copy number abnormalities in...",1,10,,,,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5c86608609d374f2dc37da50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Anaplastic medulloblastoma [focal moderate anaplasia],NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvis8l,P4Y,pgxind-kftx4is2,pgxcs-kftwb4yh,347589019,0.121,199049783,0.069,148539236,0.052,PGX_AM_BS_MedBlast-lo-J1001,{},-93.87,45.17,Point,USA,Buffalo,United States of America,"Buffalo, United States",45.17,-93.87,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:45:39.100000,PMID:17465989,"Lo KC, Rossi MR et al. (2007): Genome wide copy number abnormalities in...",1,11.5,,,,,,,,,,,,,,,,,pubmed,,,,,,,,,,arraymap import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf60,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9lr,P2Y,pgxind-kftx6bla,pgxcs-kftwpzpg,349246718,0.121,20393507,0.007,328853211,0.114,PGX_AM_BS_GSM213835,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.481000,geo:GSM213835,,1,9,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf6d,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9mc,P4Y,pgxind-kftx6bm0,pgxcs-kftwpzth,696961585,0.242,297520136,0.103,399441449,0.139,PGX_AM_BS_GSM213848,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.495000,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",1,5,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,pubmed,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,,,,,,,,geo:gsm,geo:GSM213848,,,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf6e,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9md,P4Y,pgxind-kftx6bm2,pgxcs-kftwpztt,367300834,0.128,18077896,0.006,349222938,0.121,PGX_AM_BS_GSM213849,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.496000,geo:GSM213849,,1,10,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf72,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9mk,P7Y,pgxind-kftx6bma,pgxcs-kftwpzv2,354291096,0.123,290456849,0.101,63834247,0.022,PGX_AM_BS_GSM213853,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.500000,geo:GSM213853,,1,12,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",geo:gsm,,,,,,,,,,arraymap import,,,pubmed,geo:gse,geo:GSE8634,,,,,,,,,geo:gpl,geo:GPL5685,,,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf74,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9mn,P31Y,pgxind-kftx6bme,pgxcs-kftwpzvo,298704043,0.104,23136215,0.008,275567828,0.096,PGX_AM_BS_GSM213855,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.502000,geo:GSM213855,,1,49,,,T3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GPL5685,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gpl,geo:gse,geo:GSE8634,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,M
5dc184fb09d374f6dd84bf75,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,classic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9mp,P6Y,pgxind-kftx6bmg,pgxcs-kftwpzw0,96401312,0.034,18001824,0.006,78399488,0.027,PGX_AM_BS_GSM213856,,8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.503000,geo:GSM213856,,1,4,,,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5dc184fb09d374f6dd84bf76,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,large cell/anaplastic medulloblastoma,NCIT:C6904,Large Cell Medulloblastoma,icdom-94743,Large cell medulloblastoma,icdot-C71.6,Cerebellum,pgxbs-kftvk9mq,P28Y,pgxind-kftx6bmi,pgxcs-kftwpzwb,626493213,0.218,358687303,0.125,267805910,0.093,PGX_AM_BS_GSM213857,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:46:36.504000,geo:GSM213857,,1,23,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,geo:GSE8634,,geo:gsm,,,,,,,,,,arraymap import,,,geo:gse,geo:gpl,geo:GPL5685,,,,,,,,,pubmed,PMID:19255330,"Pfister S, Remke M et al. (2009): Outcome prediction in pediatric medulloblastoma based...",,,,,,,,,,,,,,,,
5bab56c4727983b2e00acb1c,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Atypical teratoid/rhabdoid tumor,NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.6,cerebellum,pgxbs-kftvgr7l,P8Y8M,pgxind-kftx2j7v,pgxcs-kftvopve,49891483,0.017,43091476,0.015,6800007,0.002,PGX_AM_BS_19197950_MB75.723,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.595000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",0,90,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00afa49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [temporal],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.0,cerebrum,pgxbs-kftvh6nk,P15Y,pgxind-kftx3239,pgxcs-kftvteqz,306200305,0.107,248500247,0.086,57700058,0.02,PGX_AM_BS_12787322_AT-RT-wha-01,{},-1.47,53.38,Point,GBR,Sheffield,United Kingdom,"Sheffield, United Kingdom",53.38,-1.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:34.700000,PMID:12787322,"Wharton SB, Wardle C et al. (2003): Comparative genomic hybridization and pathological findings...",0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00ac89b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Extrarenal rhabdoid tumor,NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-89633,Malignant rhabdoid tumor,icdot-C71.9,"brain, NOS",pgxbs-kftvgqek,P11Y,pgxind-kftx2i7p,pgxcs-kftvogvb,255949974,0.089,0,0,255949974,0.089,PGX_AM_BS_19378321_LFS-rie-02,{},8.69,49.41,Point,DEU,Heidelberg,Germany,"Heidelberg, Germany",49.41,8.69,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:16.706000,PMID:19378321,"Rieber J, Remke M et al. (2009): Novel oncogene amplifications in tumors from...",1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c4727983b2e00acae3,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Atypical teratoid/rhabdoid tumor,NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.6,cerebellum,pgxbs-kftvgr50,P9Y11M,pgxind-kftx2j4n,pgxcs-kftvop44,27200027,0.009,0,0,27200027,0.009,PGX_AM_BS_19197950_MB115.1409,{},2.35,48.85,Point,FRA,Paris,France,"Paris, France",48.85,2.35,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:17.518000,PMID:19197950,"Fattet S, Haberler C et al. (2009): Beta-catenin status in paediatric medulloblastomas: correlation...",1,7.5,,,,,,,,,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae69e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [infratentorial],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.6,cerebellum,pgxbs-kftvh0co,P0Y8M,pgxind-kftx2u7s,pgxcs-kftvrge6,0,0,0,0,0,0,PGX_AM_BS_16206192_FamRha-fru-1,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:27.720000,PMID:16206192,"Fr√ºhwald MC, Hasselblatt M et al. (2006): Non-linkage of familial rhabdoid tumors to...",1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af37a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [L fronto-parietal],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.0,cerebrum,pgxbs-kftvh4h2,P0Y1M,pgxind-kftx2zdn,pgxcs-kftvsqer,96509146,0.034,96509146,0.034,0,0,PGX_AM_BS_14767597_ATRT-ric-01,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:32.292000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af37b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [Pineal region],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C75.3,pineal gland,pgxbs-kftvh4h3,P0Y6M,pgxind-kftx2zdp,pgxcs-kftvsqf8,192245206,0.067,192245206,0.067,0,0,PGX_AM_BS_14767597_ATRT-ric-02,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:32.294000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af37c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [Cerebellum],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.6,cerebellum,pgxbs-kftvh4h5,P0Y7M,pgxind-kftx2zdr,pgxcs-kftvsqfq,0,0,0,0,0,0,PGX_AM_BS_14767597_ATRT-ric-03,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:32.295000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af37d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [R cerebello-pontine angle],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.9,"Brain, NOS",pgxbs-kftvh4h7,P0Y10M,pgxind-kftx2zdt,pgxcs-kftvsqg7,0,0,0,0,0,0,PGX_AM_BS_14767597_ATRT-ric-04,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:32.296000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00af37e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [R fronto-temporo-parietal],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.0,cerebrum,pgxbs-kftvh4h8,P1Y5M,pgxind-kftx2zdv,pgxcs-kftvsqgo,0,0,0,0,0,0,PGX_AM_BS_14767597_ATRT-ric-05,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:32.297000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af37f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [Supra-/infratentorial],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.9,"Brain, NOS",pgxbs-kftvh4ha,P1Y10M,pgxind-kftx2zdx,pgxcs-kftvsqh5,96509146,0.034,96509146,0.034,0,0,PGX_AM_BS_14767597_ATRT-ric-06,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000955,brain,{},2020-09-10 17:44:32.299000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00af380,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [L fronto-parietal],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.0,cerebrum,pgxbs-kftvh4hc,P2Y,pgxind-kftx2zdz,pgxcs-kftvsqhm,0,0,0,0,0,0,PGX_AM_BS_14767597_ATRT-ric-07,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001869,cerebral hemisphere,{},2020-09-10 17:44:32.300000,PMID:14767597,Rickert CH et al. (2004): Chromosomal imbalances detected by comparative genomic...,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afa4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,atypical teratoid/rhabdoid tumour [cerebellum],NCIT:C6906,Atypical Teratoid/Rhabdoid Tumor,icdom-95083,Atypical teratoid/rhabdoid tumor,icdot-C71.6,cerebellum,pgxbs-kftvh6nn,P3Y,pgxind-kftx323d,pgxcs-kftvterx,287691718,0.1,235391666,0.082,52300052,0.018,PGX_AM_BS_12787322_AT-RT-wha-03,{},-1.47,53.38,Point,GBR,Sheffield,United Kingdom,"Sheffield, United Kingdom",53.38,-1.47,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002037,cerebellum,{},2020-09-10 17:44:34.703000,PMID:12787322,"Wharton SB, Wardle C et al. (2003): Comparative genomic hybridization and pathological findings...",1,11.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00afbeb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76d,P0Y2M,pgxind-kftx32qs,pgxcs-kftvtkod,127900127,0.044,12300012,0.004,115600115,0.04,PGX_AM_BS_RetBl-lil-002,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.278000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbec,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76e,P1Y10M,pgxind-kftx32qu,pgxcs-kftvtkou,217445087,0.076,98327352,0.034,119117735,0.041,PGX_AM_BS_RetBl-lil-003,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.279000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbed,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76g,P3Y1M,pgxind-kftx32qw,pgxcs-kftvtkpb,273962984,0.095,32800032,0.011,241162952,0.084,PGX_AM_BS_RetBl-lil-006,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.281000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76j,P0Y11M,pgxind-kftx32r0,pgxcs-kftvtkqa,328845831,0.114,75079715,0.026,253766116,0.088,PGX_AM_BS_RetBl-lil-010,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.283000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76l,P1Y10M,pgxind-kftx32r2,pgxcs-kftvtkqs,0,0,0,0,0,0,PGX_AM_BS_RetBl-lil-011,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.285000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76n,P1Y8M,pgxind-kftx32r4,pgxcs-kftvtkr9,279377253,0.097,88827343,0.031,190549910,0.066,PGX_AM_BS_RetBl-lil-015,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.286000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76o,P0Y2M,pgxind-kftx32r6,pgxcs-kftvtkrq,144474885,0.05,41100040,0.014,103374845,0.036,PGX_AM_BS_RetBl-lil-016,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.288000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76r,P0Y6M,pgxind-kftx32ra,pgxcs-kftvtkso,109117725,0.038,40100039,0.014,69017686,0.024,PGX_AM_BS_RetBl-lil-020,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.290000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76t,P0Y5M,pgxind-kftx32rc,pgxcs-kftvtkt5,92600093,0.032,0,0,92600093,0.032,PGX_AM_BS_RetBl-lil-021,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.292000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76u,P0Y1M,pgxind-kftx32rf,pgxcs-kftvtktm,341188688,0.119,105852488,0.037,235336200,0.082,PGX_AM_BS_RetBl-lil-022,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.293000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76w,P0Y10M,pgxind-kftx32rh,pgxcs-kftvtku3,129700130,0.045,0,0,129700130,0.045,PGX_AM_BS_RetBl-lil-023,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.294000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76y,P5Y10M,pgxind-kftx32rj,pgxcs-kftvtkul,1125689266,0.392,509366399,0.177,616322867,0.214,PGX_AM_BS_RetBl-lil-025,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.296000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbf9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh76z,P0Y2M,pgxind-kftx32rl,pgxcs-kftvtkv3,0,0,0,0,0,0,PGX_AM_BS_RetBl-lil-028,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.297000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbfa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh771,P2Y2M,pgxind-kftx32rn,pgxcs-kftvtkvk,454787856,0.158,50627305,0.018,404160551,0.141,PGX_AM_BS_RetBl-lil-032,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.298000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbfb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh773,P0Y7M,pgxind-kftx32rp,pgxcs-kftvtkw2,0,0,0,0,0,0,PGX_AM_BS_RetBl-lil-034,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.300000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbfc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh774,P0Y1M,pgxind-kftx32rr,pgxcs-kftvtkwj,94100093,0.033,0,0,94100093,0.033,PGX_AM_BS_RetBl-lil-036,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.301000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbfd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh776,P2Y1M,pgxind-kftx32rt,pgxcs-kftvtkx1,346172038,0.12,60727315,0.021,285444723,0.099,PGX_AM_BS_RetBl-lil-037,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.303000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbfe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh778,P1Y11M,pgxind-kftx32rv,pgxcs-kftvtkxi,606381810,0.211,104263951,0.036,502117859,0.175,PGX_AM_BS_RetBl-lil-039,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.304000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afbff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh779,P2Y10M,pgxind-kftx32rx,pgxcs-kftvtky0,372165696,0.129,88379728,0.031,283785968,0.099,PGX_AM_BS_RetBl-lil-042,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.305000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afc00,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh77b,P3Y,pgxind-kftx32rz,pgxcs-kftvtkyh,173577148,0.06,50627305,0.018,122949843,0.043,PGX_AM_BS_RetBl-lil-043,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.307000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afc01,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh77d,P3Y1M,pgxind-kftx32s1,pgxcs-kftvtkyy,567223715,0.197,231682774,0.081,335540941,0.117,PGX_AM_BS_RetBl-lil-046,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.308000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56ca727983b2e00afc02,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh77e,P1Y11M,pgxind-kftx32s3,pgxcs-kftvtkzf,183449903,0.064,0,0,183449903,0.064,PGX_AM_BS_RetBl-lil-053,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:35.309000,PMID:12508240,"Lillington DM, Kingston JE et al. (2003): Comparative genomic hybridization of 49 primary...",0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yl,P1Y7M,pgxind-kftx33q0,pgxcs-kftvttfa,278049997,0.097,16100016,0.006,261949981,0.091,PGX_AM_BS_RetBl-lil-004,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.141000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yo,P0Y6M,pgxind-kftx33q4,pgxcs-kftvttg9,44100045,0.015,0,0,44100045,0.015,PGX_AM_BS_RetBl-lil-008-l,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.144000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yp,P0Y6M,pgxind-kftx33q6,pgxcs-kftvttgq,44800044,0.016,0,0,44800044,0.016,PGX_AM_BS_RetBl-lil-008-r,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.145000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yr,P0Y6M,pgxind-kftx33q8,pgxcs-kftvtth7,184000183,0.064,75400075,0.026,108600108,0.038,PGX_AM_BS_RetBl-lil-009,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.147000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yt,P0Y10M,pgxind-kftx33qa,pgxcs-kftvttho,229917383,0.08,0,0,229917383,0.08,PGX_AM_BS_RetBl-lil-012,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.148000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe61,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yu,P2Y7M,pgxind-kftx33qc,pgxcs-kftvtti5,296639301,0.103,64452456,0.022,232186845,0.081,PGX_AM_BS_RetBl-lil-017,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.149000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe62,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yw,P0Y1M,pgxind-kftx33qe,pgxcs-kftvttin,207481126,0.072,0,0,207481126,0.072,PGX_AM_BS_RetBl-lil-019,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.151000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe63,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yy,P0Y7M,pgxind-kftx33qg,pgxcs-kftvttj4,361547682,0.126,78970314,0.027,282577368,0.098,PGX_AM_BS_RetBl-lil-026,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.152000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe64,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7yz,P3Y7M,pgxind-kftx33qi,pgxcs-kftvttjm,701494169,0.244,286822612,0.1,414671557,0.144,PGX_AM_BS_RetBl-lil-029,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.153000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe65,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z1,P1Y10M,pgxind-kftx33qk,pgxcs-kftvttk3,376859247,0.131,111027365,0.039,265831882,0.092,PGX_AM_BS_RetBl-lil-033,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.155000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe67,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z4,P2Y10M,pgxind-kftx33qo,pgxcs-kftvttl2,327845887,0.114,68095909,0.024,259749978,0.09,PGX_AM_BS_RetBl-lil-038,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.157000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe68,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z6,P0Y11M,pgxind-kftx33qq,pgxcs-kftvttlj,368850088,0.128,0,0,368850088,0.128,PGX_AM_BS_RetBl-lil-040,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.159000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe69,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z7,P1Y10M,pgxind-kftx33qs,pgxcs-kftvttm0,395388272,0.138,9905990,0.003,385482282,0.134,PGX_AM_BS_RetBl-lil-041,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.160000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z9,P2Y7M,pgxind-kftx33qu,pgxcs-kftvttmh,269293054,0.094,37793568,0.013,231499486,0.081,PGX_AM_BS_RetBl-lil-044,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.162000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zb,P0Y7M,pgxind-kftx33qw,pgxcs-kftvttmy,0,0,0,0,0,0,PGX_AM_BS_RetBl-lil-045,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.163000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zd,P1Y4M,pgxind-kftx33qy,pgxcs-kftvttng,481795178,0.168,65427319,0.023,416367859,0.145,PGX_AM_BS_RetBl-lil-047,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.164000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zg,P5Y7M,pgxind-kftx33r2,pgxcs-kftvttoe,470797723,0.164,168404720,0.059,302393003,0.105,PGX_AM_BS_RetBl-lil-050,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.167000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zh,P3Y10M,pgxind-kftx33r4,pgxcs-kftvttov,881523340,0.307,300972586,0.105,580550754,0.202,PGX_AM_BS_RetBl-lil-051,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.168000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe70,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zj,P1Y4M,pgxind-kftx33r6,pgxcs-kftvttpd,0,0,0,0,0,0,PGX_AM_BS_RetBl-lil-052,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.170000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe71,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zk,P0Y4M,pgxind-kftx33r8,pgxcs-kftvttpu,172800172,0.06,38000038,0.013,134800134,0.047,PGX_AM_BS_RetBl-lil-054,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.171000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe72,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7zm,P12Y10M,pgxind-kftx33ra,pgxcs-kftvttqb,1373831297,0.478,487056655,0.169,886774642,0.308,PGX_AM_BS_RetBl-lil-056,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.172000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",0,111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7ym,P2Y4M,pgxind-kftx33q2,pgxcs-kftvttfs,343207928,0.119,76057942,0.026,267149986,0.093,PGX_AM_BS_RetBl-lil-005,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.143000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe66,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7z2,P0Y8M,pgxind-kftx33qm,pgxcs-kftvttkk,662999848,0.231,329907157,0.115,333092691,0.116,PGX_AM_BS_RetBl-lil-035,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.156000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",1,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56cb727983b2e00afe6d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,retinoblastoma,NCIT:C7541,Retinoblastoma,icdom-95103,"Retinoblastoma, NOS",icdot-C69.2,Retina,pgxbs-kftvh7ze,P3Y,pgxind-kftx33r0,pgxcs-kftvttnx,397455214,0.138,53493584,0.019,343961630,0.12,PGX_AM_BS_RetBl-lil-048,{},-0.13,51.51,Point,GBR,London,United Kingdom,"London, United Kingdom",51.51,-0.13,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000966,retina,{},2020-09-10 17:44:36.166000,PMID:12232763,"Lillington DM, Goff LK et al. (2002): High level amplification of N-MYC is...",1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5bab56c1727983b2e00ab894,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma [pineal region],NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvgl8c,P2Y,pgxind-kftx2btv,pgxcs-kftvmwu9,130740028,0.045,0,0,130740028,0.045,PGX_AM_BS_21798848_PNET-mil-05,{},-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:10.950000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",0,179,,,M0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0f5b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineal parenchymal tumor of intermediate differentiation,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdf5,P51Y,pgxind-kftx3aj9,pgxcs-kftvvim2,107986259,0.038,47086198,0.016,60900061,0.021,PGX_AM_BS_PinParTum-04,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.148000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",0,89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0f5c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineal parenchymal tumor of intermediate differentiation,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdf7,P51Y,pgxind-kftx3ajb,pgxcs-kftvvimm,206754859,0.072,66254718,0.023,140500141,0.049,PGX_AM_BS_PinParTum-05,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.149000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",0,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0f5d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineal parenchymal tumor of intermediate differentiation,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdf8,P11Y,pgxind-kftx3ajd,pgxcs-kftvvin4,739895607,0.257,145138782,0.05,594756825,0.207,PGX_AM_BS_PinParTum-06,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.150000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",0,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c1727983b2e00ab890,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma [pineal region],NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvgl85,P0Y6M,pgxind-kftx2btn,pgxcs-kftvmwse,0,0,0,0,0,0,PGX_AM_BS_21798848_PNET-mil-01,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:10.944000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,10,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab892,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma [pineal region],NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvgl88,P1Y,pgxind-kftx2btr,pgxcs-kftvmwtc,385716776,0.134,69587527,0.024,316129249,0.11,PGX_AM_BS_21798848_PNET-mil-03,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:10.947000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,10,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c1727983b2e00ab893,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma [pineal region],NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvgl8a,P1Y,pgxind-kftx2btt,pgxcs-kftvmwtt,246871176,0.086,54323961,0.019,192547215,0.067,PGX_AM_BS_21798848_PNET-mil-04,,-1.15,52.95,Point,GBR,Nottingham,United Kingdom,"Nottingham, United Kingdom",52.95,-1.15,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:10.948000,PMID:21798848,"Miller S, Rogers HA et al. (2011): Genome-wide molecular characterization of central nervous...",1,20,,,T3M3,NCITstage-C27970,Stage III,TNM-C48728,T3 Stage Finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0f5e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdfa,P46Y,pgxind-kftx3ajf,pgxcs-kftvvinl,364015768,0.127,217557755,0.076,146458013,0.051,PGX_AM_BS_PinParTum-07,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.152000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cd727983b2e00b0f5f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdfc,P1Y,pgxind-kftx3ajh,pgxcs-kftvvio2,372395233,0.13,106476660,0.037,265918573,0.092,PGX_AM_BS_PinParTum-08,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.153000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",1,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cd727983b2e00b0f60,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Pineoblastoma,NCIT:C9344,Pineoblastoma,icdom-93623,Pineoblastoma,icdot-C75.3,pineal gland,pgxbs-kftvhdfd,P61Y,pgxind-kftx3ajj,pgxcs-kftvviok,125596260,0.044,77996213,0.027,47600047,0.017,PGX_AM_BS_PinParTum-09,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0034715,pineal tract,{},2020-09-10 17:44:42.154000,PMID:11107183,"Rickert CH, Simon R et al. (2001): Comparative genomic hybridization in pineal parenchymal...",1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F